[
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Results:There were 15 studies of recurrent MBC (N¼18 678 patients; 3073 ER-positive and 1239 ER-negative); meta-regression\nshowed no survival improvement among patients recurring between 1980 and 1990",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Results:There were 15 studies of recurrent MBC (N¼18 678 patients; 3073 ER-positive and 1239 ER-negative); meta-regression\nshowed no survival improvement among patients recurring between 1980 and 1990",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1990",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "For ER-positive MBC\npatients, median survival increased during 1990–2010 from 32 (95% CI¼23 to 43) to 57 (95% CI¼37 to 87) months, and for ER-\nnegative MBC patients from 14 (95% CI¼11 to 19) to 33 (95",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1990",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "For ER-positive MBC\npatients, median survival increased during 1990–2010 from 32 (95% CI¼23 to 43) to 57 (95% CI¼37 to 87) months, and for ER-\nnegative MBC patients from 14 (95% CI¼11 to 19) to 33 (95",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1990",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "For ER-positive MBC\npatients, median survival increased during 1990–2010 from 32 (95% CI¼23 to 43) to 57 (95% CI¼37 to 87) months, and for ER-\nnegative MBC patients from 14 (95% CI¼11 to 19) to 33 (95",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1990",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "For ER-positive MBC\npatients, median survival increased during 1990–2010 from 32 (95% CI¼23 to 43) to 57 (95% CI¼37 to 87) months, and for ER-\nnegative MBC patients from 14 (95% CI¼11 to 19) to 33 (95",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1990",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Among eight studies (N¼35 831) of de\nnovo stage IV MBC, median survival increased during 1990–2010 from 20 (95% CI¼16 to 24) to 31 (95% CI¼24 to 39) months",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1990",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Among eight studies (N¼35 831) of de\nnovo stage IV MBC, median survival increased during 1990–2010 from 20 (95% CI¼16 to 24) to 31 (95% CI¼24 to 39) months",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2018",
    "value": 2,
    "unit": null,
    "population": null,
    "notes": "For commercial re-use, please contact journals.permissions@oup.com\n1of10\nJNCI Cancer Spectrum(2018) 2(4): pky062\ndoi: 10.1093/jncics/pky062\nMeta-Analysis\nDownloaded from https://academic.oup.com/jncic",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2018",
    "value": 62,
    "unit": null,
    "population": null,
    "notes": "For commercial re-use, please contact journals.permissions@oup.com\n1of10\nJNCI Cancer Spectrum(2018) 2(4): pky062\ndoi: 10.1093/jncics/pky062\nMeta-Analysis\nDownloaded from https://academic.oup.com/jncic",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 678,
    "unit": "count",
    "population": null,
    "notes": "Results:There were 15 studies of recurrent MBC (N¼18 678 patients; 3073 ER-positive and 1239 ER-negative); meta-regression\nshowed no survival improvement among patients recurring between 1980 and 1990",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1970",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Methods:We  searched  for  studies  of  MBC  patients  that  reported  survival  after  metastasis  in  at  least  two  time  periods\nbetween 1970 and the present",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Results:There were 15 studies of recurrent MBC (N¼18 678 patients; 3073 ER-positive and 1239 ER-negative); meta-regression\nshowed no survival improvement among patients recurring between 1980 and 1990",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Results:There were 15 studies of recurrent MBC (N¼18 678 patients; 3073 ER-positive and 1239 ER-negative); meta-regression\nshowed no survival improvement among patients recurring between 1980 and 1990",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Results:There were 15 studies of recurrent MBC (N¼18 678 patients; 3073 ER-positive and 1239 ER-negative); meta-regression\nshowed no survival improvement among patients recurring between 1980 and 1990",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Results:There were 15 studies of recurrent MBC (N¼18 678 patients; 3073 ER-positive and 1239 ER-negative); meta-regression\nshowed no survival improvement among patients recurring between 1980 and 1990",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1990",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "For ER-positive MBC\npatients, median survival increased during 1990–2010 from 32 (95% CI¼23 to 43) to 57 (95% CI¼37 to 87) months, and for ER-\nnegative MBC patients from 14 (95% CI¼11 to 19) to 33 (95",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1990",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "For ER-positive MBC\npatients, median survival increased during 1990–2010 from 32 (95% CI¼23 to 43) to 57 (95% CI¼37 to 87) months, and for ER-\nnegative MBC patients from 14 (95% CI¼11 to 19) to 33 (95",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1990",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Among eight studies (N¼35 831) of de\nnovo stage IV MBC, median survival increased during 1990–2010 from 20 (95% CI¼16 to 24) to 31 (95% CI¼24 to 39) months",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1990",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Among eight studies (N¼35 831) of de\nnovo stage IV MBC, median survival increased during 1990–2010 from 20 (95% CI¼16 to 24) to 31 (95% CI¼24 to 39) months",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "rate",
    "timePeriod": "1990",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Conclusion:By bridging studies over time, we demonstrated improvements in survival for recurrent and de novo stage IV\nMBC overall and across ER-defined subtypes since 1990",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "For commercial re-use, please contact journals.permissions@oup.com\n1of10\nJNCI Cancer Spectrum(2018) 2(4): pky062\ndoi: 10.1093/jncics/pky062\nMeta-Analysis\nDownloaded from https://academic.oup.com/jncic",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "For commercial re-use, please contact journals.permissions@oup.com\n1of10\nJNCI Cancer Spectrum(2018) 2(4): pky062\ndoi: 10.1093/jncics/pky062\nMeta-Analysis\nDownloaded from https://academic.oup.com/jncic",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1970",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "For inclusion, studies had to fulfill the following\ncriteria: 1) assessed overall or relative survival after metastasis\nfor at least two distinct time intervals in a similar population;\n2) time interv",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": "2017",
    "value": null,
    "unit": "year",
    "population": "metastatic breast\ncancer",
    "notes": "We\nsearched PubMed October 18, 2017 and again June 28, 2018 with\nthe following terms: “population trends AND (metastatic breast\ncancer  or  advanced  breast  cancer  or  distant  recurrence)  AND\nover",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": "2017",
    "value": null,
    "unit": "year",
    "population": "metastatic breast\ncancer",
    "notes": "We\nsearched PubMed October 18, 2017 and again June 28, 2018 with\nthe following terms: “population trends AND (metastatic breast\ncancer  or  advanced  breast  cancer  or  distant  recurrence)  AND\nover",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We  tested  for\nimprovement   over   each   decade   (1980–1990,   1990–2000,   and\n2000–2010) by calculating the median survival ratio from the fit-\nted function over that decade; reportedPvalues are",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We  tested  for\nimprovement   over   each   decade   (1980–1990,   1990–2000,   and\n2000–2010) by calculating the median survival ratio from the fit-\nted function over that decade; reportedPvalues are",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We  tested  for\nimprovement   over   each   decade   (1980–1990,   1990–2000,   and\n2000–2010) by calculating the median survival ratio from the fit-\nted function over that decade; reportedPvalues are",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We  tested  for\nimprovement   over   each   decade   (1980–1990,   1990–2000,   and\n2000–2010) by calculating the median survival ratio from the fit-\nted function over that decade; reportedPvalues are",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We  tested  for\nimprovement   over   each   decade   (1980–1990,   1990–2000,   and\n2000–2010) by calculating the median survival ratio from the fit-\nted function over that decade; reportedPvalues are",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We  tested  for\nimprovement   over   each   decade   (1980–1990,   1990–2000,   and\n2000–2010) by calculating the median survival ratio from the fit-\nted function over that decade; reportedPvalues are",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2018",
    "value": 10.1093,
    "unit": null,
    "population": null,
    "notes": "For commercial re-use, please contact journals.permissions@oup.com\n1of10\nJNCI Cancer Spectrum(2018) 2(4): pky062\ndoi: 10.1093/jncics/pky062\nMeta-Analysis\nDownloaded from https://academic.oup.com/jncic",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1970",
    "value": 1970,
    "unit": null,
    "population": null,
    "notes": "Methods:We  searched  for  studies  of  MBC  patients  that  reported  survival  after  metastasis  in  at  least  two  time  periods\nbetween 1970 and the present",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 15,
    "unit": "months",
    "population": null,
    "notes": "Results:There were 15 studies of recurrent MBC (N¼18 678 patients; 3073 ER-positive and 1239 ER-negative); meta-regression\nshowed no survival improvement among patients recurring between 1980 and 1990",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 18,
    "unit": "months",
    "population": null,
    "notes": "Results:There were 15 studies of recurrent MBC (N¼18 678 patients; 3073 ER-positive and 1239 ER-negative); meta-regression\nshowed no survival improvement among patients recurring between 1980 and 1990",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 678,
    "unit": "months",
    "population": null,
    "notes": "Results:There were 15 studies of recurrent MBC (N¼18 678 patients; 3073 ER-positive and 1239 ER-negative); meta-regression\nshowed no survival improvement among patients recurring between 1980 and 1990",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 3073,
    "unit": "months",
    "population": null,
    "notes": "Results:There were 15 studies of recurrent MBC (N¼18 678 patients; 3073 ER-positive and 1239 ER-negative); meta-regression\nshowed no survival improvement among patients recurring between 1980 and 1990",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 1239,
    "unit": "months",
    "population": null,
    "notes": "Results:There were 15 studies of recurrent MBC (N¼18 678 patients; 3073 ER-positive and 1239 ER-negative); meta-regression\nshowed no survival improvement among patients recurring between 1980 and 1990",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 1980,
    "unit": "months",
    "population": null,
    "notes": "Results:There were 15 studies of recurrent MBC (N¼18 678 patients; 3073 ER-positive and 1239 ER-negative); meta-regression\nshowed no survival improvement among patients recurring between 1980 and 1990",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 1990,
    "unit": "months",
    "population": null,
    "notes": "Results:There were 15 studies of recurrent MBC (N¼18 678 patients; 3073 ER-positive and 1239 ER-negative); meta-regression\nshowed no survival improvement among patients recurring between 1980 and 1990",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 21,
    "unit": "months",
    "population": null,
    "notes": "Results:There were 15 studies of recurrent MBC (N¼18 678 patients; 3073 ER-positive and 1239 ER-negative); meta-regression\nshowed no survival improvement among patients recurring between 1980 and 1990",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "months",
    "population": null,
    "notes": "Results:There were 15 studies of recurrent MBC (N¼18 678 patients; 3073 ER-positive and 1239 ER-negative); meta-regression\nshowed no survival improvement among patients recurring between 1980 and 1990",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 18,
    "unit": "months",
    "population": null,
    "notes": "Results:There were 15 studies of recurrent MBC (N¼18 678 patients; 3073 ER-positive and 1239 ER-negative); meta-regression\nshowed no survival improvement among patients recurring between 1980 and 1990",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 25,
    "unit": "months",
    "population": null,
    "notes": "Results:There were 15 studies of recurrent MBC (N¼18 678 patients; 3073 ER-positive and 1239 ER-negative); meta-regression\nshowed no survival improvement among patients recurring between 1980 and 1990",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 38,
    "unit": "months",
    "population": null,
    "notes": "Results:There were 15 studies of recurrent MBC (N¼18 678 patients; 3073 ER-positive and 1239 ER-negative); meta-regression\nshowed no survival improvement among patients recurring between 1980 and 1990",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "months",
    "population": null,
    "notes": "Results:There were 15 studies of recurrent MBC (N¼18 678 patients; 3073 ER-positive and 1239 ER-negative); meta-regression\nshowed no survival improvement among patients recurring between 1980 and 1990",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 31,
    "unit": "months",
    "population": null,
    "notes": "Results:There were 15 studies of recurrent MBC (N¼18 678 patients; 3073 ER-positive and 1239 ER-negative); meta-regression\nshowed no survival improvement among patients recurring between 1980 and 1990",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 47,
    "unit": "months",
    "population": null,
    "notes": "Results:There were 15 studies of recurrent MBC (N¼18 678 patients; 3073 ER-positive and 1239 ER-negative); meta-regression\nshowed no survival improvement among patients recurring between 1980 and 1990",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 1990,
    "unit": "months",
    "population": null,
    "notes": "Results:There were 15 studies of recurrent MBC (N¼18 678 patients; 3073 ER-positive and 1239 ER-negative); meta-regression\nshowed no survival improvement among patients recurring between 1980 and 1990",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 2010,
    "unit": "months",
    "population": null,
    "notes": "Results:There were 15 studies of recurrent MBC (N¼18 678 patients; 3073 ER-positive and 1239 ER-negative); meta-regression\nshowed no survival improvement among patients recurring between 1980 and 1990",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1990",
    "value": 1990,
    "unit": "months",
    "population": null,
    "notes": "For ER-positive MBC\npatients, median survival increased during 1990–2010 from 32 (95% CI¼23 to 43) to 57 (95% CI¼37 to 87) months, and for ER-\nnegative MBC patients from 14 (95% CI¼11 to 19) to 33 (95",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1990",
    "value": 2010,
    "unit": "months",
    "population": null,
    "notes": "For ER-positive MBC\npatients, median survival increased during 1990–2010 from 32 (95% CI¼23 to 43) to 57 (95% CI¼37 to 87) months, and for ER-\nnegative MBC patients from 14 (95% CI¼11 to 19) to 33 (95",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1990",
    "value": 32,
    "unit": "months",
    "population": null,
    "notes": "For ER-positive MBC\npatients, median survival increased during 1990–2010 from 32 (95% CI¼23 to 43) to 57 (95% CI¼37 to 87) months, and for ER-\nnegative MBC patients from 14 (95% CI¼11 to 19) to 33 (95",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1990",
    "value": 95,
    "unit": "months",
    "population": null,
    "notes": "For ER-positive MBC\npatients, median survival increased during 1990–2010 from 32 (95% CI¼23 to 43) to 57 (95% CI¼37 to 87) months, and for ER-\nnegative MBC patients from 14 (95% CI¼11 to 19) to 33 (95",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1990",
    "value": 23,
    "unit": "months",
    "population": null,
    "notes": "For ER-positive MBC\npatients, median survival increased during 1990–2010 from 32 (95% CI¼23 to 43) to 57 (95% CI¼37 to 87) months, and for ER-\nnegative MBC patients from 14 (95% CI¼11 to 19) to 33 (95",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1990",
    "value": 43,
    "unit": "months",
    "population": null,
    "notes": "For ER-positive MBC\npatients, median survival increased during 1990–2010 from 32 (95% CI¼23 to 43) to 57 (95% CI¼37 to 87) months, and for ER-\nnegative MBC patients from 14 (95% CI¼11 to 19) to 33 (95",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1990",
    "value": 57,
    "unit": "months",
    "population": null,
    "notes": "For ER-positive MBC\npatients, median survival increased during 1990–2010 from 32 (95% CI¼23 to 43) to 57 (95% CI¼37 to 87) months, and for ER-\nnegative MBC patients from 14 (95% CI¼11 to 19) to 33 (95",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1990",
    "value": 95,
    "unit": "months",
    "population": null,
    "notes": "For ER-positive MBC\npatients, median survival increased during 1990–2010 from 32 (95% CI¼23 to 43) to 57 (95% CI¼37 to 87) months, and for ER-\nnegative MBC patients from 14 (95% CI¼11 to 19) to 33 (95",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1990",
    "value": 37,
    "unit": "months",
    "population": null,
    "notes": "For ER-positive MBC\npatients, median survival increased during 1990–2010 from 32 (95% CI¼23 to 43) to 57 (95% CI¼37 to 87) months, and for ER-\nnegative MBC patients from 14 (95% CI¼11 to 19) to 33 (95",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1990",
    "value": 87,
    "unit": "months",
    "population": null,
    "notes": "For ER-positive MBC\npatients, median survival increased during 1990–2010 from 32 (95% CI¼23 to 43) to 57 (95% CI¼37 to 87) months, and for ER-\nnegative MBC patients from 14 (95% CI¼11 to 19) to 33 (95",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1990",
    "value": 14,
    "unit": "months",
    "population": null,
    "notes": "For ER-positive MBC\npatients, median survival increased during 1990–2010 from 32 (95% CI¼23 to 43) to 57 (95% CI¼37 to 87) months, and for ER-\nnegative MBC patients from 14 (95% CI¼11 to 19) to 33 (95",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1990",
    "value": 95,
    "unit": "months",
    "population": null,
    "notes": "For ER-positive MBC\npatients, median survival increased during 1990–2010 from 32 (95% CI¼23 to 43) to 57 (95% CI¼37 to 87) months, and for ER-\nnegative MBC patients from 14 (95% CI¼11 to 19) to 33 (95",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1990",
    "value": 11,
    "unit": "months",
    "population": null,
    "notes": "For ER-positive MBC\npatients, median survival increased during 1990–2010 from 32 (95% CI¼23 to 43) to 57 (95% CI¼37 to 87) months, and for ER-\nnegative MBC patients from 14 (95% CI¼11 to 19) to 33 (95",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1990",
    "value": 19,
    "unit": "months",
    "population": null,
    "notes": "For ER-positive MBC\npatients, median survival increased during 1990–2010 from 32 (95% CI¼23 to 43) to 57 (95% CI¼37 to 87) months, and for ER-\nnegative MBC patients from 14 (95% CI¼11 to 19) to 33 (95",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1990",
    "value": 33,
    "unit": "months",
    "population": null,
    "notes": "For ER-positive MBC\npatients, median survival increased during 1990–2010 from 32 (95% CI¼23 to 43) to 57 (95% CI¼37 to 87) months, and for ER-\nnegative MBC patients from 14 (95% CI¼11 to 19) to 33 (95",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1990",
    "value": 95,
    "unit": "months",
    "population": null,
    "notes": "For ER-positive MBC\npatients, median survival increased during 1990–2010 from 32 (95% CI¼23 to 43) to 57 (95% CI¼37 to 87) months, and for ER-\nnegative MBC patients from 14 (95% CI¼11 to 19) to 33 (95",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1990",
    "value": 21,
    "unit": "months",
    "population": null,
    "notes": "For ER-positive MBC\npatients, median survival increased during 1990–2010 from 32 (95% CI¼23 to 43) to 57 (95% CI¼37 to 87) months, and for ER-\nnegative MBC patients from 14 (95% CI¼11 to 19) to 33 (95",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1990",
    "value": 51,
    "unit": "months",
    "population": null,
    "notes": "For ER-positive MBC\npatients, median survival increased during 1990–2010 from 32 (95% CI¼23 to 43) to 57 (95% CI¼37 to 87) months, and for ER-\nnegative MBC patients from 14 (95% CI¼11 to 19) to 33 (95",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1990",
    "value": 35,
    "unit": "months",
    "population": null,
    "notes": "Among eight studies (N¼35 831) of de\nnovo stage IV MBC, median survival increased during 1990–2010 from 20 (95% CI¼16 to 24) to 31 (95% CI¼24 to 39) months",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1990",
    "value": 831,
    "unit": "months",
    "population": null,
    "notes": "Among eight studies (N¼35 831) of de\nnovo stage IV MBC, median survival increased during 1990–2010 from 20 (95% CI¼16 to 24) to 31 (95% CI¼24 to 39) months",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1990",
    "value": 1990,
    "unit": "months",
    "population": null,
    "notes": "Among eight studies (N¼35 831) of de\nnovo stage IV MBC, median survival increased during 1990–2010 from 20 (95% CI¼16 to 24) to 31 (95% CI¼24 to 39) months",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1990",
    "value": 2010,
    "unit": "months",
    "population": null,
    "notes": "Among eight studies (N¼35 831) of de\nnovo stage IV MBC, median survival increased during 1990–2010 from 20 (95% CI¼16 to 24) to 31 (95% CI¼24 to 39) months",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1990",
    "value": 20,
    "unit": "months",
    "population": null,
    "notes": "Among eight studies (N¼35 831) of de\nnovo stage IV MBC, median survival increased during 1990–2010 from 20 (95% CI¼16 to 24) to 31 (95% CI¼24 to 39) months",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1990",
    "value": 95,
    "unit": "months",
    "population": null,
    "notes": "Among eight studies (N¼35 831) of de\nnovo stage IV MBC, median survival increased during 1990–2010 from 20 (95% CI¼16 to 24) to 31 (95% CI¼24 to 39) months",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1990",
    "value": 16,
    "unit": "months",
    "population": null,
    "notes": "Among eight studies (N¼35 831) of de\nnovo stage IV MBC, median survival increased during 1990–2010 from 20 (95% CI¼16 to 24) to 31 (95% CI¼24 to 39) months",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1990",
    "value": 24,
    "unit": "months",
    "population": null,
    "notes": "Among eight studies (N¼35 831) of de\nnovo stage IV MBC, median survival increased during 1990–2010 from 20 (95% CI¼16 to 24) to 31 (95% CI¼24 to 39) months",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1990",
    "value": 31,
    "unit": "months",
    "population": null,
    "notes": "Among eight studies (N¼35 831) of de\nnovo stage IV MBC, median survival increased during 1990–2010 from 20 (95% CI¼16 to 24) to 31 (95% CI¼24 to 39) months",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1990",
    "value": 95,
    "unit": "months",
    "population": null,
    "notes": "Among eight studies (N¼35 831) of de\nnovo stage IV MBC, median survival increased during 1990–2010 from 20 (95% CI¼16 to 24) to 31 (95% CI¼24 to 39) months",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1990",
    "value": 24,
    "unit": "months",
    "population": null,
    "notes": "Among eight studies (N¼35 831) of de\nnovo stage IV MBC, median survival increased during 1990–2010 from 20 (95% CI¼16 to 24) to 31 (95% CI¼24 to 39) months",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1990",
    "value": 39,
    "unit": "months",
    "population": null,
    "notes": "Among eight studies (N¼35 831) of de\nnovo stage IV MBC, median survival increased during 1990–2010 from 20 (95% CI¼16 to 24) to 31 (95% CI¼24 to 39) months",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "rate",
    "timePeriod": "1990",
    "value": 1990,
    "unit": null,
    "population": null,
    "notes": "Conclusion:By bridging studies over time, we demonstrated improvements in survival for recurrent and de novo stage IV\nMBC overall and across ER-defined subtypes since 1990",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "rate",
    "timePeriod": null,
    "value": 10,
    "unit": null,
    "population": null,
    "notes": "Most of these\ndrugs demonstrated a survival benefit in randomized controlled\ntrials (RCTs) (10–24)",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "rate",
    "timePeriod": null,
    "value": 24,
    "unit": null,
    "population": null,
    "notes": "Most of these\ndrugs demonstrated a survival benefit in randomized controlled\ntrials (RCTs) (10–24)",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2018",
    "value": 2018,
    "unit": null,
    "population": null,
    "notes": "For commercial re-use, please contact journals.permissions@oup.com\n1of10\nJNCI Cancer Spectrum(2018) 2(4): pky062\ndoi: 10.1093/jncics/pky062\nMeta-Analysis\nDownloaded from https://academic.oup.com/jncic",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2018",
    "value": 10,
    "unit": null,
    "population": null,
    "notes": "For commercial re-use, please contact journals.permissions@oup.com\n1of10\nJNCI Cancer Spectrum(2018) 2(4): pky062\ndoi: 10.1093/jncics/pky062\nMeta-Analysis\nDownloaded from https://academic.oup.com/jncic",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2018",
    "value": 1093,
    "unit": null,
    "population": null,
    "notes": "For commercial re-use, please contact journals.permissions@oup.com\n1of10\nJNCI Cancer Spectrum(2018) 2(4): pky062\ndoi: 10.1093/jncics/pky062\nMeta-Analysis\nDownloaded from https://academic.oup.com/jncic",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2018",
    "value": 5260813,
    "unit": null,
    "population": null,
    "notes": "For commercial re-use, please contact journals.permissions@oup.com\n1of10\nJNCI Cancer Spectrum(2018) 2(4): pky062\ndoi: 10.1093/jncics/pky062\nMeta-Analysis\nDownloaded from https://academic.oup.com/jncic",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2018",
    "value": 1,
    "unit": null,
    "population": null,
    "notes": "For commercial re-use, please contact journals.permissions@oup.com\n1of10\nJNCI Cancer Spectrum(2018) 2(4): pky062\ndoi: 10.1093/jncics/pky062\nMeta-Analysis\nDownloaded from https://academic.oup.com/jncic",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2018",
    "value": 2026,
    "unit": null,
    "population": null,
    "notes": "For commercial re-use, please contact journals.permissions@oup.com\n1of10\nJNCI Cancer Spectrum(2018) 2(4): pky062\ndoi: 10.1093/jncics/pky062\nMeta-Analysis\nDownloaded from https://academic.oup.com/jncic",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 25,
    "unit": null,
    "population": null,
    "notes": "To  assess  the  population-level  impact  of  MBC  treatment,\nseveral prior studies have examined the difference in survival\nbetween time periods (25–45); in recurrent disease, the majority\nof  these",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 45,
    "unit": null,
    "population": null,
    "notes": "To  assess  the  population-level  impact  of  MBC  treatment,\nseveral prior studies have examined the difference in survival\nbetween time periods (25–45); in recurrent disease, the majority\nof  these",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1970",
    "value": 1970,
    "unit": "months",
    "population": null,
    "notes": "For inclusion, studies had to fulfill the following\ncriteria: 1) assessed overall or relative survival after metastasis\nfor at least two distinct time intervals in a similar population;\n2) time interv",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": "2017",
    "value": 18,
    "unit": null,
    "population": "metastatic breast\ncancer",
    "notes": "We\nsearched PubMed October 18, 2017 and again June 28, 2018 with\nthe following terms: “population trends AND (metastatic breast\ncancer  or  advanced  breast  cancer  or  distant  recurrence)  AND\nover",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": "2017",
    "value": 2017,
    "unit": null,
    "population": "metastatic breast\ncancer",
    "notes": "We\nsearched PubMed October 18, 2017 and again June 28, 2018 with\nthe following terms: “population trends AND (metastatic breast\ncancer  or  advanced  breast  cancer  or  distant  recurrence)  AND\nover",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": "2017",
    "value": 28,
    "unit": null,
    "population": "metastatic breast\ncancer",
    "notes": "We\nsearched PubMed October 18, 2017 and again June 28, 2018 with\nthe following terms: “population trends AND (metastatic breast\ncancer  or  advanced  breast  cancer  or  distant  recurrence)  AND\nover",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": "2017",
    "value": 2018,
    "unit": null,
    "population": "metastatic breast\ncancer",
    "notes": "We\nsearched PubMed October 18, 2017 and again June 28, 2018 with\nthe following terms: “population trends AND (metastatic breast\ncancer  or  advanced  breast  cancer  or  distant  recurrence)  AND\nover",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": "2017",
    "value": 25,
    "unit": null,
    "population": "metastatic breast\ncancer",
    "notes": "We\nsearched PubMed October 18, 2017 and again June 28, 2018 with\nthe following terms: “population trends AND (metastatic breast\ncancer  or  advanced  breast  cancer  or  distant  recurrence)  AND\nover",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": "2017",
    "value": 43,
    "unit": null,
    "population": "metastatic breast\ncancer",
    "notes": "We\nsearched PubMed October 18, 2017 and again June 28, 2018 with\nthe following terms: “population trends AND (metastatic breast\ncancer  or  advanced  breast  cancer  or  distant  recurrence)  AND\nover",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 46,
    "unit": "year",
    "population": null,
    "notes": "For each case, we performed random-effects meta-\nregression  analysis  (46)  assuming  an  underlying  mixed  effect\nmodel that predicted median overall survival based on the year\nof recurrence (Suppl",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 36,
    "unit": null,
    "population": null,
    "notes": "The  statistically  significant  quadratic\nterms (P¼.036 for recurrent disease,<.001 for ER-positive, .046\nER-negative,  and  .044  for  de  novo  stage  IV  disease)  suggested\nthe  inadequacy  of  t",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1,
    "unit": null,
    "population": null,
    "notes": "The  statistically  significant  quadratic\nterms (P¼.036 for recurrent disease,<.001 for ER-positive, .046\nER-negative,  and  .044  for  de  novo  stage  IV  disease)  suggested\nthe  inadequacy  of  t",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 46,
    "unit": null,
    "population": null,
    "notes": "The  statistically  significant  quadratic\nterms (P¼.036 for recurrent disease,<.001 for ER-positive, .046\nER-negative,  and  .044  for  de  novo  stage  IV  disease)  suggested\nthe  inadequacy  of  t",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 44,
    "unit": null,
    "population": null,
    "notes": "The  statistically  significant  quadratic\nterms (P¼.036 for recurrent disease,<.001 for ER-positive, .046\nER-negative,  and  .044  for  de  novo  stage  IV  disease)  suggested\nthe  inadequacy  of  t",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 1980,
    "unit": null,
    "population": null,
    "notes": "We  tested  for\nimprovement   over   each   decade   (1980–1990,   1990–2000,   and\n2000–2010) by calculating the median survival ratio from the fit-\nted function over that decade; reportedPvalues are",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 1990,
    "unit": null,
    "population": null,
    "notes": "We  tested  for\nimprovement   over   each   decade   (1980–1990,   1990–2000,   and\n2000–2010) by calculating the median survival ratio from the fit-\nted function over that decade; reportedPvalues are",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 1990,
    "unit": null,
    "population": null,
    "notes": "We  tested  for\nimprovement   over   each   decade   (1980–1990,   1990–2000,   and\n2000–2010) by calculating the median survival ratio from the fit-\nted function over that decade; reportedPvalues are",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 2000,
    "unit": null,
    "population": null,
    "notes": "We  tested  for\nimprovement   over   each   decade   (1980–1990,   1990–2000,   and\n2000–2010) by calculating the median survival ratio from the fit-\nted function over that decade; reportedPvalues are",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 2000,
    "unit": null,
    "population": null,
    "notes": "We  tested  for\nimprovement   over   each   decade   (1980–1990,   1990–2000,   and\n2000–2010) by calculating the median survival ratio from the fit-\nted function over that decade; reportedPvalues are",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 2010,
    "unit": null,
    "population": null,
    "notes": "We  tested  for\nimprovement   over   each   decade   (1980–1990,   1990–2000,   and\n2000–2010) by calculating the median survival ratio from the fit-\nted function over that decade; reportedPvalues are",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 5,
    "unit": null,
    "population": null,
    "notes": "We  tested  for\nimprovement   over   each   decade   (1980–1990,   1990–2000,   and\n2000–2010) by calculating the median survival ratio from the fit-\nted function over that decade; reportedPvalues are",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 40,
    "unit": "months",
    "population": null,
    "notes": "For  analysis  of  de  novo  stage  IV  disease,  three  studies\nreported  5-year  relative  survival  rather  than  overall  survival\n(40,47,48),  which  we  converted  to  median  overall  survival ",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 47,
    "unit": "months",
    "population": null,
    "notes": "For  analysis  of  de  novo  stage  IV  disease,  three  studies\nreported  5-year  relative  survival  rather  than  overall  survival\n(40,47,48),  which  we  converted  to  median  overall  survival ",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 48,
    "unit": "months",
    "population": null,
    "notes": "For  analysis  of  de  novo  stage  IV  disease,  three  studies\nreported  5-year  relative  survival  rather  than  overall  survival\n(40,47,48),  which  we  converted  to  median  overall  survival ",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression of the 15 studies demonstrated no statisti-\ncally  significant  improvement  in  median  unadjusted  survival\nfrom  1980  to  1990  (median  survival  ratio  1.05;  95%  confidence\nint",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression of the 15 studies demonstrated no statisti-\ncally  significant  improvement  in  median  unadjusted  survival\nfrom  1980  to  1990  (median  survival  ratio  1.05;  95%  confidence\nint",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression of the 15 studies demonstrated no statisti-\ncally  significant  improvement  in  median  unadjusted  survival\nfrom  1980  to  1990  (median  survival  ratio  1.05;  95%  confidence\nint",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "We estimated\nthat  median  unadjusted  survival  across  all  breast  cancer  sub-\ntypes was 20 (95% CI¼17 to 25) months in 1980, 21 (95% CI¼18\nto 25)  months  in  1990, 26 (95%  CI¼23 to  30) months ",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "We estimated\nthat  median  unadjusted  survival  across  all  breast  cancer  sub-\ntypes was 20 (95% CI¼17 to 25) months in 1980, 21 (95% CI¼18\nto 25)  months  in  1990, 26 (95%  CI¼23 to  30) months ",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "We estimated\nthat  median  unadjusted  survival  across  all  breast  cancer  sub-\ntypes was 20 (95% CI¼17 to 25) months in 1980, 21 (95% CI¼18\nto 25)  months  in  1990, 26 (95%  CI¼23 to  30) months ",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "We estimated\nthat  median  unadjusted  survival  across  all  breast  cancer  sub-\ntypes was 20 (95% CI¼17 to 25) months in 1980, 21 (95% CI¼18\nto 25)  months  in  1990, 26 (95%  CI¼23 to  30) months ",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "We estimated median unadjusted survival in\nER-positive disease to have been 29 (95% CI¼17 to 51) months\nin 1980, 32 (95% CI¼23 to 43) months in 1990, 39 (95% CI¼30 to\n53) months in 2000, and 57 (95% C",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "We estimated median unadjusted survival in\nER-positive disease to have been 29 (95% CI¼17 to 51) months\nin 1980, 32 (95% CI¼23 to 43) months in 1990, 39 (95% CI¼30 to\n53) months in 2000, and 57 (95% C",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "We estimated median unadjusted survival in\nER-positive disease to have been 29 (95% CI¼17 to 51) months\nin 1980, 32 (95% CI¼23 to 43) months in 1990, 39 (95% CI¼30 to\n53) months in 2000, and 57 (95% C",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "We estimated median unadjusted survival in\nER-positive disease to have been 29 (95% CI¼17 to 51) months\nin 1980, 32 (95% CI¼23 to 43) months in 1990, 39 (95% CI¼30 to\n53) months in 2000, and 57 (95% C",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 3073,
    "unit": "count",
    "population": null,
    "notes": "We   repeated   this   analysis   for   the   eight   studies   (28–\n32,35,37,49,50) that collected data on unadjusted survival after\nrecurrence  separately  for  ER-positive  (3073  patients)  and  E",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 1239,
    "unit": "count",
    "population": null,
    "notes": "We   repeated   this   analysis   for   the   eight   studies   (28–\n32,35,37,49,50) that collected data on unadjusted survival after\nrecurrence  separately  for  ER-positive  (3073  patients)  and  E",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Meta-regression of the 15 studies demonstrated no statisti-\ncally  significant  improvement  in  median  unadjusted  survival\nfrom  1980  to  1990  (median  survival  ratio  1.05;  95%  confidence\nint",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Meta-regression of the 15 studies demonstrated no statisti-\ncally  significant  improvement  in  median  unadjusted  survival\nfrom  1980  to  1990  (median  survival  ratio  1.05;  95%  confidence\nint",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Meta-regression of the 15 studies demonstrated no statisti-\ncally  significant  improvement  in  median  unadjusted  survival\nfrom  1980  to  1990  (median  survival  ratio  1.05;  95%  confidence\nint",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Meta-regression of the 15 studies demonstrated no statisti-\ncally  significant  improvement  in  median  unadjusted  survival\nfrom  1980  to  1990  (median  survival  ratio  1.05;  95%  confidence\nint",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Meta-regression of the 15 studies demonstrated no statisti-\ncally  significant  improvement  in  median  unadjusted  survival\nfrom  1980  to  1990  (median  survival  ratio  1.05;  95%  confidence\nint",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Meta-regression of the 15 studies demonstrated no statisti-\ncally  significant  improvement  in  median  unadjusted  survival\nfrom  1980  to  1990  (median  survival  ratio  1.05;  95%  confidence\nint",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We estimated\nthat  median  unadjusted  survival  across  all  breast  cancer  sub-\ntypes was 20 (95% CI¼17 to 25) months in 1980, 21 (95% CI¼18\nto 25)  months  in  1990, 26 (95%  CI¼23 to  30) months ",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We estimated\nthat  median  unadjusted  survival  across  all  breast  cancer  sub-\ntypes was 20 (95% CI¼17 to 25) months in 1980, 21 (95% CI¼18\nto 25)  months  in  1990, 26 (95%  CI¼23 to  30) months ",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We estimated\nthat  median  unadjusted  survival  across  all  breast  cancer  sub-\ntypes was 20 (95% CI¼17 to 25) months in 1980, 21 (95% CI¼18\nto 25)  months  in  1990, 26 (95%  CI¼23 to  30) months ",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We estimated\nthat  median  unadjusted  survival  across  all  breast  cancer  sub-\ntypes was 20 (95% CI¼17 to 25) months in 1980, 21 (95% CI¼18\nto 25)  months  in  1990, 26 (95%  CI¼23 to  30) months ",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We estimated median unadjusted survival in\nER-positive disease to have been 29 (95% CI¼17 to 51) months\nin 1980, 32 (95% CI¼23 to 43) months in 1990, 39 (95% CI¼30 to\n53) months in 2000, and 57 (95% C",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We estimated median unadjusted survival in\nER-positive disease to have been 29 (95% CI¼17 to 51) months\nin 1980, 32 (95% CI¼23 to 43) months in 1990, 39 (95% CI¼30 to\n53) months in 2000, and 57 (95% C",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We estimated median unadjusted survival in\nER-positive disease to have been 29 (95% CI¼17 to 51) months\nin 1980, 32 (95% CI¼23 to 43) months in 1990, 39 (95% CI¼30 to\n53) months in 2000, and 57 (95% C",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We estimated median unadjusted survival in\nER-positive disease to have been 29 (95% CI¼17 to 51) months\nin 1980, 32 (95% CI¼23 to 43) months in 1990, 39 (95% CI¼30 to\n53) months in 2000, and 57 (95% C",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 1.05,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression of the 15 studies demonstrated no statisti-\ncally  significant  improvement  in  median  unadjusted  survival\nfrom  1980  to  1990  (median  survival  ratio  1.05;  95%  confidence\nint",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 0.91,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression of the 15 studies demonstrated no statisti-\ncally  significant  improvement  in  median  unadjusted  survival\nfrom  1980  to  1990  (median  survival  ratio  1.05;  95%  confidence\nint",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 1.22,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression of the 15 studies demonstrated no statisti-\ncally  significant  improvement  in  median  unadjusted  survival\nfrom  1980  to  1990  (median  survival  ratio  1.05;  95%  confidence\nint",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 1.24,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression of the 15 studies demonstrated no statisti-\ncally  significant  improvement  in  median  unadjusted  survival\nfrom  1980  to  1990  (median  survival  ratio  1.05;  95%  confidence\nint",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 1.16,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression of the 15 studies demonstrated no statisti-\ncally  significant  improvement  in  median  unadjusted  survival\nfrom  1980  to  1990  (median  survival  ratio  1.05;  95%  confidence\nint",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 1.32,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression of the 15 studies demonstrated no statisti-\ncally  significant  improvement  in  median  unadjusted  survival\nfrom  1980  to  1990  (median  survival  ratio  1.05;  95%  confidence\nint",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 1.45,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression of the 15 studies demonstrated no statisti-\ncally  significant  improvement  in  median  unadjusted  survival\nfrom  1980  to  1990  (median  survival  ratio  1.05;  95%  confidence\nint",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 1.21,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression of the 15 studies demonstrated no statisti-\ncally  significant  improvement  in  median  unadjusted  survival\nfrom  1980  to  1990  (median  survival  ratio  1.05;  95%  confidence\nint",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 1.73,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression of the 15 studies demonstrated no statisti-\ncally  significant  improvement  in  median  unadjusted  survival\nfrom  1980  to  1990  (median  survival  ratio  1.05;  95%  confidence\nint",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 1.08,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 0.66,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 1.79,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 0.75,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 0.95,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 0.55,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 1.66,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 0.87,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 1.25,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 1.05,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 1.49,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 1.3,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 1.08,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 1.57,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 1.44,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 0.93,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 2.21,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 1.77,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 1.13,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 2.79,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 15,
    "unit": null,
    "population": null,
    "notes": "Results\nRecurrent Breast Cancer\nWe  identified  15  studies  that  included  18  678  breast  cancer\npatients  with  primarily  recurrent  disease:  these  studies  in-\ncluded analyses of overall surv",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 18,
    "unit": null,
    "population": null,
    "notes": "Results\nRecurrent Breast Cancer\nWe  identified  15  studies  that  included  18  678  breast  cancer\npatients  with  primarily  recurrent  disease:  these  studies  in-\ncluded analyses of overall surv",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 678,
    "unit": null,
    "population": null,
    "notes": "Results\nRecurrent Breast Cancer\nWe  identified  15  studies  that  included  18  678  breast  cancer\npatients  with  primarily  recurrent  disease:  these  studies  in-\ncluded analyses of overall surv",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 25,
    "unit": null,
    "population": null,
    "notes": "Results\nRecurrent Breast Cancer\nWe  identified  15  studies  that  included  18  678  breast  cancer\npatients  with  primarily  recurrent  disease:  these  studies  in-\ncluded analyses of overall surv",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 27,
    "unit": null,
    "population": null,
    "notes": "Results\nRecurrent Breast Cancer\nWe  identified  15  studies  that  included  18  678  breast  cancer\npatients  with  primarily  recurrent  disease:  these  studies  in-\ncluded analyses of overall surv",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 34,
    "unit": null,
    "population": null,
    "notes": "Results\nRecurrent Breast Cancer\nWe  identified  15  studies  that  included  18  678  breast  cancer\npatients  with  primarily  recurrent  disease:  these  studies  in-\ncluded analyses of overall surv",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 37,
    "unit": null,
    "population": null,
    "notes": "Results\nRecurrent Breast Cancer\nWe  identified  15  studies  that  included  18  678  breast  cancer\npatients  with  primarily  recurrent  disease:  these  studies  in-\ncluded analyses of overall surv",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 33,
    "unit": null,
    "population": null,
    "notes": "Results\nRecurrent Breast Cancer\nWe  identified  15  studies  that  included  18  678  breast  cancer\npatients  with  primarily  recurrent  disease:  these  studies  in-\ncluded analyses of overall surv",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 35,
    "unit": null,
    "population": null,
    "notes": "Results\nRecurrent Breast Cancer\nWe  identified  15  studies  that  included  18  678  breast  cancer\npatients  with  primarily  recurrent  disease:  these  studies  in-\ncluded analyses of overall surv",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 36,
    "unit": null,
    "population": null,
    "notes": "Results\nRecurrent Breast Cancer\nWe  identified  15  studies  that  included  18  678  breast  cancer\npatients  with  primarily  recurrent  disease:  these  studies  in-\ncluded analyses of overall surv",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 26,
    "unit": null,
    "population": null,
    "notes": "Results\nRecurrent Breast Cancer\nWe  identified  15  studies  that  included  18  678  breast  cancer\npatients  with  primarily  recurrent  disease:  these  studies  in-\ncluded analyses of overall surv",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 28,
    "unit": null,
    "population": null,
    "notes": "Results\nRecurrent Breast Cancer\nWe  identified  15  studies  that  included  18  678  breast  cancer\npatients  with  primarily  recurrent  disease:  these  studies  in-\ncluded analyses of overall surv",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 32,
    "unit": null,
    "population": null,
    "notes": "Results\nRecurrent Breast Cancer\nWe  identified  15  studies  that  included  18  678  breast  cancer\npatients  with  primarily  recurrent  disease:  these  studies  in-\ncluded analyses of overall surv",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 38,
    "unit": null,
    "population": null,
    "notes": "Results\nRecurrent Breast Cancer\nWe  identified  15  studies  that  included  18  678  breast  cancer\npatients  with  primarily  recurrent  disease:  these  studies  in-\ncluded analyses of overall surv",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 49,
    "unit": null,
    "population": null,
    "notes": "Results\nRecurrent Breast Cancer\nWe  identified  15  studies  that  included  18  678  breast  cancer\npatients  with  primarily  recurrent  disease:  these  studies  in-\ncluded analyses of overall surv",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 51,
    "unit": null,
    "population": null,
    "notes": "Results\nRecurrent Breast Cancer\nWe  identified  15  studies  that  included  18  678  breast  cancer\npatients  with  primarily  recurrent  disease:  these  studies  in-\ncluded analyses of overall surv",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 15,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression of the 15 studies demonstrated no statisti-\ncally  significant  improvement  in  median  unadjusted  survival\nfrom  1980  to  1990  (median  survival  ratio  1.05;  95%  confidence\nint",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 1980,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression of the 15 studies demonstrated no statisti-\ncally  significant  improvement  in  median  unadjusted  survival\nfrom  1980  to  1990  (median  survival  ratio  1.05;  95%  confidence\nint",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 1990,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression of the 15 studies demonstrated no statisti-\ncally  significant  improvement  in  median  unadjusted  survival\nfrom  1980  to  1990  (median  survival  ratio  1.05;  95%  confidence\nint",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 5,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression of the 15 studies demonstrated no statisti-\ncally  significant  improvement  in  median  unadjusted  survival\nfrom  1980  to  1990  (median  survival  ratio  1.05;  95%  confidence\nint",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression of the 15 studies demonstrated no statisti-\ncally  significant  improvement  in  median  unadjusted  survival\nfrom  1980  to  1990  (median  survival  ratio  1.05;  95%  confidence\nint",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 91,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression of the 15 studies demonstrated no statisti-\ncally  significant  improvement  in  median  unadjusted  survival\nfrom  1980  to  1990  (median  survival  ratio  1.05;  95%  confidence\nint",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 22,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression of the 15 studies demonstrated no statisti-\ncally  significant  improvement  in  median  unadjusted  survival\nfrom  1980  to  1990  (median  survival  ratio  1.05;  95%  confidence\nint",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 50,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression of the 15 studies demonstrated no statisti-\ncally  significant  improvement  in  median  unadjusted  survival\nfrom  1980  to  1990  (median  survival  ratio  1.05;  95%  confidence\nint",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 1990,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression of the 15 studies demonstrated no statisti-\ncally  significant  improvement  in  median  unadjusted  survival\nfrom  1980  to  1990  (median  survival  ratio  1.05;  95%  confidence\nint",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 2000,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression of the 15 studies demonstrated no statisti-\ncally  significant  improvement  in  median  unadjusted  survival\nfrom  1980  to  1990  (median  survival  ratio  1.05;  95%  confidence\nint",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 24,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression of the 15 studies demonstrated no statisti-\ncally  significant  improvement  in  median  unadjusted  survival\nfrom  1980  to  1990  (median  survival  ratio  1.05;  95%  confidence\nint",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression of the 15 studies demonstrated no statisti-\ncally  significant  improvement  in  median  unadjusted  survival\nfrom  1980  to  1990  (median  survival  ratio  1.05;  95%  confidence\nint",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 16,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression of the 15 studies demonstrated no statisti-\ncally  significant  improvement  in  median  unadjusted  survival\nfrom  1980  to  1990  (median  survival  ratio  1.05;  95%  confidence\nint",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 32,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression of the 15 studies demonstrated no statisti-\ncally  significant  improvement  in  median  unadjusted  survival\nfrom  1980  to  1990  (median  survival  ratio  1.05;  95%  confidence\nint",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 1,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression of the 15 studies demonstrated no statisti-\ncally  significant  improvement  in  median  unadjusted  survival\nfrom  1980  to  1990  (median  survival  ratio  1.05;  95%  confidence\nint",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 2000,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression of the 15 studies demonstrated no statisti-\ncally  significant  improvement  in  median  unadjusted  survival\nfrom  1980  to  1990  (median  survival  ratio  1.05;  95%  confidence\nint",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 2010,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression of the 15 studies demonstrated no statisti-\ncally  significant  improvement  in  median  unadjusted  survival\nfrom  1980  to  1990  (median  survival  ratio  1.05;  95%  confidence\nint",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 45,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression of the 15 studies demonstrated no statisti-\ncally  significant  improvement  in  median  unadjusted  survival\nfrom  1980  to  1990  (median  survival  ratio  1.05;  95%  confidence\nint",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression of the 15 studies demonstrated no statisti-\ncally  significant  improvement  in  median  unadjusted  survival\nfrom  1980  to  1990  (median  survival  ratio  1.05;  95%  confidence\nint",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 21,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression of the 15 studies demonstrated no statisti-\ncally  significant  improvement  in  median  unadjusted  survival\nfrom  1980  to  1990  (median  survival  ratio  1.05;  95%  confidence\nint",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 73,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression of the 15 studies demonstrated no statisti-\ncally  significant  improvement  in  median  unadjusted  survival\nfrom  1980  to  1990  (median  survival  ratio  1.05;  95%  confidence\nint",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 1,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression of the 15 studies demonstrated no statisti-\ncally  significant  improvement  in  median  unadjusted  survival\nfrom  1980  to  1990  (median  survival  ratio  1.05;  95%  confidence\nint",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 20,
    "unit": "months",
    "population": null,
    "notes": "We estimated\nthat  median  unadjusted  survival  across  all  breast  cancer  sub-\ntypes was 20 (95% CI¼17 to 25) months in 1980, 21 (95% CI¼18\nto 25)  months  in  1990, 26 (95%  CI¼23 to  30) months ",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "months",
    "population": null,
    "notes": "We estimated\nthat  median  unadjusted  survival  across  all  breast  cancer  sub-\ntypes was 20 (95% CI¼17 to 25) months in 1980, 21 (95% CI¼18\nto 25)  months  in  1990, 26 (95%  CI¼23 to  30) months ",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 17,
    "unit": "months",
    "population": null,
    "notes": "We estimated\nthat  median  unadjusted  survival  across  all  breast  cancer  sub-\ntypes was 20 (95% CI¼17 to 25) months in 1980, 21 (95% CI¼18\nto 25)  months  in  1990, 26 (95%  CI¼23 to  30) months ",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 25,
    "unit": "months",
    "population": null,
    "notes": "We estimated\nthat  median  unadjusted  survival  across  all  breast  cancer  sub-\ntypes was 20 (95% CI¼17 to 25) months in 1980, 21 (95% CI¼18\nto 25)  months  in  1990, 26 (95%  CI¼23 to  30) months ",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 1980,
    "unit": "months",
    "population": null,
    "notes": "We estimated\nthat  median  unadjusted  survival  across  all  breast  cancer  sub-\ntypes was 20 (95% CI¼17 to 25) months in 1980, 21 (95% CI¼18\nto 25)  months  in  1990, 26 (95%  CI¼23 to  30) months ",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 21,
    "unit": "months",
    "population": null,
    "notes": "We estimated\nthat  median  unadjusted  survival  across  all  breast  cancer  sub-\ntypes was 20 (95% CI¼17 to 25) months in 1980, 21 (95% CI¼18\nto 25)  months  in  1990, 26 (95%  CI¼23 to  30) months ",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "months",
    "population": null,
    "notes": "We estimated\nthat  median  unadjusted  survival  across  all  breast  cancer  sub-\ntypes was 20 (95% CI¼17 to 25) months in 1980, 21 (95% CI¼18\nto 25)  months  in  1990, 26 (95%  CI¼23 to  30) months ",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 18,
    "unit": "months",
    "population": null,
    "notes": "We estimated\nthat  median  unadjusted  survival  across  all  breast  cancer  sub-\ntypes was 20 (95% CI¼17 to 25) months in 1980, 21 (95% CI¼18\nto 25)  months  in  1990, 26 (95%  CI¼23 to  30) months ",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 25,
    "unit": "months",
    "population": null,
    "notes": "We estimated\nthat  median  unadjusted  survival  across  all  breast  cancer  sub-\ntypes was 20 (95% CI¼17 to 25) months in 1980, 21 (95% CI¼18\nto 25)  months  in  1990, 26 (95%  CI¼23 to  30) months ",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 1990,
    "unit": "months",
    "population": null,
    "notes": "We estimated\nthat  median  unadjusted  survival  across  all  breast  cancer  sub-\ntypes was 20 (95% CI¼17 to 25) months in 1980, 21 (95% CI¼18\nto 25)  months  in  1990, 26 (95%  CI¼23 to  30) months ",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 26,
    "unit": "months",
    "population": null,
    "notes": "We estimated\nthat  median  unadjusted  survival  across  all  breast  cancer  sub-\ntypes was 20 (95% CI¼17 to 25) months in 1980, 21 (95% CI¼18\nto 25)  months  in  1990, 26 (95%  CI¼23 to  30) months ",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "months",
    "population": null,
    "notes": "We estimated\nthat  median  unadjusted  survival  across  all  breast  cancer  sub-\ntypes was 20 (95% CI¼17 to 25) months in 1980, 21 (95% CI¼18\nto 25)  months  in  1990, 26 (95%  CI¼23 to  30) months ",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 23,
    "unit": "months",
    "population": null,
    "notes": "We estimated\nthat  median  unadjusted  survival  across  all  breast  cancer  sub-\ntypes was 20 (95% CI¼17 to 25) months in 1980, 21 (95% CI¼18\nto 25)  months  in  1990, 26 (95%  CI¼23 to  30) months ",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 30,
    "unit": "months",
    "population": null,
    "notes": "We estimated\nthat  median  unadjusted  survival  across  all  breast  cancer  sub-\ntypes was 20 (95% CI¼17 to 25) months in 1980, 21 (95% CI¼18\nto 25)  months  in  1990, 26 (95%  CI¼23 to  30) months ",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 2000,
    "unit": "months",
    "population": null,
    "notes": "We estimated\nthat  median  unadjusted  survival  across  all  breast  cancer  sub-\ntypes was 20 (95% CI¼17 to 25) months in 1980, 21 (95% CI¼18\nto 25)  months  in  1990, 26 (95%  CI¼23 to  30) months ",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 38,
    "unit": "months",
    "population": null,
    "notes": "We estimated\nthat  median  unadjusted  survival  across  all  breast  cancer  sub-\ntypes was 20 (95% CI¼17 to 25) months in 1980, 21 (95% CI¼18\nto 25)  months  in  1990, 26 (95%  CI¼23 to  30) months ",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "months",
    "population": null,
    "notes": "We estimated\nthat  median  unadjusted  survival  across  all  breast  cancer  sub-\ntypes was 20 (95% CI¼17 to 25) months in 1980, 21 (95% CI¼18\nto 25)  months  in  1990, 26 (95%  CI¼23 to  30) months ",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 31,
    "unit": "months",
    "population": null,
    "notes": "We estimated\nthat  median  unadjusted  survival  across  all  breast  cancer  sub-\ntypes was 20 (95% CI¼17 to 25) months in 1980, 21 (95% CI¼18\nto 25)  months  in  1990, 26 (95%  CI¼23 to  30) months ",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 47,
    "unit": "months",
    "population": null,
    "notes": "We estimated\nthat  median  unadjusted  survival  across  all  breast  cancer  sub-\ntypes was 20 (95% CI¼17 to 25) months in 1980, 21 (95% CI¼18\nto 25)  months  in  1990, 26 (95%  CI¼23 to  30) months ",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 2010,
    "unit": "months",
    "population": null,
    "notes": "We estimated\nthat  median  unadjusted  survival  across  all  breast  cancer  sub-\ntypes was 20 (95% CI¼17 to 25) months in 1980, 21 (95% CI¼18\nto 25)  months  in  1990, 26 (95%  CI¼23 to  30) months ",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 28,
    "unit": null,
    "population": null,
    "notes": "We   repeated   this   analysis   for   the   eight   studies   (28–\n32,35,37,49,50) that collected data on unadjusted survival after\nrecurrence  separately  for  ER-positive  (3073  patients)  and  E",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 32,
    "unit": null,
    "population": null,
    "notes": "We   repeated   this   analysis   for   the   eight   studies   (28–\n32,35,37,49,50) that collected data on unadjusted survival after\nrecurrence  separately  for  ER-positive  (3073  patients)  and  E",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 35,
    "unit": null,
    "population": null,
    "notes": "We   repeated   this   analysis   for   the   eight   studies   (28–\n32,35,37,49,50) that collected data on unadjusted survival after\nrecurrence  separately  for  ER-positive  (3073  patients)  and  E",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 37,
    "unit": null,
    "population": null,
    "notes": "We   repeated   this   analysis   for   the   eight   studies   (28–\n32,35,37,49,50) that collected data on unadjusted survival after\nrecurrence  separately  for  ER-positive  (3073  patients)  and  E",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 49,
    "unit": null,
    "population": null,
    "notes": "We   repeated   this   analysis   for   the   eight   studies   (28–\n32,35,37,49,50) that collected data on unadjusted survival after\nrecurrence  separately  for  ER-positive  (3073  patients)  and  E",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 50,
    "unit": null,
    "population": null,
    "notes": "We   repeated   this   analysis   for   the   eight   studies   (28–\n32,35,37,49,50) that collected data on unadjusted survival after\nrecurrence  separately  for  ER-positive  (3073  patients)  and  E",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 3073,
    "unit": null,
    "population": null,
    "notes": "We   repeated   this   analysis   for   the   eight   studies   (28–\n32,35,37,49,50) that collected data on unadjusted survival after\nrecurrence  separately  for  ER-positive  (3073  patients)  and  E",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 1239,
    "unit": null,
    "population": null,
    "notes": "We   repeated   this   analysis   for   the   eight   studies   (28–\n32,35,37,49,50) that collected data on unadjusted survival after\nrecurrence  separately  for  ER-positive  (3073  patients)  and  E",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 1980,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 1990,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 8,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 66,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 79,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 75,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 55,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 66,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 87,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 1990,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 2000,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 25,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 5,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 49,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 14,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 30,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 8,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 57,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 7,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 2000,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 2010,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 44,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 93,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 21,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 10,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 77,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 13,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 79,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 1,
    "unit": "%",
    "population": null,
    "notes": "Although numbers were smaller than for recurrent disease as a\nwhole,  we  observed  similar  trends  in  survival  improvement\nover  time  in  ER-positive  and  ER-negative  recurrent  disease:\nfrom 1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 29,
    "unit": "months",
    "population": null,
    "notes": "We estimated median unadjusted survival in\nER-positive disease to have been 29 (95% CI¼17 to 51) months\nin 1980, 32 (95% CI¼23 to 43) months in 1990, 39 (95% CI¼30 to\n53) months in 2000, and 57 (95% C",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "months",
    "population": null,
    "notes": "We estimated median unadjusted survival in\nER-positive disease to have been 29 (95% CI¼17 to 51) months\nin 1980, 32 (95% CI¼23 to 43) months in 1990, 39 (95% CI¼30 to\n53) months in 2000, and 57 (95% C",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 17,
    "unit": "months",
    "population": null,
    "notes": "We estimated median unadjusted survival in\nER-positive disease to have been 29 (95% CI¼17 to 51) months\nin 1980, 32 (95% CI¼23 to 43) months in 1990, 39 (95% CI¼30 to\n53) months in 2000, and 57 (95% C",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 51,
    "unit": "months",
    "population": null,
    "notes": "We estimated median unadjusted survival in\nER-positive disease to have been 29 (95% CI¼17 to 51) months\nin 1980, 32 (95% CI¼23 to 43) months in 1990, 39 (95% CI¼30 to\n53) months in 2000, and 57 (95% C",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 1980,
    "unit": "months",
    "population": null,
    "notes": "We estimated median unadjusted survival in\nER-positive disease to have been 29 (95% CI¼17 to 51) months\nin 1980, 32 (95% CI¼23 to 43) months in 1990, 39 (95% CI¼30 to\n53) months in 2000, and 57 (95% C",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 32,
    "unit": "months",
    "population": null,
    "notes": "We estimated median unadjusted survival in\nER-positive disease to have been 29 (95% CI¼17 to 51) months\nin 1980, 32 (95% CI¼23 to 43) months in 1990, 39 (95% CI¼30 to\n53) months in 2000, and 57 (95% C",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "months",
    "population": null,
    "notes": "We estimated median unadjusted survival in\nER-positive disease to have been 29 (95% CI¼17 to 51) months\nin 1980, 32 (95% CI¼23 to 43) months in 1990, 39 (95% CI¼30 to\n53) months in 2000, and 57 (95% C",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 23,
    "unit": "months",
    "population": null,
    "notes": "We estimated median unadjusted survival in\nER-positive disease to have been 29 (95% CI¼17 to 51) months\nin 1980, 32 (95% CI¼23 to 43) months in 1990, 39 (95% CI¼30 to\n53) months in 2000, and 57 (95% C",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 43,
    "unit": "months",
    "population": null,
    "notes": "We estimated median unadjusted survival in\nER-positive disease to have been 29 (95% CI¼17 to 51) months\nin 1980, 32 (95% CI¼23 to 43) months in 1990, 39 (95% CI¼30 to\n53) months in 2000, and 57 (95% C",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 1990,
    "unit": "months",
    "population": null,
    "notes": "We estimated median unadjusted survival in\nER-positive disease to have been 29 (95% CI¼17 to 51) months\nin 1980, 32 (95% CI¼23 to 43) months in 1990, 39 (95% CI¼30 to\n53) months in 2000, and 57 (95% C",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 39,
    "unit": "months",
    "population": null,
    "notes": "We estimated median unadjusted survival in\nER-positive disease to have been 29 (95% CI¼17 to 51) months\nin 1980, 32 (95% CI¼23 to 43) months in 1990, 39 (95% CI¼30 to\n53) months in 2000, and 57 (95% C",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "months",
    "population": null,
    "notes": "We estimated median unadjusted survival in\nER-positive disease to have been 29 (95% CI¼17 to 51) months\nin 1980, 32 (95% CI¼23 to 43) months in 1990, 39 (95% CI¼30 to\n53) months in 2000, and 57 (95% C",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 30,
    "unit": "months",
    "population": null,
    "notes": "We estimated median unadjusted survival in\nER-positive disease to have been 29 (95% CI¼17 to 51) months\nin 1980, 32 (95% CI¼23 to 43) months in 1990, 39 (95% CI¼30 to\n53) months in 2000, and 57 (95% C",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 53,
    "unit": "months",
    "population": null,
    "notes": "We estimated median unadjusted survival in\nER-positive disease to have been 29 (95% CI¼17 to 51) months\nin 1980, 32 (95% CI¼23 to 43) months in 1990, 39 (95% CI¼30 to\n53) months in 2000, and 57 (95% C",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 2000,
    "unit": "months",
    "population": null,
    "notes": "We estimated median unadjusted survival in\nER-positive disease to have been 29 (95% CI¼17 to 51) months\nin 1980, 32 (95% CI¼23 to 43) months in 1990, 39 (95% CI¼30 to\n53) months in 2000, and 57 (95% C",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 57,
    "unit": "months",
    "population": null,
    "notes": "We estimated median unadjusted survival in\nER-positive disease to have been 29 (95% CI¼17 to 51) months\nin 1980, 32 (95% CI¼23 to 43) months in 1990, 39 (95% CI¼30 to\n53) months in 2000, and 57 (95% C",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "months",
    "population": null,
    "notes": "We estimated median unadjusted survival in\nER-positive disease to have been 29 (95% CI¼17 to 51) months\nin 1980, 32 (95% CI¼23 to 43) months in 1990, 39 (95% CI¼30 to\n53) months in 2000, and 57 (95% C",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 37,
    "unit": "months",
    "population": null,
    "notes": "We estimated median unadjusted survival in\nER-positive disease to have been 29 (95% CI¼17 to 51) months\nin 1980, 32 (95% CI¼23 to 43) months in 1990, 39 (95% CI¼30 to\n53) months in 2000, and 57 (95% C",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 87,
    "unit": "months",
    "population": null,
    "notes": "We estimated median unadjusted survival in\nER-positive disease to have been 29 (95% CI¼17 to 51) months\nin 1980, 32 (95% CI¼23 to 43) months in 1990, 39 (95% CI¼30 to\n53) months in 2000, and 57 (95% C",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 2010,
    "unit": "months",
    "population": null,
    "notes": "We estimated median unadjusted survival in\nER-positive disease to have been 29 (95% CI¼17 to 51) months\nin 1980, 32 (95% CI¼23 to 43) months in 1990, 39 (95% CI¼30 to\n53) months in 2000, and 57 (95% C",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 12,
    "unit": null,
    "population": null,
    "notes": "Among  the  12  studies  that  showed  survival  improvement\nover the interval studied, 10 included multivariable analysis in-\ncorporating  variables  associated  with  disease  aggressiveness\nand sur",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 10,
    "unit": null,
    "population": null,
    "notes": "Among  the  12  studies  that  showed  survival  improvement\nover the interval studied, 10 included multivariable analysis in-\ncorporating  variables  associated  with  disease  aggressiveness\nand sur",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 10,
    "unit": "year",
    "population": null,
    "notes": "In 7 of these 10 multivar-\niable  analyses,  the  association  between  recurrence  year  and\nsurvival  disappeared  with  adjustment  for  potential  confound-\ning variables related to disease aggres",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 12,
    "unit": null,
    "population": null,
    "notes": "For example, 12 stud-\nies assessed ER status over time, with five showing an increase\nin ER-positive disease and seven showing no change",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 13,
    "unit": null,
    "population": null,
    "notes": "The   most   consistent   change   was   an   increase   in\nrecurrence-free interval, assessed in 13 studies and observed in\n12 (Supplementary Table 1, available online)",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 12,
    "unit": null,
    "population": null,
    "notes": "The   most   consistent   change   was   an   increase   in\nrecurrence-free interval, assessed in 13 studies and observed in\n12 (Supplementary Table 1, available online)",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 14,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "Studies of time trends in survival \nwith metastatic breast cancer, \nidentified through citation review: \nprimarily distant recurrence (N=14) \nand de novo stage IV (N=5)\nStudies of time trends in survi",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 111,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "Studies of time trends in survival \nwith metastatic breast cancer, \nidentified through citation review: \nprimarily distant recurrence (N=14) \nand de novo stage IV (N=5)\nStudies of time trends in survi",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 107,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "Studies of time trends in survival \nwith metastatic breast cancer, \nidentified through citation review: \nprimarily distant recurrence (N=14) \nand de novo stage IV (N=5)\nStudies of time trends in survi",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 10,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "Studies of time trends in survival \nwith metastatic breast cancer, \nidentified through citation review: \nprimarily distant recurrence (N=14) \nand de novo stage IV (N=5)\nStudies of time trends in survi",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 76,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "Studies of time trends in survival \nwith metastatic breast cancer, \nidentified through citation review: \nprimarily distant recurrence (N=14) \nand de novo stage IV (N=5)\nStudies of time trends in survi",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 10,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "Studies of time trends in survival \nwith metastatic breast cancer, \nidentified through citation review: \nprimarily distant recurrence (N=14) \nand de novo stage IV (N=5)\nStudies of time trends in survi",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 15,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "Studies of time trends in survival \nwith metastatic breast cancer, \nidentified through citation review: \nprimarily distant recurrence (N=14) \nand de novo stage IV (N=5)\nStudies of time trends in survi",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 20,
    "unit": "%",
    "population": null,
    "notes": "Second,  several  studies  (25,28,30,49,51)  included  over  20%\nlocoregional  recurrences  (Figure  3A–C),  which  are  treated  very\ndifferently  from  distant  recurrences  and  have  longer  survi",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "When we repeated the analysis without these five studies,\nwe concluded there was no change in the finding that survival\nimproved, though survival was modestly lower when only dis-\ntant  recurrences  w",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "When we repeated the analysis without these five studies,\nwe concluded there was no change in the finding that survival\nimproved, though survival was modestly lower when only dis-\ntant  recurrences  w",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 19,
    "unit": "months",
    "population": null,
    "notes": "When we repeated the analysis without these five studies,\nwe concluded there was no change in the finding that survival\nimproved, though survival was modestly lower when only dis-\ntant  recurrences  w",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 23,
    "unit": "months",
    "population": null,
    "notes": "When we repeated the analysis without these five studies,\nwe concluded there was no change in the finding that survival\nimproved, though survival was modestly lower when only dis-\ntant  recurrences  w",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 34,
    "unit": "months",
    "population": null,
    "notes": "When we repeated the analysis without these five studies,\nwe concluded there was no change in the finding that survival\nimproved, though survival was modestly lower when only dis-\ntant  recurrences  w",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 43,
    "unit": "months",
    "population": null,
    "notes": "When we repeated the analysis without these five studies,\nwe concluded there was no change in the finding that survival\nimproved, though survival was modestly lower when only dis-\ntant  recurrences  w",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": "7 year",
    "value": 7,
    "unit": "years",
    "population": null,
    "notes": "In four stud-\nies, diagnosis and recurrence were truncated in the same year\n(25–28,30), and in the other four, diagnosis was truncated 2–\n7 years  before  recurrence  (29,31,33,36)",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "When we repeated the analysis without these five studies,\nwe concluded there was no change in the finding that survival\nimproved, though survival was modestly lower when only dis-\ntant  recurrences  w",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "When we repeated the analysis without these five studies,\nwe concluded there was no change in the finding that survival\nimproved, though survival was modestly lower when only dis-\ntant  recurrences  w",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": "7 year",
    "value": 25,
    "unit": "year",
    "population": null,
    "notes": "In four stud-\nies, diagnosis and recurrence were truncated in the same year\n(25–28,30), and in the other four, diagnosis was truncated 2–\n7 years  before  recurrence  (29,31,33,36)",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": "7 year",
    "value": 28,
    "unit": "year",
    "population": null,
    "notes": "In four stud-\nies, diagnosis and recurrence were truncated in the same year\n(25–28,30), and in the other four, diagnosis was truncated 2–\n7 years  before  recurrence  (29,31,33,36)",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": "7 year",
    "value": 30,
    "unit": "year",
    "population": null,
    "notes": "In four stud-\nies, diagnosis and recurrence were truncated in the same year\n(25–28,30), and in the other four, diagnosis was truncated 2–\n7 years  before  recurrence  (29,31,33,36)",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": "7 year",
    "value": 29,
    "unit": "year",
    "population": null,
    "notes": "In four stud-\nies, diagnosis and recurrence were truncated in the same year\n(25–28,30), and in the other four, diagnosis was truncated 2–\n7 years  before  recurrence  (29,31,33,36)",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": "7 year",
    "value": 31,
    "unit": "year",
    "population": null,
    "notes": "In four stud-\nies, diagnosis and recurrence were truncated in the same year\n(25–28,30), and in the other four, diagnosis was truncated 2–\n7 years  before  recurrence  (29,31,33,36)",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": "7 year",
    "value": 33,
    "unit": "year",
    "population": null,
    "notes": "In four stud-\nies, diagnosis and recurrence were truncated in the same year\n(25–28,30), and in the other four, diagnosis was truncated 2–\n7 years  before  recurrence  (29,31,33,36)",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": "7 year",
    "value": 36,
    "unit": "year",
    "population": null,
    "notes": "In four stud-\nies, diagnosis and recurrence were truncated in the same year\n(25–28,30), and in the other four, diagnosis was truncated 2–\n7 years  before  recurrence  (29,31,33,36)",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 53,
    "unit": null,
    "population": null,
    "notes": "By definition, such patients had a shorter\nrecurrence-free  interval  than  in  later  cohorts,  and  because\nshorter  recurrence-free  interval  is  associated  with  shorter\nsurvival after distant r",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 54,
    "unit": null,
    "population": null,
    "notes": "By definition, such patients had a shorter\nrecurrence-free  interval  than  in  later  cohorts,  and  because\nshorter  recurrence-free  interval  is  associated  with  shorter\nsurvival after distant r",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 25,
    "unit": "%",
    "population": null,
    "notes": "Second,  several  studies  (25,28,30,49,51)  included  over  20%\nlocoregional  recurrences  (Figure  3A–C),  which  are  treated  very\ndifferently  from  distant  recurrences  and  have  longer  survi",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 28,
    "unit": "%",
    "population": null,
    "notes": "Second,  several  studies  (25,28,30,49,51)  included  over  20%\nlocoregional  recurrences  (Figure  3A–C),  which  are  treated  very\ndifferently  from  distant  recurrences  and  have  longer  survi",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 30,
    "unit": "%",
    "population": null,
    "notes": "Second,  several  studies  (25,28,30,49,51)  included  over  20%\nlocoregional  recurrences  (Figure  3A–C),  which  are  treated  very\ndifferently  from  distant  recurrences  and  have  longer  survi",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 49,
    "unit": "%",
    "population": null,
    "notes": "Second,  several  studies  (25,28,30,49,51)  included  over  20%\nlocoregional  recurrences  (Figure  3A–C),  which  are  treated  very\ndifferently  from  distant  recurrences  and  have  longer  survi",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 51,
    "unit": "%",
    "population": null,
    "notes": "Second,  several  studies  (25,28,30,49,51)  included  over  20%\nlocoregional  recurrences  (Figure  3A–C),  which  are  treated  very\ndifferently  from  distant  recurrences  and  have  longer  survi",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 20,
    "unit": "%",
    "population": null,
    "notes": "Second,  several  studies  (25,28,30,49,51)  included  over  20%\nlocoregional  recurrences  (Figure  3A–C),  which  are  treated  very\ndifferently  from  distant  recurrences  and  have  longer  survi",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 55,
    "unit": "%",
    "population": null,
    "notes": "Second,  several  studies  (25,28,30,49,51)  included  over  20%\nlocoregional  recurrences  (Figure  3A–C),  which  are  treated  very\ndifferently  from  distant  recurrences  and  have  longer  survi",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 19,
    "unit": "months",
    "population": null,
    "notes": "When we repeated the analysis without these five studies,\nwe concluded there was no change in the finding that survival\nimproved, though survival was modestly lower when only dis-\ntant  recurrences  w",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 95,
    "unit": "months",
    "population": null,
    "notes": "When we repeated the analysis without these five studies,\nwe concluded there was no change in the finding that survival\nimproved, though survival was modestly lower when only dis-\ntant  recurrences  w",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 17,
    "unit": "months",
    "population": null,
    "notes": "When we repeated the analysis without these five studies,\nwe concluded there was no change in the finding that survival\nimproved, though survival was modestly lower when only dis-\ntant  recurrences  w",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 23,
    "unit": "months",
    "population": null,
    "notes": "When we repeated the analysis without these five studies,\nwe concluded there was no change in the finding that survival\nimproved, though survival was modestly lower when only dis-\ntant  recurrences  w",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 1990,
    "unit": "months",
    "population": null,
    "notes": "When we repeated the analysis without these five studies,\nwe concluded there was no change in the finding that survival\nimproved, though survival was modestly lower when only dis-\ntant  recurrences  w",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 34,
    "unit": "months",
    "population": null,
    "notes": "When we repeated the analysis without these five studies,\nwe concluded there was no change in the finding that survival\nimproved, though survival was modestly lower when only dis-\ntant  recurrences  w",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 95,
    "unit": "months",
    "population": null,
    "notes": "When we repeated the analysis without these five studies,\nwe concluded there was no change in the finding that survival\nimproved, though survival was modestly lower when only dis-\ntant  recurrences  w",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 27,
    "unit": "months",
    "population": null,
    "notes": "When we repeated the analysis without these five studies,\nwe concluded there was no change in the finding that survival\nimproved, though survival was modestly lower when only dis-\ntant  recurrences  w",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 43,
    "unit": "months",
    "population": null,
    "notes": "When we repeated the analysis without these five studies,\nwe concluded there was no change in the finding that survival\nimproved, though survival was modestly lower when only dis-\ntant  recurrences  w",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 2010,
    "unit": "months",
    "population": null,
    "notes": "When we repeated the analysis without these five studies,\nwe concluded there was no change in the finding that survival\nimproved, though survival was modestly lower when only dis-\ntant  recurrences  w",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1975",
    "value": 19,
    "unit": "%",
    "population": null,
    "notes": "(\n51\n)\nDiagnosis period\nDisease status\nSource population\nN\nMedian survival\n(months)\nStatistical significance\nReferences\n1975–1977 to 2006–2012\nStage IV\nMultiple registries, US\nNR*\n5 yr†: 19% to 34%\nUV",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1975",
    "value": 34,
    "unit": "%",
    "population": null,
    "notes": "(\n51\n)\nDiagnosis period\nDisease status\nSource population\nN\nMedian survival\n(months)\nStatistical significance\nReferences\n1975–1977 to 2006–2012\nStage IV\nMultiple registries, US\nNR*\n5 yr†: 19% to 34%\nUV",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1975",
    "value": 5,
    "unit": "years",
    "population": null,
    "notes": "(\n51\n)\nDiagnosis period\nDisease status\nSource population\nN\nMedian survival\n(months)\nStatistical significance\nReferences\n1975–1977 to 2006–2012\nStage IV\nMultiple registries, US\nNR*\n5 yr†: 19% to 34%\nUV",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1974",
    "value": null,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "Studies of change in survival over time for patients with metastatic breast cancer, either distant recurrence or de novo Stage IV disease\nDiagnosis period\nRecurrence time\nperiods compared\nDisease stat",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1974",
    "value": null,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "Studies of change in survival over time for patients with metastatic breast cancer, either distant recurrence or de novo Stage IV disease\nDiagnosis period\nRecurrence time\nperiods compared\nDisease stat",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1974",
    "value": null,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "Studies of change in survival over time for patients with metastatic breast cancer, either distant recurrence or de novo Stage IV disease\nDiagnosis period\nRecurrence time\nperiods compared\nDisease stat",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1974",
    "value": null,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "Studies of change in survival over time for patients with metastatic breast cancer, either distant recurrence or de novo Stage IV disease\nDiagnosis period\nRecurrence time\nperiods compared\nDisease stat",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1974",
    "value": null,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "Studies of change in survival over time for patients with metastatic breast cancer, either distant recurrence or de novo Stage IV disease\nDiagnosis period\nRecurrence time\nperiods compared\nDisease stat",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1974",
    "value": null,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "Studies of change in survival over time for patients with metastatic breast cancer, either distant recurrence or de novo Stage IV disease\nDiagnosis period\nRecurrence time\nperiods compared\nDisease stat",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1975",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "(\n51\n)\nDiagnosis period\nDisease status\nSource population\nN\nMedian survival\n(months)\nStatistical significance\nReferences\n1975–1977 to 2006–2012\nStage IV\nMultiple registries, US\nNR*\n5 yr†: 19% to 34%\nUV",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1975",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "(\n51\n)\nDiagnosis period\nDisease status\nSource population\nN\nMedian survival\n(months)\nStatistical significance\nReferences\n1975–1977 to 2006–2012\nStage IV\nMultiple registries, US\nNR*\n5 yr†: 19% to 34%\nUV",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1975",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "(\n51\n)\nDiagnosis period\nDisease status\nSource population\nN\nMedian survival\n(months)\nStatistical significance\nReferences\n1975–1977 to 2006–2012\nStage IV\nMultiple registries, US\nNR*\n5 yr†: 19% to 34%\nUV",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1975",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "(\n51\n)\nDiagnosis period\nDisease status\nSource population\nN\nMedian survival\n(months)\nStatistical significance\nReferences\n1975–1977 to 2006–2012\nStage IV\nMultiple registries, US\nNR*\n5 yr†: 19% to 34%\nUV",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": "1995",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "**Multivariable was statistically significant only comparing 1995–2002 with 1985–1994 if data on metastasis site and number were available (these p\nrognostic factors worsened over time)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": "1995",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "**Multivariable was statistically significant only comparing 1995–2002 with 1985–1994 if data on metastasis site and number were available (these p\nrognostic factors worsened over time)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": "1995",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "**Multivariable was statistically significant only comparing 1995–2002 with 1985–1994 if data on metastasis site and number were available (these p\nrognostic factors worsened over time)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": "1995",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "**Multivariable was statistically significant only comparing 1995–2002 with 1985–1994 if data on metastasis site and number were available (these p\nrognostic factors worsened over time)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1974",
    "value": 1974,
    "unit": "months",
    "population": "metastatic breast cancer",
    "notes": "Studies of change in survival over time for patients with metastatic breast cancer, either distant recurrence or de novo Stage IV disease\nDiagnosis period\nRecurrence time\nperiods compared\nDisease stat",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1974",
    "value": 1994,
    "unit": "months",
    "population": "metastatic breast cancer",
    "notes": "Studies of change in survival over time for patients with metastatic breast cancer, either distant recurrence or de novo Stage IV disease\nDiagnosis period\nRecurrence time\nperiods compared\nDisease stat",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1974",
    "value": 1974,
    "unit": "months",
    "population": "metastatic breast cancer",
    "notes": "Studies of change in survival over time for patients with metastatic breast cancer, either distant recurrence or de novo Stage IV disease\nDiagnosis period\nRecurrence time\nperiods compared\nDisease stat",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1974",
    "value": 1979,
    "unit": "months",
    "population": "metastatic breast cancer",
    "notes": "Studies of change in survival over time for patients with metastatic breast cancer, either distant recurrence or de novo Stage IV disease\nDiagnosis period\nRecurrence time\nperiods compared\nDisease stat",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1974",
    "value": 1995,
    "unit": "months",
    "population": "metastatic breast cancer",
    "notes": "Studies of change in survival over time for patients with metastatic breast cancer, either distant recurrence or de novo Stage IV disease\nDiagnosis period\nRecurrence time\nperiods compared\nDisease stat",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1974",
    "value": 2000,
    "unit": "months",
    "population": "metastatic breast cancer",
    "notes": "Studies of change in survival over time for patients with metastatic breast cancer, either distant recurrence or de novo Stage IV disease\nDiagnosis period\nRecurrence time\nperiods compared\nDisease stat",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1974",
    "value": 834,
    "unit": "months",
    "population": "metastatic breast cancer",
    "notes": "Studies of change in survival over time for patients with metastatic breast cancer, either distant recurrence or de novo Stage IV disease\nDiagnosis period\nRecurrence time\nperiods compared\nDisease stat",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1974",
    "value": 15,
    "unit": "months",
    "population": "metastatic breast cancer",
    "notes": "Studies of change in survival over time for patients with metastatic breast cancer, either distant recurrence or de novo Stage IV disease\nDiagnosis period\nRecurrence time\nperiods compared\nDisease stat",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1974",
    "value": 58,
    "unit": "months",
    "population": "metastatic breast cancer",
    "notes": "Studies of change in survival over time for patients with metastatic breast cancer, either distant recurrence or de novo Stage IV disease\nDiagnosis period\nRecurrence time\nperiods compared\nDisease stat",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1975",
    "value": 51,
    "unit": "months",
    "population": null,
    "notes": "(\n51\n)\nDiagnosis period\nDisease status\nSource population\nN\nMedian survival\n(months)\nStatistical significance\nReferences\n1975–1977 to 2006–2012\nStage IV\nMultiple registries, US\nNR*\n5 yr†: 19% to 34%\nUV",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1975",
    "value": 1975,
    "unit": "months",
    "population": null,
    "notes": "(\n51\n)\nDiagnosis period\nDisease status\nSource population\nN\nMedian survival\n(months)\nStatistical significance\nReferences\n1975–1977 to 2006–2012\nStage IV\nMultiple registries, US\nNR*\n5 yr†: 19% to 34%\nUV",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1975",
    "value": 1977,
    "unit": "months",
    "population": null,
    "notes": "(\n51\n)\nDiagnosis period\nDisease status\nSource population\nN\nMedian survival\n(months)\nStatistical significance\nReferences\n1975–1977 to 2006–2012\nStage IV\nMultiple registries, US\nNR*\n5 yr†: 19% to 34%\nUV",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1975",
    "value": 2006,
    "unit": "months",
    "population": null,
    "notes": "(\n51\n)\nDiagnosis period\nDisease status\nSource population\nN\nMedian survival\n(months)\nStatistical significance\nReferences\n1975–1977 to 2006–2012\nStage IV\nMultiple registries, US\nNR*\n5 yr†: 19% to 34%\nUV",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1975",
    "value": 2012,
    "unit": "months",
    "population": null,
    "notes": "(\n51\n)\nDiagnosis period\nDisease status\nSource population\nN\nMedian survival\n(months)\nStatistical significance\nReferences\n1975–1977 to 2006–2012\nStage IV\nMultiple registries, US\nNR*\n5 yr†: 19% to 34%\nUV",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1975",
    "value": 19,
    "unit": "months",
    "population": null,
    "notes": "(\n51\n)\nDiagnosis period\nDisease status\nSource population\nN\nMedian survival\n(months)\nStatistical significance\nReferences\n1975–1977 to 2006–2012\nStage IV\nMultiple registries, US\nNR*\n5 yr†: 19% to 34%\nUV",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1975",
    "value": 34,
    "unit": "months",
    "population": null,
    "notes": "(\n51\n)\nDiagnosis period\nDisease status\nSource population\nN\nMedian survival\n(months)\nStatistical significance\nReferences\n1975–1977 to 2006–2012\nStage IV\nMultiple registries, US\nNR*\n5 yr†: 19% to 34%\nUV",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": "1995",
    "value": 1995,
    "unit": null,
    "population": null,
    "notes": "**Multivariable was statistically significant only comparing 1995–2002 with 1985–1994 if data on metastasis site and number were available (these p\nrognostic factors worsened over time)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": "1995",
    "value": 2002,
    "unit": null,
    "population": null,
    "notes": "**Multivariable was statistically significant only comparing 1995–2002 with 1985–1994 if data on metastasis site and number were available (these p\nrognostic factors worsened over time)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": "1995",
    "value": 1985,
    "unit": null,
    "population": null,
    "notes": "**Multivariable was statistically significant only comparing 1995–2002 with 1985–1994 if data on metastasis site and number were available (these p\nrognostic factors worsened over time)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": "1995",
    "value": 1994,
    "unit": null,
    "population": null,
    "notes": "**Multivariable was statistically significant only comparing 1995–2002 with 1985–1994 if data on metastasis site and number were available (these p\nrognostic factors worsened over time)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression  found  no  statistically\nsignificant improvement from 1980 to 1990 (median survival ra-\ntio¼1.04; 95% CI¼0.92 to 1.17;P¼0.55) but statistically signifi-\ncant improvement thereafter (m",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression  found  no  statistically\nsignificant improvement from 1980 to 1990 (median survival ra-\ntio¼1.04; 95% CI¼0.92 to 1.17;P¼0.55) but statistically signifi-\ncant improvement thereafter (m",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression  found  no  statistically\nsignificant improvement from 1980 to 1990 (median survival ra-\ntio¼1.04; 95% CI¼0.92 to 1.17;P¼0.55) but statistically signifi-\ncant improvement thereafter (m",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "We estimated\nmedian unadjusted survival to have been 19 (95% CI¼15 to 23)\nmonths in 1980, 20 (95% CI¼16 to 24) months in 1990, 23 (95%\nCI¼19 to 28) months in 2000, and 31 (95% CI¼24 to 39) months\nin 2",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "We estimated\nmedian unadjusted survival to have been 19 (95% CI¼15 to 23)\nmonths in 1980, 20 (95% CI¼16 to 24) months in 1990, 23 (95%\nCI¼19 to 28) months in 2000, and 31 (95% CI¼24 to 39) months\nin 2",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "We estimated\nmedian unadjusted survival to have been 19 (95% CI¼15 to 23)\nmonths in 1980, 20 (95% CI¼16 to 24) months in 1990, 23 (95%\nCI¼19 to 28) months in 2000, and 31 (95% CI¼24 to 39) months\nin 2",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "We estimated\nmedian unadjusted survival to have been 19 (95% CI¼15 to 23)\nmonths in 1980, 20 (95% CI¼16 to 24) months in 1990, 23 (95%\nCI¼19 to 28) months in 2000, and 31 (95% CI¼24 to 39) months\nin 2",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2026",
    "value": 2,
    "unit": null,
    "population": null,
    "notes": "4\nDownloaded from https://academic.oup.com/jncics/article/2/4/pky062/5260813 by guest on 01 January 2026\n\nDe Novo Stage IV Breast Cancer\nWe identified eight studies that assessed survival improvement\n",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2026",
    "value": 62,
    "unit": null,
    "population": null,
    "notes": "4\nDownloaded from https://academic.oup.com/jncics/article/2/4/pky062/5260813 by guest on 01 January 2026\n\nDe Novo Stage IV Breast Cancer\nWe identified eight studies that assessed survival improvement\n",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2026",
    "value": 831,
    "unit": "count",
    "population": null,
    "notes": "4\nDownloaded from https://academic.oup.com/jncics/article/2/4/pky062/5260813 by guest on 01 January 2026\n\nDe Novo Stage IV Breast Cancer\nWe identified eight studies that assessed survival improvement\n",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2026",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "4\nDownloaded from https://academic.oup.com/jncics/article/2/4/pky062/5260813 by guest on 01 January 2026\n\nDe Novo Stage IV Breast Cancer\nWe identified eight studies that assessed survival improvement\n",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Meta-regression  found  no  statistically\nsignificant improvement from 1980 to 1990 (median survival ra-\ntio¼1.04; 95% CI¼0.92 to 1.17;P¼0.55) but statistically signifi-\ncant improvement thereafter (m",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Meta-regression  found  no  statistically\nsignificant improvement from 1980 to 1990 (median survival ra-\ntio¼1.04; 95% CI¼0.92 to 1.17;P¼0.55) but statistically signifi-\ncant improvement thereafter (m",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Meta-regression  found  no  statistically\nsignificant improvement from 1980 to 1990 (median survival ra-\ntio¼1.04; 95% CI¼0.92 to 1.17;P¼0.55) but statistically signifi-\ncant improvement thereafter (m",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Meta-regression  found  no  statistically\nsignificant improvement from 1980 to 1990 (median survival ra-\ntio¼1.04; 95% CI¼0.92 to 1.17;P¼0.55) but statistically signifi-\ncant improvement thereafter (m",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Meta-regression  found  no  statistically\nsignificant improvement from 1980 to 1990 (median survival ra-\ntio¼1.04; 95% CI¼0.92 to 1.17;P¼0.55) but statistically signifi-\ncant improvement thereafter (m",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Meta-regression  found  no  statistically\nsignificant improvement from 1980 to 1990 (median survival ra-\ntio¼1.04; 95% CI¼0.92 to 1.17;P¼0.55) but statistically signifi-\ncant improvement thereafter (m",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We estimated\nmedian unadjusted survival to have been 19 (95% CI¼15 to 23)\nmonths in 1980, 20 (95% CI¼16 to 24) months in 1990, 23 (95%\nCI¼19 to 28) months in 2000, and 31 (95% CI¼24 to 39) months\nin 2",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We estimated\nmedian unadjusted survival to have been 19 (95% CI¼15 to 23)\nmonths in 1980, 20 (95% CI¼16 to 24) months in 1990, 23 (95%\nCI¼19 to 28) months in 2000, and 31 (95% CI¼24 to 39) months\nin 2",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We estimated\nmedian unadjusted survival to have been 19 (95% CI¼15 to 23)\nmonths in 1980, 20 (95% CI¼16 to 24) months in 1990, 23 (95%\nCI¼19 to 28) months in 2000, and 31 (95% CI¼24 to 39) months\nin 2",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We estimated\nmedian unadjusted survival to have been 19 (95% CI¼15 to 23)\nmonths in 1980, 20 (95% CI¼16 to 24) months in 1990, 23 (95%\nCI¼19 to 28) months in 2000, and 31 (95% CI¼24 to 39) months\nin 2",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1987",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Only one of these studies reported\nsurvival separately for ER-positive and ER-negative disease (43)\nand  showed  improvement  for  ER-positive  disease  but  not  ER-\nnegative disease from 1987 to 200",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1987",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Only one of these studies reported\nsurvival separately for ER-positive and ER-negative disease (43)\nand  showed  improvement  for  ER-positive  disease  but  not  ER-\nnegative disease from 1987 to 200",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "overall  survival",
    "timePeriod": "1970",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Discussion\nThis  study  examined  population  trends  in  overall  survival  of\nbreast cancer patients with distant recurrence or de novo meta-\nstatic disease from studies spanning the 40-year interva",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "overall  survival",
    "timePeriod": "1970",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Discussion\nThis  study  examined  population  trends  in  overall  survival  of\nbreast cancer patients with distant recurrence or de novo meta-\nstatic disease from studies spanning the 40-year interva",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Even for ER-negative dis-\nease,   which   has   the   worst   prognosis,   survival   more   than\ndoubled between 1990 and 2010",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Even for ER-negative dis-\nease,   which   has   the   worst   prognosis,   survival   more   than\ndoubled between 1990 and 2010",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "In other words, the\naccelerated pace of new drug development after 1990 may have\nimproved both recurrence-free interval and survival with meta-\nstatic disease in the same patients",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 16.5,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 24.6,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 21.2,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 18.2,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 24.7,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 26.2,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 22.7,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 30.4,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 38,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 30.5,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 47.3,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 0.91,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 1.22,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 1.24,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 1.16,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 1.32,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 1.45,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 1.21,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 1.73,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 16.7,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 50.7,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 31.6,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 23.3,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 42.7,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 39.4,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 29.5,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 52.5,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 56.5,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 36.6,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 87.3,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 0.66,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 1.79,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 1.25,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 1.05,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 1.49,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 1.44,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 0.93,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 2.21,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 8.2,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 26.8,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 14.1,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 10.5,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 19,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 18.4,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 13.6,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 24.8,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 32.6,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 20.7,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 51.4,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 0.55,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 1.66,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 1.3,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 1.08,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 1.57,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 1.77,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 1.13,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 2.79,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 15.1,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 23.5,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 19.5,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 16.1,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 23.8,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 23.1,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 19,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 28,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 31,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 24.3,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 39.4,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 0.92,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 1.17,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 1.18,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 1.13,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 1.23,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 1.34,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 1.16,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 1.55,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 1.04,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression  found  no  statistically\nsignificant improvement from 1980 to 1990 (median survival ra-\ntio¼1.04; 95% CI¼0.92 to 1.17;P¼0.55) but statistically signifi-\ncant improvement thereafter (m",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 0.92,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression  found  no  statistically\nsignificant improvement from 1980 to 1990 (median survival ra-\ntio¼1.04; 95% CI¼0.92 to 1.17;P¼0.55) but statistically signifi-\ncant improvement thereafter (m",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 1.17,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression  found  no  statistically\nsignificant improvement from 1980 to 1990 (median survival ra-\ntio¼1.04; 95% CI¼0.92 to 1.17;P¼0.55) but statistically signifi-\ncant improvement thereafter (m",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 0.55,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression  found  no  statistically\nsignificant improvement from 1980 to 1990 (median survival ra-\ntio¼1.04; 95% CI¼0.92 to 1.17;P¼0.55) but statistically signifi-\ncant improvement thereafter (m",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 1.18,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression  found  no  statistically\nsignificant improvement from 1980 to 1990 (median survival ra-\ntio¼1.04; 95% CI¼0.92 to 1.17;P¼0.55) but statistically signifi-\ncant improvement thereafter (m",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 1.13,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression  found  no  statistically\nsignificant improvement from 1980 to 1990 (median survival ra-\ntio¼1.04; 95% CI¼0.92 to 1.17;P¼0.55) but statistically signifi-\ncant improvement thereafter (m",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 1.23,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression  found  no  statistically\nsignificant improvement from 1980 to 1990 (median survival ra-\ntio¼1.04; 95% CI¼0.92 to 1.17;P¼0.55) but statistically signifi-\ncant improvement thereafter (m",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 1.34,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression  found  no  statistically\nsignificant improvement from 1980 to 1990 (median survival ra-\ntio¼1.04; 95% CI¼0.92 to 1.17;P¼0.55) but statistically signifi-\ncant improvement thereafter (m",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 1.16,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression  found  no  statistically\nsignificant improvement from 1980 to 1990 (median survival ra-\ntio¼1.04; 95% CI¼0.92 to 1.17;P¼0.55) but statistically signifi-\ncant improvement thereafter (m",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 1.55,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression  found  no  statistically\nsignificant improvement from 1980 to 1990 (median survival ra-\ntio¼1.04; 95% CI¼0.92 to 1.17;P¼0.55) but statistically signifi-\ncant improvement thereafter (m",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 16,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 24,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 21,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 18,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 24,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 26,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 22,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 30,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 38,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 30,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 47,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 5,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 91,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 22,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 24,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 16,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 32,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 45,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 21,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 73,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 16,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 50,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 31,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 23,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 42,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 39,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 29,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 52,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 56,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 36,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 87,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 8,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 66,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 79,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 25,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 5,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 49,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 44,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 93,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 21,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 26,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 14,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 10,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 19,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 18,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 13,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 24,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 32,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 20,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 51,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 55,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 66,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 30,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 8,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 57,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 77,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 13,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 79,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 15,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 23,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 19,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 16,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 23,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 23,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 19,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 28,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 31,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 24,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 39,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 4,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 92,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 17,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 18,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 13,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 23,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 34,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 16,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1980",
    "value": 55,
    "unit": "year",
    "population": null,
    "notes": "Table 2.Median survival estimates and survival ratios from the model\nYear of detection of metastatic disease\nOutcome1980199020002010\nMedian survival after recurrence (95% CI) (all), mo20.2 (16.5 to 24",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2026",
    "value": 5260813,
    "unit": null,
    "population": null,
    "notes": "4\nDownloaded from https://academic.oup.com/jncics/article/2/4/pky062/5260813 by guest on 01 January 2026\n\nDe Novo Stage IV Breast Cancer\nWe identified eight studies that assessed survival improvement\n",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2026",
    "value": 1,
    "unit": null,
    "population": null,
    "notes": "4\nDownloaded from https://academic.oup.com/jncics/article/2/4/pky062/5260813 by guest on 01 January 2026\n\nDe Novo Stage IV Breast Cancer\nWe identified eight studies that assessed survival improvement\n",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2026",
    "value": 2026,
    "unit": null,
    "population": null,
    "notes": "4\nDownloaded from https://academic.oup.com/jncics/article/2/4/pky062/5260813 by guest on 01 January 2026\n\nDe Novo Stage IV Breast Cancer\nWe identified eight studies that assessed survival improvement\n",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2026",
    "value": 35,
    "unit": null,
    "population": null,
    "notes": "4\nDownloaded from https://academic.oup.com/jncics/article/2/4/pky062/5260813 by guest on 01 January 2026\n\nDe Novo Stage IV Breast Cancer\nWe identified eight studies that assessed survival improvement\n",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2026",
    "value": 831,
    "unit": null,
    "population": null,
    "notes": "4\nDownloaded from https://academic.oup.com/jncics/article/2/4/pky062/5260813 by guest on 01 January 2026\n\nDe Novo Stage IV Breast Cancer\nWe identified eight studies that assessed survival improvement\n",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 1980,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression  found  no  statistically\nsignificant improvement from 1980 to 1990 (median survival ra-\ntio¼1.04; 95% CI¼0.92 to 1.17;P¼0.55) but statistically signifi-\ncant improvement thereafter (m",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 1990,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression  found  no  statistically\nsignificant improvement from 1980 to 1990 (median survival ra-\ntio¼1.04; 95% CI¼0.92 to 1.17;P¼0.55) but statistically signifi-\ncant improvement thereafter (m",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 4,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression  found  no  statistically\nsignificant improvement from 1980 to 1990 (median survival ra-\ntio¼1.04; 95% CI¼0.92 to 1.17;P¼0.55) but statistically signifi-\ncant improvement thereafter (m",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression  found  no  statistically\nsignificant improvement from 1980 to 1990 (median survival ra-\ntio¼1.04; 95% CI¼0.92 to 1.17;P¼0.55) but statistically signifi-\ncant improvement thereafter (m",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 92,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression  found  no  statistically\nsignificant improvement from 1980 to 1990 (median survival ra-\ntio¼1.04; 95% CI¼0.92 to 1.17;P¼0.55) but statistically signifi-\ncant improvement thereafter (m",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 17,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression  found  no  statistically\nsignificant improvement from 1980 to 1990 (median survival ra-\ntio¼1.04; 95% CI¼0.92 to 1.17;P¼0.55) but statistically signifi-\ncant improvement thereafter (m",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 55,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression  found  no  statistically\nsignificant improvement from 1980 to 1990 (median survival ra-\ntio¼1.04; 95% CI¼0.92 to 1.17;P¼0.55) but statistically signifi-\ncant improvement thereafter (m",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 18,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression  found  no  statistically\nsignificant improvement from 1980 to 1990 (median survival ra-\ntio¼1.04; 95% CI¼0.92 to 1.17;P¼0.55) but statistically signifi-\ncant improvement thereafter (m",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 1990,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression  found  no  statistically\nsignificant improvement from 1980 to 1990 (median survival ra-\ntio¼1.04; 95% CI¼0.92 to 1.17;P¼0.55) but statistically signifi-\ncant improvement thereafter (m",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 2000,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression  found  no  statistically\nsignificant improvement from 1980 to 1990 (median survival ra-\ntio¼1.04; 95% CI¼0.92 to 1.17;P¼0.55) but statistically signifi-\ncant improvement thereafter (m",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression  found  no  statistically\nsignificant improvement from 1980 to 1990 (median survival ra-\ntio¼1.04; 95% CI¼0.92 to 1.17;P¼0.55) but statistically signifi-\ncant improvement thereafter (m",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 13,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression  found  no  statistically\nsignificant improvement from 1980 to 1990 (median survival ra-\ntio¼1.04; 95% CI¼0.92 to 1.17;P¼0.55) but statistically signifi-\ncant improvement thereafter (m",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 23,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression  found  no  statistically\nsignificant improvement from 1980 to 1990 (median survival ra-\ntio¼1.04; 95% CI¼0.92 to 1.17;P¼0.55) but statistically signifi-\ncant improvement thereafter (m",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 1,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression  found  no  statistically\nsignificant improvement from 1980 to 1990 (median survival ra-\ntio¼1.04; 95% CI¼0.92 to 1.17;P¼0.55) but statistically signifi-\ncant improvement thereafter (m",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 34,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression  found  no  statistically\nsignificant improvement from 1980 to 1990 (median survival ra-\ntio¼1.04; 95% CI¼0.92 to 1.17;P¼0.55) but statistically signifi-\ncant improvement thereafter (m",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 2000,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression  found  no  statistically\nsignificant improvement from 1980 to 1990 (median survival ra-\ntio¼1.04; 95% CI¼0.92 to 1.17;P¼0.55) but statistically signifi-\ncant improvement thereafter (m",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 2010,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression  found  no  statistically\nsignificant improvement from 1980 to 1990 (median survival ra-\ntio¼1.04; 95% CI¼0.92 to 1.17;P¼0.55) but statistically signifi-\ncant improvement thereafter (m",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression  found  no  statistically\nsignificant improvement from 1980 to 1990 (median survival ra-\ntio¼1.04; 95% CI¼0.92 to 1.17;P¼0.55) but statistically signifi-\ncant improvement thereafter (m",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 16,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression  found  no  statistically\nsignificant improvement from 1980 to 1990 (median survival ra-\ntio¼1.04; 95% CI¼0.92 to 1.17;P¼0.55) but statistically signifi-\ncant improvement thereafter (m",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 55,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression  found  no  statistically\nsignificant improvement from 1980 to 1990 (median survival ra-\ntio¼1.04; 95% CI¼0.92 to 1.17;P¼0.55) but statistically signifi-\ncant improvement thereafter (m",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "median survival",
    "timePeriod": "1980",
    "value": 1,
    "unit": "%",
    "population": null,
    "notes": "Meta-regression  found  no  statistically\nsignificant improvement from 1980 to 1990 (median survival ra-\ntio¼1.04; 95% CI¼0.92 to 1.17;P¼0.55) but statistically signifi-\ncant improvement thereafter (m",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 19,
    "unit": "months",
    "population": null,
    "notes": "We estimated\nmedian unadjusted survival to have been 19 (95% CI¼15 to 23)\nmonths in 1980, 20 (95% CI¼16 to 24) months in 1990, 23 (95%\nCI¼19 to 28) months in 2000, and 31 (95% CI¼24 to 39) months\nin 2",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "months",
    "population": null,
    "notes": "We estimated\nmedian unadjusted survival to have been 19 (95% CI¼15 to 23)\nmonths in 1980, 20 (95% CI¼16 to 24) months in 1990, 23 (95%\nCI¼19 to 28) months in 2000, and 31 (95% CI¼24 to 39) months\nin 2",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 15,
    "unit": "months",
    "population": null,
    "notes": "We estimated\nmedian unadjusted survival to have been 19 (95% CI¼15 to 23)\nmonths in 1980, 20 (95% CI¼16 to 24) months in 1990, 23 (95%\nCI¼19 to 28) months in 2000, and 31 (95% CI¼24 to 39) months\nin 2",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 23,
    "unit": "months",
    "population": null,
    "notes": "We estimated\nmedian unadjusted survival to have been 19 (95% CI¼15 to 23)\nmonths in 1980, 20 (95% CI¼16 to 24) months in 1990, 23 (95%\nCI¼19 to 28) months in 2000, and 31 (95% CI¼24 to 39) months\nin 2",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 1980,
    "unit": "months",
    "population": null,
    "notes": "We estimated\nmedian unadjusted survival to have been 19 (95% CI¼15 to 23)\nmonths in 1980, 20 (95% CI¼16 to 24) months in 1990, 23 (95%\nCI¼19 to 28) months in 2000, and 31 (95% CI¼24 to 39) months\nin 2",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 20,
    "unit": "months",
    "population": null,
    "notes": "We estimated\nmedian unadjusted survival to have been 19 (95% CI¼15 to 23)\nmonths in 1980, 20 (95% CI¼16 to 24) months in 1990, 23 (95%\nCI¼19 to 28) months in 2000, and 31 (95% CI¼24 to 39) months\nin 2",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "months",
    "population": null,
    "notes": "We estimated\nmedian unadjusted survival to have been 19 (95% CI¼15 to 23)\nmonths in 1980, 20 (95% CI¼16 to 24) months in 1990, 23 (95%\nCI¼19 to 28) months in 2000, and 31 (95% CI¼24 to 39) months\nin 2",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 16,
    "unit": "months",
    "population": null,
    "notes": "We estimated\nmedian unadjusted survival to have been 19 (95% CI¼15 to 23)\nmonths in 1980, 20 (95% CI¼16 to 24) months in 1990, 23 (95%\nCI¼19 to 28) months in 2000, and 31 (95% CI¼24 to 39) months\nin 2",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 24,
    "unit": "months",
    "population": null,
    "notes": "We estimated\nmedian unadjusted survival to have been 19 (95% CI¼15 to 23)\nmonths in 1980, 20 (95% CI¼16 to 24) months in 1990, 23 (95%\nCI¼19 to 28) months in 2000, and 31 (95% CI¼24 to 39) months\nin 2",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 1990,
    "unit": "months",
    "population": null,
    "notes": "We estimated\nmedian unadjusted survival to have been 19 (95% CI¼15 to 23)\nmonths in 1980, 20 (95% CI¼16 to 24) months in 1990, 23 (95%\nCI¼19 to 28) months in 2000, and 31 (95% CI¼24 to 39) months\nin 2",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 23,
    "unit": "months",
    "population": null,
    "notes": "We estimated\nmedian unadjusted survival to have been 19 (95% CI¼15 to 23)\nmonths in 1980, 20 (95% CI¼16 to 24) months in 1990, 23 (95%\nCI¼19 to 28) months in 2000, and 31 (95% CI¼24 to 39) months\nin 2",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "months",
    "population": null,
    "notes": "We estimated\nmedian unadjusted survival to have been 19 (95% CI¼15 to 23)\nmonths in 1980, 20 (95% CI¼16 to 24) months in 1990, 23 (95%\nCI¼19 to 28) months in 2000, and 31 (95% CI¼24 to 39) months\nin 2",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 19,
    "unit": "months",
    "population": null,
    "notes": "We estimated\nmedian unadjusted survival to have been 19 (95% CI¼15 to 23)\nmonths in 1980, 20 (95% CI¼16 to 24) months in 1990, 23 (95%\nCI¼19 to 28) months in 2000, and 31 (95% CI¼24 to 39) months\nin 2",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 28,
    "unit": "months",
    "population": null,
    "notes": "We estimated\nmedian unadjusted survival to have been 19 (95% CI¼15 to 23)\nmonths in 1980, 20 (95% CI¼16 to 24) months in 1990, 23 (95%\nCI¼19 to 28) months in 2000, and 31 (95% CI¼24 to 39) months\nin 2",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 2000,
    "unit": "months",
    "population": null,
    "notes": "We estimated\nmedian unadjusted survival to have been 19 (95% CI¼15 to 23)\nmonths in 1980, 20 (95% CI¼16 to 24) months in 1990, 23 (95%\nCI¼19 to 28) months in 2000, and 31 (95% CI¼24 to 39) months\nin 2",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 31,
    "unit": "months",
    "population": null,
    "notes": "We estimated\nmedian unadjusted survival to have been 19 (95% CI¼15 to 23)\nmonths in 1980, 20 (95% CI¼16 to 24) months in 1990, 23 (95%\nCI¼19 to 28) months in 2000, and 31 (95% CI¼24 to 39) months\nin 2",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 95,
    "unit": "months",
    "population": null,
    "notes": "We estimated\nmedian unadjusted survival to have been 19 (95% CI¼15 to 23)\nmonths in 1980, 20 (95% CI¼16 to 24) months in 1990, 23 (95%\nCI¼19 to 28) months in 2000, and 31 (95% CI¼24 to 39) months\nin 2",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 24,
    "unit": "months",
    "population": null,
    "notes": "We estimated\nmedian unadjusted survival to have been 19 (95% CI¼15 to 23)\nmonths in 1980, 20 (95% CI¼16 to 24) months in 1990, 23 (95%\nCI¼19 to 28) months in 2000, and 31 (95% CI¼24 to 39) months\nin 2",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 39,
    "unit": "months",
    "population": null,
    "notes": "We estimated\nmedian unadjusted survival to have been 19 (95% CI¼15 to 23)\nmonths in 1980, 20 (95% CI¼16 to 24) months in 1990, 23 (95%\nCI¼19 to 28) months in 2000, and 31 (95% CI¼24 to 39) months\nin 2",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1980",
    "value": 2010,
    "unit": "months",
    "population": null,
    "notes": "We estimated\nmedian unadjusted survival to have been 19 (95% CI¼15 to 23)\nmonths in 1980, 20 (95% CI¼16 to 24) months in 1990, 23 (95%\nCI¼19 to 28) months in 2000, and 31 (95% CI¼24 to 39) months\nin 2",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1987",
    "value": 43,
    "unit": null,
    "population": null,
    "notes": "Only one of these studies reported\nsurvival separately for ER-positive and ER-negative disease (43)\nand  showed  improvement  for  ER-positive  disease  but  not  ER-\nnegative disease from 1987 to 200",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1987",
    "value": 1987,
    "unit": null,
    "population": null,
    "notes": "Only one of these studies reported\nsurvival separately for ER-positive and ER-negative disease (43)\nand  showed  improvement  for  ER-positive  disease  but  not  ER-\nnegative disease from 1987 to 200",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1987",
    "value": 2000,
    "unit": null,
    "population": null,
    "notes": "Only one of these studies reported\nsurvival separately for ER-positive and ER-negative disease (43)\nand  showed  improvement  for  ER-positive  disease  but  not  ER-\nnegative disease from 1987 to 200",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "overall  survival",
    "timePeriod": "1970",
    "value": 40,
    "unit": "year",
    "population": null,
    "notes": "Discussion\nThis  study  examined  population  trends  in  overall  survival  of\nbreast cancer patients with distant recurrence or de novo meta-\nstatic disease from studies spanning the 40-year interva",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "overall  survival",
    "timePeriod": "1970",
    "value": 1970,
    "unit": "year",
    "population": null,
    "notes": "Discussion\nThis  study  examined  population  trends  in  overall  survival  of\nbreast cancer patients with distant recurrence or de novo meta-\nstatic disease from studies spanning the 40-year interva",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "overall  survival",
    "timePeriod": "1970",
    "value": 2010,
    "unit": "year",
    "population": null,
    "notes": "Discussion\nThis  study  examined  population  trends  in  overall  survival  of\nbreast cancer patients with distant recurrence or de novo meta-\nstatic disease from studies spanning the 40-year interva",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 1990,
    "unit": null,
    "population": null,
    "notes": "Even for ER-negative dis-\nease,   which   has   the   worst   prognosis,   survival   more   than\ndoubled between 1990 and 2010",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 2010,
    "unit": null,
    "population": null,
    "notes": "Even for ER-negative dis-\nease,   which   has   the   worst   prognosis,   survival   more   than\ndoubled between 1990 and 2010",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 27,
    "unit": null,
    "population": null,
    "notes": "We note that some studies concluded that the survival im-\nprovement  over  time  they  observed  was  more  likely  to  have\nresulted  from  a reduction in  disease  aggressiveness  over  time\nrather ",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 29,
    "unit": null,
    "population": null,
    "notes": "We note that some studies concluded that the survival im-\nprovement  over  time  they  observed  was  more  likely  to  have\nresulted  from  a reduction in  disease  aggressiveness  over  time\nrather ",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 57,
    "unit": null,
    "population": null,
    "notes": "Furthermore, we ob-\nserved survival improvement in both ER-positive and ER-negative\nMBC,  and  thus  the  survival  improvement  over  time  cannot  be\nfully  explained by a  potential increase  in th",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 58,
    "unit": null,
    "population": null,
    "notes": "Previous\nstudies have hypothesized the reverse, that the administration\nof adjuvant therapy prior to recurrence might decrease survival\nafter metastasis by selecting for resistant clones (58)",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 1990,
    "unit": null,
    "population": null,
    "notes": "In other words, the\naccelerated pace of new drug development after 1990 may have\nimproved both recurrence-free interval and survival with meta-\nstatic disease in the same patients",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 18,
    "unit": null,
    "population": null,
    "notes": "For example, HER2-targeted\ntherapies offer a longer recurrence-free interval and also longer\nsurvival after recurrence (18,59), and other drug classes includ-\ning  endocrine  therapy  and  chemotherap",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 59,
    "unit": null,
    "population": null,
    "notes": "For example, HER2-targeted\ntherapies offer a longer recurrence-free interval and also longer\nsurvival after recurrence (18,59), and other drug classes includ-\ning  endocrine  therapy  and  chemotherap",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 30,
    "unit": "%",
    "population": null,
    "notes": "However,  because  HER2-positive  cancers  were\nthe  minority  in  studies  that  reported  HER2  (<30%)  (28,50,61),\nthey are unlikely to account for all of the observed survival im-\nprovement,  sugg",
    "pageHint": 6,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 1,
    "unit": "year",
    "population": null,
    "notes": "Second,\nwe are unable to link improvement in survival to the introduc-\ntion of specific therapies, instead focusing on decade-by-decade\ntrends; going forward, data sets that allow more granular esti-\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": "2010",
    "value": 4,
    "unit": null,
    "population": null,
    "notes": "Further studies\nwill be needed to assess additional improvement after 2010, in\nparticular  of  newer  therapies  such  as  the  CDK4/6  inhibitors,\nwhere no overall survival benefit has been seen yet ",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": "1970",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Fifth,  although  we  collected  studies  across  the  entire  period\nfrom 1970 to 2018, data were too sparse between 1970 and 1980\nand between 2010 and 2018 to inform estimates",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": "1970",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Fifth,  although  we  collected  studies  across  the  entire  period\nfrom 1970 to 2018, data were too sparse between 1970 and 1980\nand between 2010 and 2018 to inform estimates",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": "1970",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Fifth,  although  we  collected  studies  across  the  entire  period\nfrom 1970 to 2018, data were too sparse between 1970 and 1980\nand between 2010 and 2018 to inform estimates",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": "1970",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Fifth,  although  we  collected  studies  across  the  entire  period\nfrom 1970 to 2018, data were too sparse between 1970 and 1980\nand between 2010 and 2018 to inform estimates",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": "1970",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Fifth,  although  we  collected  studies  across  the  entire  period\nfrom 1970 to 2018, data were too sparse between 1970 and 1980\nand between 2010 and 2018 to inform estimates",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": "1970",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Fifth,  although  we  collected  studies  across  the  entire  period\nfrom 1970 to 2018, data were too sparse between 1970 and 1980\nand between 2010 and 2018 to inform estimates",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": "2010",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Further studies\nwill be needed to assess additional improvement after 2010, in\nparticular  of  newer  therapies  such  as  the  CDK4/6  inhibitors,\nwhere no overall survival benefit has been seen yet ",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 60,
    "unit": null,
    "population": null,
    "notes": "Earlier  detection  of  distant  recurrence  [eg,  by  more  use  of  ad-\nvanced  imaging  after  primary  treatment  (60)]  over  time  could\ncause   lead-time   bias   resulting   in   longer   surv",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 30,
    "unit": "%",
    "population": null,
    "notes": "However,  because  HER2-positive  cancers  were\nthe  minority  in  studies  that  reported  HER2  (<30%)  (28,50,61),\nthey are unlikely to account for all of the observed survival im-\nprovement,  sugg",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 28,
    "unit": "%",
    "population": null,
    "notes": "However,  because  HER2-positive  cancers  were\nthe  minority  in  studies  that  reported  HER2  (<30%)  (28,50,61),\nthey are unlikely to account for all of the observed survival im-\nprovement,  sugg",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 50,
    "unit": "%",
    "population": null,
    "notes": "However,  because  HER2-positive  cancers  were\nthe  minority  in  studies  that  reported  HER2  (<30%)  (28,50,61),\nthey are unlikely to account for all of the observed survival im-\nprovement,  sugg",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 61,
    "unit": "%",
    "population": null,
    "notes": "However,  because  HER2-positive  cancers  were\nthe  minority  in  studies  that  reported  HER2  (<30%)  (28,50,61),\nthey are unlikely to account for all of the observed survival im-\nprovement,  sugg",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 27,
    "unit": null,
    "population": null,
    "notes": "Publication  bias  might\nhave biased our studies toward those showing an improvement;\nthe result that survival did not improve over time would be pro-\nvocative  with  adequate  power  (27),  but  smal",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": "1970",
    "value": 1970,
    "unit": null,
    "population": null,
    "notes": "Fifth,  although  we  collected  studies  across  the  entire  period\nfrom 1970 to 2018, data were too sparse between 1970 and 1980\nand between 2010 and 2018 to inform estimates",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": "1970",
    "value": 2018,
    "unit": null,
    "population": null,
    "notes": "Fifth,  although  we  collected  studies  across  the  entire  period\nfrom 1970 to 2018, data were too sparse between 1970 and 1980\nand between 2010 and 2018 to inform estimates",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": "1970",
    "value": 1970,
    "unit": null,
    "population": null,
    "notes": "Fifth,  although  we  collected  studies  across  the  entire  period\nfrom 1970 to 2018, data were too sparse between 1970 and 1980\nand between 2010 and 2018 to inform estimates",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": "1970",
    "value": 1980,
    "unit": null,
    "population": null,
    "notes": "Fifth,  although  we  collected  studies  across  the  entire  period\nfrom 1970 to 2018, data were too sparse between 1970 and 1980\nand between 2010 and 2018 to inform estimates",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": "1970",
    "value": 2010,
    "unit": null,
    "population": null,
    "notes": "Fifth,  although  we  collected  studies  across  the  entire  period\nfrom 1970 to 2018, data were too sparse between 1970 and 1980\nand between 2010 and 2018 to inform estimates",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": "1970",
    "value": 2018,
    "unit": null,
    "population": null,
    "notes": "Fifth,  although  we  collected  studies  across  the  entire  period\nfrom 1970 to 2018, data were too sparse between 1970 and 1980\nand between 2010 and 2018 to inform estimates",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": "2010",
    "value": 2010,
    "unit": null,
    "population": null,
    "notes": "Further studies\nwill be needed to assess additional improvement after 2010, in\nparticular  of  newer  therapies  such  as  the  CDK4/6  inhibitors,\nwhere no overall survival benefit has been seen yet ",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 40,
    "unit": "year",
    "population": null,
    "notes": "This study synthe-\nsized  evidence  across  a  40-year  horizon  and  supported  the  hy-\npothesis   that   advances   tested   in   RCTs   have   translated   to\nimproved survival in the population",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "26 year",
    "value": 26,
    "unit": "years",
    "population": "metastatic breast cancer",
    "notes": "Age-specific  trends  of survival  in\nmetastatic breast cancer: 26 years longitudinal data from a population-based\ncancer  registry  in  Stockholm,  Sweden.Breast Cancer Res Treat",
    "pageHint": 7,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 38,
    "unit": "count",
    "population": "metastatic breast cancer",
    "notes": "Prognostic factors in 1,038 women with\nmetastatic breast cancer.Ann Oncol",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2004",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "D003370.\n25.  Giordano SH, Buzdar AU, Smith TL, et al. Is breast cancer survival improving?\nCancer. 2004;100(1):44–52.\n26.  Rogoz B, Houze de l’Aulnoit A, Duhamel A, et al. Thirty-year trends of sur-\n",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2008",
    "value": null,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "rero JM, Doyen J, et al. Prognostic factors in 1,038 women with\nmetastatic breast cancer.Ann Oncol. 2008;19(12):2012–2019.\n30.  Tsuji W, Teramukai S, Ueno M, et al. Prognostic factors for survival aft",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2001",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Significant  survival  im-\nprovement of patients with recurrent breast cancer in the periods 2001-2008\nvs. 1992-2000.BMC Cancer. 2011;11:118.\n33.  Foukakis  T,  Fornander  T,  Lekberg  T,  et  al.  Ag",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Gennari A, Conte P, Rosso R, et al",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1976",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Trends in breast cancer survival in\nGermany  from  1976  to  2008—a  period  analysis  by  age  and  stage.Cancer\nEpidemiol",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1976",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Trends in breast cancer survival in\nGermany  from  1976  to  2008—a  period  analysis  by  age  and  stage.Cancer\nEpidemiol",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": "1975",
    "value": null,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "et al. Trends in the prognosis of\npatients with primary metastatic breast cancer diagnosed between 1975 and\n2002.Breast. 2007;16(4):344–351.\n42.  Pal SK, Dehaven M, Nelson RA, et al. Impact of modern ",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1975",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "710.\n47.  Jemal A, Ward EM, Johnson CJ, et al. Annual report to the nation on the status\nof cancer, 1975-2014, featuring survival.J Natl Cancer Inst. 2017;109(9):djx030.\n48.  Pavlik T, Majek O, Buchle",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2000",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "pecific population-based\nsurvival  of  cancer  patients  in  the  Czech  Republic  in  the  period  2000-2008.\nCancer Epidemiol. 2014;38(1):28–34.\n49.  Vogel  CL,  Azevedo  S,  Hilsenbeck  S,  et  al.",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Zeichner SB, Ambros T, Zaravinos J, et al",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": null,
    "unit": "year",
    "population": "metastatic breast\ncancer",
    "notes": "Trends in survival for patients with metastatic breast\ncancer: is survival improving?Tumori",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Insa A, Lluch A, Prosper F, et al",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Rapiti E, Verkooijen HM, Vlastos G, et al",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": "2017",
    "value": 289,
    "unit": null,
    "population": null,
    "notes": "6.\n9.   Hortobagyi GN. Ribociclib for HR-positive, advanced breast cancer.N Engl J\nMed. 2017;376(3):289.\n10.  Canellos GP, Pocock SJ, Taylor SG 3rd, et al. Combination chemotherapy for\nmetastatic brea",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 10,
    "unit": null,
    "population": null,
    "notes": "Canellos GP, Pocock SJ, Taylor SG 3rd, et al",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2005",
    "value": 5551,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "y of docetaxel\ncompared with paclitaxel in metastatic breast cancer.J Clin Oncol. 2005;23(24):\n5542–5551.\n14.  O’Shaughnessy J, Miles D, Vukelja S, et al. Superior survival with capecitabine\nplus  doc",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": "2017",
    "value": 732,
    "unit": null,
    "population": null,
    "notes": "nal overall survival\nresults from a randomised, open-label, phase 3 trial.Lancet Oncol. 2017;18(6):\n732–742.\n17.  Swain SM, Kim SB, Cortes J, et al. Pertuzumab, trastuzumab, and docetaxel\nfor HER2-pos",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": "2015",
    "value": 33,
    "unit": null,
    "population": null,
    "notes": "breast cancer: overall sur-\nvival  analysis  from  the  phase  II  FIRST  study.J Clin Oncol.  2015;33(32):\n3781–3787.\n22.  Mauri D, Polyzos NP, Salanti G, et al. Multiple-treatments meta-analysis of\n",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 3781,
    "unit": null,
    "population": null,
    "notes": "Mauri D, Polyzos NP, Salanti G, et al",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 3787,
    "unit": null,
    "population": null,
    "notes": "Mauri D, Polyzos NP, Salanti G, et al",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 22,
    "unit": null,
    "population": null,
    "notes": "Mauri D, Polyzos NP, Salanti G, et al",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2004",
    "value": 2004,
    "unit": "year",
    "population": null,
    "notes": "D003370.\n25.  Giordano SH, Buzdar AU, Smith TL, et al. Is breast cancer survival improving?\nCancer. 2004;100(1):44–52.\n26.  Rogoz B, Houze de l’Aulnoit A, Duhamel A, et al. Thirty-year trends of sur-\n",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 38,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "Prognostic factors in 1,038 women with\nmetastatic breast cancer.Ann Oncol",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2008",
    "value": 2008,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "rero JM, Doyen J, et al. Prognostic factors in 1,038 women with\nmetastatic breast cancer.Ann Oncol. 2008;19(12):2012–2019.\n30.  Tsuji W, Teramukai S, Ueno M, et al. Prognostic factors for survival aft",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 252,
    "unit": null,
    "population": null,
    "notes": "Prognostic factors for survival after first\nrecurrence in breast cancer: a retrospective analysis of 252 recurrent cases at\na single institution.Breast Cancer",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2001",
    "value": 2008,
    "unit": null,
    "population": null,
    "notes": "Significant  survival  im-\nprovement of patients with recurrent breast cancer in the periods 2001-2008\nvs. 1992-2000.BMC Cancer. 2011;11:118.\n33.  Foukakis  T,  Fornander  T,  Lekberg  T,  et  al.  Ag",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "26 year",
    "value": 26,
    "unit": "years",
    "population": "metastatic breast cancer",
    "notes": "Age-specific  trends  of survival  in\nmetastatic breast cancer: 26 years longitudinal data from a population-based\ncancer  registry  in  Stockholm,  Sweden.Breast Cancer Res Treat",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 2011,
    "unit": null,
    "population": null,
    "notes": "Gennari A, Conte P, Rosso R, et al",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 130,
    "unit": null,
    "population": null,
    "notes": "Gennari A, Conte P, Rosso R, et al",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 553,
    "unit": null,
    "population": null,
    "notes": "Gennari A, Conte P, Rosso R, et al",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 560,
    "unit": null,
    "population": null,
    "notes": "Gennari A, Conte P, Rosso R, et al",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 34,
    "unit": null,
    "population": null,
    "notes": "Gennari A, Conte P, Rosso R, et al",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 20,
    "unit": "year",
    "population": null,
    "notes": "Survival of metastatic breast carcinoma\npatients over a 20-year period: a retrospective analysis based on individual\npatient data from six consecutive studies.Cancer",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 535,
    "unit": null,
    "population": "metastatic breast\ncancer",
    "notes": "Trends in survival for patients with metastatic breast\ncancer: is survival improving?Tumori",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 39,
    "unit": null,
    "population": "metastatic breast\ncancer",
    "notes": "Trends in survival for patients with metastatic breast\ncancer: is survival improving?Tumori",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1976",
    "value": 1976,
    "unit": null,
    "population": null,
    "notes": "Trends in breast cancer survival in\nGermany  from  1976  to  2008—a  period  analysis  by  age  and  stage.Cancer\nEpidemiol",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1976",
    "value": 2008,
    "unit": null,
    "population": null,
    "notes": "Trends in breast cancer survival in\nGermany  from  1976  to  2008—a  period  analysis  by  age  and  stage.Cancer\nEpidemiol",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": "1975",
    "value": 1975,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "et al. Trends in the prognosis of\npatients with primary metastatic breast cancer diagnosed between 1975 and\n2002.Breast. 2007;16(4):344–351.\n42.  Pal SK, Dehaven M, Nelson RA, et al. Impact of modern ",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 42,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "Impact of modern chemotherapy on the\nsurvival of women presenting with de novo metastatic breast cancer.BMC\nCancer",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2012",
    "value": 43,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "on the\nsurvival of women presenting with de novo metastatic breast cancer.BMC\nCancer. 2012;12:435.\n43.  Andre F, Slimane K, Bachelot T, et al. Breast cancer with synchronous metas-\ntases:  trends  in",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1975",
    "value": 2710,
    "unit": null,
    "population": null,
    "notes": "Annual report to the nation on the status\nof cancer, 1975-2014, featuring survival.J Natl Cancer Inst",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1975",
    "value": 47,
    "unit": null,
    "population": null,
    "notes": "Annual report to the nation on the status\nof cancer, 1975-2014, featuring survival.J Natl Cancer Inst",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1975",
    "value": 1975,
    "unit": null,
    "population": null,
    "notes": "710.\n47.  Jemal A, Ward EM, Johnson CJ, et al. Annual report to the nation on the status\nof cancer, 1975-2014, featuring survival.J Natl Cancer Inst. 2017;109(9):djx030.\n48.  Pavlik T, Majek O, Buchle",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2000",
    "value": 48,
    "unit": null,
    "population": null,
    "notes": "Trends in stage-specific population-based\nsurvival  of  cancer  patients  in  the  Czech  Republic  in  the  period  2000-2008",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2000",
    "value": 2000,
    "unit": null,
    "population": null,
    "notes": "pecific population-based\nsurvival  of  cancer  patients  in  the  Czech  Republic  in  the  period  2000-2008.\nCancer Epidemiol. 2014;38(1):28–34.\n49.  Vogel  CL,  Azevedo  S,  Hilsenbeck  S,  et  al.",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1992,
    "unit": null,
    "population": null,
    "notes": "Zeichner SB, Ambros T, Zaravinos J, et al",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 70,
    "unit": null,
    "population": null,
    "notes": "Zeichner SB, Ambros T, Zaravinos J, et al",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 129,
    "unit": null,
    "population": null,
    "notes": "Zeichner SB, Ambros T, Zaravinos J, et al",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2015",
    "value": 135,
    "unit": null,
    "population": null,
    "notes": "Defining the survival benchmark\nfor breast cancer patients with systemic relapse.Breast Cancer (Auckl.)2015;9:\n9–17",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2015",
    "value": 50,
    "unit": null,
    "population": null,
    "notes": "Defining the survival benchmark\nfor breast cancer patients with systemic relapse.Breast Cancer (Auckl.)2015;9:\n9–17",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 2015,
    "unit": null,
    "population": "metastatic breast\ncancer",
    "notes": "Trends in survival for patients with metastatic breast\ncancer: is survival improving?Tumori",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 17,
    "unit": null,
    "population": "metastatic breast\ncancer",
    "notes": "Trends in survival for patients with metastatic breast\ncancer: is survival improving?Tumori",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 51,
    "unit": null,
    "population": "metastatic breast\ncancer",
    "notes": "Trends in survival for patients with metastatic breast\ncancer: is survival improving?Tumori",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": null,
    "value": 347,
    "unit": null,
    "population": null,
    "notes": "Time trends in incidence rates and\nsurvival  of  newly  diagnosed  stage  IV  breast  cancer  by  tumor  histology:  a\npopulation-based analysis.Breast Cancer Res Treat",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": null,
    "value": 352,
    "unit": null,
    "population": null,
    "notes": "Time trends in incidence rates and\nsurvival  of  newly  diagnosed  stage  IV  breast  cancer  by  tumor  histology:  a\npopulation-based analysis.Breast Cancer Res Treat",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": null,
    "value": 52,
    "unit": null,
    "population": null,
    "notes": "Time trends in incidence rates and\nsurvival  of  newly  diagnosed  stage  IV  breast  cancer  by  tumor  histology:  a\npopulation-based analysis.Breast Cancer Res Treat",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 2016,
    "unit": null,
    "population": null,
    "notes": "Insa A, Lluch A, Prosper F, et al",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 157,
    "unit": null,
    "population": "metastatic  breast  cancer",
    "notes": "Prognostic factors predicting survival from\nfirst  recurrence  in  patients  with  metastatic  breast  cancer:  analysis  of  439\npatients.Breast Cancer Res Treat",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 587,
    "unit": null,
    "population": "metastatic  breast  cancer",
    "notes": "Prognostic factors predicting survival from\nfirst  recurrence  in  patients  with  metastatic  breast  cancer:  analysis  of  439\npatients.Breast Cancer Res Treat",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 596,
    "unit": null,
    "population": "metastatic  breast  cancer",
    "notes": "Prognostic factors predicting survival from\nfirst  recurrence  in  patients  with  metastatic  breast  cancer:  analysis  of  439\npatients.Breast Cancer Res Treat",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 53,
    "unit": null,
    "population": "metastatic  breast  cancer",
    "notes": "Prognostic factors predicting survival from\nfirst  recurrence  in  patients  with  metastatic  breast  cancer:  analysis  of  439\npatients.Breast Cancer Res Treat",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 56,
    "unit": null,
    "population": "patients with metastatic",
    "notes": "Survival of patients with metastatic breast\ncarcinoma: importance of prognostic markers of the primary tumor.Cancer",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 67,
    "unit": null,
    "population": "patients with metastatic",
    "notes": "Survival of patients with metastatic breast\ncarcinoma: importance of prognostic markers of the primary tumor.Cancer",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 78,
    "unit": null,
    "population": "patients with metastatic",
    "notes": "Survival of patients with metastatic breast\ncarcinoma: importance of prognostic markers of the primary tumor.Cancer",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 54,
    "unit": null,
    "population": "patients with metastatic",
    "notes": "Survival of patients with metastatic breast\ncarcinoma: importance of prognostic markers of the primary tumor.Cancer",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 2014,
    "unit": null,
    "population": null,
    "notes": "Rapiti E, Verkooijen HM, Vlastos G, et al",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 15,
    "unit": null,
    "population": null,
    "notes": "Rapiti E, Verkooijen HM, Vlastos G, et al",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 156,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "Complete excision of primary breast\ntumor improves survival of patients with metastatic breast cancer at diagno-\nsis.J Clin Oncol",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 163,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "Complete excision of primary breast\ntumor improves survival of patients with metastatic breast cancer at diagno-\nsis.J Clin Oncol",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 56,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "Complete excision of primary breast\ntumor improves survival of patients with metastatic breast cancer at diagno-\nsis.J Clin Oncol",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2006",
    "value": 18,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "or improves survival of patients with metastatic breast cancer at diagno-\nsis.J Clin Oncol. 2006;24(18):2743–2749.\n57.  Ravdin PM, Cronin KA, Howlader N, et al. The decrease in breast-cancer inci-\nden",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 356,
    "unit": null,
    "population": null,
    "notes": "Survival differences among women with\nde   novo   stage   IV   and   relapsed   breast   cancer.Ann Oncol",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 16,
    "unit": null,
    "population": null,
    "notes": "Survival differences among women with\nde   novo   stage   IV   and   relapsed   breast   cancer.Ann Oncol",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 1670,
    "unit": null,
    "population": null,
    "notes": "Survival differences among women with\nde   novo   stage   IV   and   relapsed   breast   cancer.Ann Oncol",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 1674,
    "unit": null,
    "population": null,
    "notes": "Survival differences among women with\nde   novo   stage   IV   and   relapsed   breast   cancer.Ann Oncol",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 58,
    "unit": null,
    "population": null,
    "notes": "Survival differences among women with\nde   novo   stage   IV   and   relapsed   breast   cancer.Ann Oncol",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 21,
    "unit": "year",
    "population": null,
    "notes": "Four-year follow-up of trastuzumab\nplus adjuvant chemotherapy for operable human epidermal growth factor\nreceptor 2-positive breast cancer: joint analysis of data from NCCTG N9831\nand NSABP B-31.J Cli",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 11,
    "unit": "year",
    "population": null,
    "notes": "Four-year follow-up of trastuzumab\nplus adjuvant chemotherapy for operable human epidermal growth factor\nreceptor 2-positive breast cancer: joint analysis of data from NCCTG N9831\nand NSABP B-31.J Cli",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 2169,
    "unit": "year",
    "population": null,
    "notes": "Four-year follow-up of trastuzumab\nplus adjuvant chemotherapy for operable human epidermal growth factor\nreceptor 2-positive breast cancer: joint analysis of data from NCCTG N9831\nand NSABP B-31.J Cli",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 2174,
    "unit": "year",
    "population": null,
    "notes": "Four-year follow-up of trastuzumab\nplus adjuvant chemotherapy for operable human epidermal growth factor\nreceptor 2-positive breast cancer: joint analysis of data from NCCTG N9831\nand NSABP B-31.J Cli",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 59,
    "unit": "year",
    "population": null,
    "notes": "Four-year follow-up of trastuzumab\nplus adjuvant chemotherapy for operable human epidermal growth factor\nreceptor 2-positive breast cancer: joint analysis of data from NCCTG N9831\nand NSABP B-31.J Cli",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": "2017",
    "value": 29,
    "unit": null,
    "population": null,
    "notes": "Choosing wisely in oncology: are\nwereadyforvalue-basedcare?J   Oncol   Pract.2017;doi:\n10.1200/JOP.2016.019281",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": "2017",
    "value": 25,
    "unit": null,
    "population": null,
    "notes": "Choosing wisely in oncology: are\nwereadyforvalue-basedcare?J   Oncol   Pract.2017;doi:\n10.1200/JOP.2016.019281",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": "2017",
    "value": 3366,
    "unit": null,
    "population": null,
    "notes": "Choosing wisely in oncology: are\nwereadyforvalue-basedcare?J   Oncol   Pract.2017;doi:\n10.1200/JOP.2016.019281",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": "2017",
    "value": 3373,
    "unit": null,
    "population": null,
    "notes": "Choosing wisely in oncology: are\nwereadyforvalue-basedcare?J   Oncol   Pract.2017;doi:\n10.1200/JOP.2016.019281",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": "2017",
    "value": 60,
    "unit": null,
    "population": null,
    "notes": "Choosing wisely in oncology: are\nwereadyforvalue-basedcare?J   Oncol   Pract.2017;doi:\n10.1200/JOP.2016.019281",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 21,
    "unit": null,
    "population": null,
    "notes": "Validating billing/encounter codes\nas indicators of lung, colorectal, breast, and prostate cancer recurrence using\n2 large contemporary cohorts.Med Care",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 21,
    "unit": null,
    "population": null,
    "notes": "Validating billing/encounter codes\nas indicators of lung, colorectal, breast, and prostate cancer recurrence using\n2 large contemporary cohorts.Med Care",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 28,
    "unit": null,
    "population": null,
    "notes": "Validating billing/encounter codes\nas indicators of lung, colorectal, breast, and prostate cancer recurrence using\n2 large contemporary cohorts.Med Care",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 64,
    "unit": null,
    "population": null,
    "notes": "Validating billing/encounter codes\nas indicators of lung, colorectal, breast, and prostate cancer recurrence using\n2 large contemporary cohorts.Med Care",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-001",
    "filename": "Caswell_et_al.pdf",
    "metricName": null,
    "timePeriod": "2012",
    "value": 67,
    "unit": null,
    "population": null,
    "notes": "ancer events following early-stage invasive breast cancer.J\nNatl Cancer Inst. 2012;104(12):931–940.\n67.  Chawla N, Yabroff KR, Mariotto A, et al. Limited validity of diagnosis codes in\nMedicare claims",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 7,
    "unit": "%",
    "population": null,
    "notes": "Approximately 7% \nof  women  present  with  distant  metastasis  at  \ndiagnosis",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "1978",
    "value": 27,
    "unit": "%",
    "population": null,
    "notes": "A  large  German  cancer  registry  study  demonstrated  \nthe  5-year  risk  of  metastasis  for  women  with  an  initial  \ndiagnosis of early BC fell from 27% to 15% from 1978 to \n1984  to  1995–200",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "1978",
    "value": 15,
    "unit": "%",
    "population": null,
    "notes": "A  large  German  cancer  registry  study  demonstrated  \nthe  5-year  risk  of  metastasis  for  women  with  an  initial  \ndiagnosis of early BC fell from 27% to 15% from 1978 to \n1984  to  1995–200",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": 10,
    "unit": "%",
    "population": null,
    "notes": "We previously estimated the 5-year risk of metastatic BC \nat  10%  from  a  population-based  sample  of  6644  Austra-\nlian women with an initial diagnosis of non-metastatic BC \nin 2001–2002",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 5,
    "unit": "%",
    "population": null,
    "notes": "2\n This study demonstrated a marked differ-\nence  in  5-year  risk  of  metastasis  between  women  with  \nnode-negative disease (5%) versus those with node posi-\ntive  or  locally  advanced  disease ",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "median  \nsurvival",
    "timePeriod": "2001",
    "value": 27,
    "unit": "months",
    "population": null,
    "notes": "Our   recent   Australia-wide   popula-\ntion-based  study  of  women  treated  with  trastuzumab  for  \nmetastatic  BC  has  reported  an  improvement  in  median  \nsurvival from 27 months to 38 month",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "median  \nsurvival",
    "timePeriod": "2001",
    "value": 38,
    "unit": "months",
    "population": null,
    "notes": "Our   recent   Australia-wide   popula-\ntion-based  study  of  women  treated  with  trastuzumab  for  \nmetastatic  BC  has  reported  an  improvement  in  median  \nsurvival from 27 months to 38 month",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "85 \nyear",
    "value": 85,
    "unit": "years",
    "population": null,
    "notes": "IntroduCtIon  \nBreast  cancer  (BC)  is  the  most  common  \ncancer   diagnosed   in   Australian   women,   \naffecting one in eight women by the age of 85 \nyears; and the second most common cause of ",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": "5 year",
    "value": 5,
    "unit": "years",
    "population": null,
    "notes": "12–14\n In contrast, large population-based \nstudies have not consistently reported an overall improve-\nment in metastatic BC survival over time, with no improve-\nment for women with metastasis within ",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": "Metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access \nMetastatic breast cancer incidence, site \nand survival in Australia, 2001–2016: a \npopulation-based health record linkage \nstudy protocol\nSarah J Lord,\n1,2",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": "Metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access \nMetastatic breast cancer incidence, site \nand survival in Australia, 2001–2016: a \npopulation-based health record linkage \nstudy protocol\nSarah J Lord,\n1,2",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": "Metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access \nMetastatic breast cancer incidence, site \nand survival in Australia, 2001–2016: a \npopulation-based health record linkage \nstudy protocol\nSarah J Lord,\n1,2",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": null,
    "unit": "year",
    "population": "Metastatic \nbreast cancer",
    "notes": "Metastatic \nbreast cancer incidence, \nsite and survival in Australia, \n2001–2016: a population-\nbased health record linkage \nstudy protocol",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": null,
    "unit": "year",
    "population": "Metastatic \nbreast cancer",
    "notes": "Metastatic \nbreast cancer incidence, \nsite and survival in Australia, \n2001–2016: a population-\nbased health record linkage \nstudy protocol",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "The aim of this study is to investigate \nchanges in the incidence, site and survival of metastatic \ndisease for women with a first diagnosis of BC in 2001–\n2002 vs 2006–2007",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "The aim of this study is to investigate \nchanges in the incidence, site and survival of metastatic \ndisease for women with a first diagnosis of BC in 2001–\n2002 vs 2006–2007",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "The aim of this study is to investigate \nchanges in the incidence, site and survival of metastatic \ndisease for women with a first diagnosis of BC in 2001–\n2002 vs 2006–2007",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "The aim of this study is to investigate \nchanges in the incidence, site and survival of metastatic \ndisease for women with a first diagnosis of BC in 2001–\n2002 vs 2006–2007",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Methods and analysis\n\nP\nopulation-based retrospective \ncohort study of women with first primary invasive \nBC registered in the New South Wales (NSW) Cancer \nRegistry in 2001–2002 and 2006–2007",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Methods and analysis\n\nP\nopulation-based retrospective \ncohort study of women with first primary invasive \nBC registered in the New South Wales (NSW) Cancer \nRegistry in 2001–2002 and 2006–2007",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Methods and analysis\n\nP\nopulation-based retrospective \ncohort study of women with first primary invasive \nBC registered in the New South Wales (NSW) Cancer \nRegistry in 2001–2002 and 2006–2007",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Methods and analysis\n\nP\nopulation-based retrospective \ncohort study of women with first primary invasive \nBC registered in the New South Wales (NSW) Cancer \nRegistry in 2001–2002 and 2006–2007",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "1978",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "A  large  German  cancer  registry  study  demonstrated  \nthe  5-year  risk  of  metastasis  for  women  with  an  initial  \ndiagnosis of early BC fell from 27% to 15% from 1978 to \n1984  to  1995–200",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "1978",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "A  large  German  cancer  registry  study  demonstrated  \nthe  5-year  risk  of  metastasis  for  women  with  an  initial  \ndiagnosis of early BC fell from 27% to 15% from 1978 to \n1984  to  1995–200",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2007",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "8\n  A  subsequent  study  using  the  same  \nregistry with women diagnosed in 2007–2013 indicated a \nfurther reduction in 5-year risk of metastasis to approxi-\nmately 8%",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2007",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "8\n  A  subsequent  study  using  the  same  \nregistry with women diagnosed in 2007–2013 indicated a \nfurther reduction in 5-year risk of metastasis to approxi-\nmately 8%",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2007",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "8\n  A  subsequent  study  using  the  same  \nregistry with women diagnosed in 2007–2013 indicated a \nfurther reduction in 5-year risk of metastasis to approxi-\nmately 8%",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2007",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "8\n  A  subsequent  study  using  the  same  \nregistry with women diagnosed in 2007–2013 indicated a \nfurther reduction in 5-year risk of metastasis to approxi-\nmately 8%",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2003",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "For  women  with  a  diagnosis  of  \nearly  BC  up  to  2003,  large  cohort  studies  have  reported  \na reduction in bone being the first site of metastasis over \ntime, with an increased proportion ",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "2\n This study demonstrated a marked differ-\nence  in  5-year  risk  of  metastasis  between  women  with  \nnode-negative disease (5%) versus those with node posi-\ntive  or  locally  advanced  disease ",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "2\n This study demonstrated a marked differ-\nence  in  5-year  risk  of  metastasis  between  women  with  \nnode-negative disease (5%) versus those with node posi-\ntive  or  locally  advanced  disease ",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "median  \nsurvival",
    "timePeriod": "2001",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Our   recent   Australia-wide   popula-\ntion-based  study  of  women  treated  with  trastuzumab  for  \nmetastatic  BC  has  reported  an  improvement  in  median  \nsurvival from 27 months to 38 month",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "median  \nsurvival",
    "timePeriod": "2001",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Our   recent   Australia-wide   popula-\ntion-based  study  of  women  treated  with  trastuzumab  for  \nmetastatic  BC  has  reported  an  improvement  in  median  \nsurvival from 27 months to 38 month",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "median  \nsurvival",
    "timePeriod": "2001",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Our   recent   Australia-wide   popula-\ntion-based  study  of  women  treated  with  trastuzumab  for  \nmetastatic  BC  has  reported  an  improvement  in  median  \nsurvival from 27 months to 38 month",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "median  \nsurvival",
    "timePeriod": "2001",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Our   recent   Australia-wide   popula-\ntion-based  study  of  women  treated  with  trastuzumab  for  \nmetastatic  BC  has  reported  an  improvement  in  median  \nsurvival from 27 months to 38 month",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2006",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Has the \n5-year cumulative incidence of metastatic BC \nchanged  for  women  with  an  initial  diagnosis  of  early  \nBC in the period 2006–2007 vs 2001–2002, overall and \nwithin  subgroups  categoris",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2006",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Has the \n5-year cumulative incidence of metastatic BC \nchanged  for  women  with  an  initial  diagnosis  of  early  \nBC in the period 2006–2007 vs 2001–2002, overall and \nwithin  subgroups  categoris",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2006",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Has the \n5-year cumulative incidence of metastatic BC \nchanged  for  women  with  an  initial  diagnosis  of  early  \nBC in the period 2006–2007 vs 2001–2002, overall and \nwithin  subgroups  categoris",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2006",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Has the \n5-year cumulative incidence of metastatic BC \nchanged  for  women  with  an  initial  diagnosis  of  early  \nBC in the period 2006–2007 vs 2001–2002, overall and \nwithin  subgroups  categoris",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2006",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Has the distribution of first metastatic BC in the bone, \nliver\n, lung or brain changed for women with an initial \ndiagnosis of early BC in 2006–2007 vs 2001–2002",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": "2006",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Has   metastatic   BC   survival   changed   for   women   \nwith  an  initial  diagnosis  of  early  BC  in  2006–2007  vs  \n2001–2002?",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": "2006",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Has   metastatic   BC   survival   changed   for   women   \nwith  an  initial  diagnosis  of  early  BC  in  2006–2007  vs  \n2001–2002?",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": "2006",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Has   metastatic   BC   survival   changed   for   women   \nwith  an  initial  diagnosis  of  early  BC  in  2006–2007  vs  \n2001–2002?",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": "2006",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Has   metastatic   BC   survival   changed   for   women   \nwith  an  initial  diagnosis  of  early  BC  in  2006–2007  vs  \n2001–2002?",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": "2006",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "ic   BC   survival   changed   for   women   \nwith  an  initial  diagnosis  of  early  BC  in  2006–2007  vs  \n2001–2002?.\ns\necondary questions\n4.",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 10.1136,
    "unit": null,
    "population": "Metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access \nMetastatic breast cancer incidence, site \nand survival in Australia, 2001–2016: a \npopulation-based health record linkage \nstudy protocol\nSarah J Lord,\n1,2",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 10,
    "unit": null,
    "population": "Metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access \nMetastatic breast cancer incidence, site \nand survival in Australia, 2001–2016: a \npopulation-based health record linkage \nstudy protocol\nSarah J Lord,\n1,2",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 1136,
    "unit": null,
    "population": "Metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access \nMetastatic breast cancer incidence, site \nand survival in Australia, 2001–2016: a \npopulation-based health record linkage \nstudy protocol\nSarah J Lord,\n1,2",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 2018,
    "unit": null,
    "population": "Metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access \nMetastatic breast cancer incidence, site \nand survival in Australia, 2001–2016: a \npopulation-based health record linkage \nstudy protocol\nSarah J Lord,\n1,2",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 26414,
    "unit": null,
    "population": "Metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access \nMetastatic breast cancer incidence, site \nand survival in Australia, 2001–2016: a \npopulation-based health record linkage \nstudy protocol\nSarah J Lord,\n1,2",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 2001,
    "unit": null,
    "population": "Metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access \nMetastatic breast cancer incidence, site \nand survival in Australia, 2001–2016: a \npopulation-based health record linkage \nstudy protocol\nSarah J Lord,\n1,2",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 2016,
    "unit": null,
    "population": "Metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access \nMetastatic breast cancer incidence, site \nand survival in Australia, 2001–2016: a \npopulation-based health record linkage \nstudy protocol\nSarah J Lord,\n1,2",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 2001,
    "unit": null,
    "population": "Metastatic \nbreast cancer",
    "notes": "Metastatic \nbreast cancer incidence, \nsite and survival in Australia, \n2001–2016: a population-\nbased health record linkage \nstudy protocol",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 2016,
    "unit": null,
    "population": "Metastatic \nbreast cancer",
    "notes": "Metastatic \nbreast cancer incidence, \nsite and survival in Australia, \n2001–2016: a population-\nbased health record linkage \nstudy protocol",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 2001,
    "unit": null,
    "population": null,
    "notes": "The aim of this study is to investigate \nchanges in the incidence, site and survival of metastatic \ndisease for women with a first diagnosis of BC in 2001–\n2002 vs 2006–2007",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 2002,
    "unit": null,
    "population": null,
    "notes": "The aim of this study is to investigate \nchanges in the incidence, site and survival of metastatic \ndisease for women with a first diagnosis of BC in 2001–\n2002 vs 2006–2007",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 2006,
    "unit": null,
    "population": null,
    "notes": "The aim of this study is to investigate \nchanges in the incidence, site and survival of metastatic \ndisease for women with a first diagnosis of BC in 2001–\n2002 vs 2006–2007",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 2007,
    "unit": null,
    "population": null,
    "notes": "The aim of this study is to investigate \nchanges in the incidence, site and survival of metastatic \ndisease for women with a first diagnosis of BC in 2001–\n2002 vs 2006–2007",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": 2001,
    "unit": null,
    "population": null,
    "notes": "Methods and analysis\n\nP\nopulation-based retrospective \ncohort study of women with first primary invasive \nBC registered in the New South Wales (NSW) Cancer \nRegistry in 2001–2002 and 2006–2007",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": 2002,
    "unit": null,
    "population": null,
    "notes": "Methods and analysis\n\nP\nopulation-based retrospective \ncohort study of women with first primary invasive \nBC registered in the New South Wales (NSW) Cancer \nRegistry in 2001–2002 and 2006–2007",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": 2006,
    "unit": null,
    "population": null,
    "notes": "Methods and analysis\n\nP\nopulation-based retrospective \ncohort study of women with first primary invasive \nBC registered in the New South Wales (NSW) Cancer \nRegistry in 2001–2002 and 2006–2007",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": 2007,
    "unit": null,
    "population": null,
    "notes": "Methods and analysis\n\nP\nopulation-based retrospective \ncohort study of women with first primary invasive \nBC registered in the New South Wales (NSW) Cancer \nRegistry in 2001–2002 and 2006–2007",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "85 \nyear",
    "value": 85,
    "unit": "years",
    "population": null,
    "notes": "IntroduCtIon  \nBreast  cancer  (BC)  is  the  most  common  \ncancer   diagnosed   in   Australian   women,   \naffecting one in eight women by the age of 85 \nyears; and the second most common cause of ",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "1978",
    "value": 27,
    "unit": "year",
    "population": null,
    "notes": "A  large  German  cancer  registry  study  demonstrated  \nthe  5-year  risk  of  metastasis  for  women  with  an  initial  \ndiagnosis of early BC fell from 27% to 15% from 1978 to \n1984  to  1995–200",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "1978",
    "value": 15,
    "unit": "year",
    "population": null,
    "notes": "A  large  German  cancer  registry  study  demonstrated  \nthe  5-year  risk  of  metastasis  for  women  with  an  initial  \ndiagnosis of early BC fell from 27% to 15% from 1978 to \n1984  to  1995–200",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "1978",
    "value": 1978,
    "unit": "year",
    "population": null,
    "notes": "A  large  German  cancer  registry  study  demonstrated  \nthe  5-year  risk  of  metastasis  for  women  with  an  initial  \ndiagnosis of early BC fell from 27% to 15% from 1978 to \n1984  to  1995–200",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "1978",
    "value": 1984,
    "unit": "year",
    "population": null,
    "notes": "A  large  German  cancer  registry  study  demonstrated  \nthe  5-year  risk  of  metastasis  for  women  with  an  initial  \ndiagnosis of early BC fell from 27% to 15% from 1978 to \n1984  to  1995–200",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2007",
    "value": 1995,
    "unit": "year",
    "population": null,
    "notes": "8\n  A  subsequent  study  using  the  same  \nregistry with women diagnosed in 2007–2013 indicated a \nfurther reduction in 5-year risk of metastasis to approxi-\nmately 8%",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2007",
    "value": 2003,
    "unit": "year",
    "population": null,
    "notes": "8\n  A  subsequent  study  using  the  same  \nregistry with women diagnosed in 2007–2013 indicated a \nfurther reduction in 5-year risk of metastasis to approxi-\nmately 8%",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2007",
    "value": 2007,
    "unit": "year",
    "population": null,
    "notes": "8\n  A  subsequent  study  using  the  same  \nregistry with women diagnosed in 2007–2013 indicated a \nfurther reduction in 5-year risk of metastasis to approxi-\nmately 8%",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2007",
    "value": 2013,
    "unit": "year",
    "population": null,
    "notes": "8\n  A  subsequent  study  using  the  same  \nregistry with women diagnosed in 2007–2013 indicated a \nfurther reduction in 5-year risk of metastasis to approxi-\nmately 8%",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2003",
    "value": 2003,
    "unit": null,
    "population": null,
    "notes": "For  women  with  a  diagnosis  of  \nearly  BC  up  to  2003,  large  cohort  studies  have  reported  \na reduction in bone being the first site of metastasis over \ntime, with an increased proportion ",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": 10,
    "unit": "year",
    "population": null,
    "notes": "We previously estimated the 5-year risk of metastatic BC \nat  10%  from  a  population-based  sample  of  6644  Austra-\nlian women with an initial diagnosis of non-metastatic BC \nin 2001–2002",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": 6644,
    "unit": "year",
    "population": null,
    "notes": "We previously estimated the 5-year risk of metastatic BC \nat  10%  from  a  population-based  sample  of  6644  Austra-\nlian women with an initial diagnosis of non-metastatic BC \nin 2001–2002",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 2001,
    "unit": "year",
    "population": null,
    "notes": "2\n This study demonstrated a marked differ-\nence  in  5-year  risk  of  metastasis  between  women  with  \nnode-negative disease (5%) versus those with node posi-\ntive  or  locally  advanced  disease ",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 2002,
    "unit": "year",
    "population": null,
    "notes": "2\n This study demonstrated a marked differ-\nence  in  5-year  risk  of  metastasis  between  women  with  \nnode-negative disease (5%) versus those with node posi-\ntive  or  locally  advanced  disease ",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": "5 year",
    "value": 12,
    "unit": "years",
    "population": null,
    "notes": "12–14\n In contrast, large population-based \nstudies have not consistently reported an overall improve-\nment in metastatic BC survival over time, with no improve-\nment for women with metastasis within ",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": "5 year",
    "value": 14,
    "unit": "years",
    "population": null,
    "notes": "12–14\n In contrast, large population-based \nstudies have not consistently reported an overall improve-\nment in metastatic BC survival over time, with no improve-\nment for women with metastasis within ",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 15,
    "unit": null,
    "population": null,
    "notes": "15 16\n These studies \ndo not examine the impact of the increased availability of \ntargeted treatment on metastatic BC survival for specific \ntumour   subtypes",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 16,
    "unit": null,
    "population": null,
    "notes": "15 16\n These studies \ndo not examine the impact of the increased availability of \ntargeted treatment on metastatic BC survival for specific \ntumour   subtypes",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "median  \nsurvival",
    "timePeriod": "2001",
    "value": 27,
    "unit": "months",
    "population": null,
    "notes": "Our   recent   Australia-wide   popula-\ntion-based  study  of  women  treated  with  trastuzumab  for  \nmetastatic  BC  has  reported  an  improvement  in  median  \nsurvival from 27 months to 38 month",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "median  \nsurvival",
    "timePeriod": "2001",
    "value": 38,
    "unit": "months",
    "population": null,
    "notes": "Our   recent   Australia-wide   popula-\ntion-based  study  of  women  treated  with  trastuzumab  for  \nmetastatic  BC  has  reported  an  improvement  in  median  \nsurvival from 27 months to 38 month",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "median  \nsurvival",
    "timePeriod": "2001",
    "value": 2001,
    "unit": "months",
    "population": null,
    "notes": "Our   recent   Australia-wide   popula-\ntion-based  study  of  women  treated  with  trastuzumab  for  \nmetastatic  BC  has  reported  an  improvement  in  median  \nsurvival from 27 months to 38 month",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "median  \nsurvival",
    "timePeriod": "2001",
    "value": 2008,
    "unit": "months",
    "population": null,
    "notes": "Our   recent   Australia-wide   popula-\ntion-based  study  of  women  treated  with  trastuzumab  for  \nmetastatic  BC  has  reported  an  improvement  in  median  \nsurvival from 27 months to 38 month",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "median  \nsurvival",
    "timePeriod": "2001",
    "value": 2009,
    "unit": "months",
    "population": null,
    "notes": "Our   recent   Australia-wide   popula-\ntion-based  study  of  women  treated  with  trastuzumab  for  \nmetastatic  BC  has  reported  an  improvement  in  median  \nsurvival from 27 months to 38 month",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "median  \nsurvival",
    "timePeriod": "2001",
    "value": 2015,
    "unit": "months",
    "population": null,
    "notes": "Our   recent   Australia-wide   popula-\ntion-based  study  of  women  treated  with  trastuzumab  for  \nmetastatic  BC  has  reported  an  improvement  in  median  \nsurvival from 27 months to 38 month",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 17,
    "unit": null,
    "population": null,
    "notes": "17\nObservational evidence indicates that patients exposed \nto systemic therapy in the adjuvant setting may progress \nmore  rapidly  once  metastases  occur,\n18  19\n  although  some  \nhave  argued  aga",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 18,
    "unit": null,
    "population": null,
    "notes": "17\nObservational evidence indicates that patients exposed \nto systemic therapy in the adjuvant setting may progress \nmore  rapidly  once  metastases  occur,\n18  19\n  although  some  \nhave  argued  aga",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 19,
    "unit": null,
    "population": null,
    "notes": "17\nObservational evidence indicates that patients exposed \nto systemic therapy in the adjuvant setting may progress \nmore  rapidly  once  metastases  occur,\n18  19\n  although  some  \nhave  argued  aga",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 20,
    "unit": null,
    "population": null,
    "notes": "20\n  Single  centre  \nobservational  studies  including  treatment  data  suggest  \nthat while metastatic BC survival has improved for women \nwith  hormone  receptor-positive  disease  and  HER2-posi-",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": null,
    "value": 21,
    "unit": null,
    "population": null,
    "notes": "21 22\nTo  address  the  above-defined  knowledge  gaps,  we  will  \nconduct a programme of research with the aim to assess \nthe impact of systemic adjuvant therapy advances on the \nincidence,  sites  ",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": null,
    "value": 22,
    "unit": null,
    "population": null,
    "notes": "21 22\nTo  address  the  above-defined  knowledge  gaps,  we  will  \nconduct a programme of research with the aim to assess \nthe impact of systemic adjuvant therapy advances on the \nincidence,  sites  ",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2006",
    "value": 2006,
    "unit": "year",
    "population": null,
    "notes": "Has the \n5-year cumulative incidence of metastatic BC \nchanged  for  women  with  an  initial  diagnosis  of  early  \nBC in the period 2006–2007 vs 2001–2002, overall and \nwithin  subgroups  categoris",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2006",
    "value": 2007,
    "unit": "year",
    "population": null,
    "notes": "Has the \n5-year cumulative incidence of metastatic BC \nchanged  for  women  with  an  initial  diagnosis  of  early  \nBC in the period 2006–2007 vs 2001–2002, overall and \nwithin  subgroups  categoris",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2006",
    "value": 2001,
    "unit": "year",
    "population": null,
    "notes": "Has the \n5-year cumulative incidence of metastatic BC \nchanged  for  women  with  an  initial  diagnosis  of  early  \nBC in the period 2006–2007 vs 2001–2002, overall and \nwithin  subgroups  categoris",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2006",
    "value": 2002,
    "unit": "year",
    "population": null,
    "notes": "Has the \n5-year cumulative incidence of metastatic BC \nchanged  for  women  with  an  initial  diagnosis  of  early  \nBC in the period 2006–2007 vs 2001–2002, overall and \nwithin  subgroups  categoris",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2006",
    "value": 2006,
    "unit": null,
    "population": null,
    "notes": "Has the distribution of first metastatic BC in the bone, \nliver\n, lung or brain changed for women with an initial \ndiagnosis of early BC in 2006–2007 vs 2001–2002",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": "2006",
    "value": 2007,
    "unit": null,
    "population": null,
    "notes": "Has   metastatic   BC   survival   changed   for   women   \nwith  an  initial  diagnosis  of  early  BC  in  2006–2007  vs  \n2001–2002?",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": "2006",
    "value": 2001,
    "unit": null,
    "population": null,
    "notes": "Has   metastatic   BC   survival   changed   for   women   \nwith  an  initial  diagnosis  of  early  BC  in  2006–2007  vs  \n2001–2002?",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": "2006",
    "value": 2002,
    "unit": null,
    "population": null,
    "notes": "Has   metastatic   BC   survival   changed   for   women   \nwith  an  initial  diagnosis  of  early  BC  in  2006–2007  vs  \n2001–2002?",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": "2006",
    "value": 2006,
    "unit": null,
    "population": null,
    "notes": "Has   metastatic   BC   survival   changed   for   women   \nwith  an  initial  diagnosis  of  early  BC  in  2006–2007  vs  \n2001–2002?",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": "2006",
    "value": 2007,
    "unit": null,
    "population": null,
    "notes": "ic   BC   survival   changed   for   women   \nwith  an  initial  diagnosis  of  early  BC  in  2006–2007  vs  \n2001–2002?.\ns\necondary questions\n4.",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "What is the annual hazard of developing distant metas\n-\ntases for women with an initial diagnosis of early BC in \n2001–2002 and 2006–2007, overall and by extent of dis-\nease at initial diagnosis (loca",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "What is the annual hazard of developing distant metas\n-\ntases for women with an initial diagnosis of early BC in \n2001–2002 and 2006–2007, overall and by extent of dis-\nease at initial diagnosis (loca",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "What is the annual hazard of developing distant metas\n-\ntases for women with an initial diagnosis of early BC in \n2001–2002 and 2006–2007, overall and by extent of dis-\nease at initial diagnosis (loca",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "What is the annual hazard of developing distant metas\n-\ntases for women with an initial diagnosis of early BC in \n2001–2002 and 2006–2007, overall and by extent of dis-\nease at initial diagnosis (loca",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": 2001,
    "unit": null,
    "population": null,
    "notes": "What is the annual hazard of developing distant metas\n-\ntases for women with an initial diagnosis of early BC in \n2001–2002 and 2006–2007, overall and by extent of dis-\nease at initial diagnosis (loca",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": 2002,
    "unit": null,
    "population": null,
    "notes": "What is the annual hazard of developing distant metas\n-\ntases for women with an initial diagnosis of early BC in \n2001–2002 and 2006–2007, overall and by extent of dis-\nease at initial diagnosis (loca",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": 2006,
    "unit": null,
    "population": null,
    "notes": "What is the annual hazard of developing distant metas\n-\ntases for women with an initial diagnosis of early BC in \n2001–2002 and 2006–2007, overall and by extent of dis-\nease at initial diagnosis (loca",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": 2007,
    "unit": null,
    "population": null,
    "notes": "What is the annual hazard of developing distant metas\n-\ntases for women with an initial diagnosis of early BC in \n2001–2002 and 2006–2007, overall and by extent of dis-\nease at initial diagnosis (loca",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": "1978",
    "value": 5,
    "unit": "years",
    "population": null,
    "notes": "*Participants for periods 1978–1987 and 1988–1997 are not population-based samples; metastatic BC survival time is reported by site stratified by HR subtype (positive, negative).†Metastatic BC inciden",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": "1978",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "*Participants for periods 1978–1987 and 1988–1997 are not population-based samples; metastatic BC survival time is reported by site stratified by HR subtype (positive, negative).†Metastatic BC inciden",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": "1978",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "*Participants for periods 1978–1987 and 1988–1997 are not population-based samples; metastatic BC survival time is reported by site stratified by HR subtype (positive, negative).†Metastatic BC inciden",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": "1978",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "*Participants for periods 1978–1987 and 1988–1997 are not population-based samples; metastatic BC survival time is reported by site stratified by HR subtype (positive, negative).†Metastatic BC inciden",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": "1978",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "*Participants for periods 1978–1987 and 1988–1997 are not population-based samples; metastatic BC survival time is reported by site stratified by HR subtype (positive, negative).†Metastatic BC inciden",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "23\n\nAustralian  citizens  and  permanent  residents  have  access  \nto subsidised healthcare from Australia’s publicly funded \nuniversal  healthcare  system,  including  free  treatment  in  \npublic h",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 10.1136,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2016",
    "value": 7.48,
    "unit": null,
    "population": null,
    "notes": "setting\nNew  South  Wales  (NSW)  is  the  most  populous  state  in  \nAustralia  with  a  population  of  7.48  million  in  2016",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 10,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 1136,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 2018,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 26414,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 2001,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 2002,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 8133,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 15,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 2006,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 2007,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 8715,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 10,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 2017,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 16,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 2017,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 2017,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 16,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 1978,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 1987,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 9952,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 15,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 1988,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 1997,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 18,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 297,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 15,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 1998,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 2006,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 30,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 684,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 15,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 2007,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 2013,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 29,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 826,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 2013,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 1978,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 1984,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 4978,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 10,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 1985,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 1994,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 10,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 201,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 10,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 1995,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 2003,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 18,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 592,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 2017,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 34,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 1997,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 2001,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 1905,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 2002,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 2006,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 1664,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 2007,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 2011,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 819,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 2013,
    "unit": "year",
    "population": "metastatic breast cancer",
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nTable 1\n\nStudy characteristics and comparison with r\necent population-based cohort studies assessing changes in metastatic breast cancer (BC) incidence, sit",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": "1978",
    "value": 1978,
    "unit": "years",
    "population": null,
    "notes": "*Participants for periods 1978–1987 and 1988–1997 are not population-based samples; metastatic BC survival time is reported by site stratified by HR subtype (positive, negative).†Metastatic BC inciden",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": "1978",
    "value": 1987,
    "unit": "years",
    "population": null,
    "notes": "*Participants for periods 1978–1987 and 1988–1997 are not population-based samples; metastatic BC survival time is reported by site stratified by HR subtype (positive, negative).†Metastatic BC inciden",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": "1978",
    "value": 1988,
    "unit": "years",
    "population": null,
    "notes": "*Participants for periods 1978–1987 and 1988–1997 are not population-based samples; metastatic BC survival time is reported by site stratified by HR subtype (positive, negative).†Metastatic BC inciden",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": "1978",
    "value": 1997,
    "unit": "years",
    "population": null,
    "notes": "*Participants for periods 1978–1987 and 1988–1997 are not population-based samples; metastatic BC survival time is reported by site stratified by HR subtype (positive, negative).†Metastatic BC inciden",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2016",
    "value": 48,
    "unit": null,
    "population": null,
    "notes": "setting\nNew  South  Wales  (NSW)  is  the  most  populous  state  in  \nAustralia  with  a  population  of  7.48  million  in  2016",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 2016,
    "unit": null,
    "population": null,
    "notes": "23\n\nAustralian  citizens  and  permanent  residents  have  access  \nto subsidised healthcare from Australia’s publicly funded \nuniversal  healthcare  system,  including  free  treatment  in  \npublic h",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 23,
    "unit": null,
    "population": null,
    "notes": "23\n\nAustralian  citizens  and  permanent  residents  have  access  \nto subsidised healthcare from Australia’s publicly funded \nuniversal  healthcare  system,  including  free  treatment  in  \npublic h",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 24,
    "unit": null,
    "population": null,
    "notes": "The  NSW  Cancer  Registry  records  approximately  one  \nthird  of  all  new  BCs  diagnosed  in  Australia  and  reports  \nsimilar  outcomes  to  those  observed  nationally,\n24\n  there-\nfore the st",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 10,
    "unit": null,
    "population": null,
    "notes": "A  trained  \nmedical  coder  at  each  hospital  reviews  the  patient’s  \nmedical  record  to  classify  the  principal  diagnosis,  addi-\ntional   diagnoses   and   procedures   (including   surgery",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 26,
    "unit": null,
    "population": null,
    "notes": "pensed in Australia outside of public \nhospitals,  including  dates  of  prescription  and  supply.\n26",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "6 \nmonth",
    "value": 6,
    "unit": "months",
    "population": null,
    "notes": "The MBS item code provides information about \nTable 2 Summary of study variables, outcomes and data sources\nCharacteristicData extracted to code variableData source\nDemographic \n\n     AgeDate of birth",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2012",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Prior to April 2012, PBS claims were not \nrecorded  for  medicines  that  cost  less  than  the  required  \npatient copayment (up to $A35.40 or $A5.80 for conces-\nsion  holders  in  2012)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2012",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Prior to April 2012, PBS claims were not \nrecorded  for  medicines  that  cost  less  than  the  required  \npatient copayment (up to $A35.40 or $A5.80 for conces-\nsion  holders  in  2012)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "The  Commonwealth  Government  Herceptin  Program  \nsubsidised   trastuzumab   for   women   with   HER2-pos-\nitive  metastatic  BC  from  December  2001  to  June  2015,  \nafter  which  it  was  subs",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "The  Commonwealth  Government  Herceptin  Program  \nsubsidised   trastuzumab   for   women   with   HER2-pos-\nitive  metastatic  BC  from  December  2001  to  June  2015,  \nafter  which  it  was  subs",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nCommonwealth     Government     Medicare     Benefits     \nSchedule   (MBS)   claims   provide   information   on   all   \nsubsidised  outpatient  consultat",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2018",
    "value": 10.1136,
    "unit": null,
    "population": null,
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nCommonwealth     Government     Medicare     Benefits     \nSchedule   (MBS)   claims   provide   information   on   all   \nsubsidised  outpatient  consultat",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2012",
    "value": 2012,
    "unit": null,
    "population": null,
    "notes": "Prior to April 2012, PBS claims were not \nrecorded  for  medicines  that  cost  less  than  the  required  \npatient copayment (up to $A35.40 or $A5.80 for conces-\nsion  holders  in  2012)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2012",
    "value": 40,
    "unit": null,
    "population": null,
    "notes": "Prior to April 2012, PBS claims were not \nrecorded  for  medicines  that  cost  less  than  the  required  \npatient copayment (up to $A35.40 or $A5.80 for conces-\nsion  holders  in  2012)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2012",
    "value": 80,
    "unit": null,
    "population": null,
    "notes": "Prior to April 2012, PBS claims were not \nrecorded  for  medicines  that  cost  less  than  the  required  \npatient copayment (up to $A35.40 or $A5.80 for conces-\nsion  holders  in  2012)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2012",
    "value": 2012,
    "unit": null,
    "population": null,
    "notes": "Prior to April 2012, PBS claims were not \nrecorded  for  medicines  that  cost  less  than  the  required  \npatient copayment (up to $A35.40 or $A5.80 for conces-\nsion  holders  in  2012)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": 2001,
    "unit": null,
    "population": null,
    "notes": "The  Commonwealth  Government  Herceptin  Program  \nsubsidised   trastuzumab   for   women   with   HER2-pos-\nitive  metastatic  BC  from  December  2001  to  June  2015,  \nafter  which  it  was  subs",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": 2015,
    "unit": null,
    "population": null,
    "notes": "The  Commonwealth  Government  Herceptin  Program  \nsubsidised   trastuzumab   for   women   with   HER2-pos-\nitive  metastatic  BC  from  December  2001  to  June  2015,  \nafter  which  it  was  subs",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2018",
    "value": 10,
    "unit": null,
    "population": null,
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nCommonwealth     Government     Medicare     Benefits     \nSchedule   (MBS)   claims   provide   information   on   all   \nsubsidised  outpatient  consultat",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2018",
    "value": 1136,
    "unit": null,
    "population": null,
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nCommonwealth     Government     Medicare     Benefits     \nSchedule   (MBS)   claims   provide   information   on   all   \nsubsidised  outpatient  consultat",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2018",
    "value": 2018,
    "unit": null,
    "population": null,
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nCommonwealth     Government     Medicare     Benefits     \nSchedule   (MBS)   claims   provide   information   on   all   \nsubsidised  outpatient  consultat",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2018",
    "value": 26414,
    "unit": null,
    "population": null,
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nCommonwealth     Government     Medicare     Benefits     \nSchedule   (MBS)   claims   provide   information   on   all   \nsubsidised  outpatient  consultat",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "3 mo",
    "value": 11,
    "unit": "month",
    "population": null,
    "notes": "BreastScreen\n  Extent of diseaseLocal, regional, distant, unknown at diagnosisCancer Registry\n\n     MorphologyICD-O-3 morphology code (ductal, lobular and mixed ductal/lobular, other) at \nprimary diag",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": "12 \nmonth",
    "value": 12,
    "unit": "months",
    "population": null,
    "notes": "Time to first distant \nmetastasis\nDate of primary BC diagnosisCancer Registry\nDate of first notification wher\ne extent of disease is coded as distantCancer Registry\nDate of first APDC principal or add",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": "12 \nmonth",
    "value": 12,
    "unit": "months",
    "population": null,
    "notes": "Time to first distant \nmetastasis\nDate of primary BC diagnosisCancer Registry\nDate of first notification wher\ne extent of disease is coded as distantCancer Registry\nDate of first APDC principal or add",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "12  month",
    "value": 12,
    "unit": "months",
    "population": null,
    "notes": "For PBS and MBS claims, we will define metastatic BC \nif  the  item  code  indication  specifies  metastatic  BC;  or  if  \nthe  treatment  commenced  12  months  or  more  after  an  \nearly BC diagno",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "12 month",
    "value": 12,
    "unit": "months",
    "population": null,
    "notes": "A 12-month period was chosen for this \ndefinition as treatment of the primary tumour is generally \ncompleted within 12 months",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": "12 \nmonth",
    "value": 88,
    "unit": "months",
    "population": null,
    "notes": "Time to first distant \nmetastasis\nDate of primary BC diagnosisCancer Registry\nDate of first notification wher\ne extent of disease is coded as distantCancer Registry\nDate of first APDC principal or add",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": "12 \nmonth",
    "value": 12,
    "unit": "months",
    "population": null,
    "notes": "Time to first distant \nmetastasis\nDate of primary BC diagnosisCancer Registry\nDate of first notification wher\ne extent of disease is coded as distantCancer Registry\nDate of first APDC principal or add",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": "12 \nmonth",
    "value": 12,
    "unit": "months",
    "population": null,
    "notes": "Time to first distant \nmetastasis\nDate of primary BC diagnosisCancer Registry\nDate of first notification wher\ne extent of disease is coded as distantCancer Registry\nDate of first APDC principal or add",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "12  month",
    "value": 12,
    "unit": "months",
    "population": null,
    "notes": "For PBS and MBS claims, we will define metastatic BC \nif  the  item  code  indication  specifies  metastatic  BC;  or  if  \nthe  treatment  commenced  12  months  or  more  after  an  \nearly BC diagno",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "12 month",
    "value": 12,
    "unit": "month",
    "population": null,
    "notes": "A 12-month period was chosen for this \ndefinition as treatment of the primary tumour is generally \ncompleted within 12 months",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "12 month",
    "value": 12,
    "unit": "month",
    "population": null,
    "notes": "A 12-month period was chosen for this \ndefinition as treatment of the primary tumour is generally \ncompleted within 12 months",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2006",
    "value": 1,
    "unit": "%",
    "population": null,
    "notes": "study size\nTo  identify  a  1%  difference  in  the  cumulative  incidence  \nof  metastatic  BC  for  women  with  an  initial  diagnosis  of  \nnon-metastatic  BC  in  2006–2007  vs  2001–2002,  we  r",
    "pageHint": 6,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 62,
    "unit": "%",
    "population": null,
    "notes": "Thus,  with  an  estimated  6644  women  in  \ncohort 1 and 6850 women in cohort 2 (localised 62%, node \npositive or locally advanced 38%), we have sufficient power \nto address our primary research que",
    "pageHint": 6,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 38,
    "unit": "%",
    "population": null,
    "notes": "Thus,  with  an  estimated  6644  women  in  \ncohort 1 and 6850 women in cohort 2 (localised 62%, node \npositive or locally advanced 38%), we have sufficient power \nto address our primary research que",
    "pageHint": 6,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 99,
    "unit": "%",
    "population": null,
    "notes": "We will also have over 99% power to detect a 1% differ-\nence  in  5-year  cumulative  incidence  in  the  subgroup  of  \nwomen  with  localised  BC  at  diagnosis,  using  our  initial  \nstudy finding",
    "pageHint": 6,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1,
    "unit": "%",
    "population": null,
    "notes": "We will also have over 99% power to detect a 1% differ-\nence  in  5-year  cumulative  incidence  in  the  subgroup  of  \nwomen  with  localised  BC  at  diagnosis,  using  our  initial  \nstudy finding",
    "pageHint": 6,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 5.3,
    "unit": "%",
    "population": null,
    "notes": "We will also have over 99% power to detect a 1% differ-\nence  in  5-year  cumulative  incidence  in  the  subgroup  of  \nwomen  with  localised  BC  at  diagnosis,  using  our  initial  \nstudy finding",
    "pageHint": 6,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "12  month",
    "value": 12,
    "unit": "months",
    "population": null,
    "notes": "We  will  classify  treatment  \nas  adjuvant  therapy  if  commenced  within  12  months  of  \nthe initial early BC diagnosis and before the first recorded \nmetastatic  event",
    "pageHint": 6,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": 70,
    "unit": "years",
    "population": null,
    "notes": "We  will  use  Cox  proportional  hazards  regression  to  \ninvestigate   associations   between   baseline   characteris-\ntics  and  the  distant  recurrence-free  interval  including:  \nage  (<50,  ",
    "pageHint": 6,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "8 year",
    "value": 8,
    "unit": "years",
    "population": null,
    "notes": "Metastasis site\nWe  will  compare  the  distribution  of  the  first  metastatic  \nsite that is, bone, lung, liver and brain at 8 years postdiag-\nnosis between cohort 1 vs cohort 2 and by adjuvant the",
    "pageHint": 6,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": "70 year",
    "value": 70,
    "unit": "years",
    "population": null,
    "notes": "We will perform separate \nanalyses  for  M1  and  M0  groups  to  examine  postmetastasis  \nsurvival by site of metastatic spread (bone, lung, liver, brain, \nother); age at first record of distant met",
    "pageHint": 6,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 6644,
    "unit": "count",
    "population": null,
    "notes": "Thus,  with  an  estimated  6644  women  in  \ncohort 1 and 6850 women in cohort 2 (localised 62%, node \npositive or locally advanced 38%), we have sufficient power \nto address our primary research que",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 6850,
    "unit": "count",
    "population": null,
    "notes": "Thus,  with  an  estimated  6644  women  in  \ncohort 1 and 6850 women in cohort 2 (localised 62%, node \npositive or locally advanced 38%), we have sufficient power \nto address our primary research que",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 628,
    "unit": "count",
    "population": null,
    "notes": "We will also have over 99% power to detect a 1% differ-\nence  in  5-year  cumulative  incidence  in  the  subgroup  of  \nwomen  with  localised  BC  at  diagnosis,  using  our  initial  \nstudy finding",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "overall survival",
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nWe will use death from any cause in a secondary anal-\nysis of overall survival following the first record of distant \nmetastasis",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2006",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "study size\nTo  identify  a  1%  difference  in  the  cumulative  incidence  \nof  metastatic  BC  for  women  with  an  initial  diagnosis  of  \nnon-metastatic  BC  in  2006–2007  vs  2001–2002,  we  r",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2006",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "study size\nTo  identify  a  1%  difference  in  the  cumulative  incidence  \nof  metastatic  BC  for  women  with  an  initial  diagnosis  of  \nnon-metastatic  BC  in  2006–2007  vs  2001–2002,  we  r",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2006",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "study size\nTo  identify  a  1%  difference  in  the  cumulative  incidence  \nof  metastatic  BC  for  women  with  an  initial  diagnosis  of  \nnon-metastatic  BC  in  2006–2007  vs  2001–2002,  we  r",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2006",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "study size\nTo  identify  a  1%  difference  in  the  cumulative  incidence  \nof  metastatic  BC  for  women  with  an  initial  diagnosis  of  \nnon-metastatic  BC  in  2006–2007  vs  2001–2002,  we  r",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2016",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "30\n  For  this  analysis,  we  will  censor  women  with  no  \ndistant metastasis or BC death recorded at 30 September \n2016  (the  ‘reference’  date),  representing  the  last  date  \nCancer  Registr",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We will use the log-rank test to test \nfor differences in the distant recurrence-free interval by: \nextent  of  disease  at  initial  diagnosis  (localised,  regional,  \nunknown); period of diagnosis ",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We will use the log-rank test to test \nfor differences in the distant recurrence-free interval by: \nextent  of  disease  at  initial  diagnosis  (localised,  regional,  \nunknown); period of diagnosis ",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We will use the log-rank test to test \nfor differences in the distant recurrence-free interval by: \nextent  of  disease  at  initial  diagnosis  (localised,  regional,  \nunknown); period of diagnosis ",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We will use the log-rank test to test \nfor differences in the distant recurrence-free interval by: \nextent  of  disease  at  initial  diagnosis  (localised,  regional,  \nunknown); period of diagnosis ",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We will esti-\nmate annual hazard rates for distant metastasis by extent \nof disease at initial diagnosis and by period (2001–2002, \n2006–2007)",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We will esti-\nmate annual hazard rates for distant metastasis by extent \nof disease at initial diagnosis and by period (2001–2002, \n2006–2007)",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We will esti-\nmate annual hazard rates for distant metastasis by extent \nof disease at initial diagnosis and by period (2001–2002, \n2006–2007)",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We  will  use  Cox  proportional  hazards  regression  to  \ninvestigate   associations   between   baseline   characteris-\ntics  and  the  distant  recurrence-free  interval  including:  \nage  (<50,  ",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We  will  use  Cox  proportional  hazards  regression  to  \ninvestigate   associations   between   baseline   characteris-\ntics  and  the  distant  recurrence-free  interval  including:  \nage  (<50,  ",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We  will  use  Cox  proportional  hazards  regression  to  \ninvestigate   associations   between   baseline   characteris-\ntics  and  the  distant  recurrence-free  interval  including:  \nage  (<50,  ",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We  will  use  Cox  proportional  hazards  regression  to  \ninvestigate   associations   between   baseline   characteris-\ntics  and  the  distant  recurrence-free  interval  including:  \nage  (<50,  ",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "overall survival",
    "timePeriod": "2018",
    "value": 10.1136,
    "unit": null,
    "population": null,
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nWe will use death from any cause in a secondary anal-\nysis of overall survival following the first record of distant \nmetastasis",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 5.3,
    "unit": "year",
    "population": null,
    "notes": "We will also have over 99% power to detect a 1% differ-\nence  in  5-year  cumulative  incidence  in  the  subgroup  of  \nwomen  with  localised  BC  at  diagnosis,  using  our  initial  \nstudy finding",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "overall survival",
    "timePeriod": "2018",
    "value": 10,
    "unit": null,
    "population": null,
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nWe will use death from any cause in a secondary anal-\nysis of overall survival following the first record of distant \nmetastasis",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "overall survival",
    "timePeriod": "2018",
    "value": 1136,
    "unit": null,
    "population": null,
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nWe will use death from any cause in a secondary anal-\nysis of overall survival following the first record of distant \nmetastasis",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "overall survival",
    "timePeriod": "2018",
    "value": 2018,
    "unit": null,
    "population": null,
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nWe will use death from any cause in a secondary anal-\nysis of overall survival following the first record of distant \nmetastasis",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "overall survival",
    "timePeriod": "2018",
    "value": 26414,
    "unit": null,
    "population": null,
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\nWe will use death from any cause in a secondary anal-\nysis of overall survival following the first record of distant \nmetastasis",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "12  month",
    "value": 12,
    "unit": "months",
    "population": null,
    "notes": "We  will  classify  treatment  \nas  adjuvant  therapy  if  commenced  within  12  months  of  \nthe initial early BC diagnosis and before the first recorded \nmetastatic  event",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2006",
    "value": 2006,
    "unit": "%",
    "population": null,
    "notes": "study size\nTo  identify  a  1%  difference  in  the  cumulative  incidence  \nof  metastatic  BC  for  women  with  an  initial  diagnosis  of  \nnon-metastatic  BC  in  2006–2007  vs  2001–2002,  we  r",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2006",
    "value": 2007,
    "unit": "%",
    "population": null,
    "notes": "study size\nTo  identify  a  1%  difference  in  the  cumulative  incidence  \nof  metastatic  BC  for  women  with  an  initial  diagnosis  of  \nnon-metastatic  BC  in  2006–2007  vs  2001–2002,  we  r",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2006",
    "value": 2001,
    "unit": "%",
    "population": null,
    "notes": "study size\nTo  identify  a  1%  difference  in  the  cumulative  incidence  \nof  metastatic  BC  for  women  with  an  initial  diagnosis  of  \nnon-metastatic  BC  in  2006–2007  vs  2001–2002,  we  r",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2006",
    "value": 2002,
    "unit": "%",
    "population": null,
    "notes": "study size\nTo  identify  a  1%  difference  in  the  cumulative  incidence  \nof  metastatic  BC  for  women  with  an  initial  diagnosis  of  \nnon-metastatic  BC  in  2006–2007  vs  2001–2002,  we  r",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2006",
    "value": 1644,
    "unit": "%",
    "population": null,
    "notes": "study size\nTo  identify  a  1%  difference  in  the  cumulative  incidence  \nof  metastatic  BC  for  women  with  an  initial  diagnosis  of  \nnon-metastatic  BC  in  2006–2007  vs  2001–2002,  we  r",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 6644,
    "unit": "%",
    "population": null,
    "notes": "Thus,  with  an  estimated  6644  women  in  \ncohort 1 and 6850 women in cohort 2 (localised 62%, node \npositive or locally advanced 38%), we have sufficient power \nto address our primary research que",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 6850,
    "unit": "%",
    "population": null,
    "notes": "Thus,  with  an  estimated  6644  women  in  \ncohort 1 and 6850 women in cohort 2 (localised 62%, node \npositive or locally advanced 38%), we have sufficient power \nto address our primary research que",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 62,
    "unit": "%",
    "population": null,
    "notes": "Thus,  with  an  estimated  6644  women  in  \ncohort 1 and 6850 women in cohort 2 (localised 62%, node \npositive or locally advanced 38%), we have sufficient power \nto address our primary research que",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 38,
    "unit": "%",
    "population": null,
    "notes": "Thus,  with  an  estimated  6644  women  in  \ncohort 1 and 6850 women in cohort 2 (localised 62%, node \npositive or locally advanced 38%), we have sufficient power \nto address our primary research que",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 99,
    "unit": "year",
    "population": null,
    "notes": "We will also have over 99% power to detect a 1% differ-\nence  in  5-year  cumulative  incidence  in  the  subgroup  of  \nwomen  with  localised  BC  at  diagnosis,  using  our  initial  \nstudy finding",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 628,
    "unit": "year",
    "population": null,
    "notes": "We will also have over 99% power to detect a 1% differ-\nence  in  5-year  cumulative  incidence  in  the  subgroup  of  \nwomen  with  localised  BC  at  diagnosis,  using  our  initial  \nstudy finding",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2016",
    "value": 30,
    "unit": null,
    "population": null,
    "notes": "30\n  For  this  analysis,  we  will  censor  women  with  no  \ndistant metastasis or BC death recorded at 30 September \n2016  (the  ‘reference’  date),  representing  the  last  date  \nCancer  Registr",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2016",
    "value": 30,
    "unit": null,
    "population": null,
    "notes": "30\n  For  this  analysis,  we  will  censor  women  with  no  \ndistant metastasis or BC death recorded at 30 September \n2016  (the  ‘reference’  date),  representing  the  last  date  \nCancer  Registr",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2016",
    "value": 2016,
    "unit": null,
    "population": null,
    "notes": "30\n  For  this  analysis,  we  will  censor  women  with  no  \ndistant metastasis or BC death recorded at 30 September \n2016  (the  ‘reference’  date),  representing  the  last  date  \nCancer  Registr",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": 2001,
    "unit": null,
    "population": null,
    "notes": "We will use the log-rank test to test \nfor differences in the distant recurrence-free interval by: \nextent  of  disease  at  initial  diagnosis  (localised,  regional,  \nunknown); period of diagnosis ",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": 2002,
    "unit": null,
    "population": null,
    "notes": "We will use the log-rank test to test \nfor differences in the distant recurrence-free interval by: \nextent  of  disease  at  initial  diagnosis  (localised,  regional,  \nunknown); period of diagnosis ",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": 2006,
    "unit": null,
    "population": null,
    "notes": "We will use the log-rank test to test \nfor differences in the distant recurrence-free interval by: \nextent  of  disease  at  initial  diagnosis  (localised,  regional,  \nunknown); period of diagnosis ",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": 2007,
    "unit": null,
    "population": null,
    "notes": "We will use the log-rank test to test \nfor differences in the distant recurrence-free interval by: \nextent  of  disease  at  initial  diagnosis  (localised,  regional,  \nunknown); period of diagnosis ",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": 2001,
    "unit": null,
    "population": null,
    "notes": "We will esti-\nmate annual hazard rates for distant metastasis by extent \nof disease at initial diagnosis and by period (2001–2002, \n2006–2007)",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": 2002,
    "unit": null,
    "population": null,
    "notes": "We will esti-\nmate annual hazard rates for distant metastasis by extent \nof disease at initial diagnosis and by period (2001–2002, \n2006–2007)",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": 2006,
    "unit": null,
    "population": null,
    "notes": "We will esti-\nmate annual hazard rates for distant metastasis by extent \nof disease at initial diagnosis and by period (2001–2002, \n2006–2007)",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": 2007,
    "unit": "years",
    "population": null,
    "notes": "We  will  use  Cox  proportional  hazards  regression  to  \ninvestigate   associations   between   baseline   characteris-\ntics  and  the  distant  recurrence-free  interval  including:  \nage  (<50,  ",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "We  will  use  Cox  proportional  hazards  regression  to  \ninvestigate   associations   between   baseline   characteris-\ntics  and  the  distant  recurrence-free  interval  including:  \nage  (<50,  ",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "We  will  use  Cox  proportional  hazards  regression  to  \ninvestigate   associations   between   baseline   characteris-\ntics  and  the  distant  recurrence-free  interval  including:  \nage  (<50,  ",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": 69,
    "unit": "years",
    "population": null,
    "notes": "We  will  use  Cox  proportional  hazards  regression  to  \ninvestigate   associations   between   baseline   characteris-\ntics  and  the  distant  recurrence-free  interval  including:  \nage  (<50,  ",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": 70,
    "unit": "years",
    "population": null,
    "notes": "We  will  use  Cox  proportional  hazards  regression  to  \ninvestigate   associations   between   baseline   characteris-\ntics  and  the  distant  recurrence-free  interval  including:  \nage  (<50,  ",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": 2001,
    "unit": "years",
    "population": null,
    "notes": "We  will  use  Cox  proportional  hazards  regression  to  \ninvestigate   associations   between   baseline   characteris-\ntics  and  the  distant  recurrence-free  interval  including:  \nage  (<50,  ",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": 2002,
    "unit": "years",
    "population": null,
    "notes": "We  will  use  Cox  proportional  hazards  regression  to  \ninvestigate   associations   between   baseline   characteris-\ntics  and  the  distant  recurrence-free  interval  including:  \nage  (<50,  ",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2001",
    "value": 2006,
    "unit": "years",
    "population": null,
    "notes": "We  will  use  Cox  proportional  hazards  regression  to  \ninvestigate   associations   between   baseline   characteris-\ntics  and  the  distant  recurrence-free  interval  including:  \nage  (<50,  ",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": "70 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "We will perform separate \nanalyses  for  M1  and  M0  groups  to  examine  postmetastasis  \nsurvival by site of metastatic spread (bone, lung, liver, brain, \nother); age at first record of distant met",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": "70 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "We will perform separate \nanalyses  for  M1  and  M0  groups  to  examine  postmetastasis  \nsurvival by site of metastatic spread (bone, lung, liver, brain, \nother); age at first record of distant met",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": "70 year",
    "value": 69,
    "unit": "years",
    "population": null,
    "notes": "We will perform separate \nanalyses  for  M1  and  M0  groups  to  examine  postmetastasis  \nsurvival by site of metastatic spread (bone, lung, liver, brain, \nother); age at first record of distant met",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": "70 year",
    "value": 70,
    "unit": "years",
    "population": null,
    "notes": "We will perform separate \nanalyses  for  M1  and  M0  groups  to  examine  postmetastasis  \nsurvival by site of metastatic spread (bone, lung, liver, brain, \nother); age at first record of distant met",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": "5 year",
    "value": 5,
    "unit": "years",
    "population": null,
    "notes": "Internationally, our study findings will make an important \ncontribution  to  BC  care  by  providing  information  that  can  \nbe  used  to  counsel  women  with  a  new  BC  diagnosis  about  \nprogn",
    "pageHint": 7,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2005",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "dIsCussIon\nThis project will provide valuable evidence about the extent \nto  which  advances  in  systemic  adjuvant  therapy  since  2005  \nhave  had  an  impact  on  metastatic  BC  incidence,  site",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "incidence",
    "timePeriod": "2005",
    "value": 2005,
    "unit": null,
    "population": null,
    "notes": "dIsCussIon\nThis project will provide valuable evidence about the extent \nto  which  advances  in  systemic  adjuvant  therapy  since  2005  \nhave  had  an  impact  on  metastatic  BC  incidence,  site",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 33,
    "unit": null,
    "population": null,
    "notes": "33\n The authors’ \nreview of false negative findings (oestrogen receptor-positive \ncancers  not  identified  in  the  lookback  period)  indicated  \nthat cases were missed if initial diagnosis was clos",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\n4\nCancer Research Division, Cancer Council NSW, Woolloomooloo, New South Wales, \nAustralia\n5\nSydney School of Public Health, Faculty of Medicine and Health,",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\n4\nCancer Research Division, Cancer Council NSW, Woolloomooloo, New South Wales, \nAustralia\n5\nSydney School of Public Health, Faculty of Medicine and Health,",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\n4\nCancer Research Division, Cancer Council NSW, Woolloomooloo, New South Wales, \nAustralia\n5\nSydney School of Public Health, Faculty of Medicine and Health,",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2018",
    "value": 10.1136,
    "unit": null,
    "population": null,
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\n4\nCancer Research Division, Cancer Council NSW, Woolloomooloo, New South Wales, \nAustralia\n5\nSydney School of Public Health, Faculty of Medicine and Health,",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2018",
    "value": 10,
    "unit": null,
    "population": null,
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\n4\nCancer Research Division, Cancer Council NSW, Woolloomooloo, New South Wales, \nAustralia\n5\nSydney School of Public Health, Faculty of Medicine and Health,",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2018",
    "value": 1136,
    "unit": null,
    "population": null,
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\n4\nCancer Research Division, Cancer Council NSW, Woolloomooloo, New South Wales, \nAustralia\n5\nSydney School of Public Health, Faculty of Medicine and Health,",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2018",
    "value": 2018,
    "unit": null,
    "population": null,
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\n4\nCancer Research Division, Cancer Council NSW, Woolloomooloo, New South Wales, \nAustralia\n5\nSydney School of Public Health, Faculty of Medicine and Health,",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2018",
    "value": 26414,
    "unit": null,
    "population": null,
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\n4\nCancer Research Division, Cancer Council NSW, Woolloomooloo, New South Wales, \nAustralia\n5\nSydney School of Public Health, Faculty of Medicine and Health,",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2018",
    "value": 1946,
    "unit": null,
    "population": null,
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\n4\nCancer Research Division, Cancer Council NSW, Woolloomooloo, New South Wales, \nAustralia\n5\nSydney School of Public Health, Faculty of Medicine and Health,",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": "2018",
    "value": 2016,
    "unit": null,
    "population": null,
    "notes": "doi:10.1136/bmjopen-2018-026414\nOpen access\n4\nCancer Research Division, Cancer Council NSW, Woolloomooloo, New South Wales, \nAustralia\n5\nSydney School of Public Health, Faculty of Medicine and Health,",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": "26 year",
    "value": 26,
    "unit": "years",
    "population": "metastatic breast cancer",
    "notes": "Age-specific trends of \nsurvival in metastatic breast cancer: 26 years longitudinal data from \na population-based cancer registry in Stockholm, Sweden",
    "pageHint": 9,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 38,
    "unit": "count",
    "population": "metastatic breast cancer",
    "notes": "Prognostic factors in 1,038 \nwomen with metastatic breast cancer",
    "pageHint": 9,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Hudis CA, Barlow WE, Costantino JP\n, et al",
    "pageHint": 9,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 35,
    "unit": "year",
    "population": null,
    "notes": "Improved systemic treatment \nfor early breast cancer improves cure rates, modifies metastatic \npattern and shortens post-metastatic survival: 35-year results \nfrom the Munich Cancer Registry",
    "pageHint": 9,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": "2010",
    "value": 621,
    "unit": "year",
    "population": "metastatic \nbreast cancer",
    "notes": "teen-year trends in metastatic \nbreast cancer survival in Greece. Breast Cancer Res Treat \n2010;119:621–31.\n 13.\n\nGennari A, Conte P\n, Rosso R, et al. Survival of metastatic breast \ncarcinoma patients",
    "pageHint": 9,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": "2010",
    "value": 31,
    "unit": "year",
    "population": "metastatic \nbreast cancer",
    "notes": "-year trends in metastatic \nbreast cancer survival in Greece. Breast Cancer Res Treat \n2010;119:621–31.\n 13.\n\nGennari A, Conte P\n, Rosso R, et al. Survival of metastatic breast \ncarcinoma patients ove",
    "pageHint": 9,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 13,
    "unit": null,
    "population": null,
    "notes": "Gennari A, Conte P\n, Rosso R, et al",
    "pageHint": 9,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 20,
    "unit": "year",
    "population": null,
    "notes": "Survival of metastatic breast \ncarcinoma patients over a 20-year period: a retrospective \nanalysisSurvival of metastatic breast carcinoma patients over a 20-\nyear period: a retrospective analysis base",
    "pageHint": 9,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 20,
    "unit": "year",
    "population": null,
    "notes": "Survival of metastatic breast \ncarcinoma patients over a 20-year period: a retrospective \nanalysisSurvival of metastatic breast carcinoma patients over a 20-\nyear period: a retrospective analysis base",
    "pageHint": 9,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 50,
    "unit": null,
    "population": null,
    "notes": "Mauri D, Polyzos NP\n, Salanti G, et al",
    "pageHint": 9,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 14,
    "unit": null,
    "population": null,
    "notes": "Mauri D, Polyzos NP\n, Salanti G, et al",
    "pageHint": 9,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 38,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "Prognostic factors in 1,038 \nwomen with metastatic breast cancer",
    "pageHint": 9,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": "survival",
    "timePeriod": "26 year",
    "value": 26,
    "unit": "years",
    "population": "metastatic breast cancer",
    "notes": "Age-specific trends of \nsurvival in metastatic breast cancer: 26 years longitudinal data from \na population-based cancer registry in Stockholm, Sweden",
    "pageHint": 9,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 2005,
    "unit": null,
    "population": null,
    "notes": "Hudis CA, Barlow WE, Costantino JP\n, et al",
    "pageHint": 9,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 43,
    "unit": null,
    "population": null,
    "notes": "Hudis CA, Barlow WE, Costantino JP\n, et al",
    "pageHint": 9,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1130,
    "unit": null,
    "population": null,
    "notes": "Hudis CA, Barlow WE, Costantino JP\n, et al",
    "pageHint": 9,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-002",
    "filename": "Lord_et_ al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 30,
    "unit": null,
    "population": null,
    "notes": "Hudis CA, Barlow WE, Costantino JP\n, et al",
    "pageHint": 9,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 90,
    "unit": "%",
    "population": null,
    "notes": "While it is commonly reported\nover 90% of cancer deaths are from metastatic cancer, an exact\nfigure is unknown\n2",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "5 year",
    "value": 5,
    "unit": "years",
    "population": null,
    "notes": "This study analyzed trends in\nmetastatic   cancer   incidence,   the\nproportion of those with metastatic\ncancer surviving 5 years after diag-\nnosis and the locations in the body\neach cancer had spread",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2040",
    "value": 5,
    "unit": "years",
    "population": null,
    "notes": "Also,\nthe likelihood of surviving for more\nthan  5  years  after  diagnosis  with\nmetastatic  cancer  is  predicted  to\nincrease  by  2040",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2040",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Also,\nthe likelihood of surviving for more\nthan  5  years  after  diagnosis  with\nmetastatic  cancer  is  predicted  to\nincrease  by  2040",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2023",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "COMMUNICATIONS MEDICINE|            (2023) 3:76  | https://doi.org/10.1038/s43856-023-00304-x | www.nature.com/commsmed1\n1234567890():,;\n\nC\nancer is the second leading cause of death in the United\nSta",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2023",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "COMMUNICATIONS MEDICINE|            (2023) 3:76  | https://doi.org/10.1038/s43856-023-00304-x | www.nature.com/commsmed1\n1234567890():,;\n\nC\nancer is the second leading cause of death in the United\nSta",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "In 2018, approximately 280,000 of the\n600,000 cancer deaths were made up of just the 6 most common\nprimary metastatic cancers\n3",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": "patients with metastatic",
    "notes": "In this population-based study,\npatients with metastatic cancer, diagnosed between 1988 and\n2018, were abstracted from the National Cancer Institute’s Sur-\nveillance, Epidemiology, and End Results (SE",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": "patients with metastatic",
    "notes": "In this population-based study,\npatients with metastatic cancer, diagnosed between 1988 and\n2018, were abstracted from the National Cancer Institute’s Sur-\nveillance, Epidemiology, and End Results (SE",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "For each\ncalendar year, we used age-adjusted incidence rates to US\n2000 standard population across all age groups to calculate a total\nrate for all age groups by weighted averaging in which the weight",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2023",
    "value": 10.1038,
    "unit": null,
    "population": null,
    "notes": "COMMUNICATIONS MEDICINE|            (2023) 3:76  | https://doi.org/10.1038/s43856-023-00304-x | www.nature.com/commsmed1\n1234567890():,;\n\nC\nancer is the second leading cause of death in the United\nSta",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 16.16,
    "unit": null,
    "population": null,
    "notes": "Additional analyses were conducted\nusing Microsoft Excel 16.16.10 (Microsoft, Redmond, WA),\nMATLAB version R2021a and R2021b (MathWorks Inc., Natick,\nMA) and R (R foundation for Statistical Computing,",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 10,
    "unit": null,
    "population": null,
    "notes": "10\nVagelos College of Physicians & Surgeons, Columbia University, New York City, NY, USA",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 11,
    "unit": null,
    "population": null,
    "notes": "11\nDepartment of Radiation Oncology, University\nHospitals Seidman Cancer Center, Case Western Reserve School of Medicine, Cleveland, OH, USA",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2040",
    "value": 2040,
    "unit": "years",
    "population": null,
    "notes": "Also,\nthe likelihood of surviving for more\nthan  5  years  after  diagnosis  with\nmetastatic  cancer  is  predicted  to\nincrease  by  2040",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2023",
    "value": 2023,
    "unit": null,
    "population": null,
    "notes": "COMMUNICATIONS MEDICINE|            (2023) 3:76  | https://doi.org/10.1038/s43856-023-00304-x | www.nature.com/commsmed1\n1234567890():,;\n\nC\nancer is the second leading cause of death in the United\nSta",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2023",
    "value": 76,
    "unit": null,
    "population": null,
    "notes": "COMMUNICATIONS MEDICINE|            (2023) 3:76  | https://doi.org/10.1038/s43856-023-00304-x | www.nature.com/commsmed1\n1234567890():,;\n\nC\nancer is the second leading cause of death in the United\nSta",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2023",
    "value": 10,
    "unit": null,
    "population": null,
    "notes": "COMMUNICATIONS MEDICINE|            (2023) 3:76  | https://doi.org/10.1038/s43856-023-00304-x | www.nature.com/commsmed1\n1234567890():,;\n\nC\nancer is the second leading cause of death in the United\nSta",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2023",
    "value": 1038,
    "unit": null,
    "population": null,
    "notes": "COMMUNICATIONS MEDICINE|            (2023) 3:76  | https://doi.org/10.1038/s43856-023-00304-x | www.nature.com/commsmed1\n1234567890():,;\n\nC\nancer is the second leading cause of death in the United\nSta",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2023",
    "value": 23,
    "unit": null,
    "population": null,
    "notes": "COMMUNICATIONS MEDICINE|            (2023) 3:76  | https://doi.org/10.1038/s43856-023-00304-x | www.nature.com/commsmed1\n1234567890():,;\n\nC\nancer is the second leading cause of death in the United\nSta",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2023",
    "value": 304,
    "unit": null,
    "population": null,
    "notes": "COMMUNICATIONS MEDICINE|            (2023) 3:76  | https://doi.org/10.1038/s43856-023-00304-x | www.nature.com/commsmed1\n1234567890():,;\n\nC\nancer is the second leading cause of death in the United\nSta",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2023",
    "value": 1234567890,
    "unit": null,
    "population": null,
    "notes": "COMMUNICATIONS MEDICINE|            (2023) 3:76  | https://doi.org/10.1038/s43856-023-00304-x | www.nature.com/commsmed1\n1234567890():,;\n\nC\nancer is the second leading cause of death in the United\nSta",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2023",
    "value": 2018,
    "unit": null,
    "population": null,
    "notes": "COMMUNICATIONS MEDICINE|            (2023) 3:76  | https://doi.org/10.1038/s43856-023-00304-x | www.nature.com/commsmed1\n1234567890():,;\n\nC\nancer is the second leading cause of death in the United\nSta",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2023",
    "value": 600,
    "unit": null,
    "population": null,
    "notes": "COMMUNICATIONS MEDICINE|            (2023) 3:76  | https://doi.org/10.1038/s43856-023-00304-x | www.nature.com/commsmed1\n1234567890():,;\n\nC\nancer is the second leading cause of death in the United\nSta",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2023",
    "value": 0,
    "unit": null,
    "population": null,
    "notes": "COMMUNICATIONS MEDICINE|            (2023) 3:76  | https://doi.org/10.1038/s43856-023-00304-x | www.nature.com/commsmed1\n1234567890():,;\n\nC\nancer is the second leading cause of death in the United\nSta",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 90,
    "unit": "%",
    "population": null,
    "notes": "While it is commonly reported\nover 90% of cancer deaths are from metastatic cancer, an exact\nfigure is unknown\n2",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2018",
    "value": 2018,
    "unit": null,
    "population": null,
    "notes": "In 2018, approximately 280,000 of the\n600,000 cancer deaths were made up of just the 6 most common\nprimary metastatic cancers\n3",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2018",
    "value": 280,
    "unit": null,
    "population": null,
    "notes": "In 2018, approximately 280,000 of the\n600,000 cancer deaths were made up of just the 6 most common\nprimary metastatic cancers\n3",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2018",
    "value": 0,
    "unit": null,
    "population": null,
    "notes": "In 2018, approximately 280,000 of the\n600,000 cancer deaths were made up of just the 6 most common\nprimary metastatic cancers\n3",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2018",
    "value": 600,
    "unit": null,
    "population": null,
    "notes": "In 2018, approximately 280,000 of the\n600,000 cancer deaths were made up of just the 6 most common\nprimary metastatic cancers\n3",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2018",
    "value": 0,
    "unit": null,
    "population": null,
    "notes": "In 2018, approximately 280,000 of the\n600,000 cancer deaths were made up of just the 6 most common\nprimary metastatic cancers\n3",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 11,
    "unit": null,
    "population": null,
    "notes": "The introduction of metastases directed therapy has\nimproved survival outcomes in patients with low metastatic\nburden across certain cancer subtypes\n11",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 12,
    "unit": null,
    "population": null,
    "notes": "STARS IVA and IVB patients groups have been projected to\ncontain a greater proportion of long-term survivors, as these\npatients typically have indolent cancers such as with prostate\ncancers\n12",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 1988,
    "unit": null,
    "population": "patients with metastatic",
    "notes": "In this population-based study,\npatients with metastatic cancer, diagnosed between 1988 and\n2018, were abstracted from the National Cancer Institute’s Sur-\nveillance, Epidemiology, and End Results (SE",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2018,
    "unit": null,
    "population": "patients with metastatic",
    "notes": "In this population-based study,\npatients with metastatic cancer, diagnosed between 1988 and\n2018, were abstracted from the National Cancer Institute’s Sur-\nveillance, Epidemiology, and End Results (SE",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 13,
    "unit": null,
    "population": "patients with metastatic",
    "notes": "In this population-based study,\npatients with metastatic cancer, diagnosed between 1988 and\n2018, were abstracted from the National Cancer Institute’s Sur-\nveillance, Epidemiology, and End Results (SE",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 16,
    "unit": null,
    "population": null,
    "notes": "Additional analyses were conducted\nusing Microsoft Excel 16.16.10 (Microsoft, Redmond, WA),\nMATLAB version R2021a and R2021b (MathWorks Inc., Natick,\nMA) and R (R foundation for Statistical Computing,",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 16,
    "unit": null,
    "population": null,
    "notes": "Additional analyses were conducted\nusing Microsoft Excel 16.16.10 (Microsoft, Redmond, WA),\nMATLAB version R2021a and R2021b (MathWorks Inc., Natick,\nMA) and R (R foundation for Statistical Computing,",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 10,
    "unit": null,
    "population": null,
    "notes": "Additional analyses were conducted\nusing Microsoft Excel 16.16.10 (Microsoft, Redmond, WA),\nMATLAB version R2021a and R2021b (MathWorks Inc., Natick,\nMA) and R (R foundation for Statistical Computing,",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "13\nmo",
    "value": 13,
    "unit": null,
    "population": null,
    "notes": "We analyzed 13\nmost prevalent cancer types using the data abstracted from SEER\n9 (for cancer incidence and long-term survival odds)",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 2000,
    "unit": "year",
    "population": null,
    "notes": "For each\ncalendar year, we used age-adjusted incidence rates to US\n2000 standard population across all age groups to calculate a total\nrate for all age groups by weighted averaging in which the weight",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Metastatic cancer of the lung (APC=−3.44,\n95% CI [−3.73,−3.16];p< 0.001), liver and intrahepatic bile duct\n(APC=−1.14,  95% CI  [−2.10,−0.18];p=\n0.021),  ovaries\n(APC=−1.62, 95% CI [−2.05,−1.18];p< 0.",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Metastatic cancer of the lung (APC=−3.44,\n95% CI [−3.73,−3.16];p< 0.001), liver and intrahepatic bile duct\n(APC=−1.14,  95% CI  [−2.10,−0.18];p=\n0.021),  ovaries\n(APC=−1.62, 95% CI [−2.05,−1.18];p< 0.",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Metastatic cancer of the lung (APC=−3.44,\n95% CI [−3.73,−3.16];p< 0.001), liver and intrahepatic bile duct\n(APC=−1.14,  95% CI  [−2.10,−0.18];p=\n0.021),  ovaries\n(APC=−1.62, 95% CI [−2.05,−1.18];p< 0.",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Metastatic cancer of the lung (APC=−3.44,\n95% CI [−3.73,−3.16];p< 0.001), liver and intrahepatic bile duct\n(APC=−1.14,  95% CI  [−2.10,−0.18];p=\n0.021),  ovaries\n(APC=−1.62, 95% CI [−2.05,−1.18];p< 0.",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "60 month",
    "value": 60,
    "unit": "months",
    "population": null,
    "notes": "Long-term survivorship was defined as a\nbinary outcome with patients classified as alive or dead at follow-\nup at least 60 months after primary diagnosis",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "60 month",
    "value": 60,
    "unit": "months",
    "population": null,
    "notes": "Living patients\nwith follow-up time less than 60 months were excluded from the\nanalysis because it was not possible to determine whether or not\nthey would eventually be classified as long-term survivo",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2013",
    "value": 60,
    "unit": "months",
    "population": null,
    "notes": "The last year\nincluded in this analysis was 2013 as data from 2014 to 2018 was\nexcluded due to the inability to determine long-term survival\n(>60 months)",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2015",
    "value": 798,
    "unit": "count",
    "population": null,
    "notes": "During 2015, there were a total of\n20,798 patients with the index metastatic cancers studied in\nNational Cancer Institute’s Surveillance, Epidemiology, and End\nResults (SEER) database sample populatio",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "For each year from\n1988 to 2013, odds ratios (ORs) of long-term survival vs",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "For each year from\n1988 to 2013, odds ratios (ORs) of long-term survival vs",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2013",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "The last year\nincluded in this analysis was 2013 as data from 2014 to 2018 was\nexcluded due to the inability to determine long-term survival\n(>60 months)",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2013",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "The last year\nincluded in this analysis was 2013 as data from 2014 to 2018 was\nexcluded due to the inability to determine long-term survival\n(>60 months)",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2013",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "The last year\nincluded in this analysis was 2013 as data from 2014 to 2018 was\nexcluded due to the inability to determine long-term survival\n(>60 months)",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2015",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "During 2015, there were a total of\n20,798 patients with the index metastatic cancers studied in\nNational Cancer Institute’s Surveillance, Epidemiology, and End\nResults (SEER) database sample populatio",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "From 1988 to\n2018, there were statistically significant increases in AAPC of\npancreatic, kidney, melanoma, and liver cancer sites, significant\ndecreases in AAPC of colon and rectal, ovary, and prostat",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "From 1988 to\n2018, there were statistically significant increases in AAPC of\npancreatic, kidney, melanoma, and liver cancer sites, significant\ndecreases in AAPC of colon and rectal, ovary, and prostat",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2040",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We found patients diagnosed with metastatic cancer in 2040 were\nCOMMUNICATIONS MEDICINE | https://doi.org/10.1038/s43856-023-00304-xARTICLE\nCOMMUNICATIONS MEDICINE|            (2023) 3:76  | https://d",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2040",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We found patients diagnosed with metastatic cancer in 2040 were\nCOMMUNICATIONS MEDICINE | https://doi.org/10.1038/s43856-023-00304-xARTICLE\nCOMMUNICATIONS MEDICINE|            (2023) 3:76  | https://d",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 3.44,
    "unit": "%",
    "population": null,
    "notes": "Metastatic cancer of the lung (APC=−3.44,\n95% CI [−3.73,−3.16];p< 0.001), liver and intrahepatic bile duct\n(APC=−1.14,  95% CI  [−2.10,−0.18];p=\n0.021),  ovaries\n(APC=−1.62, 95% CI [−2.05,−1.18];p< 0.",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 3.73,
    "unit": "%",
    "population": null,
    "notes": "Metastatic cancer of the lung (APC=−3.44,\n95% CI [−3.73,−3.16];p< 0.001), liver and intrahepatic bile duct\n(APC=−1.14,  95% CI  [−2.10,−0.18];p=\n0.021),  ovaries\n(APC=−1.62, 95% CI [−2.05,−1.18];p< 0.",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 3.16,
    "unit": "%",
    "population": null,
    "notes": "Metastatic cancer of the lung (APC=−3.44,\n95% CI [−3.73,−3.16];p< 0.001), liver and intrahepatic bile duct\n(APC=−1.14,  95% CI  [−2.10,−0.18];p=\n0.021),  ovaries\n(APC=−1.62, 95% CI [−2.05,−1.18];p< 0.",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.001,
    "unit": "%",
    "population": null,
    "notes": "Metastatic cancer of the lung (APC=−3.44,\n95% CI [−3.73,−3.16];p< 0.001), liver and intrahepatic bile duct\n(APC=−1.14,  95% CI  [−2.10,−0.18];p=\n0.021),  ovaries\n(APC=−1.62, 95% CI [−2.05,−1.18];p< 0.",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1.14,
    "unit": "%",
    "population": null,
    "notes": "Metastatic cancer of the lung (APC=−3.44,\n95% CI [−3.73,−3.16];p< 0.001), liver and intrahepatic bile duct\n(APC=−1.14,  95% CI  [−2.10,−0.18];p=\n0.021),  ovaries\n(APC=−1.62, 95% CI [−2.05,−1.18];p< 0.",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 2.1,
    "unit": "%",
    "population": null,
    "notes": "Metastatic cancer of the lung (APC=−3.44,\n95% CI [−3.73,−3.16];p< 0.001), liver and intrahepatic bile duct\n(APC=−1.14,  95% CI  [−2.10,−0.18];p=\n0.021),  ovaries\n(APC=−1.62, 95% CI [−2.05,−1.18];p< 0.",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.18,
    "unit": "%",
    "population": null,
    "notes": "Metastatic cancer of the lung (APC=−3.44,\n95% CI [−3.73,−3.16];p< 0.001), liver and intrahepatic bile duct\n(APC=−1.14,  95% CI  [−2.10,−0.18];p=\n0.021),  ovaries\n(APC=−1.62, 95% CI [−2.05,−1.18];p< 0.",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.021,
    "unit": "%",
    "population": null,
    "notes": "Metastatic cancer of the lung (APC=−3.44,\n95% CI [−3.73,−3.16];p< 0.001), liver and intrahepatic bile duct\n(APC=−1.14,  95% CI  [−2.10,−0.18];p=\n0.021),  ovaries\n(APC=−1.62, 95% CI [−2.05,−1.18];p< 0.",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1.62,
    "unit": "%",
    "population": null,
    "notes": "Metastatic cancer of the lung (APC=−3.44,\n95% CI [−3.73,−3.16];p< 0.001), liver and intrahepatic bile duct\n(APC=−1.14,  95% CI  [−2.10,−0.18];p=\n0.021),  ovaries\n(APC=−1.62, 95% CI [−2.05,−1.18];p< 0.",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 2.05,
    "unit": "%",
    "population": null,
    "notes": "Metastatic cancer of the lung (APC=−3.44,\n95% CI [−3.73,−3.16];p< 0.001), liver and intrahepatic bile duct\n(APC=−1.14,  95% CI  [−2.10,−0.18];p=\n0.021),  ovaries\n(APC=−1.62, 95% CI [−2.05,−1.18];p< 0.",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1.18,
    "unit": "%",
    "population": null,
    "notes": "Metastatic cancer of the lung (APC=−3.44,\n95% CI [−3.73,−3.16];p< 0.001), liver and intrahepatic bile duct\n(APC=−1.14,  95% CI  [−2.10,−0.18];p=\n0.021),  ovaries\n(APC=−1.62, 95% CI [−2.05,−1.18];p< 0.",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.001,
    "unit": "%",
    "population": null,
    "notes": "Metastatic cancer of the lung (APC=−3.44,\n95% CI [−3.73,−3.16];p< 0.001), liver and intrahepatic bile duct\n(APC=−1.14,  95% CI  [−2.10,−0.18];p=\n0.021),  ovaries\n(APC=−1.62, 95% CI [−2.05,−1.18];p< 0.",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1.28,
    "unit": "%",
    "population": null,
    "notes": "Metastatic cancer of the lung (APC=−3.44,\n95% CI [−3.73,−3.16];p< 0.001), liver and intrahepatic bile duct\n(APC=−1.14,  95% CI  [−2.10,−0.18];p=\n0.021),  ovaries\n(APC=−1.62, 95% CI [−2.05,−1.18];p< 0.",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 2.22,
    "unit": "%",
    "population": null,
    "notes": "Metastatic cancer of the lung (APC=−3.44,\n95% CI [−3.73,−3.16];p< 0.001), liver and intrahepatic bile duct\n(APC=−1.14,  95% CI  [−2.10,−0.18];p=\n0.021),  ovaries\n(APC=−1.62, 95% CI [−2.05,−1.18];p< 0.",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.34,
    "unit": "%",
    "population": null,
    "notes": "Metastatic cancer of the lung (APC=−3.44,\n95% CI [−3.73,−3.16];p< 0.001), liver and intrahepatic bile duct\n(APC=−1.14,  95% CI  [−2.10,−0.18];p=\n0.021),  ovaries\n(APC=−1.62, 95% CI [−2.05,−1.18];p< 0.",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.009,
    "unit": "%",
    "population": null,
    "notes": "Metastatic cancer of the lung (APC=−3.44,\n95% CI [−3.73,−3.16];p< 0.001), liver and intrahepatic bile duct\n(APC=−1.14,  95% CI  [−2.10,−0.18];p=\n0.021),  ovaries\n(APC=−1.62, 95% CI [−2.05,−1.18];p< 0.",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2040",
    "value": 10.1038,
    "unit": null,
    "population": null,
    "notes": "We found patients diagnosed with metastatic cancer in 2040 were\nCOMMUNICATIONS MEDICINE | https://doi.org/10.1038/s43856-023-00304-xARTICLE\nCOMMUNICATIONS MEDICINE|            (2023) 3:76  | https://d",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2040",
    "value": 10.1038,
    "unit": null,
    "population": null,
    "notes": "We found patients diagnosed with metastatic cancer in 2040 were\nCOMMUNICATIONS MEDICINE | https://doi.org/10.1038/s43856-023-00304-xARTICLE\nCOMMUNICATIONS MEDICINE|            (2023) 3:76  | https://d",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "60 month",
    "value": 60,
    "unit": "months",
    "population": null,
    "notes": "Long-term survivorship was defined as a\nbinary outcome with patients classified as alive or dead at follow-\nup at least 60 months after primary diagnosis",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "60 month",
    "value": 60,
    "unit": "months",
    "population": null,
    "notes": "Living patients\nwith follow-up time less than 60 months were excluded from the\nanalysis because it was not possible to determine whether or not\nthey would eventually be classified as long-term survivo",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1988",
    "value": 1988,
    "unit": "year",
    "population": null,
    "notes": "For each year from\n1988 to 2013, odds ratios (ORs) of long-term survival vs",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1988",
    "value": 2013,
    "unit": "year",
    "population": null,
    "notes": "For each year from\n1988 to 2013, odds ratios (ORs) of long-term survival vs",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2013",
    "value": 2013,
    "unit": "months",
    "population": null,
    "notes": "The last year\nincluded in this analysis was 2013 as data from 2014 to 2018 was\nexcluded due to the inability to determine long-term survival\n(>60 months)",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2013",
    "value": 2014,
    "unit": "months",
    "population": null,
    "notes": "The last year\nincluded in this analysis was 2013 as data from 2014 to 2018 was\nexcluded due to the inability to determine long-term survival\n(>60 months)",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2013",
    "value": 2018,
    "unit": "months",
    "population": null,
    "notes": "The last year\nincluded in this analysis was 2013 as data from 2014 to 2018 was\nexcluded due to the inability to determine long-term survival\n(>60 months)",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2013",
    "value": 60,
    "unit": "months",
    "population": null,
    "notes": "The last year\nincluded in this analysis was 2013 as data from 2014 to 2018 was\nexcluded due to the inability to determine long-term survival\n(>60 months)",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2015",
    "value": 2015,
    "unit": null,
    "population": null,
    "notes": "During 2015, there were a total of\n20,798 patients with the index metastatic cancers studied in\nNational Cancer Institute’s Surveillance, Epidemiology, and End\nResults (SEER) database sample populatio",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2015",
    "value": 20,
    "unit": null,
    "population": null,
    "notes": "During 2015, there were a total of\n20,798 patients with the index metastatic cancers studied in\nNational Cancer Institute’s Surveillance, Epidemiology, and End\nResults (SEER) database sample populatio",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2015",
    "value": 798,
    "unit": null,
    "population": null,
    "notes": "During 2015, there were a total of\n20,798 patients with the index metastatic cancers studied in\nNational Cancer Institute’s Surveillance, Epidemiology, and End\nResults (SEER) database sample populatio",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 1988,
    "unit": null,
    "population": null,
    "notes": "From 1988 to\n2018, there were statistically significant increases in AAPC of\npancreatic, kidney, melanoma, and liver cancer sites, significant\ndecreases in AAPC of colon and rectal, ovary, and prostat",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2018,
    "unit": null,
    "population": null,
    "notes": "From 1988 to\n2018, there were statistically significant increases in AAPC of\npancreatic, kidney, melanoma, and liver cancer sites, significant\ndecreases in AAPC of colon and rectal, ovary, and prostat",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 44,
    "unit": "%",
    "population": null,
    "notes": "Metastatic cancer of the lung (APC=−3.44,\n95% CI [−3.73,−3.16];p< 0.001), liver and intrahepatic bile duct\n(APC=−1.14,  95% CI  [−2.10,−0.18];p=\n0.021),  ovaries\n(APC=−1.62, 95% CI [−2.05,−1.18];p< 0.",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Metastatic cancer of the lung (APC=−3.44,\n95% CI [−3.73,−3.16];p< 0.001), liver and intrahepatic bile duct\n(APC=−1.14,  95% CI  [−2.10,−0.18];p=\n0.021),  ovaries\n(APC=−1.62, 95% CI [−2.05,−1.18];p< 0.",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 73,
    "unit": "%",
    "population": null,
    "notes": "Metastatic cancer of the lung (APC=−3.44,\n95% CI [−3.73,−3.16];p< 0.001), liver and intrahepatic bile duct\n(APC=−1.14,  95% CI  [−2.10,−0.18];p=\n0.021),  ovaries\n(APC=−1.62, 95% CI [−2.05,−1.18];p< 0.",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 16,
    "unit": "%",
    "population": null,
    "notes": "Metastatic cancer of the lung (APC=−3.44,\n95% CI [−3.73,−3.16];p< 0.001), liver and intrahepatic bile duct\n(APC=−1.14,  95% CI  [−2.10,−0.18];p=\n0.021),  ovaries\n(APC=−1.62, 95% CI [−2.05,−1.18];p< 0.",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1,
    "unit": "%",
    "population": null,
    "notes": "Metastatic cancer of the lung (APC=−3.44,\n95% CI [−3.73,−3.16];p< 0.001), liver and intrahepatic bile duct\n(APC=−1.14,  95% CI  [−2.10,−0.18];p=\n0.021),  ovaries\n(APC=−1.62, 95% CI [−2.05,−1.18];p< 0.",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 14,
    "unit": "%",
    "population": null,
    "notes": "Metastatic cancer of the lung (APC=−3.44,\n95% CI [−3.73,−3.16];p< 0.001), liver and intrahepatic bile duct\n(APC=−1.14,  95% CI  [−2.10,−0.18];p=\n0.021),  ovaries\n(APC=−1.62, 95% CI [−2.05,−1.18];p< 0.",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Metastatic cancer of the lung (APC=−3.44,\n95% CI [−3.73,−3.16];p< 0.001), liver and intrahepatic bile duct\n(APC=−1.14,  95% CI  [−2.10,−0.18];p=\n0.021),  ovaries\n(APC=−1.62, 95% CI [−2.05,−1.18];p< 0.",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 10,
    "unit": "%",
    "population": null,
    "notes": "Metastatic cancer of the lung (APC=−3.44,\n95% CI [−3.73,−3.16];p< 0.001), liver and intrahepatic bile duct\n(APC=−1.14,  95% CI  [−2.10,−0.18];p=\n0.021),  ovaries\n(APC=−1.62, 95% CI [−2.05,−1.18];p< 0.",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 18,
    "unit": "%",
    "population": null,
    "notes": "Metastatic cancer of the lung (APC=−3.44,\n95% CI [−3.73,−3.16];p< 0.001), liver and intrahepatic bile duct\n(APC=−1.14,  95% CI  [−2.10,−0.18];p=\n0.021),  ovaries\n(APC=−1.62, 95% CI [−2.05,−1.18];p< 0.",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 21,
    "unit": "%",
    "population": null,
    "notes": "Metastatic cancer of the lung (APC=−3.44,\n95% CI [−3.73,−3.16];p< 0.001), liver and intrahepatic bile duct\n(APC=−1.14,  95% CI  [−2.10,−0.18];p=\n0.021),  ovaries\n(APC=−1.62, 95% CI [−2.05,−1.18];p< 0.",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 62,
    "unit": "%",
    "population": null,
    "notes": "Metastatic cancer of the lung (APC=−3.44,\n95% CI [−3.73,−3.16];p< 0.001), liver and intrahepatic bile duct\n(APC=−1.14,  95% CI  [−2.10,−0.18];p=\n0.021),  ovaries\n(APC=−1.62, 95% CI [−2.05,−1.18];p< 0.",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Metastatic cancer of the lung (APC=−3.44,\n95% CI [−3.73,−3.16];p< 0.001), liver and intrahepatic bile duct\n(APC=−1.14,  95% CI  [−2.10,−0.18];p=\n0.021),  ovaries\n(APC=−1.62, 95% CI [−2.05,−1.18];p< 0.",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 5,
    "unit": "%",
    "population": null,
    "notes": "Metastatic cancer of the lung (APC=−3.44,\n95% CI [−3.73,−3.16];p< 0.001), liver and intrahepatic bile duct\n(APC=−1.14,  95% CI  [−2.10,−0.18];p=\n0.021),  ovaries\n(APC=−1.62, 95% CI [−2.05,−1.18];p< 0.",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 18,
    "unit": "%",
    "population": null,
    "notes": "Metastatic cancer of the lung (APC=−3.44,\n95% CI [−3.73,−3.16];p< 0.001), liver and intrahepatic bile duct\n(APC=−1.14,  95% CI  [−2.10,−0.18];p=\n0.021),  ovaries\n(APC=−1.62, 95% CI [−2.05,−1.18];p< 0.",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1,
    "unit": "%",
    "population": null,
    "notes": "Metastatic cancer of the lung (APC=−3.44,\n95% CI [−3.73,−3.16];p< 0.001), liver and intrahepatic bile duct\n(APC=−1.14,  95% CI  [−2.10,−0.18];p=\n0.021),  ovaries\n(APC=−1.62, 95% CI [−2.05,−1.18];p< 0.",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 28,
    "unit": "%",
    "population": null,
    "notes": "Metastatic cancer of the lung (APC=−3.44,\n95% CI [−3.73,−3.16];p< 0.001), liver and intrahepatic bile duct\n(APC=−1.14,  95% CI  [−2.10,−0.18];p=\n0.021),  ovaries\n(APC=−1.62, 95% CI [−2.05,−1.18];p< 0.",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Metastatic cancer of the lung (APC=−3.44,\n95% CI [−3.73,−3.16];p< 0.001), liver and intrahepatic bile duct\n(APC=−1.14,  95% CI  [−2.10,−0.18];p=\n0.021),  ovaries\n(APC=−1.62, 95% CI [−2.05,−1.18];p< 0.",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 22,
    "unit": "%",
    "population": null,
    "notes": "Metastatic cancer of the lung (APC=−3.44,\n95% CI [−3.73,−3.16];p< 0.001), liver and intrahepatic bile duct\n(APC=−1.14,  95% CI  [−2.10,−0.18];p=\n0.021),  ovaries\n(APC=−1.62, 95% CI [−2.05,−1.18];p< 0.",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 34,
    "unit": "%",
    "population": null,
    "notes": "Metastatic cancer of the lung (APC=−3.44,\n95% CI [−3.73,−3.16];p< 0.001), liver and intrahepatic bile duct\n(APC=−1.14,  95% CI  [−2.10,−0.18];p=\n0.021),  ovaries\n(APC=−1.62, 95% CI [−2.05,−1.18];p< 0.",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 9,
    "unit": "%",
    "population": null,
    "notes": "Metastatic cancer of the lung (APC=−3.44,\n95% CI [−3.73,−3.16];p< 0.001), liver and intrahepatic bile duct\n(APC=−1.14,  95% CI  [−2.10,−0.18];p=\n0.021),  ovaries\n(APC=−1.62, 95% CI [−2.05,−1.18];p< 0.",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2040",
    "value": 2040,
    "unit": null,
    "population": null,
    "notes": "We found patients diagnosed with metastatic cancer in 2040 were\nCOMMUNICATIONS MEDICINE | https://doi.org/10.1038/s43856-023-00304-xARTICLE\nCOMMUNICATIONS MEDICINE|            (2023) 3:76  | https://d",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2040",
    "value": 10,
    "unit": null,
    "population": null,
    "notes": "We found patients diagnosed with metastatic cancer in 2040 were\nCOMMUNICATIONS MEDICINE | https://doi.org/10.1038/s43856-023-00304-xARTICLE\nCOMMUNICATIONS MEDICINE|            (2023) 3:76  | https://d",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2040",
    "value": 1038,
    "unit": null,
    "population": null,
    "notes": "We found patients diagnosed with metastatic cancer in 2040 were\nCOMMUNICATIONS MEDICINE | https://doi.org/10.1038/s43856-023-00304-xARTICLE\nCOMMUNICATIONS MEDICINE|            (2023) 3:76  | https://d",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2040",
    "value": 23,
    "unit": null,
    "population": null,
    "notes": "We found patients diagnosed with metastatic cancer in 2040 were\nCOMMUNICATIONS MEDICINE | https://doi.org/10.1038/s43856-023-00304-xARTICLE\nCOMMUNICATIONS MEDICINE|            (2023) 3:76  | https://d",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2040",
    "value": 304,
    "unit": null,
    "population": null,
    "notes": "We found patients diagnosed with metastatic cancer in 2040 were\nCOMMUNICATIONS MEDICINE | https://doi.org/10.1038/s43856-023-00304-xARTICLE\nCOMMUNICATIONS MEDICINE|            (2023) 3:76  | https://d",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2040",
    "value": 2023,
    "unit": null,
    "population": null,
    "notes": "We found patients diagnosed with metastatic cancer in 2040 were\nCOMMUNICATIONS MEDICINE | https://doi.org/10.1038/s43856-023-00304-xARTICLE\nCOMMUNICATIONS MEDICINE|            (2023) 3:76  | https://d",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2040",
    "value": 76,
    "unit": null,
    "population": null,
    "notes": "We found patients diagnosed with metastatic cancer in 2040 were\nCOMMUNICATIONS MEDICINE | https://doi.org/10.1038/s43856-023-00304-xARTICLE\nCOMMUNICATIONS MEDICINE|            (2023) 3:76  | https://d",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2040",
    "value": 10,
    "unit": null,
    "population": null,
    "notes": "We found patients diagnosed with metastatic cancer in 2040 were\nCOMMUNICATIONS MEDICINE | https://doi.org/10.1038/s43856-023-00304-xARTICLE\nCOMMUNICATIONS MEDICINE|            (2023) 3:76  | https://d",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2040",
    "value": 1038,
    "unit": null,
    "population": null,
    "notes": "We found patients diagnosed with metastatic cancer in 2040 were\nCOMMUNICATIONS MEDICINE | https://doi.org/10.1038/s43856-023-00304-xARTICLE\nCOMMUNICATIONS MEDICINE|            (2023) 3:76  | https://d",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2040",
    "value": 23,
    "unit": null,
    "population": null,
    "notes": "We found patients diagnosed with metastatic cancer in 2040 were\nCOMMUNICATIONS MEDICINE | https://doi.org/10.1038/s43856-023-00304-xARTICLE\nCOMMUNICATIONS MEDICINE|            (2023) 3:76  | https://d",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2040",
    "value": 304,
    "unit": null,
    "population": null,
    "notes": "We found patients diagnosed with metastatic cancer in 2040 were\nCOMMUNICATIONS MEDICINE | https://doi.org/10.1038/s43856-023-00304-xARTICLE\nCOMMUNICATIONS MEDICINE|            (2023) 3:76  | https://d",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2013",
    "value": 46.7,
    "unit": "%",
    "population": null,
    "notes": "predicted to have 46.7% greater odds of long-term survival\ncompared to the patients diagnosed in 2013 (Fig.4b)",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 0,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 10,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 20,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 30,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 40,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 50,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 60,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 70,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 80,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 90,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 100,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 2040,
    "unit": "count",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 2040,
    "unit": "count",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 2010202020302040,
    "unit": "count",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 2040,
    "unit": "count",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2013",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "predicted to have 46.7% greater odds of long-term survival\ncompared to the patients diagnosed in 2013 (Fig.4b)",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": null,
    "unit": "year",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": null,
    "unit": "year",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": null,
    "unit": "year",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": null,
    "unit": "year",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": null,
    "unit": "year",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": null,
    "unit": "year",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": null,
    "unit": "year",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": null,
    "unit": "year",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": null,
    "unit": "year",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": null,
    "unit": "year",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": null,
    "unit": "year",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": null,
    "unit": "year",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2013",
    "value": 46.7,
    "unit": "%",
    "population": null,
    "notes": "predicted to have 46.7% greater odds of long-term survival\ncompared to the patients diagnosed in 2013 (Fig.4b)",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2013",
    "value": 46,
    "unit": "%",
    "population": null,
    "notes": "predicted to have 46.7% greater odds of long-term survival\ncompared to the patients diagnosed in 2013 (Fig.4b)",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2013",
    "value": 2013,
    "unit": "%",
    "population": null,
    "notes": "predicted to have 46.7% greater odds of long-term survival\ncompared to the patients diagnosed in 2013 (Fig.4b)",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 10,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 20,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 30,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 40,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 50,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 60,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 70,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 80,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 90,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 100,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 1990,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 1995,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 2000,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 2005,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 20102015,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 20202025,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 2030,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 2035,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 2040,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 2000,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 4000,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 6000,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 8000,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 10000,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 12000,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 14000,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 16000,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 18000,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 1990,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 2000,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 20102020,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 2030,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 2040,
    "unit": "%",
    "population": "Patients with Metastatic",
    "notes": "Increases in incidence of metastatic\nkidney cancer projections may be explained by the growing\nab\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n1990\n1995\n2000\n2005\n20102015\n20202025\n2030\n2035\n2040\nPorti",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 500,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 1000,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 1500,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 2000,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 2500,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 3000,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 3500,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 4000,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 2010,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 2020,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 2030,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 2040,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 1000,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 2000,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 3000,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 4000,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 5000,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 20102020,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 2030,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 2040,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 500,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 1000,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 1500,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 2000,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 2500,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 3000,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 3500,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 4000,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 4500,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 5000,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 2010202020302040,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 200,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 400,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 600,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 800,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 1000,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 1200,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 1400,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 1600,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 1800,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 2000,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 201020202030,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 2040,
    "unit": "year",
    "population": null,
    "notes": "0\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n2010\n2020\n2030\n2040\nPatient Count\nYear\nMetastases to Lung\nMelanoma\nBladder\nLiver\nEsophagus\nUteri\nKidney\nStomach\nBreast\nOvary\nPancreas\nProstate\nColorectal\nLung\n",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "While it is possible that metastatic prostate incidence may sta-\nbilize or decrease with advances in imaging modalities, prostate\nMRI or prostate-specific membrane antigen PET (2018) could\nincrease in",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 7.301991,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 20150.9,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 7.102018,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 0.7,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 0.8,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 16.6,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 20073.9,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 20400.45,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 1.13,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 20401.66,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 1.66,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 20400.4,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 0.4,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 20402.52,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2.52,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 20141.54,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 7.142017,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 20401.84,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 0.65,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 14.641999,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 20140.47,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 4.7,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 0.41,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 1.31,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 9.201992,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 20072.55,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 201012.81,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 0.401,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 0.42,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 14.292017,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 1.62,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 1.94,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 5.041992,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 20091.63,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 3.44,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 0.82,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 6.031994,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 20163.5,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 20.472019,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 1.02,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 0.25,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 20172.33,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 1.14,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2.21,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 24.68,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 20180.66,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 0.61,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 0.8,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 7.16,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 20164.47,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 1.28,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 1.51,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 20146.3,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 7.6,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 1.9,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 3.7,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 0.7,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 20155.1,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 10.7,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 4,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 1.1,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 20152.5,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 8.5,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 3.4,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 1.8,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2.3,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2.3,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 10.1038,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 10.1038,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 23,
    "unit": null,
    "population": null,
    "notes": "prevalence of obesity and advancements in imaging studies\nleading  to  incidental  overdiagnosis\n23,24",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 24,
    "unit": null,
    "population": null,
    "notes": "prevalence of obesity and advancements in imaging studies\nleading  to  incidental  overdiagnosis\n23,24",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 25,
    "unit": null,
    "population": null,
    "notes": "proposed that advancements in pathology\nprognosis resulted in more melanoma cancer patients being\nadequately diagnosed\n25",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2018",
    "value": 2018,
    "unit": null,
    "population": null,
    "notes": "While it is possible that metastatic prostate incidence may sta-\nbilize or decrease with advances in imaging modalities, prostate\nMRI or prostate-specific membrane antigen PET (2018) could\nincrease in",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2018",
    "value": 28,
    "unit": null,
    "population": null,
    "notes": "While it is possible that metastatic prostate incidence may sta-\nbilize or decrease with advances in imaging modalities, prostate\nMRI or prostate-specific membrane antigen PET (2018) could\nincrease in",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2018",
    "value": 29,
    "unit": null,
    "population": null,
    "notes": "While it is possible that metastatic prostate incidence may sta-\nbilize or decrease with advances in imaging modalities, prostate\nMRI or prostate-specific membrane antigen PET (2018) could\nincrease in",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 1988,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2040,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 41988,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2018,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 1991,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 301991,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 20150,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 90,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2015,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2018,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 102018,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2040,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 70,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 80,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 1990,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 16,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 1990,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 20073,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 90,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2007,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 20400,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 45,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 13,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 20401,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 66,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 66,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 20400,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 40,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 40,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 20402,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 52,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 52,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 20141,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 54,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2014,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2017,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 142017,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 20401,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 84,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 65,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 1990,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 14,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 641999,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 20140,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 470,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2014,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2020,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 70,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2020,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2040,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 41,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 31,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 1992,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 201992,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 20072,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 55,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2007,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 201012,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 81,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2010,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2040,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 401,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 8,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2014,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 42,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2014,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2017,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 14,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 292017,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2040,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 62,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 94,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 1992,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 41992,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 20091,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 63,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2009,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2040,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 44,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 82,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 1994,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 31994,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 20163,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2016,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2019,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 20,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 472019,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2040,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 25,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 20172,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 33,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2017,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2040,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 14,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 21,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 1990,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 24,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 68,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 1990,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 20180,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 66,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2018,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2040,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 61,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 80,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2002,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 16,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2002,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 20164,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 47,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2016,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2040,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 28,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 51,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2010,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2040,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 42010,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2018,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 20146,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 30,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2014,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2019,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 60,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2019,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2030,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 90,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2030,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2040,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 70,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 70,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 20155,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 10,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2015,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2019,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 10,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 70,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2019,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2040,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 0,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 10,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 20152,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2015,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2018,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2018,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2040,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 40,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 80,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2040,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 30,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 30,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 10,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 1038,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 23,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 304,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2023,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 76,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 10,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 1038,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 23,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 304,
    "unit": "years",
    "population": null,
    "notes": "Table 1 APC and AAPC of trends in metastatic cancer\nCancer siteJoinpoint analysis (1988–2040)\nTrend 1Trend 2Trend 3Trend 41988–2018\nYearsAPCYearsAPCYearsAPCYearsAPCAAPC\nAll sites1988–1991−7.301991–201",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2019",
    "value": 90,
    "unit": "%",
    "population": null,
    "notes": "Are 90% of deaths from cancer\ncaused by metastases?Cancer Med.8, 5574–5576 (2019)",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2040",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "By 2040, the distribution of patients\nliving with metastatic cancer is predicted to shift in predominance\nfrom metastatic cancers traditionally diagnosed late to those\nheavily screened for and monitor",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2016",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Changes in the leading cause of death: recent\npatterns in heart disease and cancer mortality.NCHS Data Brief.1–8 (2016)\n2",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2019",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Are 90% of deaths from cancer\ncaused by metastases?Cancer Med.8, 5574–5576 (2019)",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 38,
    "unit": null,
    "population": null,
    "notes": "This change in heterogeneity, earlier\ndetection, and utilization of treatment modalities, such as neo-\nadjuvant  chemo-radiotherapy  or  surgery,  may  explain  this\nimprovement in long-term survival\n",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 39,
    "unit": null,
    "population": null,
    "notes": "This change in heterogeneity, earlier\ndetection, and utilization of treatment modalities, such as neo-\nadjuvant  chemo-radiotherapy  or  surgery,  may  explain  this\nimprovement in long-term survival\n",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": "rate",
    "timePeriod": null,
    "value": 40,
    "unit": null,
    "population": null,
    "notes": "The decreasing incidence\nrates paired with increased survival can be explained by the Will\nRogers phenomenon; whereby diagnostic improvements may lead\nto this earlier detection and improved prognosis\n",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2040",
    "value": 2040,
    "unit": null,
    "population": null,
    "notes": "By 2040, the distribution of patients\nliving with metastatic cancer is predicted to shift in predominance\nfrom metastatic cancers traditionally diagnosed late to those\nheavily screened for and monitor",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2016",
    "value": 2016,
    "unit": null,
    "population": null,
    "notes": "Changes in the leading cause of death: recent\npatterns in heart disease and cancer mortality.NCHS Data Brief.1–8 (2016)\n2",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2019",
    "value": 90,
    "unit": "%",
    "population": null,
    "notes": "Are 90% of deaths from cancer\ncaused by metastases?Cancer Med.8, 5574–5576 (2019)",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2019",
    "value": 5574,
    "unit": "%",
    "population": null,
    "notes": "Are 90% of deaths from cancer\ncaused by metastases?Cancer Med.8, 5574–5576 (2019)",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2019",
    "value": 5576,
    "unit": "%",
    "population": null,
    "notes": "Are 90% of deaths from cancer\ncaused by metastases?Cancer Med.8, 5574–5576 (2019)",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2019",
    "value": 2019,
    "unit": "%",
    "population": null,
    "notes": "Are 90% of deaths from cancer\ncaused by metastases?Cancer Med.8, 5574–5576 (2019)",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": "burden",
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "nce rates and burden of metastatic prostate cancer in the United\nStates.Eur. Urol. Focus4, 121–127 (2018).\n6.   Yabroff, K. R., Lund, J., Kepka, D. & Mariotto, A. Economic burden of cancer\nin the US: ",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2051",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "with oligometastatic cancers (SABR-COMET):\na randomised, phase 2, open-label trial.Lancet393, 2051–2058 (2019).\n12.  Zaorsky, N. G. et al. Pan-cancer analysis of prognostic metastatic phenotypes.\nInt.",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1983",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Trends in major cancer mortality in Korea,\n1983–2012, with a joinpoint analysis.Cancer Epidemiol.39, 939–946 (2015)",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1983",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Trends in major cancer mortality in Korea,\n1983–2012, with a joinpoint analysis.Cancer Epidemiol.39, 939–946 (2015)",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Annual Report to the Nation on the Status of Cancer, Part II:\nRecent changes in prostate cancer trends and disease characteristics.Cancer\n124, 2801–2814 (2018)",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": null,
    "unit": "year",
    "population": "patients with metastatic",
    "notes": "PSMA-based [18F]DCFPyL PET/CT is superior to\nconventional imaging for lesion detection in patients with metastatic prostate\ncancer.Mol",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2040",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "ead, K. T. Estimated projection of\nUS cancer incidence and death to 2040.JAMA Netw. Open4, e214708 (2021).\n31.  Barta, J. A., Powell, C. A. & Wisnivesky, J. P. Global epidemiology of lung\ncancer.Ann. ",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2021",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Safety and survival rates associated with ablative stereotactic\nradiotherapy for patients with oligometastatic cancer: a systematic review and\nmeta-analysis.JAMA Oncol.7,92–106 (2021)",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Treatment of brain metastases with stereotactic radiosurgery\nand immune checkpoint inhibitors: an international meta-analysis of\nindividual patient data.Radiother",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": "burden",
    "timePeriod": "2018",
    "value": 2018,
    "unit": null,
    "population": null,
    "notes": "nce rates and burden of metastatic prostate cancer in the United\nStates.Eur. Urol. Focus4, 121–127 (2018).\n6.   Yabroff, K. R., Lund, J., Kepka, D. & Mariotto, A. Economic burden of cancer\nin the US: ",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2051",
    "value": 2058,
    "unit": null,
    "population": null,
    "notes": "with oligometastatic cancers (SABR-COMET):\na randomised, phase 2, open-label trial.Lancet393, 2051–2058 (2019).\n12.  Zaorsky, N. G. et al. Pan-cancer analysis of prognostic metastatic phenotypes.\nInt.",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 19,
    "unit": null,
    "population": null,
    "notes": "thune, D. N. Permutation tests for\njoinpoint regression with applications to cancer rates.Stat. Med.19, 335–351\n(2000).\n19.  Lim, D., Ha, M. & Song, I. Trends in major cancer mortality in Korea,\n1983–",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1983",
    "value": 1983,
    "unit": null,
    "population": null,
    "notes": "Trends in major cancer mortality in Korea,\n1983–2012, with a joinpoint analysis.Cancer Epidemiol.39, 939–946 (2015)",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1983",
    "value": 2012,
    "unit": null,
    "population": null,
    "notes": "Trends in major cancer mortality in Korea,\n1983–2012, with a joinpoint analysis.Cancer Epidemiol.39, 939–946 (2015)",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "1983",
    "value": 946,
    "unit": null,
    "population": null,
    "notes": "s in major cancer mortality in Korea,\n1983–2012, with a joinpoint analysis.Cancer Epidemiol.39, 939–946 (2015).\n20.  Wong, M. C. S. et al. The global epidemiology of bladder cancer: a joinpoint\nregres",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2018",
    "value": 1129,
    "unit": null,
    "population": null,
    "notes": "r: a joinpoint\nregression analysis of its incidence and mortality trends and projection.Sci.\nRep.8, 1129 (2018).\n21.  Chen, H. S. et al. The joinpoint-jump and joinpoint-comparability ratio model\nfor ",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2008",
    "value": 277,
    "unit": null,
    "population": null,
    "notes": "al. Body size and renal cell cancer incidence in a large US\ncohort study.Am. J. Epidemiol.168, 268–277 (2008).\n24.  Welch, H. G. & Black, W. C. Overdiagnosis in cancer.J. Natl Cancer Inst.102,\n605–613",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2008",
    "value": 24,
    "unit": null,
    "population": null,
    "notes": "ze and renal cell cancer incidence in a large US\ncohort study.Am. J. Epidemiol.168, 268–277 (2008).\n24.  Welch, H. G. & Black, W. C. Overdiagnosis in cancer.J. Natl Cancer Inst.102,\n605–613 (2010).\n25",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2008",
    "value": 613,
    "unit": null,
    "population": null,
    "notes": "8–277 (2008).\n24.  Welch, H. G. & Black, W. C. Overdiagnosis in cancer.J. Natl Cancer Inst.102,\n605–613 (2010).\n25.  Coelho, S. G. & Hearing, V. J. UVA tanning is involved in the increased\nincidence o",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2018",
    "value": 2011,
    "unit": null,
    "population": null,
    "notes": "Annual Report to the Nation on the Status of Cancer, Part II:\nRecent changes in prostate cancer trends and disease characteristics.Cancer\n124, 2801–2814 (2018)",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": "2018",
    "value": 27,
    "unit": null,
    "population": null,
    "notes": "Annual Report to the Nation on the Status of Cancer, Part II:\nRecent changes in prostate cancer trends and disease characteristics.Cancer\n124, 2801–2814 (2018)",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 2016,
    "unit": null,
    "population": "patients with metastatic",
    "notes": "PSMA-based [18F]DCFPyL PET/CT is superior to\nconventional imaging for lesion detection in patients with metastatic prostate\ncancer.Mol",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 29,
    "unit": null,
    "population": "patients with metastatic",
    "notes": "PSMA-based [18F]DCFPyL PET/CT is superior to\nconventional imaging for lesion detection in patients with metastatic prostate\ncancer.Mol",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2040",
    "value": 2021,
    "unit": null,
    "population": null,
    "notes": "ead, K. T. Estimated projection of\nUS cancer incidence and death to 2040.JAMA Netw. Open4, e214708 (2021).\n31.  Barta, J. A., Powell, C. A. & Wisnivesky, J. P. Global epidemiology of lung\ncancer.Ann. ",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2021",
    "value": 2020,
    "unit": null,
    "population": null,
    "notes": "Safety and survival rates associated with ablative stereotactic\nradiotherapy for patients with oligometastatic cancer: a systematic review and\nmeta-analysis.JAMA Oncol.7,92–106 (2021)",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2021",
    "value": 36,
    "unit": null,
    "population": null,
    "notes": "Safety and survival rates associated with ablative stereotactic\nradiotherapy for patients with oligometastatic cancer: a systematic review and\nmeta-analysis.JAMA Oncol.7,92–106 (2021)",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 92,
    "unit": null,
    "population": null,
    "notes": "Treatment of brain metastases with stereotactic radiosurgery\nand immune checkpoint inhibitors: an international meta-analysis of\nindividual patient data.Radiother",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 106,
    "unit": null,
    "population": null,
    "notes": "Treatment of brain metastases with stereotactic radiosurgery\nand immune checkpoint inhibitors: an international meta-analysis of\nindividual patient data.Radiother",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 2021,
    "unit": null,
    "population": null,
    "notes": "Treatment of brain metastases with stereotactic radiosurgery\nand immune checkpoint inhibitors: an international meta-analysis of\nindividual patient data.Radiother",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 37,
    "unit": null,
    "population": null,
    "notes": "Treatment of brain metastases with stereotactic radiosurgery\nand immune checkpoint inhibitors: an international meta-analysis of\nindividual patient data.Radiother",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2019",
    "value": 38,
    "unit": null,
    "population": null,
    "notes": "rs: an international meta-analysis of\nindividual patient data.Radiother. Oncol.130, 104–112 (2019).\n38.  Njei, B., McCarty, T. R. & Birk, J. W. Trends in esophageal cancer survival in\nUnited States ad",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-004",
    "filename": "Hudock_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 131,
    "unit": null,
    "population": null,
    "notes": "R., Sosin, D",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 72,
    "unit": "%",
    "population": null,
    "notes": "Among women \ndiagnosed with invasive breast cancer, compared with NH- White women, minority women were 72% more likely to be diagnosed under \nthe age of 50 years (relative risk [RR], 1.72; 95% confide",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Among women \ndiagnosed with invasive breast cancer, compared with NH- White women, minority women were 72% more likely to be diagnosed under \nthe age of 50 years (relative risk [RR], 1.72; 95% confide",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 58,
    "unit": "%",
    "population": null,
    "notes": "Among women \ndiagnosed with invasive breast cancer, compared with NH- White women, minority women were 72% more likely to be diagnosed under \nthe age of 50 years (relative risk [RR], 1.72; 95% confide",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Among women \ndiagnosed with invasive breast cancer, compared with NH- White women, minority women were 72% more likely to be diagnosed under \nthe age of 50 years (relative risk [RR], 1.72; 95% confide",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 24,
    "unit": "%",
    "population": null,
    "notes": "Among women \ndiagnosed with invasive breast cancer, compared with NH- White women, minority women were 72% more likely to be diagnosed under \nthe age of 50 years (relative risk [RR], 1.72; 95% confide",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Among women \ndiagnosed with invasive breast cancer, compared with NH- White women, minority women were 72% more likely to be diagnosed under \nthe age of 50 years (relative risk [RR], 1.72; 95% confide",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "They  evaluated  inci-\ndence rates and percentages of invasive breast cancer cases and breast cancer deaths occurring before the age of 50 years along with \nadvanced-  stage  incidence  rates  and  pe",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Among women \ndiagnosed with invasive breast cancer, compared with NH- White women, minority women were 72% more likely to be diagnosed under \nthe age of 50 years (relative risk [RR], 1.72; 95% confide",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Among women \ndiagnosed with invasive breast cancer, compared with NH- White women, minority women were 72% more likely to be diagnosed under \nthe age of 50 years (relative risk [RR], 1.72; 95% confide",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": null,
    "unit": "year",
    "population": "US Women",
    "notes": "4384\nCancer    December 1, 2021\nOriginal Article\nAge Distributions of Breast Cancer Diagnosis and Mortality by \nRace and Ethnicity in US Women\nR",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "1973",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Malak, MD, MPH\n4\nBACKGROUND: Surveillance, Epidemiology, and End Results (SEER) data from 1973- 2010 have been used to show that minority women \nhave disproportionately higher percentages of breast ca",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "1973",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Malak, MD, MPH\n4\nBACKGROUND: Surveillance, Epidemiology, and End Results (SEER) data from 1973- 2010 have been used to show that minority women \nhave disproportionately higher percentages of breast ca",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "METHODS: \nThe authors analyzed SEER 21 invasive breast cancer incidence data for 2014- 2017 and National Center for Health Statistics mortality \ndata for 2014- 2018 and compared invasive incidence and",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "METHODS: \nThe authors analyzed SEER 21 invasive breast cancer incidence data for 2014- 2017 and National Center for Health Statistics mortality \ndata for 2014- 2018 and compared invasive incidence and",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "METHODS: \nThe authors analyzed SEER 21 invasive breast cancer incidence data for 2014- 2017 and National Center for Health Statistics mortality \ndata for 2014- 2018 and compared invasive incidence and",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "METHODS: \nThe authors analyzed SEER 21 invasive breast cancer incidence data for 2014- 2017 and National Center for Health Statistics mortality \ndata for 2014- 2018 and compared invasive incidence and",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "2\nIn a June 2018 research letter, Stapleton et al\n3\n wrote that the diagnosis of invasive breast cancer cases peaked for \nBlack, Asian, and Hispanic women in their 40s but peaked for White women in th",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.72,
    "unit": "years",
    "population": null,
    "notes": "Among women \ndiagnosed with invasive breast cancer, compared with NH- White women, minority women were 72% more likely to be diagnosed under \nthe age of 50 years (relative risk [RR], 1.72; 95% confide",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.7,
    "unit": "years",
    "population": null,
    "notes": "Among women \ndiagnosed with invasive breast cancer, compared with NH- White women, minority women were 72% more likely to be diagnosed under \nthe age of 50 years (relative risk [RR], 1.72; 95% confide",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.75,
    "unit": "years",
    "population": null,
    "notes": "Among women \ndiagnosed with invasive breast cancer, compared with NH- White women, minority women were 72% more likely to be diagnosed under \nthe age of 50 years (relative risk [RR], 1.72; 95% confide",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.58,
    "unit": "years",
    "population": null,
    "notes": "Among women \ndiagnosed with invasive breast cancer, compared with NH- White women, minority women were 72% more likely to be diagnosed under \nthe age of 50 years (relative risk [RR], 1.72; 95% confide",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.55,
    "unit": "years",
    "population": null,
    "notes": "Among women \ndiagnosed with invasive breast cancer, compared with NH- White women, minority women were 72% more likely to be diagnosed under \nthe age of 50 years (relative risk [RR], 1.72; 95% confide",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.61,
    "unit": "years",
    "population": null,
    "notes": "Among women \ndiagnosed with invasive breast cancer, compared with NH- White women, minority women were 72% more likely to be diagnosed under \nthe age of 50 years (relative risk [RR], 1.72; 95% confide",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.24,
    "unit": "years",
    "population": null,
    "notes": "Among women \ndiagnosed with invasive breast cancer, compared with NH- White women, minority women were 72% more likely to be diagnosed under \nthe age of 50 years (relative risk [RR], 1.72; 95% confide",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.23,
    "unit": "years",
    "population": null,
    "notes": "Among women \ndiagnosed with invasive breast cancer, compared with NH- White women, minority women were 72% more likely to be diagnosed under \nthe age of 50 years (relative risk [RR], 1.72; 95% confide",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.25,
    "unit": "years",
    "population": null,
    "notes": "Among women \ndiagnosed with invasive breast cancer, compared with NH- White women, minority women were 72% more likely to be diagnosed under \nthe age of 50 years (relative risk [RR], 1.72; 95% confide",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 4384,
    "unit": null,
    "population": "US Women",
    "notes": "4384\nCancer    December 1, 2021\nOriginal Article\nAge Distributions of Breast Cancer Diagnosis and Mortality by \nRace and Ethnicity in US Women\nR",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 2021,
    "unit": null,
    "population": "US Women",
    "notes": "4384\nCancer    December 1, 2021\nOriginal Article\nAge Distributions of Breast Cancer Diagnosis and Mortality by \nRace and Ethnicity in US Women\nR",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "1973",
    "value": 1973,
    "unit": null,
    "population": null,
    "notes": "Malak, MD, MPH\n4\nBACKGROUND: Surveillance, Epidemiology, and End Results (SEER) data from 1973- 2010 have been used to show that minority women \nhave disproportionately higher percentages of breast ca",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "1973",
    "value": 2010,
    "unit": null,
    "population": null,
    "notes": "Malak, MD, MPH\n4\nBACKGROUND: Surveillance, Epidemiology, and End Results (SEER) data from 1973- 2010 have been used to show that minority women \nhave disproportionately higher percentages of breast ca",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 21,
    "unit": null,
    "population": null,
    "notes": "METHODS: \nThe authors analyzed SEER 21 invasive breast cancer incidence data for 2014- 2017 and National Center for Health Statistics mortality \ndata for 2014- 2018 and compared invasive incidence and",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 2014,
    "unit": null,
    "population": null,
    "notes": "METHODS: \nThe authors analyzed SEER 21 invasive breast cancer incidence data for 2014- 2017 and National Center for Health Statistics mortality \ndata for 2014- 2018 and compared invasive incidence and",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 2017,
    "unit": null,
    "population": null,
    "notes": "METHODS: \nThe authors analyzed SEER 21 invasive breast cancer incidence data for 2014- 2017 and National Center for Health Statistics mortality \ndata for 2014- 2018 and compared invasive incidence and",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 2014,
    "unit": null,
    "population": null,
    "notes": "METHODS: \nThe authors analyzed SEER 21 invasive breast cancer incidence data for 2014- 2017 and National Center for Health Statistics mortality \ndata for 2014- 2018 and compared invasive incidence and",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 2018,
    "unit": null,
    "population": null,
    "notes": "METHODS: \nThe authors analyzed SEER 21 invasive breast cancer incidence data for 2014- 2017 and National Center for Health Statistics mortality \ndata for 2014- 2018 and compared invasive incidence and",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "They  evaluated  inci-\ndence rates and percentages of invasive breast cancer cases and breast cancer deaths occurring before the age of 50 years along with \nadvanced-  stage  incidence  rates  and  pe",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 72,
    "unit": "years",
    "population": null,
    "notes": "Among women \ndiagnosed with invasive breast cancer, compared with NH- White women, minority women were 72% more likely to be diagnosed under \nthe age of 50 years (relative risk [RR], 1.72; 95% confide",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Among women \ndiagnosed with invasive breast cancer, compared with NH- White women, minority women were 72% more likely to be diagnosed under \nthe age of 50 years (relative risk [RR], 1.72; 95% confide",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 72,
    "unit": "years",
    "population": null,
    "notes": "Among women \ndiagnosed with invasive breast cancer, compared with NH- White women, minority women were 72% more likely to be diagnosed under \nthe age of 50 years (relative risk [RR], 1.72; 95% confide",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 95,
    "unit": "years",
    "population": null,
    "notes": "Among women \ndiagnosed with invasive breast cancer, compared with NH- White women, minority women were 72% more likely to be diagnosed under \nthe age of 50 years (relative risk [RR], 1.72; 95% confide",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 70,
    "unit": "years",
    "population": null,
    "notes": "Among women \ndiagnosed with invasive breast cancer, compared with NH- White women, minority women were 72% more likely to be diagnosed under \nthe age of 50 years (relative risk [RR], 1.72; 95% confide",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 75,
    "unit": "years",
    "population": null,
    "notes": "Among women \ndiagnosed with invasive breast cancer, compared with NH- White women, minority women were 72% more likely to be diagnosed under \nthe age of 50 years (relative risk [RR], 1.72; 95% confide",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 58,
    "unit": "years",
    "population": null,
    "notes": "Among women \ndiagnosed with invasive breast cancer, compared with NH- White women, minority women were 72% more likely to be diagnosed under \nthe age of 50 years (relative risk [RR], 1.72; 95% confide",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Among women \ndiagnosed with invasive breast cancer, compared with NH- White women, minority women were 72% more likely to be diagnosed under \nthe age of 50 years (relative risk [RR], 1.72; 95% confide",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 58,
    "unit": "years",
    "population": null,
    "notes": "Among women \ndiagnosed with invasive breast cancer, compared with NH- White women, minority women were 72% more likely to be diagnosed under \nthe age of 50 years (relative risk [RR], 1.72; 95% confide",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 95,
    "unit": "years",
    "population": null,
    "notes": "Among women \ndiagnosed with invasive breast cancer, compared with NH- White women, minority women were 72% more likely to be diagnosed under \nthe age of 50 years (relative risk [RR], 1.72; 95% confide",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 55,
    "unit": "years",
    "population": null,
    "notes": "Among women \ndiagnosed with invasive breast cancer, compared with NH- White women, minority women were 72% more likely to be diagnosed under \nthe age of 50 years (relative risk [RR], 1.72; 95% confide",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 61,
    "unit": "years",
    "population": null,
    "notes": "Among women \ndiagnosed with invasive breast cancer, compared with NH- White women, minority women were 72% more likely to be diagnosed under \nthe age of 50 years (relative risk [RR], 1.72; 95% confide",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 24,
    "unit": "years",
    "population": null,
    "notes": "Among women \ndiagnosed with invasive breast cancer, compared with NH- White women, minority women were 72% more likely to be diagnosed under \nthe age of 50 years (relative risk [RR], 1.72; 95% confide",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 24,
    "unit": "years",
    "population": null,
    "notes": "Among women \ndiagnosed with invasive breast cancer, compared with NH- White women, minority women were 72% more likely to be diagnosed under \nthe age of 50 years (relative risk [RR], 1.72; 95% confide",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 95,
    "unit": "years",
    "population": null,
    "notes": "Among women \ndiagnosed with invasive breast cancer, compared with NH- White women, minority women were 72% more likely to be diagnosed under \nthe age of 50 years (relative risk [RR], 1.72; 95% confide",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 23,
    "unit": "years",
    "population": null,
    "notes": "Among women \ndiagnosed with invasive breast cancer, compared with NH- White women, minority women were 72% more likely to be diagnosed under \nthe age of 50 years (relative risk [RR], 1.72; 95% confide",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 25,
    "unit": "years",
    "population": null,
    "notes": "Among women \ndiagnosed with invasive breast cancer, compared with NH- White women, minority women were 72% more likely to be diagnosed under \nthe age of 50 years (relative risk [RR], 1.72; 95% confide",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2018",
    "value": 2018,
    "unit": null,
    "population": null,
    "notes": "2\nIn a June 2018 research letter, Stapleton et al\n3\n wrote that the diagnosis of invasive breast cancer cases peaked for \nBlack, Asian, and Hispanic women in their 40s but peaked for White women in th",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Breast Cancer Diagnosis and Mortality by Race/Hendrick et al\n4385\nCancer    December 1, 2021\nResults  (SEER)  data  up  to  2011,  Daly  and  Olopade\n4\n\nnoted that, compared with White women, Black wo",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2017",
    "value": 62,
    "unit": "years",
    "population": null,
    "notes": "DeSantis et al\n5\n focused on 2017 SEER data \nand  found  similar  disparities;  for  example,  the  median  \nage at breast cancer death for Black women was 62 years, \nwhereas  it  was  70  years  for ",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2017",
    "value": 70,
    "unit": "years",
    "population": null,
    "notes": "DeSantis et al\n5\n focused on 2017 SEER data \nand  found  similar  disparities;  for  example,  the  median  \nage at breast cancer death for Black women was 62 years, \nwhereas  it  was  70  years  for ",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "rate",
    "timePeriod": "75 year",
    "value": 75,
    "unit": "years",
    "population": null,
    "notes": "We  also  evaluated  population  distributions  \nby age, along with breast cancer incidence rates by age at \ndiagnosis, as percentages of the total from the ages of 40 \nto 75 years for each race or et",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "We  used  2014-  2017  SEER  21  data  for  \nwomen  of  all  ages  to  determine  the  percentage  of  in-\nvasive  breast  cancer  cases  diagnosed  under  the  age  of  \n50 years, the percentage of i",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "We  used  2014-  2017  SEER  21  data  for  \nwomen  of  all  ages  to  determine  the  percentage  of  in-\nvasive  breast  cancer  cases  diagnosed  under  the  age  of  \n50 years, the percentage of i",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "We used \nNCHS  breast  cancer  mortality  data  from  2014-  2018  \nfor  women  of  all  ages  to  determine  the  percentage  of  \nbreast cancer deaths occurring under the age of 50 years \nfor each r",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "12\nTwo- tailed z tests with an α value of .05 were used \nto test the significance of differences between NH- White \nwomen  and  each  minority  cohort  and  minority  women  \ncollectively in the propo",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "12\nTwo- tailed z tests with an α value of .05 were used \nto test the significance of differences between NH- White \nwomen  and  each  minority  cohort  and  minority  women  \ncollectively in the propo",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "12\nTwo- tailed z tests with an α value of .05 were used \nto test the significance of differences between NH- White \nwomen  and  each  minority  cohort  and  minority  women  \ncollectively in the propo",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "rate",
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "To remove population distribution effects, we com-\npared invasive breast cancer incidence rates, advanced- \nstage  breast  cancer  incidence  rates,  and  breast  cancer  \nmortality rates for women un",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 31,
    "unit": null,
    "population": null,
    "notes": "We further compared ratios \n 10970142, 2021, 23, Downloaded from https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.33846, Wiley Online Library on [31/12/2025]",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Breast Cancer Diagnosis and Mortality by Race/Hendrick et al\n4385\nCancer    December 1, 2021\nResults  (SEER)  data  up  to  2011,  Daly  and  Olopade\n4\n\nnoted that, compared with White women, Black wo",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Breast Cancer Diagnosis and Mortality by Race/Hendrick et al\n4385\nCancer    December 1, 2021\nResults  (SEER)  data  up  to  2011,  Daly  and  Olopade\n4\n\nnoted that, compared with White women, Black wo",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2017",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "DeSantis et al\n5\n focused on 2017 SEER data \nand  found  similar  disparities;  for  example,  the  median  \nage at breast cancer death for Black women was 62 years, \nwhereas  it  was  70  years  for ",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We  used  2014-  2017  SEER  21  data  for  \nwomen  of  all  ages  to  determine  the  percentage  of  in-\nvasive  breast  cancer  cases  diagnosed  under  the  age  of  \n50 years, the percentage of i",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We  used  2014-  2017  SEER  21  data  for  \nwomen  of  all  ages  to  determine  the  percentage  of  in-\nvasive  breast  cancer  cases  diagnosed  under  the  age  of  \n50 years, the percentage of i",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We used \nNCHS  breast  cancer  mortality  data  from  2014-  2018  \nfor  women  of  all  ages  to  determine  the  percentage  of  \nbreast cancer deaths occurring under the age of 50 years \nfor each r",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We used \nNCHS  breast  cancer  mortality  data  from  2014-  2018  \nfor  women  of  all  ages  to  determine  the  percentage  of  \nbreast cancer deaths occurring under the age of 50 years \nfor each r",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We further compared ratios \n 10970142, 2021, 23, Downloaded from https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.33846, Wiley Online Library on [31/12/2025]",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We further compared ratios \n 10970142, 2021, 23, Downloaded from https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.33846, Wiley Online Library on [31/12/2025]",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 10.1002,
    "unit": null,
    "population": null,
    "notes": "We further compared ratios \n 10970142, 2021, 23, Downloaded from https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.33846, Wiley Online Library on [31/12/2025]",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 4385,
    "unit": "years",
    "population": null,
    "notes": "Breast Cancer Diagnosis and Mortality by Race/Hendrick et al\n4385\nCancer    December 1, 2021\nResults  (SEER)  data  up  to  2011,  Daly  and  Olopade\n4\n\nnoted that, compared with White women, Black wo",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 2021,
    "unit": "years",
    "population": null,
    "notes": "Breast Cancer Diagnosis and Mortality by Race/Hendrick et al\n4385\nCancer    December 1, 2021\nResults  (SEER)  data  up  to  2011,  Daly  and  Olopade\n4\n\nnoted that, compared with White women, Black wo",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 2011,
    "unit": "years",
    "population": null,
    "notes": "Breast Cancer Diagnosis and Mortality by Race/Hendrick et al\n4385\nCancer    December 1, 2021\nResults  (SEER)  data  up  to  2011,  Daly  and  Olopade\n4\n\nnoted that, compared with White women, Black wo",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Breast Cancer Diagnosis and Mortality by Race/Hendrick et al\n4385\nCancer    December 1, 2021\nResults  (SEER)  data  up  to  2011,  Daly  and  Olopade\n4\n\nnoted that, compared with White women, Black wo",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2017",
    "value": 2017,
    "unit": "years",
    "population": null,
    "notes": "DeSantis et al\n5\n focused on 2017 SEER data \nand  found  similar  disparities;  for  example,  the  median  \nage at breast cancer death for Black women was 62 years, \nwhereas  it  was  70  years  for ",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2017",
    "value": 62,
    "unit": "years",
    "population": null,
    "notes": "DeSantis et al\n5\n focused on 2017 SEER data \nand  found  similar  disparities;  for  example,  the  median  \nage at breast cancer death for Black women was 62 years, \nwhereas  it  was  70  years  for ",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2017",
    "value": 70,
    "unit": "years",
    "population": null,
    "notes": "DeSantis et al\n5\n focused on 2017 SEER data \nand  found  similar  disparities;  for  example,  the  median  \nage at breast cancer death for Black women was 62 years, \nwhereas  it  was  70  years  for ",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "rate",
    "timePeriod": "75 year",
    "value": 40,
    "unit": "years",
    "population": null,
    "notes": "We  also  evaluated  population  distributions  \nby age, along with breast cancer incidence rates by age at \ndiagnosis, as percentages of the total from the ages of 40 \nto 75 years for each race or et",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "rate",
    "timePeriod": "75 year",
    "value": 75,
    "unit": "years",
    "population": null,
    "notes": "We  also  evaluated  population  distributions  \nby age, along with breast cancer incidence rates by age at \ndiagnosis, as percentages of the total from the ages of 40 \nto 75 years for each race or et",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 2014,
    "unit": "years",
    "population": null,
    "notes": "We  used  2014-  2017  SEER  21  data  for  \nwomen  of  all  ages  to  determine  the  percentage  of  in-\nvasive  breast  cancer  cases  diagnosed  under  the  age  of  \n50 years, the percentage of i",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 2017,
    "unit": "years",
    "population": null,
    "notes": "We  used  2014-  2017  SEER  21  data  for  \nwomen  of  all  ages  to  determine  the  percentage  of  in-\nvasive  breast  cancer  cases  diagnosed  under  the  age  of  \n50 years, the percentage of i",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 21,
    "unit": "years",
    "population": null,
    "notes": "We  used  2014-  2017  SEER  21  data  for  \nwomen  of  all  ages  to  determine  the  percentage  of  in-\nvasive  breast  cancer  cases  diagnosed  under  the  age  of  \n50 years, the percentage of i",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "We  used  2014-  2017  SEER  21  data  for  \nwomen  of  all  ages  to  determine  the  percentage  of  in-\nvasive  breast  cancer  cases  diagnosed  under  the  age  of  \n50 years, the percentage of i",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "We  used  2014-  2017  SEER  21  data  for  \nwomen  of  all  ages  to  determine  the  percentage  of  in-\nvasive  breast  cancer  cases  diagnosed  under  the  age  of  \n50 years, the percentage of i",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 2014,
    "unit": "years",
    "population": null,
    "notes": "We used \nNCHS  breast  cancer  mortality  data  from  2014-  2018  \nfor  women  of  all  ages  to  determine  the  percentage  of  \nbreast cancer deaths occurring under the age of 50 years \nfor each r",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 2018,
    "unit": "years",
    "population": null,
    "notes": "We used \nNCHS  breast  cancer  mortality  data  from  2014-  2018  \nfor  women  of  all  ages  to  determine  the  percentage  of  \nbreast cancer deaths occurring under the age of 50 years \nfor each r",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "We used \nNCHS  breast  cancer  mortality  data  from  2014-  2018  \nfor  women  of  all  ages  to  determine  the  percentage  of  \nbreast cancer deaths occurring under the age of 50 years \nfor each r",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 12,
    "unit": "years",
    "population": null,
    "notes": "12\nTwo- tailed z tests with an α value of .05 were used \nto test the significance of differences between NH- White \nwomen  and  each  minority  cohort  and  minority  women  \ncollectively in the propo",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 5,
    "unit": "years",
    "population": null,
    "notes": "12\nTwo- tailed z tests with an α value of .05 were used \nto test the significance of differences between NH- White \nwomen  and  each  minority  cohort  and  minority  women  \ncollectively in the propo",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "12\nTwo- tailed z tests with an α value of .05 were used \nto test the significance of differences between NH- White \nwomen  and  each  minority  cohort  and  minority  women  \ncollectively in the propo",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "12\nTwo- tailed z tests with an α value of .05 were used \nto test the significance of differences between NH- White \nwomen  and  each  minority  cohort  and  minority  women  \ncollectively in the propo",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "12\nTwo- tailed z tests with an α value of .05 were used \nto test the significance of differences between NH- White \nwomen  and  each  minority  cohort  and  minority  women  \ncollectively in the propo",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "rate",
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "To remove population distribution effects, we com-\npared invasive breast cancer incidence rates, advanced- \nstage  breast  cancer  incidence  rates,  and  breast  cancer  \nmortality rates for women un",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 10970142,
    "unit": null,
    "population": null,
    "notes": "We further compared ratios \n 10970142, 2021, 23, Downloaded from https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.33846, Wiley Online Library on [31/12/2025]",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 2021,
    "unit": null,
    "population": null,
    "notes": "We further compared ratios \n 10970142, 2021, 23, Downloaded from https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.33846, Wiley Online Library on [31/12/2025]",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 23,
    "unit": null,
    "population": null,
    "notes": "We further compared ratios \n 10970142, 2021, 23, Downloaded from https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.33846, Wiley Online Library on [31/12/2025]",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 10,
    "unit": null,
    "population": null,
    "notes": "We further compared ratios \n 10970142, 2021, 23, Downloaded from https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.33846, Wiley Online Library on [31/12/2025]",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 1002,
    "unit": null,
    "population": null,
    "notes": "We further compared ratios \n 10970142, 2021, 23, Downloaded from https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.33846, Wiley Online Library on [31/12/2025]",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 33846,
    "unit": null,
    "population": null,
    "notes": "We further compared ratios \n 10970142, 2021, 23, Downloaded from https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.33846, Wiley Online Library on [31/12/2025]",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 31,
    "unit": null,
    "population": null,
    "notes": "We further compared ratios \n 10970142, 2021, 23, Downloaded from https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.33846, Wiley Online Library on [31/12/2025]",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 12,
    "unit": null,
    "population": null,
    "notes": "We further compared ratios \n 10970142, 2021, 23, Downloaded from https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.33846, Wiley Online Library on [31/12/2025]",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 2025,
    "unit": null,
    "population": null,
    "notes": "We further compared ratios \n 10970142, 2021, 23, Downloaded from https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.33846, Wiley Online Library on [31/12/2025]",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "For  women  of  all  ages,  RRs  and  95%  CIs  for  1)  \nthe percentage of women with invasive breast cancer di-\nagnosed  under  the  age  of  50  years,  2)  the  percentage  of  \nwomen under the ag",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "For women of all ages, Table 2 shows the numbers \nand  percentages  of  invasive  cancers  diagnosed  before  \nthe age of 50 years for each race/ethnicity cohort along \nwith RRs and 95% CIs for diagno",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Among women diagnosed with in-\nvasive breast cancer, each minority cohort had a signifi-\ncantly  higher  RR  of  having  an  invasive  breast  cancer  \ndiagnosed  before  the  age  of  50  years  than",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 72,
    "unit": "%",
    "population": null,
    "notes": "Among  women  with  invasive  breast  cancer,  minority  \nwomen  collectively  had  a  72%  higher  risk  of  having  \nan  invasive  breast  cancer  diagnosed  before  the  age  of  \n50 years than NH-",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Among  women  with  invasive  breast  cancer,  minority  \nwomen  collectively  had  a  72%  higher  risk  of  having  \nan  invasive  breast  cancer  diagnosed  before  the  age  of  \n50 years than NH-",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "rate",
    "timePeriod": "2021",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Original Article\n4386\nCancer    December 1, 2021\nof advanced breast cancer rates to invasive breast cancers \nrates for women under the age of 50 years and of breast \ncancer  mortality  rates  to  inva",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "rate",
    "timePeriod": "2021",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Original Article\n4386\nCancer    December 1, 2021\nof advanced breast cancer rates to invasive breast cancers \nrates for women under the age of 50 years and of breast \ncancer  mortality  rates  to  inva",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "For  women  of  all  ages,  RRs  and  95%  CIs  for  1)  \nthe percentage of women with invasive breast cancer di-\nagnosed  under  the  age  of  50  years,  2)  the  percentage  of  \nwomen under the ag",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "For  women  of  all  ages,  RRs  and  95%  CIs  for  1)  \nthe percentage of women with invasive breast cancer di-\nagnosed  under  the  age  of  50  years,  2)  the  percentage  of  \nwomen under the ag",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "For  women  of  all  ages,  RRs  and  95%  CIs  for  1)  \nthe percentage of women with invasive breast cancer di-\nagnosed  under  the  age  of  50  years,  2)  the  percentage  of  \nwomen under the ag",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 75,
    "unit": "years",
    "population": null,
    "notes": "The distribution of invasive breast cancers by age at \ndiagnosis  as  a  percentage  of  the  total  for  the  ages  of  40  \nto 75 years, based on 2014- 2017 SEER 21 data (Fig",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "75 year",
    "value": 75,
    "unit": "years",
    "population": null,
    "notes": "Table 1 shows the population composition, me-\ndian  age  at  diagnosis,  interquartile  range,  and  mode  age  \nat diagnosis for each race/ethnicity cohort for women 40 \nto 75 years old",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "1973",
    "value": 2,
    "unit": "years",
    "population": null,
    "notes": "Compared with SEER data spanning the \nyears  1973- 2010,\n3\n  recent  SEER  incidence  data  show  an  \nincrease in the median age at diagnosis of 1 to 2 years for \neach race/ethnicity cohort",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "For women of all ages, Table 2 shows the numbers \nand  percentages  of  invasive  cancers  diagnosed  before  \nthe age of 50 years for each race/ethnicity cohort along \nwith RRs and 95% CIs for diagno",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "For women of all ages, Table 2 shows the numbers \nand  percentages  of  invasive  cancers  diagnosed  before  \nthe age of 50 years for each race/ethnicity cohort along \nwith RRs and 95% CIs for diagno",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Among women diagnosed with in-\nvasive breast cancer, each minority cohort had a signifi-\ncantly  higher  RR  of  having  an  invasive  breast  cancer  \ndiagnosed  before  the  age  of  50  years  than",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Among  women  with  invasive  breast  cancer,  minority  \nwomen  collectively  had  a  72%  higher  risk  of  having  \nan  invasive  breast  cancer  diagnosed  before  the  age  of  \n50 years than NH-",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 75,
    "unit": "years",
    "population": null,
    "notes": "Distribution   of   invasive   breast   cancer   cases,   \nexpressed  as  percentages  of  the  total  for  the  ages  of  40  to  \n75 years, by the age at diagnosis for each race/ethnicity cohort \nac",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "rate",
    "timePeriod": "2021",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Original Article\n4386\nCancer    December 1, 2021\nof advanced breast cancer rates to invasive breast cancers \nrates for women under the age of 50 years and of breast \ncancer  mortality  rates  to  inva",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "The same 2014- \n2017 SEER 21 incidence data and the same 2014- 2018 \nNCHS mortality data used in the aforementioned anal-\nyses were used for these analyses",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "The same 2014- \n2017 SEER 21 incidence data and the same 2014- 2018 \nNCHS mortality data used in the aforementioned anal-\nyses were used for these analyses",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "The same 2014- \n2017 SEER 21 incidence data and the same 2014- 2018 \nNCHS mortality data used in the aforementioned anal-\nyses were used for these analyses",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "The same 2014- \n2017 SEER 21 incidence data and the same 2014- 2018 \nNCHS mortality data used in the aforementioned anal-\nyses were used for these analyses",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "An  analysis  of  NCHS  mortality  data  \nfor  2014-  2018  included  208,329  female  breast  cancer  \ndeaths",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "An  analysis  of  NCHS  mortality  data  \nfor  2014-  2018  included  208,329  female  breast  cancer  \ndeaths",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "The distribution of invasive breast cancers by age at \ndiagnosis  as  a  percentage  of  the  total  for  the  ages  of  40  \nto 75 years, based on 2014- 2017 SEER 21 data (Fig",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "The distribution of invasive breast cancers by age at \ndiagnosis  as  a  percentage  of  the  total  for  the  ages  of  40  \nto 75 years, based on 2014- 2017 SEER 21 data (Fig",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "1973",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Compared with SEER data spanning the \nyears  1973- 2010,\n3\n  recent  SEER  incidence  data  show  an  \nincrease in the median age at diagnosis of 1 to 2 years for \neach race/ethnicity cohort",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "1973",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Compared with SEER data spanning the \nyears  1973- 2010,\n3\n  recent  SEER  incidence  data  show  an  \nincrease in the median age at diagnosis of 1 to 2 years for \neach race/ethnicity cohort",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Distribution   of   invasive   breast   cancer   cases,   \nexpressed  as  percentages  of  the  total  for  the  ages  of  40  to  \n75 years, by the age at diagnosis for each race/ethnicity cohort \nac",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Distribution   of   invasive   breast   cancer   cases,   \nexpressed  as  percentages  of  the  total  for  the  ages  of  40  to  \n75 years, by the age at diagnosis for each race/ethnicity cohort \nac",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 1.93,
    "unit": "years",
    "population": null,
    "notes": "Among women diagnosed with in-\nvasive breast cancer, each minority cohort had a signifi-\ncantly  higher  RR  of  having  an  invasive  breast  cancer  \ndiagnosed  before  the  age  of  50  years  than",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 1.9,
    "unit": "years",
    "population": null,
    "notes": "Among women diagnosed with in-\nvasive breast cancer, each minority cohort had a signifi-\ncantly  higher  RR  of  having  an  invasive  breast  cancer  \ndiagnosed  before  the  age  of  50  years  than",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 1.96,
    "unit": "years",
    "population": null,
    "notes": "Among women diagnosed with in-\nvasive breast cancer, each minority cohort had a signifi-\ncantly  higher  RR  of  having  an  invasive  breast  cancer  \ndiagnosed  before  the  age  of  50  years  than",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.72,
    "unit": "years",
    "population": null,
    "notes": "Among  women  with  invasive  breast  cancer,  minority  \nwomen  collectively  had  a  72%  higher  risk  of  having  \nan  invasive  breast  cancer  diagnosed  before  the  age  of  \n50 years than NH-",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.7,
    "unit": "years",
    "population": null,
    "notes": "Among  women  with  invasive  breast  cancer,  minority  \nwomen  collectively  had  a  72%  higher  risk  of  having  \nan  invasive  breast  cancer  diagnosed  before  the  age  of  \n50 years than NH-",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.75,
    "unit": "years",
    "population": null,
    "notes": "Among  women  with  invasive  breast  cancer,  minority  \nwomen  collectively  had  a  72%  higher  risk  of  having  \nan  invasive  breast  cancer  diagnosed  before  the  age  of  \n50 years than NH-",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "rate",
    "timePeriod": "2021",
    "value": 4386,
    "unit": "years",
    "population": null,
    "notes": "Original Article\n4386\nCancer    December 1, 2021\nof advanced breast cancer rates to invasive breast cancers \nrates for women under the age of 50 years and of breast \ncancer  mortality  rates  to  inva",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "rate",
    "timePeriod": "2021",
    "value": 2021,
    "unit": "years",
    "population": null,
    "notes": "Original Article\n4386\nCancer    December 1, 2021\nof advanced breast cancer rates to invasive breast cancers \nrates for women under the age of 50 years and of breast \ncancer  mortality  rates  to  inva",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "rate",
    "timePeriod": "2021",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Original Article\n4386\nCancer    December 1, 2021\nof advanced breast cancer rates to invasive breast cancers \nrates for women under the age of 50 years and of breast \ncancer  mortality  rates  to  inva",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "rate",
    "timePeriod": "2021",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Original Article\n4386\nCancer    December 1, 2021\nof advanced breast cancer rates to invasive breast cancers \nrates for women under the age of 50 years and of breast \ncancer  mortality  rates  to  inva",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 2014,
    "unit": null,
    "population": null,
    "notes": "The same 2014- \n2017 SEER 21 incidence data and the same 2014- 2018 \nNCHS mortality data used in the aforementioned anal-\nyses were used for these analyses",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 2017,
    "unit": null,
    "population": null,
    "notes": "The same 2014- \n2017 SEER 21 incidence data and the same 2014- 2018 \nNCHS mortality data used in the aforementioned anal-\nyses were used for these analyses",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 21,
    "unit": null,
    "population": null,
    "notes": "The same 2014- \n2017 SEER 21 incidence data and the same 2014- 2018 \nNCHS mortality data used in the aforementioned anal-\nyses were used for these analyses",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 2014,
    "unit": null,
    "population": null,
    "notes": "The same 2014- \n2017 SEER 21 incidence data and the same 2014- 2018 \nNCHS mortality data used in the aforementioned anal-\nyses were used for these analyses",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 2018,
    "unit": null,
    "population": null,
    "notes": "The same 2014- \n2017 SEER 21 incidence data and the same 2014- 2018 \nNCHS mortality data used in the aforementioned anal-\nyses were used for these analyses",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 95,
    "unit": "years",
    "population": null,
    "notes": "For  women  of  all  ages,  RRs  and  95%  CIs  for  1)  \nthe percentage of women with invasive breast cancer di-\nagnosed  under  the  age  of  50  years,  2)  the  percentage  of  \nwomen under the ag",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "For  women  of  all  ages,  RRs  and  95%  CIs  for  1)  \nthe percentage of women with invasive breast cancer di-\nagnosed  under  the  age  of  50  years,  2)  the  percentage  of  \nwomen under the ag",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "For  women  of  all  ages,  RRs  and  95%  CIs  for  1)  \nthe percentage of women with invasive breast cancer di-\nagnosed  under  the  age  of  50  years,  2)  the  percentage  of  \nwomen under the ag",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "For  women  of  all  ages,  RRs  and  95%  CIs  for  1)  \nthe percentage of women with invasive breast cancer di-\nagnosed  under  the  age  of  50  years,  2)  the  percentage  of  \nwomen under the ag",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 2014,
    "unit": null,
    "population": null,
    "notes": "An  analysis  of  NCHS  mortality  data  \nfor  2014-  2018  included  208,329  female  breast  cancer  \ndeaths",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 2018,
    "unit": null,
    "population": null,
    "notes": "An  analysis  of  NCHS  mortality  data  \nfor  2014-  2018  included  208,329  female  breast  cancer  \ndeaths",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 208,
    "unit": null,
    "population": null,
    "notes": "An  analysis  of  NCHS  mortality  data  \nfor  2014-  2018  included  208,329  female  breast  cancer  \ndeaths",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 329,
    "unit": null,
    "population": null,
    "notes": "An  analysis  of  NCHS  mortality  data  \nfor  2014-  2018  included  208,329  female  breast  cancer  \ndeaths",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 40,
    "unit": "years",
    "population": null,
    "notes": "The distribution of invasive breast cancers by age at \ndiagnosis  as  a  percentage  of  the  total  for  the  ages  of  40  \nto 75 years, based on 2014- 2017 SEER 21 data (Fig",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 75,
    "unit": "years",
    "population": null,
    "notes": "The distribution of invasive breast cancers by age at \ndiagnosis  as  a  percentage  of  the  total  for  the  ages  of  40  \nto 75 years, based on 2014- 2017 SEER 21 data (Fig",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 2014,
    "unit": "years",
    "population": null,
    "notes": "The distribution of invasive breast cancers by age at \ndiagnosis  as  a  percentage  of  the  total  for  the  ages  of  40  \nto 75 years, based on 2014- 2017 SEER 21 data (Fig",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 2017,
    "unit": "years",
    "population": null,
    "notes": "The distribution of invasive breast cancers by age at \ndiagnosis  as  a  percentage  of  the  total  for  the  ages  of  40  \nto 75 years, based on 2014- 2017 SEER 21 data (Fig",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 21,
    "unit": "years",
    "population": null,
    "notes": "The distribution of invasive breast cancers by age at \ndiagnosis  as  a  percentage  of  the  total  for  the  ages  of  40  \nto 75 years, based on 2014- 2017 SEER 21 data (Fig",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "75 year",
    "value": 40,
    "unit": "years",
    "population": null,
    "notes": "Table 1 shows the population composition, me-\ndian  age  at  diagnosis,  interquartile  range,  and  mode  age  \nat diagnosis for each race/ethnicity cohort for women 40 \nto 75 years old",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "75 year",
    "value": 75,
    "unit": "years",
    "population": null,
    "notes": "Table 1 shows the population composition, me-\ndian  age  at  diagnosis,  interquartile  range,  and  mode  age  \nat diagnosis for each race/ethnicity cohort for women 40 \nto 75 years old",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "1973",
    "value": 1973,
    "unit": "years",
    "population": null,
    "notes": "Compared with SEER data spanning the \nyears  1973- 2010,\n3\n  recent  SEER  incidence  data  show  an  \nincrease in the median age at diagnosis of 1 to 2 years for \neach race/ethnicity cohort",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "1973",
    "value": 2010,
    "unit": "years",
    "population": null,
    "notes": "Compared with SEER data spanning the \nyears  1973- 2010,\n3\n  recent  SEER  incidence  data  show  an  \nincrease in the median age at diagnosis of 1 to 2 years for \neach race/ethnicity cohort",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "For women of all ages, Table 2 shows the numbers \nand  percentages  of  invasive  cancers  diagnosed  before  \nthe age of 50 years for each race/ethnicity cohort along \nwith RRs and 95% CIs for diagno",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 95,
    "unit": "years",
    "population": null,
    "notes": "For women of all ages, Table 2 shows the numbers \nand  percentages  of  invasive  cancers  diagnosed  before  \nthe age of 50 years for each race/ethnicity cohort along \nwith RRs and 95% CIs for diagno",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "For women of all ages, Table 2 shows the numbers \nand  percentages  of  invasive  cancers  diagnosed  before  \nthe age of 50 years for each race/ethnicity cohort along \nwith RRs and 95% CIs for diagno",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Among women diagnosed with in-\nvasive breast cancer, each minority cohort had a signifi-\ncantly  higher  RR  of  having  an  invasive  breast  cancer  \ndiagnosed  before  the  age  of  50  years  than",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 1,
    "unit": "years",
    "population": null,
    "notes": "Among women diagnosed with in-\nvasive breast cancer, each minority cohort had a signifi-\ncantly  higher  RR  of  having  an  invasive  breast  cancer  \ndiagnosed  before  the  age  of  50  years  than",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 93,
    "unit": "years",
    "population": null,
    "notes": "Among women diagnosed with in-\nvasive breast cancer, each minority cohort had a signifi-\ncantly  higher  RR  of  having  an  invasive  breast  cancer  \ndiagnosed  before  the  age  of  50  years  than",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 95,
    "unit": "years",
    "population": null,
    "notes": "Among women diagnosed with in-\nvasive breast cancer, each minority cohort had a signifi-\ncantly  higher  RR  of  having  an  invasive  breast  cancer  \ndiagnosed  before  the  age  of  50  years  than",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 90,
    "unit": "years",
    "population": null,
    "notes": "Among women diagnosed with in-\nvasive breast cancer, each minority cohort had a signifi-\ncantly  higher  RR  of  having  an  invasive  breast  cancer  \ndiagnosed  before  the  age  of  50  years  than",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 96,
    "unit": "years",
    "population": null,
    "notes": "Among women diagnosed with in-\nvasive breast cancer, each minority cohort had a signifi-\ncantly  higher  RR  of  having  an  invasive  breast  cancer  \ndiagnosed  before  the  age  of  50  years  than",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 72,
    "unit": "years",
    "population": null,
    "notes": "Among  women  with  invasive  breast  cancer,  minority  \nwomen  collectively  had  a  72%  higher  risk  of  having  \nan  invasive  breast  cancer  diagnosed  before  the  age  of  \n50 years than NH-",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Among  women  with  invasive  breast  cancer,  minority  \nwomen  collectively  had  a  72%  higher  risk  of  having  \nan  invasive  breast  cancer  diagnosed  before  the  age  of  \n50 years than NH-",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 72,
    "unit": "years",
    "population": null,
    "notes": "Among  women  with  invasive  breast  cancer,  minority  \nwomen  collectively  had  a  72%  higher  risk  of  having  \nan  invasive  breast  cancer  diagnosed  before  the  age  of  \n50 years than NH-",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 95,
    "unit": "years",
    "population": null,
    "notes": "Among  women  with  invasive  breast  cancer,  minority  \nwomen  collectively  had  a  72%  higher  risk  of  having  \nan  invasive  breast  cancer  diagnosed  before  the  age  of  \n50 years than NH-",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 70,
    "unit": "years",
    "population": null,
    "notes": "Among  women  with  invasive  breast  cancer,  minority  \nwomen  collectively  had  a  72%  higher  risk  of  having  \nan  invasive  breast  cancer  diagnosed  before  the  age  of  \n50 years than NH-",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 75,
    "unit": "years",
    "population": null,
    "notes": "Among  women  with  invasive  breast  cancer,  minority  \nwomen  collectively  had  a  72%  higher  risk  of  having  \nan  invasive  breast  cancer  diagnosed  before  the  age  of  \n50 years than NH-",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 40,
    "unit": "years",
    "population": null,
    "notes": "Distribution   of   invasive   breast   cancer   cases,   \nexpressed  as  percentages  of  the  total  for  the  ages  of  40  to  \n75 years, by the age at diagnosis for each race/ethnicity cohort \nac",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 75,
    "unit": "years",
    "population": null,
    "notes": "Distribution   of   invasive   breast   cancer   cases,   \nexpressed  as  percentages  of  the  total  for  the  ages  of  40  to  \n75 years, by the age at diagnosis for each race/ethnicity cohort \nac",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 2014,
    "unit": "years",
    "population": null,
    "notes": "Distribution   of   invasive   breast   cancer   cases,   \nexpressed  as  percentages  of  the  total  for  the  ages  of  40  to  \n75 years, by the age at diagnosis for each race/ethnicity cohort \nac",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 2017,
    "unit": "years",
    "population": null,
    "notes": "Distribution   of   invasive   breast   cancer   cases,   \nexpressed  as  percentages  of  the  total  for  the  ages  of  40  to  \n75 years, by the age at diagnosis for each race/ethnicity cohort \nac",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 21,
    "unit": "years",
    "population": null,
    "notes": "Distribution   of   invasive   breast   cancer   cases,   \nexpressed  as  percentages  of  the  total  for  the  ages  of  40  to  \n75 years, by the age at diagnosis for each race/ethnicity cohort \nac",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 24,
    "unit": "%",
    "population": null,
    "notes": "Minority women collectively had a \n24% higher risk than NH- White women of an advanced \nbreast cancer at diagnosis (RR, 1.24; 95% CI, 1.23- 1.25), \nwhereas  for  women  under  the  age  of  50  years,",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Minority women collectively had a \n24% higher risk than NH- White women of an advanced \nbreast cancer at diagnosis (RR, 1.24; 95% CI, 1.23- 1.25), \nwhereas  for  women  under  the  age  of  50  years,",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 58,
    "unit": "%",
    "population": null,
    "notes": "Minority women collectively had a \n24% higher risk than NH- White women of an advanced \nbreast cancer at diagnosis (RR, 1.24; 95% CI, 1.23- 1.25), \nwhereas  for  women  under  the  age  of  50  years,",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Minority women collectively had a \n24% higher risk than NH- White women of an advanced \nbreast cancer at diagnosis (RR, 1.24; 95% CI, 1.23- 1.25), \nwhereas  for  women  under  the  age  of  50  years,",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "rate",
    "timePeriod": "50  year",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Table  5  reports  invasive  breast  cancer  incidence  \nrates,  advanced-  stage  breast  cancer  incidence  rates,  and  \nbreast  cancer  mortality  rates  for  women  under  50  years  \nof  age  al",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Among women diagnosed with invasive breast cancer, the RRs and 95% CIs compare a given minority woman diagnosed under the age of 50 years with a NH- \nWhite woman",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Breast Cancer Diagnosis and Mortality by Race/Hendrick et al\n4387\nCancer    December 1, 2021\nof 50 years (Table 3)",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Minority women collectively had a \n24% higher risk than NH- White women of an advanced \nbreast cancer at diagnosis (RR, 1.24; 95% CI, 1.23- 1.25), \nwhereas  for  women  under  the  age  of  50  years,",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "rate",
    "timePeriod": "75  year",
    "value": 75,
    "unit": "years",
    "population": null,
    "notes": "Distributions of invasive breast cancer rates \nby  the  age  at  diagnosis  for  women  aged  40  to  75  years  \nfrom  SEER  21  are  shown  in  Figure  4",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "rate",
    "timePeriod": "50  year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Table  5  reports  invasive  breast  cancer  incidence  \nrates,  advanced-  stage  breast  cancer  incidence  rates,  and  \nbreast  cancer  mortality  rates  for  women  under  50  years  \nof  age  al",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "This analysis removes population distribution differences \nby  comparing  incidence  and  mortality  rates  for  women  \nunder the age of 50 years rather than comparing percent-\nages of invasive breas",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "This analysis removes population distribution differences \nby  comparing  incidence  and  mortality  rates  for  women  \nunder the age of 50 years rather than comparing percent-\nages of invasive breas",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 75,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Numbers of Invasive Breast Cancers and Numbers and Percentages of Women Diagnosed With \nInvasive Breast Cancer Under the Age of 50 Years in Each Race/Ethnicity Cohort According to 2014- 2017 \nSEER 21 ",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Among women diagnosed with invasive breast cancer, the RRs and 95% CIs compare a given minority woman diagnosed under the age of 50 years with a NH- \nWhite woman",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Breast Cancer Diagnosis and Mortality by Race/Hendrick et al\n4387\nCancer    December 1, 2021\nof 50 years (Table 3)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "The distribution of breast cancer deaths by age as a \npercentage  of  the  total  for  all  ages  based  on  2014-  2018  \nNCHS data (Fig",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "The distribution of breast cancer deaths by age as a \npercentage  of  the  total  for  all  ages  based  on  2014-  2018  \nNCHS data (Fig",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Numbers of Invasive Breast Cancers and Numbers and Percentages of Women Diagnosed With \nInvasive Breast Cancer Under the Age of 50 Years in Each Race/Ethnicity Cohort According to 2014- 2017 \nSEER 21 ",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Numbers of Invasive Breast Cancers and Numbers and Percentages of Women Diagnosed With \nInvasive Breast Cancer Under the Age of 50 Years in Each Race/Ethnicity Cohort According to 2014- 2017 \nSEER 21 ",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 1.24,
    "unit": "years",
    "population": null,
    "notes": "Minority women collectively had a \n24% higher risk than NH- White women of an advanced \nbreast cancer at diagnosis (RR, 1.24; 95% CI, 1.23- 1.25), \nwhereas  for  women  under  the  age  of  50  years,",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 1.23,
    "unit": "years",
    "population": null,
    "notes": "Minority women collectively had a \n24% higher risk than NH- White women of an advanced \nbreast cancer at diagnosis (RR, 1.24; 95% CI, 1.23- 1.25), \nwhereas  for  women  under  the  age  of  50  years,",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 1.25,
    "unit": "years",
    "population": null,
    "notes": "Minority women collectively had a \n24% higher risk than NH- White women of an advanced \nbreast cancer at diagnosis (RR, 1.24; 95% CI, 1.23- 1.25), \nwhereas  for  women  under  the  age  of  50  years,",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 1.58,
    "unit": "years",
    "population": null,
    "notes": "Minority women collectively had a \n24% higher risk than NH- White women of an advanced \nbreast cancer at diagnosis (RR, 1.24; 95% CI, 1.23- 1.25), \nwhereas  for  women  under  the  age  of  50  years,",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 1.55,
    "unit": "years",
    "population": null,
    "notes": "Minority women collectively had a \n24% higher risk than NH- White women of an advanced \nbreast cancer at diagnosis (RR, 1.24; 95% CI, 1.23- 1.25), \nwhereas  for  women  under  the  age  of  50  years,",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 1.61,
    "unit": "years",
    "population": null,
    "notes": "Minority women collectively had a \n24% higher risk than NH- White women of an advanced \nbreast cancer at diagnosis (RR, 1.24; 95% CI, 1.23- 1.25), \nwhereas  for  women  under  the  age  of  50  years,",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 44460.86153,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 60.4,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 9.2,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 83711.75851,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 58.5,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 9.3,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 46010.65749,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 57.3,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 9.6,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 8490.75951,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 58.8,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 9.3,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 46916.35649,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 57,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 9.5,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 58.6,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 9.4,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 4387,
    "unit": "years",
    "population": null,
    "notes": "Breast Cancer Diagnosis and Mortality by Race/Hendrick et al\n4387\nCancer    December 1, 2021\nof 50 years (Table 3)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 2021,
    "unit": "years",
    "population": null,
    "notes": "Breast Cancer Diagnosis and Mortality by Race/Hendrick et al\n4387\nCancer    December 1, 2021\nof 50 years (Table 3)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Breast Cancer Diagnosis and Mortality by Race/Hendrick et al\n4387\nCancer    December 1, 2021\nof 50 years (Table 3)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 24,
    "unit": "years",
    "population": null,
    "notes": "Minority women collectively had a \n24% higher risk than NH- White women of an advanced \nbreast cancer at diagnosis (RR, 1.24; 95% CI, 1.23- 1.25), \nwhereas  for  women  under  the  age  of  50  years,",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 24,
    "unit": "years",
    "population": null,
    "notes": "Minority women collectively had a \n24% higher risk than NH- White women of an advanced \nbreast cancer at diagnosis (RR, 1.24; 95% CI, 1.23- 1.25), \nwhereas  for  women  under  the  age  of  50  years,",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 95,
    "unit": "years",
    "population": null,
    "notes": "Minority women collectively had a \n24% higher risk than NH- White women of an advanced \nbreast cancer at diagnosis (RR, 1.24; 95% CI, 1.23- 1.25), \nwhereas  for  women  under  the  age  of  50  years,",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 23,
    "unit": "years",
    "population": null,
    "notes": "Minority women collectively had a \n24% higher risk than NH- White women of an advanced \nbreast cancer at diagnosis (RR, 1.24; 95% CI, 1.23- 1.25), \nwhereas  for  women  under  the  age  of  50  years,",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 25,
    "unit": "years",
    "population": null,
    "notes": "Minority women collectively had a \n24% higher risk than NH- White women of an advanced \nbreast cancer at diagnosis (RR, 1.24; 95% CI, 1.23- 1.25), \nwhereas  for  women  under  the  age  of  50  years,",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Minority women collectively had a \n24% higher risk than NH- White women of an advanced \nbreast cancer at diagnosis (RR, 1.24; 95% CI, 1.23- 1.25), \nwhereas  for  women  under  the  age  of  50  years,",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 58,
    "unit": "years",
    "population": null,
    "notes": "Minority women collectively had a \n24% higher risk than NH- White women of an advanced \nbreast cancer at diagnosis (RR, 1.24; 95% CI, 1.23- 1.25), \nwhereas  for  women  under  the  age  of  50  years,",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 58,
    "unit": "years",
    "population": null,
    "notes": "Minority women collectively had a \n24% higher risk than NH- White women of an advanced \nbreast cancer at diagnosis (RR, 1.24; 95% CI, 1.23- 1.25), \nwhereas  for  women  under  the  age  of  50  years,",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 95,
    "unit": "years",
    "population": null,
    "notes": "Minority women collectively had a \n24% higher risk than NH- White women of an advanced \nbreast cancer at diagnosis (RR, 1.24; 95% CI, 1.23- 1.25), \nwhereas  for  women  under  the  age  of  50  years,",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 55,
    "unit": "years",
    "population": null,
    "notes": "Minority women collectively had a \n24% higher risk than NH- White women of an advanced \nbreast cancer at diagnosis (RR, 1.24; 95% CI, 1.23- 1.25), \nwhereas  for  women  under  the  age  of  50  years,",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 61,
    "unit": "years",
    "population": null,
    "notes": "Minority women collectively had a \n24% higher risk than NH- White women of an advanced \nbreast cancer at diagnosis (RR, 1.24; 95% CI, 1.23- 1.25), \nwhereas  for  women  under  the  age  of  50  years,",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 1,
    "unit": "years",
    "population": null,
    "notes": "Minority women collectively had a \n24% higher risk than NH- White women of an advanced \nbreast cancer at diagnosis (RR, 1.24; 95% CI, 1.23- 1.25), \nwhereas  for  women  under  the  age  of  50  years,",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 2014,
    "unit": null,
    "population": null,
    "notes": "The distribution of breast cancer deaths by age as a \npercentage  of  the  total  for  all  ages  based  on  2014-  2018  \nNCHS data (Fig",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 2018,
    "unit": null,
    "population": null,
    "notes": "The distribution of breast cancer deaths by age as a \npercentage  of  the  total  for  all  ages  based  on  2014-  2018  \nNCHS data (Fig",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "rate",
    "timePeriod": "75  year",
    "value": 40,
    "unit": "years",
    "population": null,
    "notes": "Distributions of invasive breast cancer rates \nby  the  age  at  diagnosis  for  women  aged  40  to  75  years  \nfrom  SEER  21  are  shown  in  Figure  4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "rate",
    "timePeriod": "75  year",
    "value": 75,
    "unit": "years",
    "population": null,
    "notes": "Distributions of invasive breast cancer rates \nby  the  age  at  diagnosis  for  women  aged  40  to  75  years  \nfrom  SEER  21  are  shown  in  Figure  4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "rate",
    "timePeriod": "75  year",
    "value": 21,
    "unit": "years",
    "population": null,
    "notes": "Distributions of invasive breast cancer rates \nby  the  age  at  diagnosis  for  women  aged  40  to  75  years  \nfrom  SEER  21  are  shown  in  Figure  4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "rate",
    "timePeriod": "50  year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Table  5  reports  invasive  breast  cancer  incidence  \nrates,  advanced-  stage  breast  cancer  incidence  rates,  and  \nbreast  cancer  mortality  rates  for  women  under  50  years  \nof  age  al",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "rate",
    "timePeriod": "50  year",
    "value": 95,
    "unit": "years",
    "population": null,
    "notes": "Table  5  reports  invasive  breast  cancer  incidence  \nrates,  advanced-  stage  breast  cancer  incidence  rates,  and  \nbreast  cancer  mortality  rates  for  women  under  50  years  \nof  age  al",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "This analysis removes population distribution differences \nby  comparing  incidence  and  mortality  rates  for  women  \nunder the age of 50 years rather than comparing percent-\nages of invasive breas",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "This analysis removes population distribution differences \nby  comparing  incidence  and  mortality  rates  for  women  \nunder the age of 50 years rather than comparing percent-\nages of invasive breas",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 2014,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 2017,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 21,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 40,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 75,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 919,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 44460,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 86153,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 67,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 60,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 67,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 709,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 83711,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 75851,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 66,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 58,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 65,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 602,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 46010,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 65749,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 65,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 57,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 59,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 8490,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 75951,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 66,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 58,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 60,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 379,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 46916,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 35649,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 64,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 57,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 40,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 75,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 264,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 591006052,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 67,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 58,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 65,
    "unit": "years",
    "population": null,
    "notes": "Population Composition, Median Ages at Diagnosis (and IQRs), Mean Ages at Diagnosis (and SDs), \nand Mode Ages (Ages at Peak Diagnosis) for Invasive Breast Cancers by Cohort According to 2014- 2017 \nSE",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Numbers of Invasive Breast Cancers and Numbers and Percentages of Women Diagnosed With \nInvasive Breast Cancer Under the Age of 50 Years in Each Race/Ethnicity Cohort According to 2014- 2017 \nSEER 21 ",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 2014,
    "unit": "years",
    "population": null,
    "notes": "Numbers of Invasive Breast Cancers and Numbers and Percentages of Women Diagnosed With \nInvasive Breast Cancer Under the Age of 50 Years in Each Race/Ethnicity Cohort According to 2014- 2017 \nSEER 21 ",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 2017,
    "unit": "years",
    "population": null,
    "notes": "Numbers of Invasive Breast Cancers and Numbers and Percentages of Women Diagnosed With \nInvasive Breast Cancer Under the Age of 50 Years in Each Race/Ethnicity Cohort According to 2014- 2017 \nSEER 21 ",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 21,
    "unit": "years",
    "population": null,
    "notes": "Numbers of Invasive Breast Cancers and Numbers and Percentages of Women Diagnosed With \nInvasive Breast Cancer Under the Age of 50 Years in Each Race/Ethnicity Cohort According to 2014- 2017 \nSEER 21 ",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Numbers of Invasive Breast Cancers and Numbers and Percentages of Women Diagnosed With \nInvasive Breast Cancer Under the Age of 50 Years in Each Race/Ethnicity Cohort According to 2014- 2017 \nSEER 21 ",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 95,
    "unit": "years",
    "population": null,
    "notes": "Among women diagnosed with invasive breast cancer, the RRs and 95% CIs compare a given minority woman diagnosed under the age of 50 years with a NH- \nWhite woman",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Among women diagnosed with invasive breast cancer, the RRs and 95% CIs compare a given minority woman diagnosed under the age of 50 years with a NH- \nWhite woman",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "rate",
    "timePeriod": null,
    "value": 18,
    "unit": "%",
    "population": null,
    "notes": "For NH- \nBlack women, on the other hand, although invasive breast \ncancer  rates  are  slightly  lower  than  those  of  NH-  White  \nwomen, rates of advanced breast cancers are significantly \nhigher ",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "rate",
    "timePeriod": null,
    "value": 88,
    "unit": "%",
    "population": null,
    "notes": "For NH- \nBlack women, on the other hand, although invasive breast \ncancer  rates  are  slightly  lower  than  those  of  NH-  White  \nwomen, rates of advanced breast cancers are significantly \nhigher ",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Table  6  shows  ratios  of  advanced-  stage  breast  can-\ncer  rates  to  invasive  breast  cancer  rates  in  women  under  \nthe  age  of  50  years  for  each  race/ethnicity  cohort  along  \nwith",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Table  6  also  shows  ratios  of  breast  cancer  mortal-\nity  rates  to  invasive  breast  cancer  rates  in  women  under  \nthe  age  of  50  years  for  each  race/ethnicity  cohort  along  \nwith ",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 72,
    "unit": "%",
    "population": null,
    "notes": "Among  women  diagnosed  with  invasive  breast  \ncancer,  minority  women  collectively  have  a  significant  \n72%  higher  risk  of  being  diagnosed  under  the  age  of  \n50 years than NH- White ",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 93,
    "unit": "%",
    "population": null,
    "notes": "Among  women  diagnosed  with  invasive  breast  \ncancer,  minority  women  collectively  have  a  significant  \n72%  higher  risk  of  being  diagnosed  under  the  age  of  \n50 years than NH- White ",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 83,
    "unit": "%",
    "population": null,
    "notes": "Among  women  diagnosed  with  invasive  breast  \ncancer,  minority  women  collectively  have  a  significant  \n72%  higher  risk  of  being  diagnosed  under  the  age  of  \n50 years than NH- White ",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 24,
    "unit": "%",
    "population": null,
    "notes": "Collectively,  \nminority  women  have  a  significant  24%  higher  risk  of  \nbeing  diagnosed  with  regional-    or  distant-  stage  breast  \ncancer than NH- White women, with NH- Black women \nhav",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 35,
    "unit": "%",
    "population": null,
    "notes": "Collectively,  \nminority  women  have  a  significant  24%  higher  risk  of  \nbeing  diagnosed  with  regional-    or  distant-  stage  breast  \ncancer than NH- White women, with NH- Black women \nhav",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 26,
    "unit": "%",
    "population": null,
    "notes": "Collectively,  \nminority  women  have  a  significant  24%  higher  risk  of  \nbeing  diagnosed  with  regional-    or  distant-  stage  breast  \ncancer than NH- White women, with NH- Black women \nhav",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 58,
    "unit": "%",
    "population": null,
    "notes": "When we con-\nsider women under the age of 50 years, minority women \ncollectively  have  a  significant  58%  higher  risk  of  being  \ndiagnosed  with  an  advanced-  stage  breast  cancer  than  \nNH-",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 31,
    "unit": "%",
    "population": null,
    "notes": "When we con-\nsider women under the age of 50 years, minority women \ncollectively  have  a  significant  58%  higher  risk  of  being  \ndiagnosed  with  an  advanced-  stage  breast  cancer  than  \nNH-",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 81,
    "unit": "%",
    "population": null,
    "notes": "When we con-\nsider women under the age of 50 years, minority women \ncollectively  have  a  significant  58%  higher  risk  of  being  \ndiagnosed  with  an  advanced-  stage  breast  cancer  than  \nNH-",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Table  6  shows  ratios  of  advanced-  stage  breast  can-\ncer  rates  to  invasive  breast  cancer  rates  in  women  under  \nthe  age  of  50  years  for  each  race/ethnicity  cohort  along  \nwith",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Significantly higher ratios of advanced breast cancer rates \nto invasive breast cancer rates exist for NH- Black, Native \nAmerican, and Hispanic women under the age of 50 years \nin comparison with NH-",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Significantly higher ratios of advanced breast cancer rates \nto invasive breast cancer rates exist for NH- Black, Native \nAmerican, and Hispanic women under the age of 50 years \nin comparison with NH-",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Table  6  also  shows  ratios  of  breast  cancer  mortal-\nity  rates  to  invasive  breast  cancer  rates  in  women  under  \nthe  age  of  50  years  for  each  race/ethnicity  cohort  along  \nwith ",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Similarly, significantly higher breast cancer mor-\ntality to incidence rate ratios exist for NH- Black, Native \nAmerican, and Hispanic women under the age of 50 years \nin comparison with NH- White wom",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Similarly, significantly higher breast cancer mor-\ntality to incidence rate ratios exist for NH- Black, Native \nAmerican, and Hispanic women under the age of 50 years \nin comparison with NH- White wom",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Numbers of Invasive BCs of Known Stages and Numbers and Percentages of Women Diagnosed With Advanced- \nStage (Regional or \nDistant) BC for Each Race/Ethnicity Cohort and Numbers and Percentages of Adv",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "85 year",
    "value": 85,
    "unit": "years",
    "population": null,
    "notes": "The last (farthest right) data \npoints represent the percentages of breast cancer deaths for \nwomen aged 85 years or older",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\n\nBreas",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Among  women  diagnosed  with  invasive  breast  \ncancer,  minority  women  collectively  have  a  significant  \n72%  higher  risk  of  being  diagnosed  under  the  age  of  \n50 years than NH- White ",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "When we con-\nsider women under the age of 50 years, minority women \ncollectively  have  a  significant  58%  higher  risk  of  being  \ndiagnosed  with  an  advanced-  stage  breast  cancer  than  \nNH-",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "When we con-\nsider women under the age of 50 years, minority women \ncollectively  have  a  significant  58%  higher  risk  of  being  \ndiagnosed  with  an  advanced-  stage  breast  cancer  than  \nNH-",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Numbers of Breast Cancer Deaths and Numbers and Percentages of Breast Cancer Deaths Under \nthe Age of 50 Years in Each Race/Ethnicity Cohort According to 2014- 2018 NCHS Data for Females of All \nAges\n",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 75,
    "unit": "years",
    "population": null,
    "notes": "Distribution  of  invasive  breast  cancer  rates  (per  \n100,000 women) by the age at diagnosis for women aged 40 to \n75 years according to 2014- 2017 SEER 21 data",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 0,
    "unit": "count",
    "population": null,
    "notes": "Distribution  of  invasive  breast  cancer  rates  (per  \n100,000 women) by the age at diagnosis for women aged 40 to \n75 years according to 2014- 2017 SEER 21 data",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Original Article\n4388\nCancer    December 1, 2021\nbreast cancer deaths are lower for AAPI, Native American, \nand Hispanic women than NH- White women",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Numbers of Invasive BCs of Known Stages and Numbers and Percentages of Women Diagnosed With Advanced- \nStage (Regional or \nDistant) BC for Each Race/Ethnicity Cohort and Numbers and Percentages of Adv",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Numbers of Invasive BCs of Known Stages and Numbers and Percentages of Women Diagnosed With Advanced- \nStage (Regional or \nDistant) BC for Each Race/Ethnicity Cohort and Numbers and Percentages of Adv",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Distribution  of  female  breast  cancer  deaths  by  age  \nat death, expressed as percentages of the total from the ages \nof 20 to 85+ years, for each race/ethnicity cohort according to \n2014- 2018 N",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Distribution  of  female  breast  cancer  deaths  by  age  \nat death, expressed as percentages of the total from the ages \nof 20 to 85+ years, for each race/ethnicity cohort according to \n2014- 2018 N",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\n\nBreas",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Numbers of Breast Cancer Deaths and Numbers and Percentages of Breast Cancer Deaths Under \nthe Age of 50 Years in Each Race/Ethnicity Cohort According to 2014- 2018 NCHS Data for Females of All \nAges\n",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Numbers of Breast Cancer Deaths and Numbers and Percentages of Breast Cancer Deaths Under \nthe Age of 50 Years in Each Race/Ethnicity Cohort According to 2014- 2018 NCHS Data for Females of All \nAges\n",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Distribution  of  invasive  breast  cancer  rates  (per  \n100,000 women) by the age at diagnosis for women aged 40 to \n75 years according to 2014- 2017 SEER 21 data",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Distribution  of  invasive  breast  cancer  rates  (per  \n100,000 women) by the age at diagnosis for women aged 40 to \n75 years according to 2014- 2017 SEER 21 data",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 30.7,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 20,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 41.4,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.35,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.33,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.36,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 26.3,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.31,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.27,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.35,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 33.1,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.08,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.06,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.1,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 33.6,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.68,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.63,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.73,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 37.2,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.21,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.13,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.29,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 29,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.45,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.27,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.66,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 38.7,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.26,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.24,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.28,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 36.1,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.81,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.76,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.85,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 38.2,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.24,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.23,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.25,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 31.6,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.58,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.55,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1.61,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 8177.61,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 418506616.12,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 112.05,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 2.18,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 52.292,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 2.42,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 41.621,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1.91,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 568293520.12,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 642.55,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 2.74,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 413924517.32,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 272.21,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 2.33,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 4388,
    "unit": null,
    "population": null,
    "notes": "Original Article\n4388\nCancer    December 1, 2021\nbreast cancer deaths are lower for AAPI, Native American, \nand Hispanic women than NH- White women",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 2021,
    "unit": null,
    "population": null,
    "notes": "Original Article\n4388\nCancer    December 1, 2021\nbreast cancer deaths are lower for AAPI, Native American, \nand Hispanic women than NH- White women",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "rate",
    "timePeriod": null,
    "value": 18,
    "unit": "%",
    "population": null,
    "notes": "For NH- \nBlack women, on the other hand, although invasive breast \ncancer  rates  are  slightly  lower  than  those  of  NH-  White  \nwomen, rates of advanced breast cancers are significantly \nhigher ",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "rate",
    "timePeriod": null,
    "value": 88,
    "unit": "%",
    "population": null,
    "notes": "For NH- \nBlack women, on the other hand, although invasive breast \ncancer  rates  are  slightly  lower  than  those  of  NH-  White  \nwomen, rates of advanced breast cancers are significantly \nhigher ",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Table  6  shows  ratios  of  advanced-  stage  breast  can-\ncer  rates  to  invasive  breast  cancer  rates  in  women  under  \nthe  age  of  50  years  for  each  race/ethnicity  cohort  along  \nwith",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 95,
    "unit": "years",
    "population": null,
    "notes": "Table  6  shows  ratios  of  advanced-  stage  breast  can-\ncer  rates  to  invasive  breast  cancer  rates  in  women  under  \nthe  age  of  50  years  for  each  race/ethnicity  cohort  along  \nwith",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Significantly higher ratios of advanced breast cancer rates \nto invasive breast cancer rates exist for NH- Black, Native \nAmerican, and Hispanic women under the age of 50 years \nin comparison with NH-",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Significantly higher ratios of advanced breast cancer rates \nto invasive breast cancer rates exist for NH- Black, Native \nAmerican, and Hispanic women under the age of 50 years \nin comparison with NH-",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Table  6  also  shows  ratios  of  breast  cancer  mortal-\nity  rates  to  invasive  breast  cancer  rates  in  women  under  \nthe  age  of  50  years  for  each  race/ethnicity  cohort  along  \nwith ",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 95,
    "unit": "years",
    "population": null,
    "notes": "Table  6  also  shows  ratios  of  breast  cancer  mortal-\nity  rates  to  invasive  breast  cancer  rates  in  women  under  \nthe  age  of  50  years  for  each  race/ethnicity  cohort  along  \nwith ",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Similarly, significantly higher breast cancer mor-\ntality to incidence rate ratios exist for NH- Black, Native \nAmerican, and Hispanic women under the age of 50 years \nin comparison with NH- White wom",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Similarly, significantly higher breast cancer mor-\ntality to incidence rate ratios exist for NH- Black, Native \nAmerican, and Hispanic women under the age of 50 years \nin comparison with NH- White wom",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Numbers of Invasive BCs of Known Stages and Numbers and Percentages of Women Diagnosed With Advanced- \nStage (Regional or \nDistant) BC for Each Race/Ethnicity Cohort and Numbers and Percentages of Adv",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 2014,
    "unit": "years",
    "population": null,
    "notes": "Numbers of Invasive BCs of Known Stages and Numbers and Percentages of Women Diagnosed With Advanced- \nStage (Regional or \nDistant) BC for Each Race/Ethnicity Cohort and Numbers and Percentages of Adv",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 2017,
    "unit": "years",
    "population": null,
    "notes": "Numbers of Invasive BCs of Known Stages and Numbers and Percentages of Women Diagnosed With Advanced- \nStage (Regional or \nDistant) BC for Each Race/Ethnicity Cohort and Numbers and Percentages of Adv",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 21,
    "unit": "years",
    "population": null,
    "notes": "Numbers of Invasive BCs of Known Stages and Numbers and Percentages of Women Diagnosed With Advanced- \nStage (Regional or \nDistant) BC for Each Race/Ethnicity Cohort and Numbers and Percentages of Adv",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Numbers of Invasive BCs of Known Stages and Numbers and Percentages of Women Diagnosed With Advanced- \nStage (Regional or \nDistant) BC for Each Race/Ethnicity Cohort and Numbers and Percentages of Adv",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 95,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 244,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 681,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 75,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 193,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 30,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 15,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 38,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 20,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 39,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 444,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 16,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 319,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 41,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 35,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 33,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 36,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 4284,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 26,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 31,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 27,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 35,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 29,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 432,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 9756,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 33,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 8,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 6,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 10,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 3280,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 33,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 68,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 63,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 73,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 1413,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 525,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 37,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 21,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 13,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 29,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 152,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 29,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 45,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 27,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 66,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 40,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 181,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 15,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 546,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 38,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 26,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 24,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 28,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 5614,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 36,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 81,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 76,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 85,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 110,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 470,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 42,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 146,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 38,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 24,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 23,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 25,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 13,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 330,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 31,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 58,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 55,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 61,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 95,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "of \nAdvanced BCs \nat \n<\n50 y\n% Advanced \nBCs at \n<\n50 y\nRR of Advanced \nBCs at \n<\n50 y\n95% CI\nNH- White\n244,681\n75,193\n30.7\n1\n— \n15,038\n20.0\n1\nNH- Black\n39,444\n16,319\n41.4\n1.35\n1.33- 1.36\n4284\n26.3\n1.",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 20,
    "unit": "years",
    "population": null,
    "notes": "Distribution  of  female  breast  cancer  deaths  by  age  \nat death, expressed as percentages of the total from the ages \nof 20 to 85+ years, for each race/ethnicity cohort according to \n2014- 2018 N",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 85,
    "unit": "years",
    "population": null,
    "notes": "Distribution  of  female  breast  cancer  deaths  by  age  \nat death, expressed as percentages of the total from the ages \nof 20 to 85+ years, for each race/ethnicity cohort according to \n2014- 2018 N",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 2014,
    "unit": "years",
    "population": null,
    "notes": "Distribution  of  female  breast  cancer  deaths  by  age  \nat death, expressed as percentages of the total from the ages \nof 20 to 85+ years, for each race/ethnicity cohort according to \n2014- 2018 N",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 2018,
    "unit": "years",
    "population": null,
    "notes": "Distribution  of  female  breast  cancer  deaths  by  age  \nat death, expressed as percentages of the total from the ages \nof 20 to 85+ years, for each race/ethnicity cohort according to \n2014- 2018 N",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "85 year",
    "value": 85,
    "unit": "years",
    "population": null,
    "notes": "The last (farthest right) data \npoints represent the percentages of breast cancer deaths for \nwomen aged 85 years or older",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 4389,
    "unit": "years",
    "population": null,
    "notes": "See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\n\nBreas",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 2021,
    "unit": "years",
    "population": null,
    "notes": "See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\n\nBreas",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\n\nBreas",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 72,
    "unit": "years",
    "population": null,
    "notes": "Among  women  diagnosed  with  invasive  breast  \ncancer,  minority  women  collectively  have  a  significant  \n72%  higher  risk  of  being  diagnosed  under  the  age  of  \n50 years than NH- White ",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Among  women  diagnosed  with  invasive  breast  \ncancer,  minority  women  collectively  have  a  significant  \n72%  higher  risk  of  being  diagnosed  under  the  age  of  \n50 years than NH- White ",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 93,
    "unit": "years",
    "population": null,
    "notes": "Among  women  diagnosed  with  invasive  breast  \ncancer,  minority  women  collectively  have  a  significant  \n72%  higher  risk  of  being  diagnosed  under  the  age  of  \n50 years than NH- White ",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 83,
    "unit": "years",
    "population": null,
    "notes": "Among  women  diagnosed  with  invasive  breast  \ncancer,  minority  women  collectively  have  a  significant  \n72%  higher  risk  of  being  diagnosed  under  the  age  of  \n50 years than NH- White ",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 24,
    "unit": "%",
    "population": null,
    "notes": "Collectively,  \nminority  women  have  a  significant  24%  higher  risk  of  \nbeing  diagnosed  with  regional-    or  distant-  stage  breast  \ncancer than NH- White women, with NH- Black women \nhav",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 35,
    "unit": "%",
    "population": null,
    "notes": "Collectively,  \nminority  women  have  a  significant  24%  higher  risk  of  \nbeing  diagnosed  with  regional-    or  distant-  stage  breast  \ncancer than NH- White women, with NH- Black women \nhav",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 26,
    "unit": "%",
    "population": null,
    "notes": "Collectively,  \nminority  women  have  a  significant  24%  higher  risk  of  \nbeing  diagnosed  with  regional-    or  distant-  stage  breast  \ncancer than NH- White women, with NH- Black women \nhav",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "When we con-\nsider women under the age of 50 years, minority women \ncollectively  have  a  significant  58%  higher  risk  of  being  \ndiagnosed  with  an  advanced-  stage  breast  cancer  than  \nNH-",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 58,
    "unit": "years",
    "population": null,
    "notes": "When we con-\nsider women under the age of 50 years, minority women \ncollectively  have  a  significant  58%  higher  risk  of  being  \ndiagnosed  with  an  advanced-  stage  breast  cancer  than  \nNH-",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 31,
    "unit": "years",
    "population": null,
    "notes": "When we con-\nsider women under the age of 50 years, minority women \ncollectively  have  a  significant  58%  higher  risk  of  being  \ndiagnosed  with  an  advanced-  stage  breast  cancer  than  \nNH-",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 81,
    "unit": "years",
    "population": null,
    "notes": "When we con-\nsider women under the age of 50 years, minority women \ncollectively  have  a  significant  58%  higher  risk  of  being  \ndiagnosed  with  an  advanced-  stage  breast  cancer  than  \nNH-",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "When we con-\nsider women under the age of 50 years, minority women \ncollectively  have  a  significant  58%  higher  risk  of  being  \ndiagnosed  with  an  advanced-  stage  breast  cancer  than  \nNH-",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Numbers of Breast Cancer Deaths and Numbers and Percentages of Breast Cancer Deaths Under \nthe Age of 50 Years in Each Race/Ethnicity Cohort According to 2014- 2018 NCHS Data for Females of All \nAges\n",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 2014,
    "unit": "years",
    "population": null,
    "notes": "Numbers of Breast Cancer Deaths and Numbers and Percentages of Breast Cancer Deaths Under \nthe Age of 50 Years in Each Race/Ethnicity Cohort According to 2014- 2018 NCHS Data for Females of All \nAges\n",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 2018,
    "unit": "years",
    "population": null,
    "notes": "Numbers of Breast Cancer Deaths and Numbers and Percentages of Breast Cancer Deaths Under \nthe Age of 50 Years in Each Race/Ethnicity Cohort According to 2014- 2018 NCHS Data for Females of All \nAges\n",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "Numbers of Breast Cancer Deaths and Numbers and Percentages of Breast Cancer Deaths Under \nthe Age of 50 Years in Each Race/Ethnicity Cohort According to 2014- 2018 NCHS Data for Females of All \nAges\n",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 50,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 50,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 50,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 91611,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 8177,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 61,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 418506616,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 12,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 112,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 5,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 18,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 52,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 292,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 16,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 42,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 41,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 621,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 38,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 91,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 568293520,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 12,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 642,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 55,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 74,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 413924517,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 32,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 272,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 21,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 33,
    "unit": "%",
    "population": null,
    "notes": "Under Age of 50 y% Under Age of 50 y\nRR of Cancer Death at \n<50 y95% CI\nNH- White154,91611,8177.61— \nNH- Black31,418506616.12.112.05- 2.18\nAAPI6386111517.52.292.16- 2.42\nNative American104112912.41.62",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 100,
    "unit": "per  \n100,000",
    "population": null,
    "notes": "Distribution  of  invasive  breast  cancer  rates  (per  \n100,000 women) by the age at diagnosis for women aged 40 to \n75 years according to 2014- 2017 SEER 21 data",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 0,
    "unit": "per  \n100,000",
    "population": null,
    "notes": "Distribution  of  invasive  breast  cancer  rates  (per  \n100,000 women) by the age at diagnosis for women aged 40 to \n75 years according to 2014- 2017 SEER 21 data",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 40,
    "unit": "per  \n100,000",
    "population": null,
    "notes": "Distribution  of  invasive  breast  cancer  rates  (per  \n100,000 women) by the age at diagnosis for women aged 40 to \n75 years according to 2014- 2017 SEER 21 data",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 75,
    "unit": "per  \n100,000",
    "population": null,
    "notes": "Distribution  of  invasive  breast  cancer  rates  (per  \n100,000 women) by the age at diagnosis for women aged 40 to \n75 years according to 2014- 2017 SEER 21 data",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 2014,
    "unit": "per  \n100,000",
    "population": null,
    "notes": "Distribution  of  invasive  breast  cancer  rates  (per  \n100,000 women) by the age at diagnosis for women aged 40 to \n75 years according to 2014- 2017 SEER 21 data",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 2017,
    "unit": "per  \n100,000",
    "population": null,
    "notes": "Distribution  of  invasive  breast  cancer  rates  (per  \n100,000 women) by the age at diagnosis for women aged 40 to \n75 years according to 2014- 2017 SEER 21 data",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 21,
    "unit": "years",
    "population": null,
    "notes": "100,000 women) by the age at diagnosis for women aged 40 to \n75 years according to 2014- 2017 SEER 21 data. AAPI indicates \nAsian   American/Pacific   Islander;   NH-   Black,   non-   Hispanic   \nBla",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 18,
    "unit": "%",
    "population": null,
    "notes": "RRs  of  advanced-  stage  breast  cancers  and  breast  cancer  \ndeaths are significantly higher for NH- Black women than \nNH-  White  women  under  the  age  of  50  years  (by  18%  \nand 88%, respe",
    "pageHint": 6,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 88,
    "unit": "%",
    "population": null,
    "notes": "RRs  of  advanced-  stage  breast  cancers  and  breast  cancer  \ndeaths are significantly higher for NH- Black women than \nNH-  White  women  under  the  age  of  50  years  (by  18%  \nand 88%, respe",
    "pageHint": 6,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 15,
    "unit": "%",
    "population": null,
    "notes": "In  women  under  the  age  of  50  years,  ratios  of  \nadvanced-  stage  breast  cancer  incidence  rates  to  invasive  \nbreast cancer incidence rates were significantly higher for \nNH-  Black,  Na",
    "pageHint": 6,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 21,
    "unit": "%",
    "population": null,
    "notes": "In  women  under  the  age  of  50  years,  ratios  of  \nadvanced-  stage  breast  cancer  incidence  rates  to  invasive  \nbreast cancer incidence rates were significantly higher for \nNH-  Black,  Na",
    "pageHint": 6,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "75 year",
    "value": 75,
    "unit": "years",
    "population": null,
    "notes": "Differences in population distributions between mi-\nnority cohorts and NH- White women are responsible for \nmost of the differences seen in invasive breast cancer dis-\ntributions in women 40 to 75 yea",
    "pageHint": 6,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "rate",
    "timePeriod": "50  year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "When  population  distribution  differences  are  re-\nmoved by comparisons of invasive breast cancer incidence \nrates,  advanced-  stage  breast  cancer  rates,  and  mortality  \nrates  for  women  un",
    "pageHint": 6,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "RRs  of  advanced-  stage  breast  cancers  and  breast  cancer  \ndeaths are significantly higher for NH- Black women than \nNH-  White  women  under  the  age  of  50  years  (by  18%  \nand 88%, respe",
    "pageHint": 6,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "RRs  of  advanced-  stage  breast  cancers  and  breast  cancer  \ndeaths are significantly higher for NH- Black women than \nNH-  White  women  under  the  age  of  50  years  (by  18%  \nand 88%, respe",
    "pageHint": 6,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "In  women  under  the  age  of  50  years,  ratios  of  \nadvanced-  stage  breast  cancer  incidence  rates  to  invasive  \nbreast cancer incidence rates were significantly higher for \nNH-  Black,  Na",
    "pageHint": 6,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Original Article\n4390\nCancer    December 1, 2021\nproportion  of  later-  stage  breast  cancer  diagnoses  means  \nthat more aggressive treatment is needed among minority \nwomen with breast cancer, an",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 4390,
    "unit": null,
    "population": null,
    "notes": "Original Article\n4390\nCancer    December 1, 2021\nproportion  of  later-  stage  breast  cancer  diagnoses  means  \nthat more aggressive treatment is needed among minority \nwomen with breast cancer, an",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 2021,
    "unit": null,
    "population": null,
    "notes": "Original Article\n4390\nCancer    December 1, 2021\nproportion  of  later-  stage  breast  cancer  diagnoses  means  \nthat more aggressive treatment is needed among minority \nwomen with breast cancer, an",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "75 year",
    "value": 40,
    "unit": "years",
    "population": null,
    "notes": "Differences in population distributions between mi-\nnority cohorts and NH- White women are responsible for \nmost of the differences seen in invasive breast cancer dis-\ntributions in women 40 to 75 yea",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "75 year",
    "value": 75,
    "unit": "years",
    "population": null,
    "notes": "Differences in population distributions between mi-\nnority cohorts and NH- White women are responsible for \nmost of the differences seen in invasive breast cancer dis-\ntributions in women 40 to 75 yea",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "rate",
    "timePeriod": "50  year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "When  population  distribution  differences  are  re-\nmoved by comparisons of invasive breast cancer incidence \nrates,  advanced-  stage  breast  cancer  rates,  and  mortality  \nrates  for  women  un",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "RRs  of  advanced-  stage  breast  cancers  and  breast  cancer  \ndeaths are significantly higher for NH- Black women than \nNH-  White  women  under  the  age  of  50  years  (by  18%  \nand 88%, respe",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 18,
    "unit": "years",
    "population": null,
    "notes": "RRs  of  advanced-  stage  breast  cancers  and  breast  cancer  \ndeaths are significantly higher for NH- Black women than \nNH-  White  women  under  the  age  of  50  years  (by  18%  \nand 88%, respe",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 88,
    "unit": "years",
    "population": null,
    "notes": "RRs  of  advanced-  stage  breast  cancers  and  breast  cancer  \ndeaths are significantly higher for NH- Black women than \nNH-  White  women  under  the  age  of  50  years  (by  18%  \nand 88%, respe",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "RRs  of  advanced-  stage  breast  cancers  and  breast  cancer  \ndeaths are significantly higher for NH- Black women than \nNH-  White  women  under  the  age  of  50  years  (by  18%  \nand 88%, respe",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "In  women  under  the  age  of  50  years,  ratios  of  \nadvanced-  stage  breast  cancer  incidence  rates  to  invasive  \nbreast cancer incidence rates were significantly higher for \nNH-  Black,  Na",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 15,
    "unit": "years",
    "population": null,
    "notes": "In  women  under  the  age  of  50  years,  ratios  of  \nadvanced-  stage  breast  cancer  incidence  rates  to  invasive  \nbreast cancer incidence rates were significantly higher for \nNH-  Black,  Na",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "50  year",
    "value": 21,
    "unit": "years",
    "population": null,
    "notes": "In  women  under  the  age  of  50  years,  ratios  of  \nadvanced-  stage  breast  cancer  incidence  rates  to  invasive  \nbreast cancer incidence rates were significantly higher for \nNH-  Black,  Na",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 8,
    "unit": "%",
    "population": null,
    "notes": "See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\n\nBreas",
    "pageHint": 7,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 93,
    "unit": "%",
    "population": null,
    "notes": "See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\n\nBreas",
    "pageHint": 7,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 48.1,
    "unit": "%",
    "population": null,
    "notes": "They  \nfound  that  a  significantly  greater  proportion  of  younger  \nwomen  (48.1%)  were  diagnosed  at  late  stages  (regional  \nand  distant)  in  comparison  with  older  women  (38.7%;  \nP <",
    "pageHint": 7,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 38.7,
    "unit": "%",
    "population": null,
    "notes": "They  \nfound  that  a  significantly  greater  proportion  of  younger  \nwomen  (48.1%)  were  diagnosed  at  late  stages  (regional  \nand  distant)  in  comparison  with  older  women  (38.7%;  \nP <",
    "pageHint": 7,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 54.5,
    "unit": "%",
    "population": null,
    "notes": "Significantly,  54.5%  of  younger  NH-  Black  \nwomen  and  52.9%  of  younger  Hispanic  women  were  \ndiagnosed  with  late-  stage  disease,  whereas  46.0%  of  \nyounger  NH-  White  women  were ",
    "pageHint": 7,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 52.9,
    "unit": "%",
    "population": null,
    "notes": "Significantly,  54.5%  of  younger  NH-  Black  \nwomen  and  52.9%  of  younger  Hispanic  women  were  \ndiagnosed  with  late-  stage  disease,  whereas  46.0%  of  \nyounger  NH-  White  women  were ",
    "pageHint": 7,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 46,
    "unit": "%",
    "population": null,
    "notes": "Significantly,  54.5%  of  younger  NH-  Black  \nwomen  and  52.9%  of  younger  Hispanic  women  were  \ndiagnosed  with  late-  stage  disease,  whereas  46.0%  of  \nyounger  NH-  White  women  were ",
    "pageHint": 7,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 64.5,
    "unit": "%",
    "population": null,
    "notes": "6,15\nKurian et al\n16\n found that White women had a higher \nproportion of tumors diagnosed at a local stage than Black \nwomen (64.5% vs 54.5%) and also more tumors diagnosed \nat a size of 2 cm or less ",
    "pageHint": 7,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 54.5,
    "unit": "%",
    "population": null,
    "notes": "6,15\nKurian et al\n16\n found that White women had a higher \nproportion of tumors diagnosed at a local stage than Black \nwomen (64.5% vs 54.5%) and also more tumors diagnosed \nat a size of 2 cm or less ",
    "pageHint": 7,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 61.7,
    "unit": "%",
    "population": null,
    "notes": "6,15\nKurian et al\n16\n found that White women had a higher \nproportion of tumors diagnosed at a local stage than Black \nwomen (64.5% vs 54.5%) and also more tumors diagnosed \nat a size of 2 cm or less ",
    "pageHint": 7,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 48.6,
    "unit": "%",
    "population": null,
    "notes": "6,15\nKurian et al\n16\n found that White women had a higher \nproportion of tumors diagnosed at a local stage than Black \nwomen (64.5% vs 54.5%) and also more tumors diagnosed \nat a size of 2 cm or less ",
    "pageHint": 7,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 37,
    "unit": "%",
    "population": null,
    "notes": "Black  women  were  less  \nlikely to be diagnosed with stage I breast cancer than NH- \nWhite  women  (37.0%  vs  50.8%;  odds  ratio,  0.65),  and  \nthey  were  nearly  twice  as  likely  to  die  wit",
    "pageHint": 7,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 50.8,
    "unit": "%",
    "population": null,
    "notes": "Black  women  were  less  \nlikely to be diagnosed with stage I breast cancer than NH- \nWhite  women  (37.0%  vs  50.8%;  odds  ratio,  0.65),  and  \nthey  were  nearly  twice  as  likely  to  die  wit",
    "pageHint": 7,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 4.6,
    "unit": "%",
    "population": null,
    "notes": "After the \nexclusion  of  women  with  TNBC,  the  age-  adjusted  HR  \nfor death remained significantly higher for Black women \nin comparison with their NH- White counterparts (4.6% \nvs 2.4%; HR, 1.7",
    "pageHint": 7,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 2.4,
    "unit": "%",
    "population": null,
    "notes": "After the \nexclusion  of  women  with  TNBC,  the  age-  adjusted  HR  \nfor death remained significantly higher for Black women \nin comparison with their NH- White counterparts (4.6% \nvs 2.4%; HR, 1.7",
    "pageHint": 7,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\n\nBreas",
    "pageHint": 7,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "rate",
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "In women under the age of 50 years, the \nratio  of  breast  cancer  mortality  rates  to  invasive  breast  \ncancer rates was significantly lower for AAPI women than \nNH- White  women",
    "pageHint": 7,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 0,
    "unit": "count",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Incidence",
    "timePeriod": null,
    "value": 0,
    "unit": "count",
    "population": null,
    "notes": "Incidence and mortality rates are presented per 100,000 women",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\n\nBreas",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 49.2,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 19.6,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 4,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 47.9,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 0.97,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 0.95,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 1,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 23.1,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 1.18,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 1.14,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 1.22,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 7.5,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 1.88,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 1.82,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 1.94,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 45.5,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 0.92,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 0.9,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 0.95,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 17.7,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 0.91,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 0.87,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 0.94,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 3,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 0.74,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 0.69,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 0.79,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 28.6,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 0.58,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 0.52,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 0.65,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 13.4,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 0.68,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 0.58,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 0.8,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 3,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 0.76,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 0.64,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 0.9,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 36.8,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 0.75,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 0.73,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 0.76,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 16.9,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 0.87,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 0.84,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 0.89,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 3.2,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 0.81,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 0.78,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 0.84,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 48.1,
    "unit": "%",
    "population": null,
    "notes": "They  \nfound  that  a  significantly  greater  proportion  of  younger  \nwomen  (48.1%)  were  diagnosed  at  late  stages  (regional  \nand  distant)  in  comparison  with  older  women  (38.7%;  \nP <",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 38.7,
    "unit": "%",
    "population": null,
    "notes": "They  \nfound  that  a  significantly  greater  proportion  of  younger  \nwomen  (48.1%)  were  diagnosed  at  late  stages  (regional  \nand  distant)  in  comparison  with  older  women  (38.7%;  \nP <",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 54.5,
    "unit": "%",
    "population": null,
    "notes": "Significantly,  54.5%  of  younger  NH-  Black  \nwomen  and  52.9%  of  younger  Hispanic  women  were  \ndiagnosed  with  late-  stage  disease,  whereas  46.0%  of  \nyounger  NH-  White  women  were ",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 52.9,
    "unit": "%",
    "population": null,
    "notes": "Significantly,  54.5%  of  younger  NH-  Black  \nwomen  and  52.9%  of  younger  Hispanic  women  were  \ndiagnosed  with  late-  stage  disease,  whereas  46.0%  of  \nyounger  NH-  White  women  were ",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 46,
    "unit": "%",
    "population": null,
    "notes": "Significantly,  54.5%  of  younger  NH-  Black  \nwomen  and  52.9%  of  younger  Hispanic  women  were  \ndiagnosed  with  late-  stage  disease,  whereas  46.0%  of  \nyounger  NH-  White  women  were ",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 64.5,
    "unit": "%",
    "population": null,
    "notes": "6,15\nKurian et al\n16\n found that White women had a higher \nproportion of tumors diagnosed at a local stage than Black \nwomen (64.5% vs 54.5%) and also more tumors diagnosed \nat a size of 2 cm or less ",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 54.5,
    "unit": "%",
    "population": null,
    "notes": "6,15\nKurian et al\n16\n found that White women had a higher \nproportion of tumors diagnosed at a local stage than Black \nwomen (64.5% vs 54.5%) and also more tumors diagnosed \nat a size of 2 cm or less ",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 61.7,
    "unit": "%",
    "population": null,
    "notes": "6,15\nKurian et al\n16\n found that White women had a higher \nproportion of tumors diagnosed at a local stage than Black \nwomen (64.5% vs 54.5%) and also more tumors diagnosed \nat a size of 2 cm or less ",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 48.6,
    "unit": "%",
    "population": null,
    "notes": "6,15\nKurian et al\n16\n found that White women had a higher \nproportion of tumors diagnosed at a local stage than Black \nwomen (64.5% vs 54.5%) and also more tumors diagnosed \nat a size of 2 cm or less ",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 37,
    "unit": "%",
    "population": null,
    "notes": "Black  women  were  less  \nlikely to be diagnosed with stage I breast cancer than NH- \nWhite  women  (37.0%  vs  50.8%;  odds  ratio,  0.65),  and  \nthey  were  nearly  twice  as  likely  to  die  wit",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 50.8,
    "unit": "%",
    "population": null,
    "notes": "Black  women  were  less  \nlikely to be diagnosed with stage I breast cancer than NH- \nWhite  women  (37.0%  vs  50.8%;  odds  ratio,  0.65),  and  \nthey  were  nearly  twice  as  likely  to  die  wit",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.65,
    "unit": "%",
    "population": null,
    "notes": "Black  women  were  less  \nlikely to be diagnosed with stage I breast cancer than NH- \nWhite  women  (37.0%  vs  50.8%;  odds  ratio,  0.65),  and  \nthey  were  nearly  twice  as  likely  to  die  wit",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 4.6,
    "unit": "%",
    "population": null,
    "notes": "After the \nexclusion  of  women  with  TNBC,  the  age-  adjusted  HR  \nfor death remained significantly higher for Black women \nin comparison with their NH- White counterparts (4.6% \nvs 2.4%; HR, 1.7",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 2.4,
    "unit": "%",
    "population": null,
    "notes": "After the \nexclusion  of  women  with  TNBC,  the  age-  adjusted  HR  \nfor death remained significantly higher for Black women \nin comparison with their NH- White counterparts (4.6% \nvs 2.4%; HR, 1.7",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1.73,
    "unit": "%",
    "population": null,
    "notes": "After the \nexclusion  of  women  with  TNBC,  the  age-  adjusted  HR  \nfor death remained significantly higher for Black women \nin comparison with their NH- White counterparts (4.6% \nvs 2.4%; HR, 1.7",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 50,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 100,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 0,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 95,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 95,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 95,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 95,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 49,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 19,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 47,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 97,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 95,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 0,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 3,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 23,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 18,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 14,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 22,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 1,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 88,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 82,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 94,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 1,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 45,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 92,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 90,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 95,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 1,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 17,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 91,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 87,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 94,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 1,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 74,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 69,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 79,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 1,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 28,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 58,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 52,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 65,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 1,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 13,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 68,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 58,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 80,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 1,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 76,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 64,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 90,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 2,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 36,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 75,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 73,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 76,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 1,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 16,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 87,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 84,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 89,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 1,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 81,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 78,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 84,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 1,
    "unit": "per 100,000",
    "population": null,
    "notes": "For Women Younger Than 50 Years of Age, Invasive Breast Cancer Incidence Rates, Advanced- \nStage (Regional Plus Distant) Breast \nCancer Incidence Rates, and Breast Cancer Mortality Rates Per 100,000 W",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Incidence",
    "timePeriod": null,
    "value": 100,
    "unit": "per 100,000",
    "population": null,
    "notes": "Incidence and mortality rates are presented per 100,000 women",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Incidence",
    "timePeriod": null,
    "value": 0,
    "unit": "per 100,000",
    "population": null,
    "notes": "Incidence and mortality rates are presented per 100,000 women",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 4391,
    "unit": "years",
    "population": null,
    "notes": "See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\n\nBreas",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 2021,
    "unit": "years",
    "population": null,
    "notes": "See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\n\nBreas",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\n\nBreas",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2021",
    "value": 93,
    "unit": "years",
    "population": null,
    "notes": "See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\n\nBreas",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "rate",
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "In women under the age of 50 years, the \nratio  of  breast  cancer  mortality  rates  to  invasive  breast  \ncancer rates was significantly lower for AAPI women than \nNH- White  women",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 48,
    "unit": "%",
    "population": null,
    "notes": "They  \nfound  that  a  significantly  greater  proportion  of  younger  \nwomen  (48.1%)  were  diagnosed  at  late  stages  (regional  \nand  distant)  in  comparison  with  older  women  (38.7%;  \nP <",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 38,
    "unit": "%",
    "population": null,
    "notes": "They  \nfound  that  a  significantly  greater  proportion  of  younger  \nwomen  (48.1%)  were  diagnosed  at  late  stages  (regional  \nand  distant)  in  comparison  with  older  women  (38.7%;  \nP <",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1,
    "unit": "%",
    "population": null,
    "notes": "They  \nfound  that  a  significantly  greater  proportion  of  younger  \nwomen  (48.1%)  were  diagnosed  at  late  stages  (regional  \nand  distant)  in  comparison  with  older  women  (38.7%;  \nP <",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 54,
    "unit": "%",
    "population": null,
    "notes": "Significantly,  54.5%  of  younger  NH-  Black  \nwomen  and  52.9%  of  younger  Hispanic  women  were  \ndiagnosed  with  late-  stage  disease,  whereas  46.0%  of  \nyounger  NH-  White  women  were ",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 52,
    "unit": "%",
    "population": null,
    "notes": "Significantly,  54.5%  of  younger  NH-  Black  \nwomen  and  52.9%  of  younger  Hispanic  women  were  \ndiagnosed  with  late-  stage  disease,  whereas  46.0%  of  \nyounger  NH-  White  women  were ",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 46,
    "unit": "%",
    "population": null,
    "notes": "Significantly,  54.5%  of  younger  NH-  Black  \nwomen  and  52.9%  of  younger  Hispanic  women  were  \ndiagnosed  with  late-  stage  disease,  whereas  46.0%  of  \nyounger  NH-  White  women  were ",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1,
    "unit": "%",
    "population": null,
    "notes": "Significantly,  54.5%  of  younger  NH-  Black  \nwomen  and  52.9%  of  younger  Hispanic  women  were  \ndiagnosed  with  late-  stage  disease,  whereas  46.0%  of  \nyounger  NH-  White  women  were ",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 14,
    "unit": "years",
    "population": null,
    "notes": "14\n  In  their  \nanalysis, younger Hispanic women had a higher propor-\ntion  of  years  of  life  lost,  but  they  were  less  likely  to  die  \nof  their  disease  than  NH-  White  women",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 15,
    "unit": "%",
    "population": null,
    "notes": "6,15\nKurian et al\n16\n found that White women had a higher \nproportion of tumors diagnosed at a local stage than Black \nwomen (64.5% vs 54.5%) and also more tumors diagnosed \nat a size of 2 cm or less ",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 16,
    "unit": "%",
    "population": null,
    "notes": "6,15\nKurian et al\n16\n found that White women had a higher \nproportion of tumors diagnosed at a local stage than Black \nwomen (64.5% vs 54.5%) and also more tumors diagnosed \nat a size of 2 cm or less ",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 64,
    "unit": "%",
    "population": null,
    "notes": "6,15\nKurian et al\n16\n found that White women had a higher \nproportion of tumors diagnosed at a local stage than Black \nwomen (64.5% vs 54.5%) and also more tumors diagnosed \nat a size of 2 cm or less ",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 54,
    "unit": "%",
    "population": null,
    "notes": "6,15\nKurian et al\n16\n found that White women had a higher \nproportion of tumors diagnosed at a local stage than Black \nwomen (64.5% vs 54.5%) and also more tumors diagnosed \nat a size of 2 cm or less ",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 61,
    "unit": "%",
    "population": null,
    "notes": "6,15\nKurian et al\n16\n found that White women had a higher \nproportion of tumors diagnosed at a local stage than Black \nwomen (64.5% vs 54.5%) and also more tumors diagnosed \nat a size of 2 cm or less ",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 48,
    "unit": "%",
    "population": null,
    "notes": "6,15\nKurian et al\n16\n found that White women had a higher \nproportion of tumors diagnosed at a local stage than Black \nwomen (64.5% vs 54.5%) and also more tumors diagnosed \nat a size of 2 cm or less ",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 37,
    "unit": "%",
    "population": null,
    "notes": "Black  women  were  less  \nlikely to be diagnosed with stage I breast cancer than NH- \nWhite  women  (37.0%  vs  50.8%;  odds  ratio,  0.65),  and  \nthey  were  nearly  twice  as  likely  to  die  wit",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 50,
    "unit": "%",
    "population": null,
    "notes": "Black  women  were  less  \nlikely to be diagnosed with stage I breast cancer than NH- \nWhite  women  (37.0%  vs  50.8%;  odds  ratio,  0.65),  and  \nthey  were  nearly  twice  as  likely  to  die  wit",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 65,
    "unit": "%",
    "population": null,
    "notes": "Black  women  were  less  \nlikely to be diagnosed with stage I breast cancer than NH- \nWhite  women  (37.0%  vs  50.8%;  odds  ratio,  0.65),  and  \nthey  were  nearly  twice  as  likely  to  die  wit",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 73,
    "unit": "%",
    "population": null,
    "notes": "After the \nexclusion  of  women  with  TNBC,  the  age-  adjusted  HR  \nfor death remained significantly higher for Black women \nin comparison with their NH- White counterparts (4.6% \nvs 2.4%; HR, 1.7",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1,
    "unit": null,
    "population": null,
    "notes": "17\n Others have noted that \nalthough  TNBC  is  overrepresented  in  Black  women,  es-\npecially  premenopausal  Black  women,\n18\n  and  contributes  \nto disparities, the greatest disparities still oc",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 17,
    "unit": null,
    "population": null,
    "notes": "17\n Others have noted that \nalthough  TNBC  is  overrepresented  in  Black  women,  es-\npecially  premenopausal  Black  women,\n18\n  and  contributes  \nto disparities, the greatest disparities still oc",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 18,
    "unit": null,
    "population": null,
    "notes": "17\n Others have noted that \nalthough  TNBC  is  overrepresented  in  Black  women,  es-\npecially  premenopausal  Black  women,\n18\n  and  contributes  \nto disparities, the greatest disparities still oc",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 19,
    "unit": null,
    "population": null,
    "notes": "19,20\nA  limitation  of  our  study  is  that  although  SEER  \nprovides  a  large  data  set  from  which  to  analyze  trends,  \nSEER  has  limited  information  on  several  variables  that  \nmay a",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 20,
    "unit": null,
    "population": null,
    "notes": "19,20\nA  limitation  of  our  study  is  that  although  SEER  \nprovides  a  large  data  set  from  which  to  analyze  trends,  \nSEER  has  limited  information  on  several  variables  that  \nmay a",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2021",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\n\nOrigi",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2017",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Breast  cancer  \nstatistics, 2017, racial disparity in mortality by state",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Differences  in  \nbreast cancer stage at diagnosis and cancer- specific survival by race and \nethnicity in the United States",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Race,  breast  cancer  sub-\ntypes,  and  survival  in  the  Carolina  Breast  Cancer  Study",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Racial  disparities  in  breast  carci-\nnoma survival rates: separating factors that affect diagnosis from factors \nthat affect treatment",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Racial differences \nin the effects of comorbidity on breast cancer– specific survival",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 4010.081,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 481.211,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 1.24,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 0.161,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 931.88,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 1.97,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 390.98,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 1.01,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 110.06,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 800.77,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 0.86,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 471.181,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 1.32,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 60.111,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 311.15,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 1.5,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 461.151,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 1.18,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 0.091,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 81.05,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 1.12,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 95,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 4010,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 81,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 481,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 211,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 18,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 24,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 1,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 161,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 931,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 88,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 97,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 1,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 390,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 980,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 95,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 1,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 110,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 60,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 800,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 77,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 86,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 1,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 471,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 181,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 5,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 32,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 60,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 111,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 311,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 15,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 1,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 461,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 151,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 13,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 18,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 1,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 91,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 81,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 5,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 12,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "Rate",
    "timePeriod": "50 year",
    "value": 1,
    "unit": "years",
    "population": null,
    "notes": "For Women Younger Than 50 Years, Ratios of ABC Incidence Rates to Invasive BC Incidence \nRates and Ratios of Breast Cancer Mortality Rates to Invasive Breast Cancer Incidence Rates for Each Race \nEthn",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2021",
    "value": 4392,
    "unit": null,
    "population": null,
    "notes": "See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\n\nOrigi",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2021",
    "value": 2021,
    "unit": null,
    "population": null,
    "notes": "See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\n\nOrigi",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2021",
    "value": 22,
    "unit": null,
    "population": null,
    "notes": "See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\n\nOrigi",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 14,
    "unit": null,
    "population": null,
    "notes": "Stapleton SM, Oseni TO, Bababekov YJ, Hung Y- C, Chang DC",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1137,
    "unit": null,
    "population": null,
    "notes": "Stapleton SM, Oseni TO, Bababekov YJ, Hung Y- C, Chang DC",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1143,
    "unit": null,
    "population": null,
    "notes": "Stapleton SM, Oseni TO, Bababekov YJ, Hung Y- C, Chang DC",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2017",
    "value": 2017,
    "unit": null,
    "population": null,
    "notes": "Breast  cancer  \nstatistics, 2017, racial disparity in mortality by state",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 2010,
    "unit": null,
    "population": null,
    "notes": "Differences  in  \nbreast cancer stage at diagnosis and cancer- specific survival by race and \nethnicity in the United States",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 12,
    "unit": null,
    "population": null,
    "notes": "Differences  in  \nbreast cancer stage at diagnosis and cancer- specific survival by race and \nethnicity in the United States",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 17,
    "unit": null,
    "population": null,
    "notes": "Differences  in  \nbreast cancer stage at diagnosis and cancer- specific survival by race and \nethnicity in the United States",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 2015,
    "unit": null,
    "population": null,
    "notes": "Race,  breast  cancer  sub-\ntypes,  and  survival  in  the  Carolina  Breast  Cancer  Study",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 313,
    "unit": null,
    "population": null,
    "notes": "Race,  breast  cancer  sub-\ntypes,  and  survival  in  the  Carolina  Breast  Cancer  Study",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 165,
    "unit": null,
    "population": null,
    "notes": "Race,  breast  cancer  sub-\ntypes,  and  survival  in  the  Carolina  Breast  Cancer  Study",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 173,
    "unit": null,
    "population": null,
    "notes": "Race,  breast  cancer  sub-\ntypes,  and  survival  in  the  Carolina  Breast  Cancer  Study",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 18,
    "unit": null,
    "population": null,
    "notes": "Race,  breast  cancer  sub-\ntypes,  and  survival  in  the  Carolina  Breast  Cancer  Study",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 2017,
    "unit": null,
    "population": null,
    "notes": "Racial  disparities  in  breast  carci-\nnoma survival rates: separating factors that affect diagnosis from factors \nthat affect treatment",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 23,
    "unit": null,
    "population": null,
    "notes": "Racial  disparities  in  breast  carci-\nnoma survival rates: separating factors that affect diagnosis from factors \nthat affect treatment",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 2655,
    "unit": null,
    "population": null,
    "notes": "Racial  disparities  in  breast  carci-\nnoma survival rates: separating factors that affect diagnosis from factors \nthat affect treatment",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 2664,
    "unit": null,
    "population": null,
    "notes": "Racial  disparities  in  breast  carci-\nnoma survival rates: separating factors that affect diagnosis from factors \nthat affect treatment",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 20,
    "unit": null,
    "population": null,
    "notes": "Racial  disparities  in  breast  carci-\nnoma survival rates: separating factors that affect diagnosis from factors \nthat affect treatment",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": null,
    "timePeriod": "2003",
    "value": 2860,
    "unit": null,
    "population": null,
    "notes": "eparating factors that affect diagnosis from factors \nthat affect treatment. Cancer.  2003;97:2853- 2860.\n 21. Yedjou CG, Sims JN, et al. Health and racial disparity in breast cancer. \nAdv Exp Med Bio",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 2019,
    "unit": null,
    "population": null,
    "notes": "Racial differences \nin the effects of comorbidity on breast cancer– specific survival",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 1152,
    "unit": null,
    "population": null,
    "notes": "Racial differences \nin the effects of comorbidity on breast cancer– specific survival",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 31,
    "unit": null,
    "population": null,
    "notes": "Racial differences \nin the effects of comorbidity on breast cancer– specific survival",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 49,
    "unit": null,
    "population": null,
    "notes": "Racial differences \nin the effects of comorbidity on breast cancer– specific survival",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-005",
    "filename": "Hendrick_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 22,
    "unit": null,
    "population": null,
    "notes": "Racial differences \nin the effects of comorbidity on breast cancer– specific survival",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "24 month",
    "value": 30,
    "unit": "%",
    "population": "metastaticbreastcancer",
    "notes": "Approxi-\nmately 30% of women with early stage BC will develop\nmetastases, whereas metastaticbreastcancer (MBC) occursin\napproximately6%–7%ofnewlydiagnosedcases[3].The5-year\nrelativesurvivalforwomenwit",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "24 month",
    "value": 6,
    "unit": "%",
    "population": "metastaticbreastcancer",
    "notes": "Approxi-\nmately 30% of women with early stage BC will develop\nmetastases, whereas metastaticbreastcancer (MBC) occursin\napproximately6%–7%ofnewlydiagnosedcases[3].The5-year\nrelativesurvivalforwomenwit",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "24 month",
    "value": 7,
    "unit": "%",
    "population": "metastaticbreastcancer",
    "notes": "Approxi-\nmately 30% of women with early stage BC will develop\nmetastases, whereas metastaticbreastcancer (MBC) occursin\napproximately6%–7%ofnewlydiagnosedcases[3].The5-year\nrelativesurvivalforwomenwit",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "24 month",
    "value": 25,
    "unit": "%",
    "population": "metastaticbreastcancer",
    "notes": "Approxi-\nmately 30% of women with early stage BC will develop\nmetastases, whereas metastaticbreastcancer (MBC) occursin\napproximately6%–7%ofnewlydiagnosedcases[3].The5-year\nrelativesurvivalforwomenwit",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "12 month",
    "value": 12,
    "unit": "months",
    "population": null,
    "notes": "After first-line treatment,\nthemedianPPSofluminalA,luminalB,andhumanepidermal\ngrowth factor receptor 2 (HER2)-positive groups was longer\nthan 12 months",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "24 month",
    "value": 24,
    "unit": "months",
    "population": "metastaticbreastcancer",
    "notes": "Approxi-\nmately 30% of women with early stage BC will develop\nmetastases, whereas metastaticbreastcancer (MBC) occursin\napproximately6%–7%ofnewlydiagnosedcases[3].The5-year\nrelativesurvivalforwomenwit",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 472,
    "unit": "count",
    "population": null,
    "notes": "This study analyzed the impact of patient\nandtumorcharacteristicsonthemajormeasuresofoutcome\nacross different lines of treatment in a cohort of 472 patients\ntreated for MBC",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 472,
    "unit": null,
    "population": null,
    "notes": "This study analyzed the impact of patient\nandtumorcharacteristicsonthemajormeasuresofoutcome\nacross different lines of treatment in a cohort of 472 patients\ntreated for MBC",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "12 month",
    "value": 12,
    "unit": "months",
    "population": null,
    "notes": "After first-line treatment,\nthemedianPPSofluminalA,luminalB,andhumanepidermal\ngrowth factor receptor 2 (HER2)-positive groups was longer\nthan 12 months",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "24 month",
    "value": 30,
    "unit": "months",
    "population": "metastaticbreastcancer",
    "notes": "Approxi-\nmately 30% of women with early stage BC will develop\nmetastases, whereas metastaticbreastcancer (MBC) occursin\napproximately6%–7%ofnewlydiagnosedcases[3].The5-year\nrelativesurvivalforwomenwit",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "24 month",
    "value": 25,
    "unit": "months",
    "population": "metastaticbreastcancer",
    "notes": "Approxi-\nmately 30% of women with early stage BC will develop\nmetastases, whereas metastaticbreastcancer (MBC) occursin\napproximately6%–7%ofnewlydiagnosedcases[3].The5-year\nrelativesurvivalforwomenwit",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "24 month",
    "value": 24,
    "unit": "months",
    "population": "metastaticbreastcancer",
    "notes": "Approxi-\nmately 30% of women with early stage BC will develop\nmetastases, whereas metastaticbreastcancer (MBC) occursin\napproximately6%–7%ofnewlydiagnosedcases[3].The5-year\nrelativesurvivalforwomenwit",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 12,
    "unit": null,
    "population": null,
    "notes": "Some recent trials\non first-line treatment of MBC report median values of OS that\nare notably longer than those observed in previous studies\n[7–12].Althoughcomparisonacrossdifferenttrialsneedstobe\nper",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 13,
    "unit": null,
    "population": null,
    "notes": "Among the different disease- and patient-related variables\nthat may influence the prognosis of patients with MBC, tumor\nsubtypes, sites of metastatic involvement, burden of disease,\nand patient comorb",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 33100,
    "unit": null,
    "population": null,
    "notes": "Only a percentage of patients who receive\nCorrespondence: Fabio Puglisi, M.D.,Ph.D., Department of Oncology, UniversityHospital of Udine, PiazzaleS.M.Misericordia, 33100 Udine, Italy",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 14,
    "unit": "%",
    "population": null,
    "notes": "Foreachpatient,individualdataandinformationonprimary\nand advanced disease were collected from electronic health\nrecords.Basedonthisdataset,thefollowingBCsubgroupswere\ndefined:“luminal A”(positive for ",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 67.14,
    "unit": "%",
    "population": null,
    "notes": "Foreachpatient,individualdataandinformationonprimary\nand advanced disease were collected from electronic health\nrecords.Basedonthisdataset,thefollowingBCsubgroupswere\ndefined:“luminal A”(positive for ",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1,
    "unit": "%",
    "population": null,
    "notes": "HER2 positive and ER and PR negative).The\ncutoff point of 1% was used to define ER and/or PR positivity\n[25]",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "12 month",
    "value": 12,
    "unit": "months",
    "population": null,
    "notes": "When median PPS is short, the correlation\nbetween the hazard ratios (HRs) for PFS and OS is high, but when\nmedian PPS is longer than 12 months, the correlation between\nthe two HR estimates decreases s",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "35 year",
    "value": 35,
    "unit": "years",
    "population": null,
    "notes": "no), age at diagnosis (,35 years, 65–70\nyears, or.70 years vs",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "35 year",
    "value": 70,
    "unit": "years",
    "population": null,
    "notes": "no), age at diagnosis (,35 years, 65–70\nyears, or.70 years vs",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "35 year",
    "value": 70,
    "unit": "years",
    "population": null,
    "notes": "no), age at diagnosis (,35 years, 65–70\nyears, or.70 years vs",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2004",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "MATERIALS ANDMETHODS\nStudy Design\nWe retrospectively reviewed a total of 472 consecutive MBC\npatients, treated at the Department of Oncology of the\nUniversity Hospital of Udine, Udine, Italy, from Jan",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2004",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "MATERIALS ANDMETHODS\nStudy Design\nWe retrospectively reviewed a total of 472 consecutive MBC\npatients, treated at the Department of Oncology of the\nUniversity Hospital of Udine, Udine, Italy, from Jan",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 67.14,
    "unit": "%",
    "population": null,
    "notes": "Foreachpatient,individualdataandinformationonprimary\nand advanced disease were collected from electronic health\nrecords.Basedonthisdataset,thefollowingBCsubgroupswere\ndefined:“luminal A”(positive for ",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 16,
    "unit": null,
    "population": null,
    "notes": "The primary measure of\nclinicalbenefitinMBChastraditionallybeenOS[16].OS,defined\nas the time from randomization to death from any cause,\naddresses both safety and efficacy",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 17,
    "unit": null,
    "population": null,
    "notes": "Nonetheless, confounded by\nsubsequent therapy and crossover, the value of OS as a primary\nendpoint in trials that evaluate new therapeutic agents for MBC\nhas been questioned, especially in the context",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 19,
    "unit": null,
    "population": null,
    "notes": "Nonetheless, confounded by\nsubsequent therapy and crossover, the value of OS as a primary\nendpoint in trials that evaluate new therapeutic agents for MBC\nhas been questioned, especially in the context",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 19,
    "unit": null,
    "population": null,
    "notes": "Progression-\nfree survival (PFS), defined as the time from randomization to\ntumor progression or death from any cause, is commonly\nadopted as an alternative endpoint to OS in first-linesetting [19]",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 20,
    "unit": null,
    "population": null,
    "notes": "PFS was informally accepted as a surrogate endpoint for OS in\nclinical cancer research [20, 21]",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 21,
    "unit": null,
    "population": null,
    "notes": "PFS was informally accepted as a surrogate endpoint for OS in\nclinical cancer research [20, 21]",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 19,
    "unit": null,
    "population": null,
    "notes": "However, in several studies,\ntreatment that demonstrated advantage in terms of PFS did not\ndetermine the same effect on OS[19]",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "12 month",
    "value": 12,
    "unit": "months",
    "population": null,
    "notes": "When median PPS is short, the correlation\nbetween the hazard ratios (HRs) for PFS and OS is high, but when\nmedian PPS is longer than 12 months, the correlation between\nthe two HR estimates decreases s",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 22,
    "unit": null,
    "population": null,
    "notes": "Accordingly, the\nnotion that drugs that significantly prolong PFS should\nnecessarily prolong OS is questionable [22]",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2004",
    "value": 472,
    "unit": null,
    "population": null,
    "notes": "MATERIALS ANDMETHODS\nStudy Design\nWe retrospectively reviewed a total of 472 consecutive MBC\npatients, treated at the Department of Oncology of the\nUniversity Hospital of Udine, Udine, Italy, from Jan",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2004",
    "value": 2004,
    "unit": null,
    "population": null,
    "notes": "MATERIALS ANDMETHODS\nStudy Design\nWe retrospectively reviewed a total of 472 consecutive MBC\npatients, treated at the Department of Oncology of the\nUniversity Hospital of Udine, Udine, Italy, from Jan",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2004",
    "value": 2012,
    "unit": null,
    "population": null,
    "notes": "MATERIALS ANDMETHODS\nStudy Design\nWe retrospectively reviewed a total of 472 consecutive MBC\npatients, treated at the Department of Oncology of the\nUniversity Hospital of Udine, Udine, Italy, from Jan",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 67,
    "unit": "%",
    "population": null,
    "notes": "Foreachpatient,individualdataandinformationonprimary\nand advanced disease were collected from electronic health\nrecords.Basedonthisdataset,thefollowingBCsubgroupswere\ndefined:“luminal A”(positive for ",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 14,
    "unit": "%",
    "population": null,
    "notes": "Foreachpatient,individualdataandinformationonprimary\nand advanced disease were collected from electronic health\nrecords.Basedonthisdataset,thefollowingBCsubgroupswere\ndefined:“luminal A”(positive for ",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 67,
    "unit": "%",
    "population": null,
    "notes": "Foreachpatient,individualdataandinformationonprimary\nand advanced disease were collected from electronic health\nrecords.Basedonthisdataset,thefollowingBCsubgroupswere\ndefined:“luminal A”(positive for ",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 14,
    "unit": "%",
    "population": null,
    "notes": "Foreachpatient,individualdataandinformationonprimary\nand advanced disease were collected from electronic health\nrecords.Basedonthisdataset,thefollowingBCsubgroupswere\ndefined:“luminal A”(positive for ",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 23,
    "unit": "%",
    "population": null,
    "notes": "Foreachpatient,individualdataandinformationonprimary\nand advanced disease were collected from electronic health\nrecords.Basedonthisdataset,thefollowingBCsubgroupswere\ndefined:“luminal A”(positive for ",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 24,
    "unit": "%",
    "population": null,
    "notes": "Foreachpatient,individualdataandinformationonprimary\nand advanced disease were collected from electronic health\nrecords.Basedonthisdataset,thefollowingBCsubgroupswere\ndefined:“luminal A”(positive for ",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 25,
    "unit": "%",
    "population": null,
    "notes": "HER2 positive and ER and PR negative).The\ncutoff point of 1% was used to define ER and/or PR positivity\n[25]",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 67,
    "unit": null,
    "population": null,
    "notes": "Thefollowingvariableswerestudiedaspossibleprognostic\nfactors for specific clinical outcome: ER status, PR status, HER2\nstatus, Ki-67 status, previous adjuvant endocrine therapy (ET)\nand/or chemotherap",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "35 year",
    "value": 35,
    "unit": "years",
    "population": null,
    "notes": "no), age at diagnosis (,35 years, 65–70\nyears, or.70 years vs",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "35 year",
    "value": 65,
    "unit": "years",
    "population": null,
    "notes": "no), age at diagnosis (,35 years, 65–70\nyears, or.70 years vs",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "35 year",
    "value": 70,
    "unit": "years",
    "population": null,
    "notes": "no), age at diagnosis (,35 years, 65–70\nyears, or.70 years vs",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "35 year",
    "value": 70,
    "unit": "years",
    "population": null,
    "notes": "no), age at diagnosis (,35 years, 65–70\nyears, or.70 years vs",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 14,
    "unit": "%",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 14,
    "unit": "%",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 58,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 63,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 1,
    "unit": "count",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 35173.6,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 6529562.5,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 70449.3,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 7011624.6,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 3571.5,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 6524852.5,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 706614,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 7015132,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 1266.3,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 221451.8,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 317341.9,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 11131.9,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 23768.1,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 24410.3,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 114634.4,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 23555.3,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 23811.7,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 112438.1,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 16350.2,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 23213.3,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 19840.7,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 22013.1,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 17146.4,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 6240.5,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 58,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 35173,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 35,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 6529562,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 65,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 70449,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 7011624,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 63,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 3571,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 35,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 6524852,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 65,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 706614,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 7015132,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 59,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 1266,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 221451,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 317341,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 39,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 38,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 124,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 14,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 11131,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 14,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 23768,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 52,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 113,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 38,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 47,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 24410,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 114634,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 23555,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 10,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 23811,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 112438,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 16350,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 23213,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 19840,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 11146,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 22013,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 17146,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1984",
    "value": 6240,
    "unit": "years",
    "population": null,
    "notes": "Table 1.Patient and disease characteristics\nCharacteristicSample size (missing value)\na\nSubgroupn%\nAge at diagnosis (years)\nMedian value: 58 years\nn5472 (0 missing),35173.6\n35-6529562.5\n65-70449.3\n.70",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 78.3,
    "unit": "%",
    "population": null,
    "notes": "Most patients (78.3%) had ER-positive disease",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 24.5,
    "unit": "%",
    "population": null,
    "notes": "Eighty-\neightpatients(24.5%)hadaluminalAdisease,138(38.4%)had\na luminal B disease, 89 (24.8%) had a HER2-positive disease,\nand 44 (12.3%) had a triple-negative phenotype",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 38.4,
    "unit": "%",
    "population": null,
    "notes": "Eighty-\neightpatients(24.5%)hadaluminalAdisease,138(38.4%)had\na luminal B disease, 89 (24.8%) had a HER2-positive disease,\nand 44 (12.3%) had a triple-negative phenotype",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 24.8,
    "unit": "%",
    "population": null,
    "notes": "Eighty-\neightpatients(24.5%)hadaluminalAdisease,138(38.4%)had\na luminal B disease, 89 (24.8%) had a HER2-positive disease,\nand 44 (12.3%) had a triple-negative phenotype",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 12.3,
    "unit": "%",
    "population": null,
    "notes": "Eighty-\neightpatients(24.5%)hadaluminalAdisease,138(38.4%)had\na luminal B disease, 89 (24.8%) had a HER2-positive disease,\nand 44 (12.3%) had a triple-negative phenotype",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "HER2-positivediseasewasassociatedwithlongerPFS1_tot\n(HR: 0.42 [95% CI: 0.3–0.6],p,.0001) and PFS2_tot (HR: 0.63\n[95% CI: 0.46–0.88],p5.01)",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "HER2-positivediseasewasassociatedwithlongerPFS1_tot\n(HR: 0.42 [95% CI: 0.3–0.6],p,.0001) and PFS2_tot (HR: 0.63\n[95% CI: 0.46–0.88],p5.01)",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "www.TheOncologist.com©AlphaMed Press 2014\nBonotto, Gerratana, Poletto et al.611\nDownloaded from https://academic.oup.com/oncolo/article/19/6/608/6399978 by guest on 01 January 2026\n\nanunfavorableimpac",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "www.TheOncologist.com©AlphaMed Press 2014\nBonotto, Gerratana, Poletto et al.611\nDownloaded from https://academic.oup.com/oncolo/article/19/6/608/6399978 by guest on 01 January 2026\n\nanunfavorableimpac",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "HER2-positive disease was\nassociated with better prognosis in terms of OS_tot (HR: 0.65\n[95% CI: 0.42–0.99],p5.0488), OS_CT (HR: 0.51 [95% CI:\n0.31–0.83],p5.0065), and PFS1_ET (HR: 0.48 [95% CI:\n0.3–0",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "HER2-positive disease was\nassociated with better prognosis in terms of OS_tot (HR: 0.65\n[95% CI: 0.42–0.99],p5.0488), OS_CT (HR: 0.51 [95% CI:\n0.31–0.83],p5.0065), and PFS1_ET (HR: 0.48 [95% CI:\n0.3–0",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "HER2-positive disease was\nassociated with better prognosis in terms of OS_tot (HR: 0.65\n[95% CI: 0.42–0.99],p5.0488), OS_CT (HR: 0.51 [95% CI:\n0.31–0.83],p5.0065), and PFS1_ET (HR: 0.48 [95% CI:\n0.3–0",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.42,
    "unit": "%",
    "population": null,
    "notes": "HER2-positivediseasewasassociatedwithlongerPFS1_tot\n(HR: 0.42 [95% CI: 0.3–0.6],p,.0001) and PFS2_tot (HR: 0.63\n[95% CI: 0.46–0.88],p5.01)",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.63,
    "unit": "%",
    "population": null,
    "notes": "HER2-positivediseasewasassociatedwithlongerPFS1_tot\n(HR: 0.42 [95% CI: 0.3–0.6],p,.0001) and PFS2_tot (HR: 0.63\n[95% CI: 0.46–0.88],p5.01)",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 0.56,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 1.75,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 2.09,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 1.92,
    "unit": "%",
    "population": null,
    "notes": "www.TheOncologist.com©AlphaMed Press 2014\nBonotto, Gerratana, Poletto et al.611\nDownloaded from https://academic.oup.com/oncolo/article/19/6/608/6399978 by guest on 01 January 2026\n\nanunfavorableimpac",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 2.05,
    "unit": "%",
    "population": null,
    "notes": "www.TheOncologist.com©AlphaMed Press 2014\nBonotto, Gerratana, Poletto et al.611\nDownloaded from https://academic.oup.com/oncolo/article/19/6/608/6399978 by guest on 01 January 2026\n\nanunfavorableimpac",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 3.1,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1.8,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 3.6,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 2.77,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 2.17,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 2.09,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.65,
    "unit": "%",
    "population": null,
    "notes": "HER2-positive disease was\nassociated with better prognosis in terms of OS_tot (HR: 0.65\n[95% CI: 0.42–0.99],p5.0488), OS_CT (HR: 0.51 [95% CI:\n0.31–0.83],p5.0065), and PFS1_ET (HR: 0.48 [95% CI:\n0.3–0",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.51,
    "unit": "%",
    "population": null,
    "notes": "HER2-positive disease was\nassociated with better prognosis in terms of OS_tot (HR: 0.65\n[95% CI: 0.42–0.99],p5.0488), OS_CT (HR: 0.51 [95% CI:\n0.31–0.83],p5.0065), and PFS1_ET (HR: 0.48 [95% CI:\n0.3–0",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.48,
    "unit": "%",
    "population": null,
    "notes": "HER2-positive disease was\nassociated with better prognosis in terms of OS_tot (HR: 0.65\n[95% CI: 0.42–0.99],p5.0488), OS_CT (HR: 0.51 [95% CI:\n0.31–0.83],p5.0065), and PFS1_ET (HR: 0.48 [95% CI:\n0.3–0",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "7month",
    "value": 21.7,
    "unit": "months",
    "population": null,
    "notes": "Mediantime to development of MBC frominitial diagnosis\nofBC was 21.7months (range: 0–175 months); median OS was\n34 months (25th–75th percentile: 13.7–58.5)",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "7month",
    "value": 175,
    "unit": "months",
    "population": null,
    "notes": "Mediantime to development of MBC frominitial diagnosis\nofBC was 21.7months (range: 0–175 months); median OS was\n34 months (25th–75th percentile: 13.7–58.5)",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "7month",
    "value": 34,
    "unit": "months",
    "population": null,
    "notes": "Mediantime to development of MBC frominitial diagnosis\nofBC was 21.7months (range: 0–175 months); median OS was\n34 months (25th–75th percentile: 13.7–58.5)",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "3month",
    "value": 26,
    "unit": "months",
    "population": null,
    "notes": "In particular, among\nHER2-positive cases,abetteroutcome was noted forhormone\nreceptor positive disease versus hormone receptor negative\ndisease(OS:55.3monthsvs.26.0months;PFS:17.5monthsvs",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "58 year",
    "value": 58,
    "unit": "years",
    "population": null,
    "notes": "RESULTS\nMedian age at diagnosis was 58 years, and median age at\ndiagnosisofMBCwas63years;147patientspresenteddenovo\nmetastatic disease",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "58 year",
    "value": 63,
    "unit": "years",
    "population": null,
    "notes": "RESULTS\nMedian age at diagnosis was 58 years, and median age at\ndiagnosisofMBCwas63years;147patientspresenteddenovo\nmetastatic disease",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 19,
    "unit": "%",
    "population": null,
    "notes": "www.TheOncologist.com©AlphaMed Press 2014\nBonotto, Gerratana, Poletto et al.611\nDownloaded from https://academic.oup.com/oncolo/article/19/6/608/6399978 by guest on 01 January 2026\n\nanunfavorableimpac",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 608,
    "unit": "%",
    "population": null,
    "notes": "www.TheOncologist.com©AlphaMed Press 2014\nBonotto, Gerratana, Poletto et al.611\nDownloaded from https://academic.oup.com/oncolo/article/19/6/608/6399978 by guest on 01 January 2026\n\nanunfavorableimpac",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "www.TheOncologist.com©AlphaMed Press 2014\nBonotto, Gerratana, Poletto et al.611\nDownloaded from https://academic.oup.com/oncolo/article/19/6/608/6399978 by guest on 01 January 2026\n\nanunfavorableimpac",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "www.TheOncologist.com©AlphaMed Press 2014\nBonotto, Gerratana, Poletto et al.611\nDownloaded from https://academic.oup.com/oncolo/article/19/6/608/6399978 by guest on 01 January 2026\n\nanunfavorableimpac",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 78.3,
    "unit": "%",
    "population": null,
    "notes": "Most patients (78.3%) had ER-positive disease",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 24.5,
    "unit": "%",
    "population": null,
    "notes": "Eighty-\neightpatients(24.5%)hadaluminalAdisease,138(38.4%)had\na luminal B disease, 89 (24.8%) had a HER2-positive disease,\nand 44 (12.3%) had a triple-negative phenotype",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 38.4,
    "unit": "%",
    "population": null,
    "notes": "Eighty-\neightpatients(24.5%)hadaluminalAdisease,138(38.4%)had\na luminal B disease, 89 (24.8%) had a HER2-positive disease,\nand 44 (12.3%) had a triple-negative phenotype",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 24.8,
    "unit": "%",
    "population": null,
    "notes": "Eighty-\neightpatients(24.5%)hadaluminalAdisease,138(38.4%)had\na luminal B disease, 89 (24.8%) had a HER2-positive disease,\nand 44 (12.3%) had a triple-negative phenotype",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 12.3,
    "unit": "%",
    "population": null,
    "notes": "Eighty-\neightpatients(24.5%)hadaluminalAdisease,138(38.4%)had\na luminal B disease, 89 (24.8%) had a HER2-positive disease,\nand 44 (12.3%) had a triple-negative phenotype",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "7month",
    "value": 13.7,
    "unit": "months",
    "population": null,
    "notes": "Mediantime to development of MBC frominitial diagnosis\nofBC was 21.7months (range: 0–175 months); median OS was\n34 months (25th–75th percentile: 13.7–58.5)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "7month",
    "value": 58.5,
    "unit": "months",
    "population": null,
    "notes": "Mediantime to development of MBC frominitial diagnosis\nofBC was 21.7months (range: 0–175 months); median OS was\n34 months (25th–75th percentile: 13.7–58.5)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.42,
    "unit": "%",
    "population": null,
    "notes": "HER2-positivediseasewasassociatedwithlongerPFS1_tot\n(HR: 0.42 [95% CI: 0.3–0.6],p,.0001) and PFS2_tot (HR: 0.63\n[95% CI: 0.46–0.88],p5.01)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.3,
    "unit": "%",
    "population": null,
    "notes": "HER2-positivediseasewasassociatedwithlongerPFS1_tot\n(HR: 0.42 [95% CI: 0.3–0.6],p,.0001) and PFS2_tot (HR: 0.63\n[95% CI: 0.46–0.88],p5.01)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.6,
    "unit": "%",
    "population": null,
    "notes": "HER2-positivediseasewasassociatedwithlongerPFS1_tot\n(HR: 0.42 [95% CI: 0.3–0.6],p,.0001) and PFS2_tot (HR: 0.63\n[95% CI: 0.46–0.88],p5.01)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.63,
    "unit": "%",
    "population": null,
    "notes": "HER2-positivediseasewasassociatedwithlongerPFS1_tot\n(HR: 0.42 [95% CI: 0.3–0.6],p,.0001) and PFS2_tot (HR: 0.63\n[95% CI: 0.46–0.88],p5.01)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.46,
    "unit": "%",
    "population": null,
    "notes": "HER2-positivediseasewasassociatedwithlongerPFS1_tot\n(HR: 0.42 [95% CI: 0.3–0.6],p,.0001) and PFS2_tot (HR: 0.63\n[95% CI: 0.46–0.88],p5.01)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.88,
    "unit": "%",
    "population": null,
    "notes": "HER2-positivediseasewasassociatedwithlongerPFS1_tot\n(HR: 0.42 [95% CI: 0.3–0.6],p,.0001) and PFS2_tot (HR: 0.63\n[95% CI: 0.46–0.88],p5.01)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 0.56,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 0.31,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 0.92,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 1.75,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 1.09,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 2.79,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 2.09,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 1.3,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 3.35,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 58.5,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 517.7,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 65.3,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 110.3,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 48.4,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 4.2,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 18.2,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 42.5,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 10.6,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 2.2,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 8.4,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 2,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 6.1,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 53.7,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 19.7,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 72.7,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 10.4,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 92.4,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 7.3,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 21.5,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 10.6,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 13.5,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 14.4,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 72.1,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 8.4,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 32.1,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 5.7,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 51.8,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 4.2,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 35.1,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 36.2,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 24.3,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 27.4,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 22.7,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 18.9,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 2.1,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 14.9,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 7.6,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 39.1,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 24.6,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 31.5,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 50.8,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 30.6,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 71.2,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 32.9,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 73.1,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 28.2,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 82.5,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 17.4,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 61.6,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 12.2,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 30.76,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 9.6,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 1.92,
    "unit": "%",
    "population": null,
    "notes": "www.TheOncologist.com©AlphaMed Press 2014\nBonotto, Gerratana, Poletto et al.611\nDownloaded from https://academic.oup.com/oncolo/article/19/6/608/6399978 by guest on 01 January 2026\n\nanunfavorableimpac",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 1.29,
    "unit": "%",
    "population": null,
    "notes": "www.TheOncologist.com©AlphaMed Press 2014\nBonotto, Gerratana, Poletto et al.611\nDownloaded from https://academic.oup.com/oncolo/article/19/6/608/6399978 by guest on 01 January 2026\n\nanunfavorableimpac",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 2.86,
    "unit": "%",
    "population": null,
    "notes": "www.TheOncologist.com©AlphaMed Press 2014\nBonotto, Gerratana, Poletto et al.611\nDownloaded from https://academic.oup.com/oncolo/article/19/6/608/6399978 by guest on 01 January 2026\n\nanunfavorableimpac",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 2.05,
    "unit": "%",
    "population": null,
    "notes": "www.TheOncologist.com©AlphaMed Press 2014\nBonotto, Gerratana, Poletto et al.611\nDownloaded from https://academic.oup.com/oncolo/article/19/6/608/6399978 by guest on 01 January 2026\n\nanunfavorableimpac",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 1.32,
    "unit": "%",
    "population": null,
    "notes": "www.TheOncologist.com©AlphaMed Press 2014\nBonotto, Gerratana, Poletto et al.611\nDownloaded from https://academic.oup.com/oncolo/article/19/6/608/6399978 by guest on 01 January 2026\n\nanunfavorableimpac",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 3.2,
    "unit": "%",
    "population": null,
    "notes": "www.TheOncologist.com©AlphaMed Press 2014\nBonotto, Gerratana, Poletto et al.611\nDownloaded from https://academic.oup.com/oncolo/article/19/6/608/6399978 by guest on 01 January 2026\n\nanunfavorableimpac",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 3.1,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1.9,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 5.04,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1.8,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1.04,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 3.16,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 3.6,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 2.35,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 5.48,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 2.77,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1.68,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 4.57,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 2.17,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1.36,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 3.46,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 2.09,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1.2,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 3.65,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.65,
    "unit": "%",
    "population": null,
    "notes": "HER2-positive disease was\nassociated with better prognosis in terms of OS_tot (HR: 0.65\n[95% CI: 0.42–0.99],p5.0488), OS_CT (HR: 0.51 [95% CI:\n0.31–0.83],p5.0065), and PFS1_ET (HR: 0.48 [95% CI:\n0.3–0",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.42,
    "unit": "%",
    "population": null,
    "notes": "HER2-positive disease was\nassociated with better prognosis in terms of OS_tot (HR: 0.65\n[95% CI: 0.42–0.99],p5.0488), OS_CT (HR: 0.51 [95% CI:\n0.31–0.83],p5.0065), and PFS1_ET (HR: 0.48 [95% CI:\n0.3–0",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.99,
    "unit": "%",
    "population": null,
    "notes": "HER2-positive disease was\nassociated with better prognosis in terms of OS_tot (HR: 0.65\n[95% CI: 0.42–0.99],p5.0488), OS_CT (HR: 0.51 [95% CI:\n0.31–0.83],p5.0065), and PFS1_ET (HR: 0.48 [95% CI:\n0.3–0",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.51,
    "unit": "%",
    "population": null,
    "notes": "HER2-positive disease was\nassociated with better prognosis in terms of OS_tot (HR: 0.65\n[95% CI: 0.42–0.99],p5.0488), OS_CT (HR: 0.51 [95% CI:\n0.31–0.83],p5.0065), and PFS1_ET (HR: 0.48 [95% CI:\n0.3–0",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.31,
    "unit": "%",
    "population": null,
    "notes": "HER2-positive disease was\nassociated with better prognosis in terms of OS_tot (HR: 0.65\n[95% CI: 0.42–0.99],p5.0488), OS_CT (HR: 0.51 [95% CI:\n0.31–0.83],p5.0065), and PFS1_ET (HR: 0.48 [95% CI:\n0.3–0",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.83,
    "unit": "%",
    "population": null,
    "notes": "HER2-positive disease was\nassociated with better prognosis in terms of OS_tot (HR: 0.65\n[95% CI: 0.42–0.99],p5.0488), OS_CT (HR: 0.51 [95% CI:\n0.31–0.83],p5.0065), and PFS1_ET (HR: 0.48 [95% CI:\n0.3–0",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.48,
    "unit": "%",
    "population": null,
    "notes": "HER2-positive disease was\nassociated with better prognosis in terms of OS_tot (HR: 0.65\n[95% CI: 0.42–0.99],p5.0488), OS_CT (HR: 0.51 [95% CI:\n0.31–0.83],p5.0065), and PFS1_ET (HR: 0.48 [95% CI:\n0.3–0",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.3,
    "unit": "%",
    "population": null,
    "notes": "HER2-positive disease was\nassociated with better prognosis in terms of OS_tot (HR: 0.65\n[95% CI: 0.42–0.99],p5.0488), OS_CT (HR: 0.51 [95% CI:\n0.31–0.83],p5.0065), and PFS1_ET (HR: 0.48 [95% CI:\n0.3–0",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.79,
    "unit": "%",
    "population": null,
    "notes": "HER2-positive disease was\nassociated with better prognosis in terms of OS_tot (HR: 0.65\n[95% CI: 0.42–0.99],p5.0488), OS_CT (HR: 0.51 [95% CI:\n0.31–0.83],p5.0065), and PFS1_ET (HR: 0.48 [95% CI:\n0.3–0",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 321.9,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 713.9,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 52.4,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 518.3,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 81.1,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 24.9,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 18.2,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 28.2,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 34.5,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 14.7,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 5.9,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 21.4,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 92.5,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 6.1,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 39.8,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 95.2,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 33.1,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 38.9,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 10.8,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 12.2,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "58 year",
    "value": 58,
    "unit": "years",
    "population": null,
    "notes": "RESULTS\nMedian age at diagnosis was 58 years, and median age at\ndiagnosisofMBCwas63years;147patientspresenteddenovo\nmetastatic disease",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 78,
    "unit": "%",
    "population": null,
    "notes": "Most patients (78.3%) had ER-positive disease",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 24,
    "unit": "%",
    "population": null,
    "notes": "Eighty-\neightpatients(24.5%)hadaluminalAdisease,138(38.4%)had\na luminal B disease, 89 (24.8%) had a HER2-positive disease,\nand 44 (12.3%) had a triple-negative phenotype",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 138,
    "unit": "%",
    "population": null,
    "notes": "Eighty-\neightpatients(24.5%)hadaluminalAdisease,138(38.4%)had\na luminal B disease, 89 (24.8%) had a HER2-positive disease,\nand 44 (12.3%) had a triple-negative phenotype",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 38,
    "unit": "%",
    "population": null,
    "notes": "Eighty-\neightpatients(24.5%)hadaluminalAdisease,138(38.4%)had\na luminal B disease, 89 (24.8%) had a HER2-positive disease,\nand 44 (12.3%) had a triple-negative phenotype",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 89,
    "unit": "%",
    "population": null,
    "notes": "Eighty-\neightpatients(24.5%)hadaluminalAdisease,138(38.4%)had\na luminal B disease, 89 (24.8%) had a HER2-positive disease,\nand 44 (12.3%) had a triple-negative phenotype",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 24,
    "unit": "%",
    "population": null,
    "notes": "Eighty-\neightpatients(24.5%)hadaluminalAdisease,138(38.4%)had\na luminal B disease, 89 (24.8%) had a HER2-positive disease,\nand 44 (12.3%) had a triple-negative phenotype",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 44,
    "unit": "%",
    "population": null,
    "notes": "Eighty-\neightpatients(24.5%)hadaluminalAdisease,138(38.4%)had\na luminal B disease, 89 (24.8%) had a HER2-positive disease,\nand 44 (12.3%) had a triple-negative phenotype",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 12,
    "unit": "%",
    "population": null,
    "notes": "Eighty-\neightpatients(24.5%)hadaluminalAdisease,138(38.4%)had\na luminal B disease, 89 (24.8%) had a HER2-positive disease,\nand 44 (12.3%) had a triple-negative phenotype",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "7month",
    "value": 21,
    "unit": "months",
    "population": null,
    "notes": "Mediantime to development of MBC frominitial diagnosis\nofBC was 21.7months (range: 0–175 months); median OS was\n34 months (25th–75th percentile: 13.7–58.5)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "7month",
    "value": 175,
    "unit": "months",
    "population": null,
    "notes": "Mediantime to development of MBC frominitial diagnosis\nofBC was 21.7months (range: 0–175 months); median OS was\n34 months (25th–75th percentile: 13.7–58.5)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "7month",
    "value": 34,
    "unit": "months",
    "population": null,
    "notes": "Mediantime to development of MBC frominitial diagnosis\nofBC was 21.7months (range: 0–175 months); median OS was\n34 months (25th–75th percentile: 13.7–58.5)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "7month",
    "value": 13,
    "unit": "months",
    "population": null,
    "notes": "Mediantime to development of MBC frominitial diagnosis\nofBC was 21.7months (range: 0–175 months); median OS was\n34 months (25th–75th percentile: 13.7–58.5)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "7month",
    "value": 58,
    "unit": "months",
    "population": null,
    "notes": "Mediantime to development of MBC frominitial diagnosis\nofBC was 21.7months (range: 0–175 months); median OS was\n34 months (25th–75th percentile: 13.7–58.5)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "3month",
    "value": 55,
    "unit": "months",
    "population": null,
    "notes": "In particular, among\nHER2-positive cases,abetteroutcome was noted forhormone\nreceptor positive disease versus hormone receptor negative\ndisease(OS:55.3monthsvs.26.0months;PFS:17.5monthsvs",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "3month",
    "value": 26,
    "unit": "months",
    "population": null,
    "notes": "In particular, among\nHER2-positive cases,abetteroutcome was noted forhormone\nreceptor positive disease versus hormone receptor negative\ndisease(OS:55.3monthsvs.26.0months;PFS:17.5monthsvs",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "3month",
    "value": 17,
    "unit": "months",
    "population": null,
    "notes": "In particular, among\nHER2-positive cases,abetteroutcome was noted forhormone\nreceptor positive disease versus hormone receptor negative\ndisease(OS:55.3monthsvs.26.0months;PFS:17.5monthsvs",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 42,
    "unit": "%",
    "population": null,
    "notes": "HER2-positivediseasewasassociatedwithlongerPFS1_tot\n(HR: 0.42 [95% CI: 0.3–0.6],p,.0001) and PFS2_tot (HR: 0.63\n[95% CI: 0.46–0.88],p5.01)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "HER2-positivediseasewasassociatedwithlongerPFS1_tot\n(HR: 0.42 [95% CI: 0.3–0.6],p,.0001) and PFS2_tot (HR: 0.63\n[95% CI: 0.46–0.88],p5.01)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1,
    "unit": "%",
    "population": null,
    "notes": "HER2-positivediseasewasassociatedwithlongerPFS1_tot\n(HR: 0.42 [95% CI: 0.3–0.6],p,.0001) and PFS2_tot (HR: 0.63\n[95% CI: 0.46–0.88],p5.01)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 63,
    "unit": "%",
    "population": null,
    "notes": "HER2-positivediseasewasassociatedwithlongerPFS1_tot\n(HR: 0.42 [95% CI: 0.3–0.6],p,.0001) and PFS2_tot (HR: 0.63\n[95% CI: 0.46–0.88],p5.01)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "HER2-positivediseasewasassociatedwithlongerPFS1_tot\n(HR: 0.42 [95% CI: 0.3–0.6],p,.0001) and PFS2_tot (HR: 0.63\n[95% CI: 0.46–0.88],p5.01)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 46,
    "unit": "%",
    "population": null,
    "notes": "HER2-positivediseasewasassociatedwithlongerPFS1_tot\n(HR: 0.42 [95% CI: 0.3–0.6],p,.0001) and PFS2_tot (HR: 0.63\n[95% CI: 0.46–0.88],p5.01)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 88,
    "unit": "%",
    "population": null,
    "notes": "HER2-positivediseasewasassociatedwithlongerPFS1_tot\n(HR: 0.42 [95% CI: 0.3–0.6],p,.0001) and PFS2_tot (HR: 0.63\n[95% CI: 0.46–0.88],p5.01)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1,
    "unit": "%",
    "population": null,
    "notes": "HER2-positivediseasewasassociatedwithlongerPFS1_tot\n(HR: 0.42 [95% CI: 0.3–0.6],p,.0001) and PFS2_tot (HR: 0.63\n[95% CI: 0.46–0.88],p5.01)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 56,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 95,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 31,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 92,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 2,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 75,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 95,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 9,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 79,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 2,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 9,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 95,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 35,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 2,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 507,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 58,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 517,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 65,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 110,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 48,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 4,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 18,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 42,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 10,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 2,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 2,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 53,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 19,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 72,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 10,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 92,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 21,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 10,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 13,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 14,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 72,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 32,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 51,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 35,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 36,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 24,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 27,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 22,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 18,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 2,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 14,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 7,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 39,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 24,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 31,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 50,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 30,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 71,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 32,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 73,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 28,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 82,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 17,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 61,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 12,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 30,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 76,
    "unit": "months",
    "population": null,
    "notes": "Bone-only disease was\nassociated  with  longer  PPS1_tot  (HR:  0.56  [95%  CI:\n0.31–0.92],p5.02), whereas liver metastasis (HR: 1.75 [95%\nCI: 1.09–2.79],p5.02) and lung metastasis (HR: 2.09 [95% CI:\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 2014,
    "unit": "%",
    "population": null,
    "notes": "www.TheOncologist.com©AlphaMed Press 2014\nBonotto, Gerratana, Poletto et al.611\nDownloaded from https://academic.oup.com/oncolo/article/19/6/608/6399978 by guest on 01 January 2026\n\nanunfavorableimpac",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 611,
    "unit": "%",
    "population": null,
    "notes": "www.TheOncologist.com©AlphaMed Press 2014\nBonotto, Gerratana, Poletto et al.611\nDownloaded from https://academic.oup.com/oncolo/article/19/6/608/6399978 by guest on 01 January 2026\n\nanunfavorableimpac",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 19,
    "unit": "%",
    "population": null,
    "notes": "www.TheOncologist.com©AlphaMed Press 2014\nBonotto, Gerratana, Poletto et al.611\nDownloaded from https://academic.oup.com/oncolo/article/19/6/608/6399978 by guest on 01 January 2026\n\nanunfavorableimpac",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 608,
    "unit": "%",
    "population": null,
    "notes": "www.TheOncologist.com©AlphaMed Press 2014\nBonotto, Gerratana, Poletto et al.611\nDownloaded from https://academic.oup.com/oncolo/article/19/6/608/6399978 by guest on 01 January 2026\n\nanunfavorableimpac",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 6399978,
    "unit": "%",
    "population": null,
    "notes": "www.TheOncologist.com©AlphaMed Press 2014\nBonotto, Gerratana, Poletto et al.611\nDownloaded from https://academic.oup.com/oncolo/article/19/6/608/6399978 by guest on 01 January 2026\n\nanunfavorableimpac",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 1,
    "unit": "%",
    "population": null,
    "notes": "www.TheOncologist.com©AlphaMed Press 2014\nBonotto, Gerratana, Poletto et al.611\nDownloaded from https://academic.oup.com/oncolo/article/19/6/608/6399978 by guest on 01 January 2026\n\nanunfavorableimpac",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 2026,
    "unit": "%",
    "population": null,
    "notes": "www.TheOncologist.com©AlphaMed Press 2014\nBonotto, Gerratana, Poletto et al.611\nDownloaded from https://academic.oup.com/oncolo/article/19/6/608/6399978 by guest on 01 January 2026\n\nanunfavorableimpac",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 92,
    "unit": "%",
    "population": null,
    "notes": "www.TheOncologist.com©AlphaMed Press 2014\nBonotto, Gerratana, Poletto et al.611\nDownloaded from https://academic.oup.com/oncolo/article/19/6/608/6399978 by guest on 01 January 2026\n\nanunfavorableimpac",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "www.TheOncologist.com©AlphaMed Press 2014\nBonotto, Gerratana, Poletto et al.611\nDownloaded from https://academic.oup.com/oncolo/article/19/6/608/6399978 by guest on 01 January 2026\n\nanunfavorableimpac",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 29,
    "unit": "%",
    "population": null,
    "notes": "www.TheOncologist.com©AlphaMed Press 2014\nBonotto, Gerratana, Poletto et al.611\nDownloaded from https://academic.oup.com/oncolo/article/19/6/608/6399978 by guest on 01 January 2026\n\nanunfavorableimpac",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 86,
    "unit": "%",
    "population": null,
    "notes": "www.TheOncologist.com©AlphaMed Press 2014\nBonotto, Gerratana, Poletto et al.611\nDownloaded from https://academic.oup.com/oncolo/article/19/6/608/6399978 by guest on 01 January 2026\n\nanunfavorableimpac",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 1,
    "unit": "%",
    "population": null,
    "notes": "www.TheOncologist.com©AlphaMed Press 2014\nBonotto, Gerratana, Poletto et al.611\nDownloaded from https://academic.oup.com/oncolo/article/19/6/608/6399978 by guest on 01 January 2026\n\nanunfavorableimpac",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 5,
    "unit": "%",
    "population": null,
    "notes": "www.TheOncologist.com©AlphaMed Press 2014\nBonotto, Gerratana, Poletto et al.611\nDownloaded from https://academic.oup.com/oncolo/article/19/6/608/6399978 by guest on 01 January 2026\n\nanunfavorableimpac",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "www.TheOncologist.com©AlphaMed Press 2014\nBonotto, Gerratana, Poletto et al.611\nDownloaded from https://academic.oup.com/oncolo/article/19/6/608/6399978 by guest on 01 January 2026\n\nanunfavorableimpac",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 32,
    "unit": "%",
    "population": null,
    "notes": "www.TheOncologist.com©AlphaMed Press 2014\nBonotto, Gerratana, Poletto et al.611\nDownloaded from https://academic.oup.com/oncolo/article/19/6/608/6399978 by guest on 01 January 2026\n\nanunfavorableimpac",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2014",
    "value": 1,
    "unit": "%",
    "population": null,
    "notes": "www.TheOncologist.com©AlphaMed Press 2014\nBonotto, Gerratana, Poletto et al.611\nDownloaded from https://academic.oup.com/oncolo/article/19/6/608/6399978 by guest on 01 January 2026\n\nanunfavorableimpac",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 4,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 4,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 16,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 353,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 35,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 48,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 77,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 68,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 57,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 17,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 36,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 46,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 11,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 9,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 65,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 9,
    "unit": "%",
    "population": null,
    "notes": "On multivariate\nanalysis, the triple-negative phenotype conferred a signifi-\ncantly poorer outcome in terms of OS_tot (HR: 3.1 [95% CI:\n1.9–5.04],p5.0001), OS_CT (HR: 1.8 [95% CI: 1.04–3.16],\np5.0353)",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 65,
    "unit": "%",
    "population": null,
    "notes": "HER2-positive disease was\nassociated with better prognosis in terms of OS_tot (HR: 0.65\n[95% CI: 0.42–0.99],p5.0488), OS_CT (HR: 0.51 [95% CI:\n0.31–0.83],p5.0065), and PFS1_ET (HR: 0.48 [95% CI:\n0.3–0",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "HER2-positive disease was\nassociated with better prognosis in terms of OS_tot (HR: 0.65\n[95% CI: 0.42–0.99],p5.0488), OS_CT (HR: 0.51 [95% CI:\n0.31–0.83],p5.0065), and PFS1_ET (HR: 0.48 [95% CI:\n0.3–0",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 42,
    "unit": "%",
    "population": null,
    "notes": "HER2-positive disease was\nassociated with better prognosis in terms of OS_tot (HR: 0.65\n[95% CI: 0.42–0.99],p5.0488), OS_CT (HR: 0.51 [95% CI:\n0.31–0.83],p5.0065), and PFS1_ET (HR: 0.48 [95% CI:\n0.3–0",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 99,
    "unit": "%",
    "population": null,
    "notes": "HER2-positive disease was\nassociated with better prognosis in terms of OS_tot (HR: 0.65\n[95% CI: 0.42–0.99],p5.0488), OS_CT (HR: 0.51 [95% CI:\n0.31–0.83],p5.0065), and PFS1_ET (HR: 0.48 [95% CI:\n0.3–0",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 488,
    "unit": "%",
    "population": null,
    "notes": "HER2-positive disease was\nassociated with better prognosis in terms of OS_tot (HR: 0.65\n[95% CI: 0.42–0.99],p5.0488), OS_CT (HR: 0.51 [95% CI:\n0.31–0.83],p5.0065), and PFS1_ET (HR: 0.48 [95% CI:\n0.3–0",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 51,
    "unit": "%",
    "population": null,
    "notes": "HER2-positive disease was\nassociated with better prognosis in terms of OS_tot (HR: 0.65\n[95% CI: 0.42–0.99],p5.0488), OS_CT (HR: 0.51 [95% CI:\n0.31–0.83],p5.0065), and PFS1_ET (HR: 0.48 [95% CI:\n0.3–0",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "HER2-positive disease was\nassociated with better prognosis in terms of OS_tot (HR: 0.65\n[95% CI: 0.42–0.99],p5.0488), OS_CT (HR: 0.51 [95% CI:\n0.31–0.83],p5.0065), and PFS1_ET (HR: 0.48 [95% CI:\n0.3–0",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 31,
    "unit": "%",
    "population": null,
    "notes": "HER2-positive disease was\nassociated with better prognosis in terms of OS_tot (HR: 0.65\n[95% CI: 0.42–0.99],p5.0488), OS_CT (HR: 0.51 [95% CI:\n0.31–0.83],p5.0065), and PFS1_ET (HR: 0.48 [95% CI:\n0.3–0",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 83,
    "unit": "%",
    "population": null,
    "notes": "HER2-positive disease was\nassociated with better prognosis in terms of OS_tot (HR: 0.65\n[95% CI: 0.42–0.99],p5.0488), OS_CT (HR: 0.51 [95% CI:\n0.31–0.83],p5.0065), and PFS1_ET (HR: 0.48 [95% CI:\n0.3–0",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 65,
    "unit": "%",
    "population": null,
    "notes": "HER2-positive disease was\nassociated with better prognosis in terms of OS_tot (HR: 0.65\n[95% CI: 0.42–0.99],p5.0488), OS_CT (HR: 0.51 [95% CI:\n0.31–0.83],p5.0065), and PFS1_ET (HR: 0.48 [95% CI:\n0.3–0",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 48,
    "unit": "%",
    "population": null,
    "notes": "HER2-positive disease was\nassociated with better prognosis in terms of OS_tot (HR: 0.65\n[95% CI: 0.42–0.99],p5.0488), OS_CT (HR: 0.51 [95% CI:\n0.31–0.83],p5.0065), and PFS1_ET (HR: 0.48 [95% CI:\n0.3–0",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "HER2-positive disease was\nassociated with better prognosis in terms of OS_tot (HR: 0.65\n[95% CI: 0.42–0.99],p5.0488), OS_CT (HR: 0.51 [95% CI:\n0.31–0.83],p5.0065), and PFS1_ET (HR: 0.48 [95% CI:\n0.3–0",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 79,
    "unit": "%",
    "population": null,
    "notes": "HER2-positive disease was\nassociated with better prognosis in terms of OS_tot (HR: 0.65\n[95% CI: 0.42–0.99],p5.0488), OS_CT (HR: 0.51 [95% CI:\n0.31–0.83],p5.0065), and PFS1_ET (HR: 0.48 [95% CI:\n0.3–0",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 35,
    "unit": "%",
    "population": null,
    "notes": "HER2-positive disease was\nassociated with better prognosis in terms of OS_tot (HR: 0.65\n[95% CI: 0.42–0.99],p5.0488), OS_CT (HR: 0.51 [95% CI:\n0.31–0.83],p5.0065), and PFS1_ET (HR: 0.48 [95% CI:\n0.3–0",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 19,
    "unit": null,
    "population": null,
    "notes": "Pros and cons have been raised about the use of PFS and\nOS[19,29–31],thelatterbeing consideredthemostobjective;\nhowever, the use of OS as a measure of efficacy could be\nconfounded by treatment beyond ",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 29,
    "unit": null,
    "population": null,
    "notes": "Pros and cons have been raised about the use of PFS and\nOS[19,29–31],thelatterbeing consideredthemostobjective;\nhowever, the use of OS as a measure of efficacy could be\nconfounded by treatment beyond ",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 31,
    "unit": null,
    "population": null,
    "notes": "Pros and cons have been raised about the use of PFS and\nOS[19,29–31],thelatterbeing consideredthemostobjective;\nhowever, the use of OS as a measure of efficacy could be\nconfounded by treatment beyond ",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 22,
    "unit": null,
    "population": null,
    "notes": "In fact, in\nclinical trials, the probability of pointing out differences in OS\nbetween two or more treatment arms is inversely related to\nthedurationofPPS,arecentlyintroducedmeasureofoutcome\nthat may ",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 32,
    "unit": null,
    "population": null,
    "notes": "In such cases, a long median PPS\nmay explain the lack of statistical difference in OS [32]",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 321,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 56,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 713,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 52,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 518,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 81,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 24,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 18,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 15,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 28,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 34,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 14,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 5,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 21,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 92,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 39,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 95,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 33,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 38,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 10,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 12,
    "unit": "months",
    "population": null,
    "notes": "This is\nTable 4.Outcome estimates according to breast cancer\nsubtypes\nOutcomen\nMedian\n(months)\nIQR\n(25th–75th\npercentile)\nOS\nLuminal A8845.321.9–56\nLuminal B13829.713.9–52.4\nHER2 positive8943.518.3–81",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 67.14,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "34 month",
    "value": 34,
    "unit": "months",
    "population": null,
    "notes": "Interestingly, median OS was 34 months for the whole\npopulation, suggesting that prognosis of patients with MBC is\nbetterthanexpectedbasedontheresultsoftheearliestclinical\ntrials testing chemotherapy ",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.26,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.66,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.22,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.52,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1.16,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 2.84,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1.39,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 3.38,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.32,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.69,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.3,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.6,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 67.14,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1.55,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1.16,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 2.06,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 1.28,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 1.01,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 1.64,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 1.03,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 1.99,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 0.46,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 0.88,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 11.35,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 1.04,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 1.76,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 1.92,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 1.29,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 2.86,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 1.2,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 3.51,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 22.05,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 1.32,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 3.2,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 0.31,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 0.92,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 1.3,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 3.35,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 1.09,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 2.79,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 11.88,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 1.31,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 2.68,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 22.44,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 1.44,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 4.16,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 1.16,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 3.12,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 12.03,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 1.46,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 2.83,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 4,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 2.49,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 6.43,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 11.94,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 1.35,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 2.78,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 27.23,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 4.2,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 12.45,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 0.19,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 0.82,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 12.33,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 1.48,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 3.67,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 4.39,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 2.42,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 7.97,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 33,
    "unit": null,
    "population": null,
    "notes": "In contrast, the EMBRACE study, which\nanalyzed the role of eribulin in heavily treated patients with\nMBC, had more chances to observe benefit for OS because of\nthe short PPS [33]",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 34,
    "unit": null,
    "population": "us population",
    "notes": "Because earlier clinical trials were conducted in heteroge-\nneous populations that were not differentiated for prognostic\nandpredictivefactors,informationaboutestimateofoutcome\nis not reliably transfe",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "34 month",
    "value": 34,
    "unit": "months",
    "population": null,
    "notes": "Interestingly, median OS was 34 months for the whole\npopulation, suggesting that prognosis of patients with MBC is\nbetterthanexpectedbasedontheresultsoftheearliestclinical\ntrials testing chemotherapy ",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 35,
    "unit": null,
    "population": null,
    "notes": "The observation of\nincremental improvement of survival over time has been\ndocumented by several analyses of retrospective series\n[35–37]",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 37,
    "unit": null,
    "population": null,
    "notes": "The observation of\nincremental improvement of survival over time has been\ndocumented by several analyses of retrospective series\n[35–37]",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 38,
    "unit": "years",
    "population": null,
    "notes": "Although only inferred, the advances in OS docu-\nmented in more recent years have been attributed to the\nintroduction ofactive anticanceragents administeredsequen-\ntially across different lines of tre",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 41,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 26,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 66,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 3,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 34,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 22,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 52,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 81,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 16,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 84,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 17,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 39,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 38,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 6,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 47,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 32,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 69,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 42,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 67,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 14,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 55,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 16,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 6,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 3,
    "unit": "%",
    "population": null,
    "notes": "Table 5.Multivariate Cox proportional hazards\nregression model\nVariableHR95% CIpvalue\nOS, all treatment\nER positive0.41   0.26–0.66.0003\nHER2 positive0.34   0.22–0.52,.0001\nLung metastases1.81   1.16–",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 28,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 1,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 64,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 4,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 43,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 3,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 99,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 3,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 63,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 46,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 88,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 1,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 11,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 35,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 4,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 76,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 3,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 92,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 29,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 86,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 1,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 5,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 20,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 51,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 8,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 22,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 5,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 32,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 1,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 56,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 31,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 92,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 2,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 9,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 35,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 2,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 75,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 9,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 79,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 2,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 11,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 88,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 31,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 68,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 6,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 22,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 44,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 44,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 16,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 1,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 91,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 16,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 12,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 1,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 12,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 3,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 46,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 83,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 1,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 0,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 49,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 43,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 1,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 11,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 94,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 35,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 78,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 3,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 27,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 23,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 20,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 12,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 45,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 1,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 39,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 19,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 82,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 1,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 12,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 33,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 48,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 67,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 3,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 39,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 42,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 97,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 1,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "no)\n1.28   1.01–1.64.04\nLiver metastases1.43   1.03–1.99.03\nPFS2, all treatment\nHER2 positive0.63   0.46–0.88.01\nECOG PS at second line 11.35   1.04–1.76.03\nECOG PS at second line$2   1.92   1.29–2.86",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2008",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Estimates of cancer incidence and mortality in\nEurope in 2008",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 199,
    "unit": null,
    "population": null,
    "notes": "Interestingly, similar results were recently reported by\nSeah et al., who analyzed a series of 199 consecutive patients\nwith MBC at the Dana-Farber Cancer Institute in Boston,\nMassachusetts [34]",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 34,
    "unit": null,
    "population": null,
    "notes": "Interestingly, similar results were recently reported by\nSeah et al., who analyzed a series of 199 consecutive patients\nwith MBC at the Dana-Farber Cancer Institute in Boston,\nMassachusetts [34]",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 12,
    "unit": "month",
    "population": null,
    "notes": "In both\ncases, the figure is over the 12-month threshold that could\ndecrease the chance to point out OS differences in the context\nof a hypothetical clinical trial [22]",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 22,
    "unit": "month",
    "population": null,
    "notes": "In both\ncases, the figure is over the 12-month threshold that could\ndecrease the chance to point out OS differences in the context\nof a hypothetical clinical trial [22]",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 39,
    "unit": null,
    "population": null,
    "notes": "Results confirmed the prognostic role of specific\ndiseaseandpatientcharacteristicsandwereinlinewithdatain\ntheliterature,suggestingthatoutcomeislargelydependenton\nimmunophenotype as defined in a sample",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2008",
    "value": 2008,
    "unit": null,
    "population": null,
    "notes": "Estimates of cancer incidence and mortality in\nEurope in 2008",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2005",
    "value": 10,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "Extending survival with che-\nmotherapy in metastatic breast cancer.The Oncol-\nogist2005;10(suppl 3):20–29",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2005",
    "value": 20,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "Extending survival with che-\nmotherapy in metastatic breast cancer.The Oncol-\nogist2005;10(suppl 3):20–29",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2005",
    "value": 29,
    "unit": null,
    "population": "metastatic breast cancer",
    "notes": "Extending survival with che-\nmotherapy in metastatic breast cancer.The Oncol-\nogist2005;10(suppl 3):20–29",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 13,
    "unit": null,
    "population": null,
    "notes": "13.Cardoso F, Harbeck N, Fallowfield L et al",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2011",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Treatment\noutcome and prognostic factors for patients with\nbone-only metastases of breast cancer: A single-\ninstitution retrospective analysis.The  Oncologist\n2011;16:155–164",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2011",
    "value": 16,
    "unit": null,
    "population": null,
    "notes": "In the end\nwhatmattersmost?Areviewofclinicalendpoints in\nadvanced breast cancer.The  Oncologist2011;16:\n25–35",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2011",
    "value": 25,
    "unit": null,
    "population": null,
    "notes": "In the end\nwhatmattersmost?Areviewofclinicalendpoints in\nadvanced breast cancer.The  Oncologist2011;16:\n25–35",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2011",
    "value": 35,
    "unit": null,
    "population": null,
    "notes": "In the end\nwhatmattersmost?Areviewofclinicalendpoints in\nadvanced breast cancer.The  Oncologist2011;16:\n25–35",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2011",
    "value": 2011,
    "unit": null,
    "population": null,
    "notes": "Treatment\noutcome and prognostic factors for patients with\nbone-only metastases of breast cancer: A single-\ninstitution retrospective analysis.The  Oncologist\n2011;16:155–164",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2011",
    "value": 16,
    "unit": null,
    "population": null,
    "notes": "Treatment\noutcome and prognostic factors for patients with\nbone-only metastases of breast cancer: A single-\ninstitution retrospective analysis.The  Oncologist\n2011;16:155–164",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2011",
    "value": 155,
    "unit": null,
    "population": null,
    "notes": "Treatment\noutcome and prognostic factors for patients with\nbone-only metastases of breast cancer: A single-\ninstitution retrospective analysis.The  Oncologist\n2011;16:155–164",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2011",
    "value": 164,
    "unit": null,
    "population": null,
    "notes": "Treatment\noutcome and prognostic factors for patients with\nbone-only metastases of breast cancer: A single-\ninstitution retrospective analysis.The  Oncologist\n2011;16:155–164",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-006",
    "filename": "Bonotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 38,
    "unit": null,
    "population": null,
    "notes": "38.Mauri D, Polyzos NP, Salanti G et al",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 23,
    "unit": "%",
    "population": "metastatic  breast  cancer",
    "notes": "In  a  retrospective  \nanalysis  of  1581  patients  with  metastatic  breast  cancer,  \nabout 23% of patients had lung metastases, 5.6% of patients \nwith  metastases  confined  to  lungs  [4]",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 5.6,
    "unit": "%",
    "population": "metastatic  breast  cancer",
    "notes": "In  a  retrospective  \nanalysis  of  1581  patients  with  metastatic  breast  cancer,  \nabout 23% of patients had lung metastases, 5.6% of patients \nwith  metastases  confined  to  lungs  [4]",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "median  survival",
    "timePeriod": "21  month",
    "value": 15.5,
    "unit": "%",
    "population": null,
    "notes": "The  median  survival  time  for  patients  with  BCLM  was  \n21  months,  and  15.5%  of  the  patients  were  alive  more  than  3  years",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "We  calculated  95%  confidence  intervals  (95%  CI)  for  \nall  estimates  (ORs  and  HRs)  across  strata",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "We  calculated  95%  confidence  intervals  (95%  CI)  for  \nall  estimates  (ORs  and  HRs)  across  strata",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2010",
    "value": 67.7,
    "unit": "%",
    "population": null,
    "notes": "The  incidence  proportion  of  HR\n+\n/HER2\n−\n,  HR\n+\n/HER2\n+\n, \nHR\n−\n/HER2\n+\n,    triple-    negative,    and    unknown    subtypes    \namong  240,808  patients  diagnosed  with  malignant  breast  \n",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 9.3,
    "unit": "%",
    "population": null,
    "notes": "Among the 11,568 patients \ndiagnosed with metastatic diseases at distant sites analyzed \nfor  incidence,  51.8%,  13.2%,  6.9%,  11.1%,  and  17.0%  \nhad    HR\n+\n/HER2\n−\n,    HR\n+\n/HER2\n+\n,    HR\n−\n/H",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 4.1,
    "unit": "%",
    "population": null,
    "notes": "Among the 11,568 patients \ndiagnosed with metastatic diseases at distant sites analyzed \nfor  incidence,  51.8%,  13.2%,  6.9%,  11.1%,  and  17.0%  \nhad    HR\n+\n/HER2\n−\n,    HR\n+\n/HER2\n+\n,    HR\n−\n/H",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 10.7,
    "unit": "%",
    "population": null,
    "notes": "Among the 11,568 patients \ndiagnosed with metastatic diseases at distant sites analyzed \nfor  incidence,  51.8%,  13.2%,  6.9%,  11.1%,  and  17.0%  \nhad    HR\n+\n/HER2\n−\n,    HR\n+\n/HER2\n+\n,    HR\n−\n/H",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 8.3,
    "unit": "%",
    "population": null,
    "notes": "Among the 11,568 patients \ndiagnosed with metastatic diseases at distant sites analyzed \nfor  incidence,  51.8%,  13.2%,  6.9%,  11.1%,  and  17.0%  \nhad    HR\n+\n/HER2\n−\n,    HR\n+\n/HER2\n+\n,    HR\n−\n/H",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 51.8,
    "unit": "%",
    "population": null,
    "notes": "Among the 11,568 patients \ndiagnosed with metastatic diseases at distant sites analyzed \nfor  incidence,  51.8%,  13.2%,  6.9%,  11.1%,  and  17.0%  \nhad    HR\n+\n/HER2\n−\n,    HR\n+\n/HER2\n+\n,    HR\n−\n/H",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 13.2,
    "unit": "%",
    "population": null,
    "notes": "Among the 11,568 patients \ndiagnosed with metastatic diseases at distant sites analyzed \nfor  incidence,  51.8%,  13.2%,  6.9%,  11.1%,  and  17.0%  \nhad    HR\n+\n/HER2\n−\n,    HR\n+\n/HER2\n+\n,    HR\n−\n/H",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 6.9,
    "unit": "%",
    "population": null,
    "notes": "Among the 11,568 patients \ndiagnosed with metastatic diseases at distant sites analyzed \nfor  incidence,  51.8%,  13.2%,  6.9%,  11.1%,  and  17.0%  \nhad    HR\n+\n/HER2\n−\n,    HR\n+\n/HER2\n+\n,    HR\n−\n/H",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 11.1,
    "unit": "%",
    "population": null,
    "notes": "Among the 11,568 patients \ndiagnosed with metastatic diseases at distant sites analyzed \nfor  incidence,  51.8%,  13.2%,  6.9%,  11.1%,  and  17.0%  \nhad    HR\n+\n/HER2\n−\n,    HR\n+\n/HER2\n+\n,    HR\n−\n/H",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 17,
    "unit": "%",
    "population": null,
    "notes": "Among the 11,568 patients \ndiagnosed with metastatic diseases at distant sites analyzed \nfor  incidence,  51.8%,  13.2%,  6.9%,  11.1%,  and  17.0%  \nhad    HR\n+\n/HER2\n−\n,    HR\n+\n/HER2\n+\n,    HR\n−\n/H",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "overall   survival",
    "timePeriod": "5  month",
    "value": 22.5,
    "unit": "months",
    "population": null,
    "notes": "It  is  reported  that  \nfor   breast   cancer   patients   with   metastases   confined   to   \nlungs,   the   median   overall   survival   (OS)   after   systemic   \nchemotherapy  was  22.5  months",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "median  survival",
    "timePeriod": "21  month",
    "value": 21,
    "unit": "months",
    "population": null,
    "notes": "The  median  survival  time  for  patients  with  BCLM  was  \n21  months,  and  15.5%  of  the  patients  were  alive  more  than  3  years",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "0  month",
    "value": 0,
    "unit": "months",
    "population": null,
    "notes": "Subsequently,  \nwe  excluded  patients  who  were  diagnosed  by  autopsy  or  \ndeath  certificate  and  whose  survival  record  presented  with  \n0  month,  leaving  a  survival  cohort  of  3772  p",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2010",
    "value": 18,
    "unit": "years",
    "population": null,
    "notes": "Using SEER*Stat \n(version   8.3.4   National   Cancer   Institute,   Bethesda,   MD,   \nUSA),  we  attained  a  cohort  of  247,364  patients  diagnosed  \nas   primary   and   histologically   validat",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1581,
    "unit": "count",
    "population": "metastatic  breast  cancer",
    "notes": "In  a  retrospective  \nanalysis  of  1581  patients  with  metastatic  breast  cancer,  \nabout 23% of patients had lung metastases, 5.6% of patients \nwith  metastases  confined  to  lungs  [4]",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2010",
    "value": 364,
    "unit": "count",
    "population": null,
    "notes": "Using SEER*Stat \n(version   8.3.4   National   Cancer   Institute,   Bethesda,   MD,   \nUSA),  we  attained  a  cohort  of  247,364  patients  diagnosed  \nas   primary   and   histologically   validat",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 808,
    "unit": "count",
    "population": null,
    "notes": "Furthermore,  we  gen-\nerated  a  final  incidence  cohort  of  240,808  patients  with  \ndefinite  lung  metastases  status  at  diagnosis  (Yes  or  No)",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 4213,
    "unit": "count",
    "population": null,
    "notes": "Within  the  case  listing,  4213  patients  had  lung  metastases  \nwhen  first  diagnosed  as  having  breast  cancer",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "0  month",
    "value": 3772,
    "unit": "count",
    "population": null,
    "notes": "Subsequently,  \nwe  excluded  patients  who  were  diagnosed  by  autopsy  or  \ndeath  certificate  and  whose  survival  record  presented  with  \n0  month,  leaving  a  survival  cohort  of  3772  p",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2010",
    "value": 808,
    "unit": "count",
    "population": null,
    "notes": "The  incidence  proportion  of  HR\n+\n/HER2\n−\n,  HR\n+\n/HER2\n+\n, \nHR\n−\n/HER2\n+\n,    triple-    negative,    and    unknown    subtypes    \namong  240,808  patients  diagnosed  with  malignant  breast  \n",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 568,
    "unit": "count",
    "population": null,
    "notes": "Among the 11,568 patients \ndiagnosed with metastatic diseases at distant sites analyzed \nfor  incidence,  51.8%,  13.2%,  6.9%,  11.1%,  and  17.0%  \nhad    HR\n+\n/HER2\n−\n,    HR\n+\n/HER2\n+\n,    HR\n−\n/H",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2018",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "ORIGINAL RESEARCH\nRisk factors and survival outcomes in patients with breast \ncancer and lung metastasis: a population- based study\nWeikai Xiao*, Shaoquan Zheng*, Peng Liu*, Yutian Zou, Xinhua Xie, Pi",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2010",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Using SEER*Stat \n(version   8.3.4   National   Cancer   Institute,   Bethesda,   MD,   \nUSA),  we  attained  a  cohort  of  247,364  patients  diagnosed  \nas   primary   and   histologically   validat",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Those  with  carcinoma  \nin  situ  were  excluded  in  this  cohort",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2010",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "The  incidence  proportion  of  HR\n+\n/HER2\n−\n,  HR\n+\n/HER2\n+\n, \nHR\n−\n/HER2\n+\n,    triple-    negative,    and    unknown    subtypes    \namong  240,808  patients  diagnosed  with  malignant  breast  \n",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2010",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "The  incidence  proportion  of  HR\n+\n/HER2\n−\n,  HR\n+\n/HER2\n+\n, \nHR\n−\n/HER2\n+\n,    triple-    negative,    and    unknown    subtypes    \namong  240,808  patients  diagnosed  with  malignant  breast  \n",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 5.6,
    "unit": "%",
    "population": "metastatic  breast  cancer",
    "notes": "In  a  retrospective  \nanalysis  of  1581  patients  with  metastatic  breast  cancer,  \nabout 23% of patients had lung metastases, 5.6% of patients \nwith  metastases  confined  to  lungs  [4]",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "overall   survival",
    "timePeriod": "5  month",
    "value": 22.5,
    "unit": "months",
    "population": null,
    "notes": "It  is  reported  that  \nfor   breast   cancer   patients   with   metastases   confined   to   \nlungs,   the   median   overall   survival   (OS)   after   systemic   \nchemotherapy  was  22.5  months",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "median  survival",
    "timePeriod": "21  month",
    "value": 15.5,
    "unit": "months",
    "population": null,
    "notes": "The  median  survival  time  for  patients  with  BCLM  was  \n21  months,  and  15.5%  of  the  patients  were  alive  more  than  3  years",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2010",
    "value": 8.3,
    "unit": "years",
    "population": null,
    "notes": "Using SEER*Stat \n(version   8.3.4   National   Cancer   Institute,   Bethesda,   MD,   \nUSA),  we  attained  a  cohort  of  247,364  patients  diagnosed  \nas   primary   and   histologically   validat",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 9.4,
    "unit": null,
    "population": null,
    "notes": "Statistical  analysis  was  performed  \nusing  SPSS  statistical  software  (SPSS  IBM  STATISTICS  21,  \nIBM  Corporation,  Armonk,  USA),  apart  from  the  Kaplan–\nMeier  method  by  SAS  9.4  soft",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2010",
    "value": 67.7,
    "unit": "%",
    "population": null,
    "notes": "The  incidence  proportion  of  HR\n+\n/HER2\n−\n,  HR\n+\n/HER2\n+\n, \nHR\n−\n/HER2\n+\n,    triple-    negative,    and    unknown    subtypes    \namong  240,808  patients  diagnosed  with  malignant  breast  \n",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 9.3,
    "unit": "%",
    "population": null,
    "notes": "Among the 11,568 patients \ndiagnosed with metastatic diseases at distant sites analyzed \nfor  incidence,  51.8%,  13.2%,  6.9%,  11.1%,  and  17.0%  \nhad    HR\n+\n/HER2\n−\n,    HR\n+\n/HER2\n+\n,    HR\n−\n/H",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 4.1,
    "unit": "%",
    "population": null,
    "notes": "Among the 11,568 patients \ndiagnosed with metastatic diseases at distant sites analyzed \nfor  incidence,  51.8%,  13.2%,  6.9%,  11.1%,  and  17.0%  \nhad    HR\n+\n/HER2\n−\n,    HR\n+\n/HER2\n+\n,    HR\n−\n/H",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 10.7,
    "unit": "%",
    "population": null,
    "notes": "Among the 11,568 patients \ndiagnosed with metastatic diseases at distant sites analyzed \nfor  incidence,  51.8%,  13.2%,  6.9%,  11.1%,  and  17.0%  \nhad    HR\n+\n/HER2\n−\n,    HR\n+\n/HER2\n+\n,    HR\n−\n/H",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 8.3,
    "unit": "%",
    "population": null,
    "notes": "Among the 11,568 patients \ndiagnosed with metastatic diseases at distant sites analyzed \nfor  incidence,  51.8%,  13.2%,  6.9%,  11.1%,  and  17.0%  \nhad    HR\n+\n/HER2\n−\n,    HR\n+\n/HER2\n+\n,    HR\n−\n/H",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 51.8,
    "unit": "%",
    "population": null,
    "notes": "Among the 11,568 patients \ndiagnosed with metastatic diseases at distant sites analyzed \nfor  incidence,  51.8%,  13.2%,  6.9%,  11.1%,  and  17.0%  \nhad    HR\n+\n/HER2\n−\n,    HR\n+\n/HER2\n+\n,    HR\n−\n/H",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 13.2,
    "unit": "%",
    "population": null,
    "notes": "Among the 11,568 patients \ndiagnosed with metastatic diseases at distant sites analyzed \nfor  incidence,  51.8%,  13.2%,  6.9%,  11.1%,  and  17.0%  \nhad    HR\n+\n/HER2\n−\n,    HR\n+\n/HER2\n+\n,    HR\n−\n/H",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 6.9,
    "unit": "%",
    "population": null,
    "notes": "Among the 11,568 patients \ndiagnosed with metastatic diseases at distant sites analyzed \nfor  incidence,  51.8%,  13.2%,  6.9%,  11.1%,  and  17.0%  \nhad    HR\n+\n/HER2\n−\n,    HR\n+\n/HER2\n+\n,    HR\n−\n/H",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 11.1,
    "unit": "%",
    "population": null,
    "notes": "Among the 11,568 patients \ndiagnosed with metastatic diseases at distant sites analyzed \nfor  incidence,  51.8%,  13.2%,  6.9%,  11.1%,  and  17.0%  \nhad    HR\n+\n/HER2\n−\n,    HR\n+\n/HER2\n+\n,    HR\n−\n/H",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 17,
    "unit": "%",
    "population": null,
    "notes": "Among the 11,568 patients \ndiagnosed with metastatic diseases at distant sites analyzed \nfor  incidence,  51.8%,  13.2%,  6.9%,  11.1%,  and  17.0%  \nhad    HR\n+\n/HER2\n−\n,    HR\n+\n/HER2\n+\n,    HR\n−\n/H",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 922,
    "unit": null,
    "population": null,
    "notes": "922\nIntroduction\nLung   metastasis   is   one   of   the   most   common   distant   \nmetastases  of  breast  cancer  [1,  2]",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1581,
    "unit": "%",
    "population": "metastatic  breast  cancer",
    "notes": "In  a  retrospective  \nanalysis  of  1581  patients  with  metastatic  breast  cancer,  \nabout 23% of patients had lung metastases, 5.6% of patients \nwith  metastases  confined  to  lungs  [4]",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 23,
    "unit": "%",
    "population": "metastatic  breast  cancer",
    "notes": "In  a  retrospective  \nanalysis  of  1581  patients  with  metastatic  breast  cancer,  \nabout 23% of patients had lung metastases, 5.6% of patients \nwith  metastases  confined  to  lungs  [4]",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "overall   survival",
    "timePeriod": "5  month",
    "value": 22,
    "unit": "months",
    "population": null,
    "notes": "It  is  reported  that  \nfor   breast   cancer   patients   with   metastases   confined   to   \nlungs,   the   median   overall   survival   (OS)   after   systemic   \nchemotherapy  was  22.5  months",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 11,
    "unit": null,
    "population": null,
    "notes": "However,   the   effect   of   \ntumor  subtypes  on  BCLM  survival  is  unclear",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2018",
    "value": 651,
    "unit": null,
    "population": null,
    "notes": "ORIGINAL RESEARCH\nRisk factors and survival outcomes in patients with breast \ncancer and lung metastasis: a population- based study\nWeikai Xiao*, Shaoquan Zheng*, Peng Liu*, Yutian Zou, Xinhua Xie, Pi",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2018",
    "value": 510060,
    "unit": null,
    "population": null,
    "notes": "ORIGINAL RESEARCH\nRisk factors and survival outcomes in patients with breast \ncancer and lung metastasis: a population- based study\nWeikai Xiao*, Shaoquan Zheng*, Peng Liu*, Yutian Zou, Xinhua Xie, Pi",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2018",
    "value": 2018,
    "unit": null,
    "population": null,
    "notes": "ORIGINAL RESEARCH\nRisk factors and survival outcomes in patients with breast \ncancer and lung metastasis: a population- based study\nWeikai Xiao*, Shaoquan Zheng*, Peng Liu*, Yutian Zou, Xinhua Xie, Pi",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 651,
    "unit": null,
    "population": null,
    "notes": "Keywords\nBreast cancer, incidence, lung metastases, \nprognosis\nCorrespondence\nXiaoming Xie and Hailin Tang, Department of \nBreast Oncology, State Key Laboratory of \nOncology in South China, Collaborat",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 510060,
    "unit": null,
    "population": null,
    "notes": "Keywords\nBreast cancer, incidence, lung metastases, \nprognosis\nCorrespondence\nXiaoming Xie and Hailin Tang, Department of \nBreast Oncology, State Key Laboratory of \nOncology in South China, Collaborat",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "median  survival",
    "timePeriod": "21  month",
    "value": 21,
    "unit": "months",
    "population": null,
    "notes": "The  median  survival  time  for  patients  with  BCLM  was  \n21  months,  and  15.5%  of  the  patients  were  alive  more  than  3  years",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "median  survival",
    "timePeriod": "21  month",
    "value": 15,
    "unit": "months",
    "population": null,
    "notes": "The  median  survival  time  for  patients  with  BCLM  was  \n21  months,  and  15.5%  of  the  patients  were  alive  more  than  3  years",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2010",
    "value": 12,
    "unit": "years",
    "population": null,
    "notes": "Using SEER*Stat \n(version   8.3.4   National   Cancer   Institute,   Bethesda,   MD,   \nUSA),  we  attained  a  cohort  of  247,364  patients  diagnosed  \nas   primary   and   histologically   validat",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2010",
    "value": 247,
    "unit": "years",
    "population": null,
    "notes": "Using SEER*Stat \n(version   8.3.4   National   Cancer   Institute,   Bethesda,   MD,   \nUSA),  we  attained  a  cohort  of  247,364  patients  diagnosed  \nas   primary   and   histologically   validat",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2010",
    "value": 364,
    "unit": "years",
    "population": null,
    "notes": "Using SEER*Stat \n(version   8.3.4   National   Cancer   Institute,   Bethesda,   MD,   \nUSA),  we  attained  a  cohort  of  247,364  patients  diagnosed  \nas   primary   and   histologically   validat",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2010",
    "value": 18,
    "unit": "years",
    "population": null,
    "notes": "Using SEER*Stat \n(version   8.3.4   National   Cancer   Institute,   Bethesda,   MD,   \nUSA),  we  attained  a  cohort  of  247,364  patients  diagnosed  \nas   primary   and   histologically   validat",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2010",
    "value": 2010,
    "unit": "years",
    "population": null,
    "notes": "Using SEER*Stat \n(version   8.3.4   National   Cancer   Institute,   Bethesda,   MD,   \nUSA),  we  attained  a  cohort  of  247,364  patients  diagnosed  \nas   primary   and   histologically   validat",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 2013,
    "unit": null,
    "population": null,
    "notes": "Those  with  carcinoma  \nin  situ  were  excluded  in  this  cohort",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 240,
    "unit": null,
    "population": null,
    "notes": "Furthermore,  we  gen-\nerated  a  final  incidence  cohort  of  240,808  patients  with  \ndefinite  lung  metastases  status  at  diagnosis  (Yes  or  No)",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 808,
    "unit": null,
    "population": null,
    "notes": "Furthermore,  we  gen-\nerated  a  final  incidence  cohort  of  240,808  patients  with  \ndefinite  lung  metastases  status  at  diagnosis  (Yes  or  No)",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 4213,
    "unit": null,
    "population": null,
    "notes": "Within  the  case  listing,  4213  patients  had  lung  metastases  \nwhen  first  diagnosed  as  having  breast  cancer",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "0  month",
    "value": 3772,
    "unit": "month",
    "population": null,
    "notes": "Subsequently,  \nwe  excluded  patients  who  were  diagnosed  by  autopsy  or  \ndeath  certificate  and  whose  survival  record  presented  with  \n0  month,  leaving  a  survival  cohort  of  3772  p",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "We  calculated  95%  confidence  intervals  (95%  CI)  for  \nall  estimates  (ORs  and  HRs)  across  strata",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "We  calculated  95%  confidence  intervals  (95%  CI)  for  \nall  estimates  (ORs  and  HRs)  across  strata",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 21,
    "unit": null,
    "population": null,
    "notes": "Statistical  analysis  was  performed  \nusing  SPSS  statistical  software  (SPSS  IBM  STATISTICS  21,  \nIBM  Corporation,  Armonk,  USA),  apart  from  the  Kaplan–\nMeier  method  by  SAS  9.4  soft",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2010",
    "value": 240,
    "unit": "%",
    "population": null,
    "notes": "The  incidence  proportion  of  HR\n+\n/HER2\n−\n,  HR\n+\n/HER2\n+\n, \nHR\n−\n/HER2\n+\n,    triple-    negative,    and    unknown    subtypes    \namong  240,808  patients  diagnosed  with  malignant  breast  \n",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2010",
    "value": 808,
    "unit": "%",
    "population": null,
    "notes": "The  incidence  proportion  of  HR\n+\n/HER2\n−\n,  HR\n+\n/HER2\n+\n, \nHR\n−\n/HER2\n+\n,    triple-    negative,    and    unknown    subtypes    \namong  240,808  patients  diagnosed  with  malignant  breast  \n",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2010",
    "value": 2010,
    "unit": "%",
    "population": null,
    "notes": "The  incidence  proportion  of  HR\n+\n/HER2\n−\n,  HR\n+\n/HER2\n+\n, \nHR\n−\n/HER2\n+\n,    triple-    negative,    and    unknown    subtypes    \namong  240,808  patients  diagnosed  with  malignant  breast  \n",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2010",
    "value": 2013,
    "unit": "%",
    "population": null,
    "notes": "The  incidence  proportion  of  HR\n+\n/HER2\n−\n,  HR\n+\n/HER2\n+\n, \nHR\n−\n/HER2\n+\n,    triple-    negative,    and    unknown    subtypes    \namong  240,808  patients  diagnosed  with  malignant  breast  \n",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2010",
    "value": 67,
    "unit": "%",
    "population": null,
    "notes": "The  incidence  proportion  of  HR\n+\n/HER2\n−\n,  HR\n+\n/HER2\n+\n, \nHR\n−\n/HER2\n+\n,    triple-    negative,    and    unknown    subtypes    \namong  240,808  patients  diagnosed  with  malignant  breast  \n",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 10,
    "unit": "%",
    "population": null,
    "notes": "Among the 11,568 patients \ndiagnosed with metastatic diseases at distant sites analyzed \nfor  incidence,  51.8%,  13.2%,  6.9%,  11.1%,  and  17.0%  \nhad    HR\n+\n/HER2\n−\n,    HR\n+\n/HER2\n+\n,    HR\n−\n/H",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 11,
    "unit": "%",
    "population": null,
    "notes": "Among the 11,568 patients \ndiagnosed with metastatic diseases at distant sites analyzed \nfor  incidence,  51.8%,  13.2%,  6.9%,  11.1%,  and  17.0%  \nhad    HR\n+\n/HER2\n−\n,    HR\n+\n/HER2\n+\n,    HR\n−\n/H",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 568,
    "unit": "%",
    "population": null,
    "notes": "Among the 11,568 patients \ndiagnosed with metastatic diseases at distant sites analyzed \nfor  incidence,  51.8%,  13.2%,  6.9%,  11.1%,  and  17.0%  \nhad    HR\n+\n/HER2\n−\n,    HR\n+\n/HER2\n+\n,    HR\n−\n/H",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 51,
    "unit": "%",
    "population": null,
    "notes": "Among the 11,568 patients \ndiagnosed with metastatic diseases at distant sites analyzed \nfor  incidence,  51.8%,  13.2%,  6.9%,  11.1%,  and  17.0%  \nhad    HR\n+\n/HER2\n−\n,    HR\n+\n/HER2\n+\n,    HR\n−\n/H",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 13,
    "unit": "%",
    "population": null,
    "notes": "Among the 11,568 patients \ndiagnosed with metastatic diseases at distant sites analyzed \nfor  incidence,  51.8%,  13.2%,  6.9%,  11.1%,  and  17.0%  \nhad    HR\n+\n/HER2\n−\n,    HR\n+\n/HER2\n+\n,    HR\n−\n/H",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 11,
    "unit": "%",
    "population": null,
    "notes": "Among the 11,568 patients \ndiagnosed with metastatic diseases at distant sites analyzed \nfor  incidence,  51.8%,  13.2%,  6.9%,  11.1%,  and  17.0%  \nhad    HR\n+\n/HER2\n−\n,    HR\n+\n/HER2\n+\n,    HR\n−\n/H",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 17,
    "unit": "%",
    "population": null,
    "notes": "Among the 11,568 patients \ndiagnosed with metastatic diseases at distant sites analyzed \nfor  incidence,  51.8%,  13.2%,  6.9%,  11.1%,  and  17.0%  \nhad    HR\n+\n/HER2\n−\n,    HR\n+\n/HER2\n+\n,    HR\n−\n/H",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "grade  I;  OR,  8.41;  95%  CI:  5.92–11.94;  P  <  0.001)  were  \nmore  likely  to  be  diagnosed  as  lung  metastases  at  initial  \ndiagnosis",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "uninsured;  \nOR,  0.64;  95%  CI:  0.54–0.77;  P <  0.001)  status  seemed  to  \nbe  associated  with  lower  odds  of  lung  metastases  at  diag-\nnosis",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "median   survival",
    "timePeriod": "21  month",
    "value": 21,
    "unit": "months",
    "population": null,
    "notes": "The   median   survival   among   the   \ncohort  was  21  months,  of  which  the  median  survival  of  \npatients  with  metastases  confined  to  lungs  was  25  months",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "median  survival",
    "timePeriod": "31  month",
    "value": 25,
    "unit": "months",
    "population": null,
    "notes": "Patients  with  HR\n+\n/HER2\n+\n  had  the  longest  median  survival  \n(31  months)  and  triple-  negative  the  shortest  (11  months)",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "median  survival",
    "timePeriod": "31  month",
    "value": 31,
    "unit": "months",
    "population": null,
    "notes": "Patients  with  HR\n+\n/HER2\n+\n  had  the  longest  median  survival  \n(31  months)  and  triple-  negative  the  shortest  (11  months)",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "overall  survival",
    "timePeriod": null,
    "value": 11,
    "unit": "months",
    "population": null,
    "notes": "Figure  shows  the  overall  survival  (Fig",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 3772,
    "unit": "count",
    "population": null,
    "notes": "Survival\nIn  the  survival  cohort  of  3772  patients  diagnosed  as  lung  \nmetastases,  the  median  survival  stratified  by  subtypes  is  \nprovided   in   Table   1",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 8.41,
    "unit": "%",
    "population": null,
    "notes": "grade  I;  OR,  8.41;  95%  CI:  5.92–11.94;  P  <  0.001)  were  \nmore  likely  to  be  diagnosed  as  lung  metastases  at  initial  \ndiagnosis",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 5.92,
    "unit": "%",
    "population": null,
    "notes": "grade  I;  OR,  8.41;  95%  CI:  5.92–11.94;  P  <  0.001)  were  \nmore  likely  to  be  diagnosed  as  lung  metastases  at  initial  \ndiagnosis",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 11.94,
    "unit": "%",
    "population": null,
    "notes": "grade  I;  OR,  8.41;  95%  CI:  5.92–11.94;  P  <  0.001)  were  \nmore  likely  to  be  diagnosed  as  lung  metastases  at  initial  \ndiagnosis",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.001,
    "unit": "%",
    "population": null,
    "notes": "grade  I;  OR,  8.41;  95%  CI:  5.92–11.94;  P  <  0.001)  were  \nmore  likely  to  be  diagnosed  as  lung  metastases  at  initial  \ndiagnosis",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.64,
    "unit": "%",
    "population": null,
    "notes": "uninsured;  \nOR,  0.64;  95%  CI:  0.54–0.77;  P <  0.001)  status  seemed  to  \nbe  associated  with  lower  odds  of  lung  metastases  at  diag-\nnosis",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.54,
    "unit": "%",
    "population": null,
    "notes": "uninsured;  \nOR,  0.64;  95%  CI:  0.54–0.77;  P <  0.001)  status  seemed  to  \nbe  associated  with  lower  odds  of  lung  metastases  at  diag-\nnosis",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.77,
    "unit": "%",
    "population": null,
    "notes": "uninsured;  \nOR,  0.64;  95%  CI:  0.54–0.77;  P <  0.001)  status  seemed  to  \nbe  associated  with  lower  odds  of  lung  metastases  at  diag-\nnosis",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.001,
    "unit": "%",
    "population": null,
    "notes": "uninsured;  \nOR,  0.64;  95%  CI:  0.54–0.77;  P <  0.001)  status  seemed  to  \nbe  associated  with  lower  odds  of  lung  metastases  at  diag-\nnosis",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 41,
    "unit": "%",
    "population": null,
    "notes": "grade  I;  OR,  8.41;  95%  CI:  5.92–11.94;  P  <  0.001)  were  \nmore  likely  to  be  diagnosed  as  lung  metastases  at  initial  \ndiagnosis",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "grade  I;  OR,  8.41;  95%  CI:  5.92–11.94;  P  <  0.001)  were  \nmore  likely  to  be  diagnosed  as  lung  metastases  at  initial  \ndiagnosis",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 92,
    "unit": "%",
    "population": null,
    "notes": "grade  I;  OR,  8.41;  95%  CI:  5.92–11.94;  P  <  0.001)  were  \nmore  likely  to  be  diagnosed  as  lung  metastases  at  initial  \ndiagnosis",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 11,
    "unit": "%",
    "population": null,
    "notes": "grade  I;  OR,  8.41;  95%  CI:  5.92–11.94;  P  <  0.001)  were  \nmore  likely  to  be  diagnosed  as  lung  metastases  at  initial  \ndiagnosis",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 94,
    "unit": "%",
    "population": null,
    "notes": "grade  I;  OR,  8.41;  95%  CI:  5.92–11.94;  P  <  0.001)  were  \nmore  likely  to  be  diagnosed  as  lung  metastases  at  initial  \ndiagnosis",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1,
    "unit": "%",
    "population": null,
    "notes": "grade  I;  OR,  8.41;  95%  CI:  5.92–11.94;  P  <  0.001)  were  \nmore  likely  to  be  diagnosed  as  lung  metastases  at  initial  \ndiagnosis",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 64,
    "unit": "%",
    "population": null,
    "notes": "uninsured;  \nOR,  0.64;  95%  CI:  0.54–0.77;  P <  0.001)  status  seemed  to  \nbe  associated  with  lower  odds  of  lung  metastases  at  diag-\nnosis",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "uninsured;  \nOR,  0.64;  95%  CI:  0.54–0.77;  P <  0.001)  status  seemed  to  \nbe  associated  with  lower  odds  of  lung  metastases  at  diag-\nnosis",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 54,
    "unit": "%",
    "population": null,
    "notes": "uninsured;  \nOR,  0.64;  95%  CI:  0.54–0.77;  P <  0.001)  status  seemed  to  \nbe  associated  with  lower  odds  of  lung  metastases  at  diag-\nnosis",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 77,
    "unit": "%",
    "population": null,
    "notes": "uninsured;  \nOR,  0.64;  95%  CI:  0.54–0.77;  P <  0.001)  status  seemed  to  \nbe  associated  with  lower  odds  of  lung  metastases  at  diag-\nnosis",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1,
    "unit": "%",
    "population": null,
    "notes": "uninsured;  \nOR,  0.64;  95%  CI:  0.54–0.77;  P <  0.001)  status  seemed  to  \nbe  associated  with  lower  odds  of  lung  metastases  at  diag-\nnosis",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 3772,
    "unit": null,
    "population": null,
    "notes": "Survival\nIn  the  survival  cohort  of  3772  patients  diagnosed  as  lung  \nmetastases,  the  median  survival  stratified  by  subtypes  is  \nprovided   in   Table   1",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "median   survival",
    "timePeriod": "21  month",
    "value": 21,
    "unit": "months",
    "population": null,
    "notes": "The   median   survival   among   the   \ncohort  was  21  months,  of  which  the  median  survival  of  \npatients  with  metastases  confined  to  lungs  was  25  months",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "median  survival",
    "timePeriod": "31  month",
    "value": 25,
    "unit": "months",
    "population": null,
    "notes": "Patients  with  HR\n+\n/HER2\n+\n  had  the  longest  median  survival  \n(31  months)  and  triple-  negative  the  shortest  (11  months)",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "median  survival",
    "timePeriod": "31  month",
    "value": 31,
    "unit": "months",
    "population": null,
    "notes": "Patients  with  HR\n+\n/HER2\n+\n  had  the  longest  median  survival  \n(31  months)  and  triple-  negative  the  shortest  (11  months)",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "overall  survival",
    "timePeriod": null,
    "value": 11,
    "unit": null,
    "population": null,
    "notes": "Figure  shows  the  overall  survival  (Fig",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "grade  I;  hazard  \nratio,  2.12;  95%  CI:  1.38–3.25;  P  =  0.001)  were  signifi-\ncantly   associated   with   a   increased   all-   cause   mortality",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "HR\n+\n/HER2\n−\n    subtype;    OR,    0.82;    95%    CI:    0.70–0.94;    \nP =  0.001)  were  significantly  associated  with  decreased  \nall-  cause  mortality",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 2.12,
    "unit": "%",
    "population": null,
    "notes": "grade  I;  hazard  \nratio,  2.12;  95%  CI:  1.38–3.25;  P  =  0.001)  were  signifi-\ncantly   associated   with   a   increased   all-   cause   mortality",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1.38,
    "unit": "%",
    "population": null,
    "notes": "grade  I;  hazard  \nratio,  2.12;  95%  CI:  1.38–3.25;  P  =  0.001)  were  signifi-\ncantly   associated   with   a   increased   all-   cause   mortality",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 3.25,
    "unit": "%",
    "population": null,
    "notes": "grade  I;  hazard  \nratio,  2.12;  95%  CI:  1.38–3.25;  P  =  0.001)  were  signifi-\ncantly   associated   with   a   increased   all-   cause   mortality",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.001,
    "unit": "%",
    "population": null,
    "notes": "grade  I;  hazard  \nratio,  2.12;  95%  CI:  1.38–3.25;  P  =  0.001)  were  signifi-\ncantly   associated   with   a   increased   all-   cause   mortality",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.82,
    "unit": "%",
    "population": null,
    "notes": "HR\n+\n/HER2\n−\n    subtype;    OR,    0.82;    95%    CI:    0.70–0.94;    \nP =  0.001)  were  significantly  associated  with  decreased  \nall-  cause  mortality",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.7,
    "unit": "%",
    "population": null,
    "notes": "HR\n+\n/HER2\n−\n    subtype;    OR,    0.82;    95%    CI:    0.70–0.94;    \nP =  0.001)  were  significantly  associated  with  decreased  \nall-  cause  mortality",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.94,
    "unit": "%",
    "population": null,
    "notes": "HR\n+\n/HER2\n−\n    subtype;    OR,    0.82;    95%    CI:    0.70–0.94;    \nP =  0.001)  were  significantly  associated  with  decreased  \nall-  cause  mortality",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.001,
    "unit": "%",
    "population": null,
    "notes": "HR\n+\n/HER2\n−\n    subtype;    OR,    0.82;    95%    CI:    0.70–0.94;    \nP =  0.001)  were  significantly  associated  with  decreased  \nall-  cause  mortality",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 952599319071.231,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 828,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 10,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 59,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 45515295122.333,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 531,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 98407983303.441,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 421,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 7,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 46,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 63812846332.549,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 311,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 4,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 20,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 92319648314.242,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 312,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 3,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 34,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 56842131.836,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 421,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 7,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 48,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 12,
    "unit": "%",
    "population": null,
    "notes": "grade  I;  hazard  \nratio,  2.12;  95%  CI:  1.38–3.25;  P  =  0.001)  were  signifi-\ncantly   associated   with   a   increased   all-   cause   mortality",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "grade  I;  hazard  \nratio,  2.12;  95%  CI:  1.38–3.25;  P  =  0.001)  were  signifi-\ncantly   associated   with   a   increased   all-   cause   mortality",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 38,
    "unit": "%",
    "population": null,
    "notes": "grade  I;  hazard  \nratio,  2.12;  95%  CI:  1.38–3.25;  P  =  0.001)  were  signifi-\ncantly   associated   with   a   increased   all-   cause   mortality",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 25,
    "unit": "%",
    "population": null,
    "notes": "grade  I;  hazard  \nratio,  2.12;  95%  CI:  1.38–3.25;  P  =  0.001)  were  signifi-\ncantly   associated   with   a   increased   all-   cause   mortality",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1,
    "unit": "%",
    "population": null,
    "notes": "grade  I;  hazard  \nratio,  2.12;  95%  CI:  1.38–3.25;  P  =  0.001)  were  signifi-\ncantly   associated   with   a   increased   all-   cause   mortality",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 82,
    "unit": "%",
    "population": null,
    "notes": "HR\n+\n/HER2\n−\n    subtype;    OR,    0.82;    95%    CI:    0.70–0.94;    \nP =  0.001)  were  significantly  associated  with  decreased  \nall-  cause  mortality",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "HR\n+\n/HER2\n−\n    subtype;    OR,    0.82;    95%    CI:    0.70–0.94;    \nP =  0.001)  were  significantly  associated  with  decreased  \nall-  cause  mortality",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 70,
    "unit": "%",
    "population": null,
    "notes": "HR\n+\n/HER2\n−\n    subtype;    OR,    0.82;    95%    CI:    0.70–0.94;    \nP =  0.001)  were  significantly  associated  with  decreased  \nall-  cause  mortality",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 94,
    "unit": "%",
    "population": null,
    "notes": "HR\n+\n/HER2\n−\n    subtype;    OR,    0.82;    95%    CI:    0.70–0.94;    \nP =  0.001)  were  significantly  associated  with  decreased  \nall-  cause  mortality",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1,
    "unit": "%",
    "population": null,
    "notes": "HR\n+\n/HER2\n−\n    subtype;    OR,    0.82;    95%    CI:    0.70–0.94;    \nP =  0.001)  were  significantly  associated  with  decreased  \nall-  cause  mortality",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 162,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 952599319071,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 231,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 828,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 10,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 59,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 22,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 45515295122,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 333,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 531,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 15,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 98407983303,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 441,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 421,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 46,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 63812846332,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 549,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 311,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 20,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 92319648314,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 242,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 312,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 34,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 80811,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 56842131,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 836,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 421,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1907",
    "value": 48,
    "unit": "months",
    "population": null,
    "notes": "Incidence proportion of lung metastasis, \n%\nMedian survival of patients with lung \nmetastases (IQR), months\nWith \nbreast \ncancer\nWith \nmetastatic \ndiseases\nWith lung \nmetastases\nAmong entire \ncohort\nA",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1.8,
    "unit": "%",
    "population": null,
    "notes": "In  this  study,  we  identified  4213  cases  \nof  lung  metastases  from  patients  with  newly  diagnosed  \nbreast  cancer,  accounting  for  1.8%  of  all  patients  with  \nbreast   cancer,   36.4",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 36.4,
    "unit": "%",
    "population": null,
    "notes": "In  this  study,  we  identified  4213  cases  \nof  lung  metastases  from  patients  with  newly  diagnosed  \nbreast  cancer,  accounting  for  1.8%  of  all  patients  with  \nbreast   cancer,   36.4",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 4213,
    "unit": "count",
    "population": null,
    "notes": "In  this  study,  we  identified  4213  cases  \nof  lung  metastases  from  patients  with  newly  diagnosed  \nbreast  cancer,  accounting  for  1.8%  of  all  patients  with  \nbreast   cancer,   36.4",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1.8,
    "unit": "%",
    "population": null,
    "notes": "In  this  study,  we  identified  4213  cases  \nof  lung  metastases  from  patients  with  newly  diagnosed  \nbreast  cancer,  accounting  for  1.8%  of  all  patients  with  \nbreast   cancer,   36.4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 36.4,
    "unit": "%",
    "population": null,
    "notes": "In  this  study,  we  identified  4213  cases  \nof  lung  metastases  from  patients  with  newly  diagnosed  \nbreast  cancer,  accounting  for  1.8%  of  all  patients  with  \nbreast   cancer,   36.4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 4555121.27,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.14,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.42,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.0071,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.9,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.15,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.791,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 98403301.62,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.41,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.85,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.0011,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.17,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.6,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.001,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 6386331.42,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.27,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.57,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.0011,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.6,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 2.07,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.001,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 9238311.63,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.48,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.81,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.0011,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.24,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.56,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.001,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 8414231.18,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.39,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.0551,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.13,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.63,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.001,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 71319501.68,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.42,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.98,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.0011,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.54,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 2.22,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.001,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 7846532.02,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.69,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 2.42,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.0012,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.73,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 2.62,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.001,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.48,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 2.59,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.0011,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.29,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 2.65,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.001,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 6127921.4,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.28,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.53,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.0011,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.07,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.33,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.001,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 4792830.98,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.86,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.12,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.7391,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.12,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.54,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.001,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1372311.5,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.02,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 2.2,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.0381,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.97,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 2.57,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.066,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.31,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.91,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.0211,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.57,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 2.1,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.791,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 66515990.65,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.6,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.7,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.001,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.78,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.92,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.001,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 9632530.77,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.66,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.89,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.0011,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.85,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.2,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.945,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 36238350.42,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.36,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.49,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.001,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.54,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.77,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.001,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.36,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.49,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.001,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.61,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.12,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.224,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 2210683235.03,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 31.65,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 38.77,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.0011,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.18,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.44,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.001,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 3228148102.98,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 76.9,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 137.92,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.0013,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 2.84,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 4.98,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.001,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 32.84,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 47.27,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.0013,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 2.96,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 4.58,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.001,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 96911922.93,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 2.5,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 3.44,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.0011,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.16,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.69,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.001,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 23616804.77,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 4.06,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 5.62,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.0011,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.54,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 2.24,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.001,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 41101488.41,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 5.92,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 11.94,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.0012,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.62,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 4.01,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.001,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 949111610.16,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 8.57,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 12.04,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.0011,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.17,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1.73,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0.001,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 4213,
    "unit": "%",
    "population": null,
    "notes": "In  this  study,  we  identified  4213  cases  \nof  lung  metastases  from  patients  with  newly  diagnosed  \nbreast  cancer,  accounting  for  1.8%  of  all  patients  with  \nbreast   cancer,   36.4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 36,
    "unit": "%",
    "population": null,
    "notes": "In  this  study,  we  identified  4213  cases  \nof  lung  metastases  from  patients  with  newly  diagnosed  \nbreast  cancer,  accounting  for  1.8%  of  all  patients  with  \nbreast   cancer,   36.4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 240,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 808,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 4213,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 95,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 95,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 162,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 95219071,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 22,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 4555121,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 27,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 14,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 42,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 71,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 2,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 90,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 15,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 791,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 98403301,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 62,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 41,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 85,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 11,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 37,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 17,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 60,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 6386331,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 42,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 27,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 57,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 11,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 82,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 60,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 7,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 9238311,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 63,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 48,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 81,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 11,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 39,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 24,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 56,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 18,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 3911,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 2251871,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 40,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 5995,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 8414231,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 18,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 0,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 39,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 551,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 36,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 13,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 63,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 60,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 79107,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 71319501,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 68,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 42,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 98,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 11,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 85,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 54,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 22,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 8026,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 7846532,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 2,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 69,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 42,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 12,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 13,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 73,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 62,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 93441511,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 96,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 48,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 59,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 11,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 85,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 29,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 65,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 79030921,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 6127921,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 40,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 28,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 53,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 11,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 19,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 7,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 33,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 19,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 4792830,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 98,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 86,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 12,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 7391,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 31,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 12,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 54,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1372311,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 50,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 2,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 20,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 381,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 58,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 97,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 57,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 66,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 53,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 31,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 91,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 211,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 9,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 57,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 10,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 791,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 18023611,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 66515990,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 65,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 60,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 70,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 10,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 85,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 78,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 92,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 9632530,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 77,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 66,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 89,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 11,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 85,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 20,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 945,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 36238350,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 42,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 36,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 49,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 10,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 64,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 54,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 77,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 47,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 36,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 49,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 10,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 83,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 61,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 12,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 224,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1237,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 89929741,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 2210683235,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 3,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 31,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 65,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 38,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 77,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 11,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 30,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 18,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 44,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 3228148102,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 98,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 76,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 90,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 137,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 92,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 13,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 76,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 84,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 98,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 40,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 32,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 84,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 47,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 27,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 13,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 68,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 96,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 58,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 151,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 5531771,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 298,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 96911922,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 93,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 50,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 44,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 11,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 40,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 16,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 69,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 373,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 23616804,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 77,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 6,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 62,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 11,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 86,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 54,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 24,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 41101488,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 41,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 92,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 11,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 94,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 12,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 55,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 62,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 949111610,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 16,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 57,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 12,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 4,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 11,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 42,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 17,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 73,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 1,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 95,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1907",
    "value": 95,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAmong entire cohort\nAmong subset with metastatic \ndiseases\nPatients \n(n = 240,808)\nWith lung metastases \n(n = 4213)OR (95% CI)P valueOR (95% CI)P value\nSubtype\nHR\n+\n/HER2\n−\n162,9",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1986",
    "value": 9.1,
    "unit": "%",
    "population": null,
    "notes": "[1]  reported  that  the  cumula-\ntive  rates  of  lung  metastases  in  HR\n+\n/HER2\n−\n,  HR\n+\n/HER2\n+\n, \nHR\n−\n/HER2\n+,\n   and   triple-   negative   subtypes   were   9.1%,   \n17.7%, 24.1%, 15.7%, res",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1986",
    "value": 17.7,
    "unit": "%",
    "population": null,
    "notes": "[1]  reported  that  the  cumula-\ntive  rates  of  lung  metastases  in  HR\n+\n/HER2\n−\n,  HR\n+\n/HER2\n+\n, \nHR\n−\n/HER2\n+,\n   and   triple-   negative   subtypes   were   9.1%,   \n17.7%, 24.1%, 15.7%, res",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1986",
    "value": 24.1,
    "unit": "%",
    "population": null,
    "notes": "[1]  reported  that  the  cumula-\ntive  rates  of  lung  metastases  in  HR\n+\n/HER2\n−\n,  HR\n+\n/HER2\n+\n, \nHR\n−\n/HER2\n+,\n   and   triple-   negative   subtypes   were   9.1%,   \n17.7%, 24.1%, 15.7%, res",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1986",
    "value": 15.7,
    "unit": "%",
    "population": null,
    "notes": "[1]  reported  that  the  cumula-\ntive  rates  of  lung  metastases  in  HR\n+\n/HER2\n−\n,  HR\n+\n/HER2\n+\n, \nHR\n−\n/HER2\n+,\n   and   triple-   negative   subtypes   were   9.1%,   \n17.7%, 24.1%, 15.7%, res",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "overall  survival",
    "timePeriod": "6  month",
    "value": 38,
    "unit": "%",
    "population": null,
    "notes": "However, \npatients  with  metastases  confined  to  lungs  undergoing  \npulmonary    metastasectomy    had    a    median    OS    of    \n35–75.6  months  and  a  5-  year  overall  survival  rate  of",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 54,
    "unit": "%",
    "population": null,
    "notes": "We  did  not  have  information  \non  lung  surgery  and  systemic  therapy  for  lung  metastases  \nin  this  cohort,  so  we  were  unable  to  analyze  the  differ-\nences  in  survival  due  to  tr",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "median  survival",
    "timePeriod": "21  month",
    "value": 21,
    "unit": "months",
    "population": null,
    "notes": "In  the  present  study,  the  median  survival  of  patients  \nwith  lung  metastases  was  21  months,while  those  who  \nwith  metastases  confined  to  lungs  had  a  median  survival  \nof   25   ",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "median  survival",
    "timePeriod": "25   month",
    "value": 25,
    "unit": "months",
    "population": null,
    "notes": "months,while  those  who  \nwith  metastases  confined  to  lungs  had  a  median  survival  \nof   25   months.   In   a   retrospective   analysis   of   M.   D.   \nAnderson Cancer Center, the median ",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "5 month",
    "value": 22.5,
    "unit": "months",
    "population": null,
    "notes": "Anderson Cancer Center, the median OS was 22.5 months \nfor  breast  cancer  patients  with  metastases  confined  to  \nlungs treated with systemic chemotherapy [15]",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "overall  survival",
    "timePeriod": "6  month",
    "value": 75.6,
    "unit": "months",
    "population": null,
    "notes": "However, \npatients  with  metastases  confined  to  lungs  undergoing  \npulmonary    metastasectomy    had    a    median    OS    of    \n35–75.6  months  and  a  5-  year  overall  survival  rate  of",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1986",
    "value": 3726,
    "unit": "count",
    "population": null,
    "notes": "[1]  reported  that  the  cumula-\ntive  rates  of  lung  metastases  in  HR\n+\n/HER2\n−\n,  HR\n+\n/HER2\n+\n, \nHR\n−\n/HER2\n+,\n   and   triple-   negative   subtypes   were   9.1%,   \n17.7%, 24.1%, 15.7%, res",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1986",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "[1]  reported  that  the  cumula-\ntive  rates  of  lung  metastases  in  HR\n+\n/HER2\n−\n,  HR\n+\n/HER2\n+\n, \nHR\n−\n/HER2\n+,\n   and   triple-   negative   subtypes   were   9.1%,   \n17.7%, 24.1%, 15.7%, res",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1986",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "[1]  reported  that  the  cumula-\ntive  rates  of  lung  metastases  in  HR\n+\n/HER2\n−\n,  HR\n+\n/HER2\n+\n, \nHR\n−\n/HER2\n+,\n   and   triple-   negative   subtypes   were   9.1%,   \n17.7%, 24.1%, 15.7%, res",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1986",
    "value": 9.1,
    "unit": "%",
    "population": null,
    "notes": "[1]  reported  that  the  cumula-\ntive  rates  of  lung  metastases  in  HR\n+\n/HER2\n−\n,  HR\n+\n/HER2\n+\n, \nHR\n−\n/HER2\n+,\n   and   triple-   negative   subtypes   were   9.1%,   \n17.7%, 24.1%, 15.7%, res",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1986",
    "value": 17.7,
    "unit": "%",
    "population": null,
    "notes": "[1]  reported  that  the  cumula-\ntive  rates  of  lung  metastases  in  HR\n+\n/HER2\n−\n,  HR\n+\n/HER2\n+\n, \nHR\n−\n/HER2\n+,\n   and   triple-   negative   subtypes   were   9.1%,   \n17.7%, 24.1%, 15.7%, res",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1986",
    "value": 24.1,
    "unit": "%",
    "population": null,
    "notes": "[1]  reported  that  the  cumula-\ntive  rates  of  lung  metastases  in  HR\n+\n/HER2\n−\n,  HR\n+\n/HER2\n+\n, \nHR\n−\n/HER2\n+,\n   and   triple-   negative   subtypes   were   9.1%,   \n17.7%, 24.1%, 15.7%, res",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1986",
    "value": 15.7,
    "unit": "%",
    "population": null,
    "notes": "[1]  reported  that  the  cumula-\ntive  rates  of  lung  metastases  in  HR\n+\n/HER2\n−\n,  HR\n+\n/HER2\n+\n, \nHR\n−\n/HER2\n+,\n   and   triple-   negative   subtypes   were   9.1%,   \n17.7%, 24.1%, 15.7%, res",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "5 month",
    "value": 22.5,
    "unit": "months",
    "population": null,
    "notes": "Anderson Cancer Center, the median OS was 22.5 months \nfor  breast  cancer  patients  with  metastases  confined  to  \nlungs treated with systemic chemotherapy [15]",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "overall  survival",
    "timePeriod": "6  month",
    "value": 75.6,
    "unit": "months",
    "population": null,
    "notes": "However, \npatients  with  metastases  confined  to  lungs  undergoing  \npulmonary    metastasectomy    had    a    median    OS    of    \n35–75.6  months  and  a  5-  year  overall  survival  rate  of",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1986",
    "value": 17,
    "unit": "%",
    "population": null,
    "notes": "[1]  reported  that  the  cumula-\ntive  rates  of  lung  metastases  in  HR\n+\n/HER2\n−\n,  HR\n+\n/HER2\n+\n, \nHR\n−\n/HER2\n+,\n   and   triple-   negative   subtypes   were   9.1%,   \n17.7%, 24.1%, 15.7%, res",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1986",
    "value": 24,
    "unit": "%",
    "population": null,
    "notes": "[1]  reported  that  the  cumula-\ntive  rates  of  lung  metastases  in  HR\n+\n/HER2\n−\n,  HR\n+\n/HER2\n+\n, \nHR\n−\n/HER2\n+,\n   and   triple-   negative   subtypes   were   9.1%,   \n17.7%, 24.1%, 15.7%, res",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1986",
    "value": 15,
    "unit": "%",
    "population": null,
    "notes": "[1]  reported  that  the  cumula-\ntive  rates  of  lung  metastases  in  HR\n+\n/HER2\n−\n,  HR\n+\n/HER2\n+\n, \nHR\n−\n/HER2\n+,\n   and   triple-   negative   subtypes   were   9.1%,   \n17.7%, 24.1%, 15.7%, res",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1986",
    "value": 3726,
    "unit": "%",
    "population": null,
    "notes": "[1]  reported  that  the  cumula-\ntive  rates  of  lung  metastases  in  HR\n+\n/HER2\n−\n,  HR\n+\n/HER2\n+\n, \nHR\n−\n/HER2\n+,\n   and   triple-   negative   subtypes   were   9.1%,   \n17.7%, 24.1%, 15.7%, res",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1986",
    "value": 1986,
    "unit": "%",
    "population": null,
    "notes": "[1]  reported  that  the  cumula-\ntive  rates  of  lung  metastases  in  HR\n+\n/HER2\n−\n,  HR\n+\n/HER2\n+\n, \nHR\n−\n/HER2\n+,\n   and   triple-   negative   subtypes   were   9.1%,   \n17.7%, 24.1%, 15.7%, res",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "1986",
    "value": 1992,
    "unit": "%",
    "population": null,
    "notes": "[1]  reported  that  the  cumula-\ntive  rates  of  lung  metastases  in  HR\n+\n/HER2\n−\n,  HR\n+\n/HER2\n+\n, \nHR\n−\n/HER2\n+,\n   and   triple-   negative   subtypes   were   9.1%,   \n17.7%, 24.1%, 15.7%, res",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "median  survival",
    "timePeriod": "21  month",
    "value": 21,
    "unit": "months",
    "population": null,
    "notes": "In  the  present  study,  the  median  survival  of  patients  \nwith  lung  metastases  was  21  months,while  those  who  \nwith  metastases  confined  to  lungs  had  a  median  survival  \nof   25   ",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "median  survival",
    "timePeriod": "25   month",
    "value": 25,
    "unit": "months",
    "population": null,
    "notes": "months,while  those  who  \nwith  metastases  confined  to  lungs  had  a  median  survival  \nof   25   months.   In   a   retrospective   analysis   of   M.   D.   \nAnderson Cancer Center, the median",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "5 month",
    "value": 22,
    "unit": "months",
    "population": null,
    "notes": "Anderson Cancer Center, the median OS was 22.5 months \nfor  breast  cancer  patients  with  metastases  confined  to  \nlungs treated with systemic chemotherapy [15]",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "overall  survival",
    "timePeriod": "6  month",
    "value": 15,
    "unit": "months",
    "population": null,
    "notes": "However, \npatients  with  metastases  confined  to  lungs  undergoing  \npulmonary    metastasectomy    had    a    median    OS    of    \n35–75.6  months  and  a  5-  year  overall  survival  rate  of",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "overall  survival",
    "timePeriod": "6  month",
    "value": 35,
    "unit": "months",
    "population": null,
    "notes": "However, \npatients  with  metastases  confined  to  lungs  undergoing  \npulmonary    metastasectomy    had    a    median    OS    of    \n35–75.6  months  and  a  5-  year  overall  survival  rate  of",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "overall  survival",
    "timePeriod": "6  month",
    "value": 75,
    "unit": "months",
    "population": null,
    "notes": "However, \npatients  with  metastases  confined  to  lungs  undergoing  \npulmonary    metastasectomy    had    a    median    OS    of    \n35–75.6  months  and  a  5-  year  overall  survival  rate  of",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "overall  survival",
    "timePeriod": "6  month",
    "value": 38,
    "unit": "months",
    "population": null,
    "notes": "However, \npatients  with  metastases  confined  to  lungs  undergoing  \npulmonary    metastasectomy    had    a    median    OS    of    \n35–75.6  months  and  a  5-  year  overall  survival  rate  of",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 54,
    "unit": null,
    "population": null,
    "notes": "We  did  not  have  information  \non  lung  surgery  and  systemic  therapy  for  lung  metastases  \nin  this  cohort,  so  we  were  unable  to  analyze  the  differ-\nences  in  survival  due  to  tr",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 16,
    "unit": null,
    "population": null,
    "notes": "We  did  not  have  information  \non  lung  surgery  and  systemic  therapy  for  lung  metastases  \nin  this  cohort,  so  we  were  unable  to  analyze  the  differ-\nences  in  survival  due  to  tr",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 19,
    "unit": null,
    "population": null,
    "notes": "We  did  not  have  information  \non  lung  surgery  and  systemic  therapy  for  lung  metastases  \nin  this  cohort,  so  we  were  unable  to  analyze  the  differ-\nences  in  survival  due  to  tr",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "white,  OR,  1.38;  95%  CI,  1.25–1.51;  P  <  0.001)  had  \nsignificantly  greater  likelihood  of  lung  metastases  at  the  \ntime  of  diagnosis,  but  this  association  was  not  found  in  \ndi",
    "pageHint": 6,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 3164830.82,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.7,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.94,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.006,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.69,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.94,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.007,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 97603081.3,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.11,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.53,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.0011,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.03,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.44,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.025,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 4675922.45,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 2.18,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 2.76,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.0012,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.96,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 2.52,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.001,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 766001.69,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.5,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.91,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.0011,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.74,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 2.25,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.001,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 52413201.36,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.09,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.7,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.0061,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.12,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.72,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.003,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 85117401.79,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.44,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 2.23,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.0011,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.34,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 2.07,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.001,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 2355343.03,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 2.39,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 3.84,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.0012,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.87,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 3.04,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.001,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.53,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.11,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.165,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.41,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.05,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.079,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 3457111.24,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.12,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.38,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.0011,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.03,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.32,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.015,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 3002510.95,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.8,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.13,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.558,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.71,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.07,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.18,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1361280.98,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.62,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.54,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.931,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.73,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.89,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.51,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.19,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.37,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.183,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.24,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.44,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.24,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 3114730.79,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.72,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.86,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.001,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.73,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.89,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.001,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 6372140.72,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.59,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.87,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.001,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.55,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.85,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.001,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 75134670.85,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.71,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.02,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.081,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.74,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.11,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.36,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.65,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.24,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.504,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.67,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.43,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.9,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1710415021.39,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.26,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.54,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.0011,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.24,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.57,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.001,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 218607082.18,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.94,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 2.46,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.0012,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 2,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 2.64,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.001,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 31931233.01,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 2.42,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 3.76,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.0013,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 2.44,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 4.21,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.001,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.34,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.91,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.0011,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.32,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 2.06,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.001,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 43211131.22,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.96,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.56,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.107,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.67,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.93,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.001,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 73615621.73,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.36,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 2.21,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.0011,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.02,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.47,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.03,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 41083422.12,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.38,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 3.25,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.0012,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 2.07,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 2.73,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.001,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 2068891.56,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.22,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 2,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.0011,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1.48,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 2,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0.001,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1.38,
    "unit": "%",
    "population": null,
    "notes": "white,  OR,  1.38;  95%  CI,  1.25–1.51;  P  <  0.001)  had  \nsignificantly  greater  likelihood  of  lung  metastases  at  the  \ntime  of  diagnosis,  but  this  association  was  not  found  in  \ndi",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1.25,
    "unit": "%",
    "population": null,
    "notes": "white,  OR,  1.38;  95%  CI,  1.25–1.51;  P  <  0.001)  had  \nsignificantly  greater  likelihood  of  lung  metastases  at  the  \ntime  of  diagnosis,  but  this  association  was  not  found  in  \ndi",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1.51,
    "unit": "%",
    "population": null,
    "notes": "white,  OR,  1.38;  95%  CI,  1.25–1.51;  P  <  0.001)  had  \nsignificantly  greater  likelihood  of  lung  metastases  at  the  \ntime  of  diagnosis,  but  this  association  was  not  found  in  \ndi",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.001,
    "unit": "%",
    "population": null,
    "notes": "white,  OR,  1.38;  95%  CI,  1.25–1.51;  P  <  0.001)  had  \nsignificantly  greater  likelihood  of  lung  metastases  at  the  \ntime  of  diagnosis,  but  this  association  was  not  found  in  \ndi",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 18,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 26,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 9,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 53,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 0.001,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 9,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 46,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 17,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 5,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 41,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 0.011,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 5,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 35,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 17,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 4,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 40,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 0.34,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 322,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 8,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 41,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 17,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 6,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 40,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 0.157,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 310,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 3,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 22,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 16,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 4,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 52,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 0.081,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 21,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 31,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 12,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 0.001,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 17,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 22,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 6,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 0.001,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 12,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 17,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 5,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 40,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 0.024,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 334,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 16,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 22,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 6,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 0.002,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 315,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 3,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 9,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 4,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 0.524,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 11,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 17,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 4,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 36,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 0.001,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 10,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 49,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 16,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 4,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 36,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 0.001,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 6,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 40,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 9,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 3,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 17,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 0.025,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 326,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 8,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 45,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 17,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 5,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 36,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 0.096,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 39,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 6,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 34,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 5,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 2,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 12,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 0.1,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 4,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 24,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 7,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 3,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 15,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 0.001,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 5,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 18,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 7,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 2,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 14,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 0.015,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 3,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 15,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 5,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 2,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 10,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 0.082,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 38,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 4,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 14,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 5,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 3,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 11,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 0.071,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 35,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 1,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 9,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 4,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 1,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 12,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 0.384,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 7,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 51,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 12,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 35,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 0.001,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 34,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 8,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 2,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 26,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 0.007,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 2,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 22,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 2,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 17,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 0.073,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 312,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 3,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 29,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 9,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 2,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 28,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 0.278,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 316,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 9,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 48,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 2,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 1,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 7,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 0.013,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 14,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 21,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 6,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 45,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 0.001,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 8,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 49,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 14,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 4,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 33,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 0.001,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 4,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 34,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 9,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 2,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 28,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 0.007,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 320,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 6,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 43,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 15,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 4,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 36,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 0.001,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 310,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 5,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 23,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 7,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 2,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 23,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 0.461,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 13,
    "unit": null,
    "population": null,
    "notes": "Our  findings  were  similar  to  previous  reports  \non  the  effect  of  tumor  subtypes  on  OS  of  patients  with  \nbreast  cancer  [13,  20–22]",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 20,
    "unit": null,
    "population": null,
    "notes": "Our  findings  were  similar  to  previous  reports  \non  the  effect  of  tumor  subtypes  on  OS  of  patients  with  \nbreast  cancer  [13,  20–22]",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 22,
    "unit": null,
    "population": null,
    "notes": "Our  findings  were  similar  to  previous  reports  \non  the  effect  of  tumor  subtypes  on  OS  of  patients  with  \nbreast  cancer  [13,  20–22]",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 23,
    "unit": null,
    "population": null,
    "notes": "Several  studies  showed  that  \ntriple-  negative  breast  cancer  was  associated  with  poor  \nprognosis  [23,  24]",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 24,
    "unit": null,
    "population": null,
    "notes": "Several  studies  showed  that  \ntriple-  negative  breast  cancer  was  associated  with  poor  \nprognosis  [23,  24]",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 238,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 781,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 3772,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 95,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 95,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 162,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 16217891,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 22,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 3164830,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 82,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 70,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 94,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 60,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 81,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 69,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 94,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 7,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 97603081,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 30,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 11,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 53,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 11,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 22,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 3,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 44,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 25,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 4675922,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 45,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 18,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 76,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 12,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 22,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 96,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 52,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 766001,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 69,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 50,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 91,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 11,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 98,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 74,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 25,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 20,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 3911,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1711781,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 40,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 5994,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 52413201,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 36,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 9,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 70,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 61,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 39,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 12,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 72,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 3,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 60,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 79106,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 85117401,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 79,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 44,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 23,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 11,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 67,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 34,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 7,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 8026,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 2355343,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 3,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 39,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 84,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 12,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 39,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 87,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 4,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 77,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 53,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 11,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1650,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 66,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 41,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 5,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 79,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 35227701,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 3457111,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 24,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 12,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 38,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 11,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 17,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 3,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 32,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 15,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 19,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 3002510,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 95,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 80,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 13,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 5580,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 87,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 71,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 7,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 18,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1361280,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 98,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 62,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 54,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 931,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 17,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 73,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 89,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 51,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 51,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 19,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 37,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1830,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 58,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 24,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 44,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 24,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 13120851,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 3114730,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 79,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 72,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 86,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 10,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 81,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 73,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 89,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 6372140,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 72,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 59,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 87,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 10,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 68,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 55,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 85,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 75134670,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 85,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 71,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 2,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 810,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 91,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 74,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 11,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 36,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 90,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 65,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 24,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 5040,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 98,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 67,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 43,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 90,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 229,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 10512141,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1710415021,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 39,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 26,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 54,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 11,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 40,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 24,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 57,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 218607082,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 18,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 94,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 46,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 12,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 30,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 64,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 31931233,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 42,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 76,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 13,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 20,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 44,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 21,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 60,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 34,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 91,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 11,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 65,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 32,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 6,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 151,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 3241661,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 298,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 43211131,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 22,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 96,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 56,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1070,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 79,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 67,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 93,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 373,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 73615621,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 73,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 36,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 21,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 11,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 22,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 2,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 47,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 3,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 41083422,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 12,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 38,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 25,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 12,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 38,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 7,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 73,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 2068891,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 56,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 22,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 11,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 72,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 48,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 0,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 1,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 95,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2085",
    "value": 95,
    "unit": "year",
    "population": null,
    "notes": "Variables\nPatients, NoAll- cause  mortalityBreast cancer- special mortality\nPatients \n(n = 238,781)\nWith lung \nmetastases \n(n = 3772)\nHazard ratio \n(95% CI)P valueHazard ratio (95% CI)P value\nSubtype\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 38,
    "unit": "%",
    "population": null,
    "notes": "white,  OR,  1.38;  95%  CI,  1.25–1.51;  P  <  0.001)  had  \nsignificantly  greater  likelihood  of  lung  metastases  at  the  \ntime  of  diagnosis,  but  this  association  was  not  found  in  \ndi",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "white,  OR,  1.38;  95%  CI,  1.25–1.51;  P  <  0.001)  had  \nsignificantly  greater  likelihood  of  lung  metastases  at  the  \ntime  of  diagnosis,  but  this  association  was  not  found  in  \ndi",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 25,
    "unit": "%",
    "population": null,
    "notes": "white,  OR,  1.38;  95%  CI,  1.25–1.51;  P  <  0.001)  had  \nsignificantly  greater  likelihood  of  lung  metastases  at  the  \ntime  of  diagnosis,  but  this  association  was  not  found  in  \ndi",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 51,
    "unit": "%",
    "population": null,
    "notes": "white,  OR,  1.38;  95%  CI,  1.25–1.51;  P  <  0.001)  had  \nsignificantly  greater  likelihood  of  lung  metastases  at  the  \ntime  of  diagnosis,  but  this  association  was  not  found  in  \ndi",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1,
    "unit": "%",
    "population": null,
    "notes": "white,  OR,  1.38;  95%  CI,  1.25–1.51;  P  <  0.001)  had  \nsignificantly  greater  likelihood  of  lung  metastases  at  the  \ntime  of  diagnosis,  but  this  association  was  not  found  in  \ndi",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 28,
    "unit": null,
    "population": null,
    "notes": "This  result  emphasized  the  \npotentially  significant  impact  of  social  support  on  breast  \ncancer  detection  and  survival",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 29,
    "unit": null,
    "population": null,
    "notes": "This  result  emphasized  the  \npotentially  significant  impact  of  social  support  on  breast  \ncancer  detection  and  survival",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 18,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 26,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 53,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 1,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 46,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 17,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 41,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 11,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 35,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 17,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 40,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 340,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 322,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 41,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 17,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 40,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 157,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 310,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 22,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 16,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 52,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 81,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 21,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 31,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 12,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 1,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 17,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 22,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 1,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 12,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 17,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 40,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 24,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 334,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 16,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 22,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 2,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 315,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 524,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 11,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 17,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 36,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 1,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 10,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 49,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 16,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 36,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 1,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 40,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 17,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 25,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 326,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 45,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 17,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 36,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 96,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 39,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 34,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 12,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 100,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 24,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 15,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 1,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 18,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 14,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 15,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 15,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 10,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 82,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 38,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 14,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 11,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 71,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 35,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 12,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 384,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 51,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 12,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 35,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 1,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 34,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 26,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 7,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 22,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 17,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 73,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 312,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 29,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 28,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 278,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 316,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 48,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 13,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 14,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 21,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 45,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 1,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 49,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 14,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 33,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 1,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 34,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 28,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 7,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 320,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 43,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 15,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 36,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 1,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 310,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 23,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 23,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "Survival",
    "timePeriod": null,
    "value": 461,
    "unit": "months",
    "population": null,
    "notes": "SubtypeType of metastasis\nSurvival, median(IQR), months\nWithout lung metastasisWith lung metastasisLog Rank P value\nHR\n+\n/HER2\n−\nBone36.0 (18.0–NR)26.0 (9.0–53.0)<0.001\nLiver24.0 (9.0–46.0)17.0 (5.0–4",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Prognostic  factors  for  recurrent  \nbreast  cancer  patients  with  an  isolated,  limited  number  \nof  lung  metastases  and  implications  for  pulmonary  \nmetastasectomy",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Breast  cancer  subtype  affects  patterns  of  failure  of  \nbrain  metastases  after  treatment  with  stereotactic  \nradiosurgery",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Breast  cancer  subtypes  \npredispose  the  site  of  distant  metastases",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2015",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": ").\n13.  Soni,  A.,  Z.  Ren,  O.  Hameed,  D.  Chanda,  C.  J.  \nMorgan,  G.  P.  Siegal,  et  al.  2015.  Breast  cancer  subtypes  \npredispose  the  site  of  distant  metastases.  Am.  J.  Clin.  \n",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 2010,
    "unit": null,
    "population": null,
    "notes": "Prognostic  factors  for  recurrent  \nbreast  cancer  patients  with  an  isolated,  limited  number  \nof  lung  metastases  and  implications  for  pulmonary  \nmetastasectomy",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 2012,
    "unit": null,
    "population": null,
    "notes": "Breast  cancer  subtype  affects  patterns  of  failure  of  \nbrain  metastases  after  treatment  with  stereotactic  \nradiosurgery",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 60,
    "unit": null,
    "population": null,
    "notes": "Prognostic  \nsignificance  of  basal-  like  phenotype  and  fascin  \nexpression  in  node-  negative  invasive  breast  carcinomas",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 290,
    "unit": null,
    "population": null,
    "notes": "Prognostic  \nsignificance  of  basal-  like  phenotype  and  fascin  \nexpression  in  node-  negative  invasive  breast  carcinomas",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 294,
    "unit": null,
    "population": null,
    "notes": "Prognostic  \nsignificance  of  basal-  like  phenotype  and  fascin  \nexpression  in  node-  negative  invasive  breast  carcinomas",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 12,
    "unit": null,
    "population": null,
    "notes": "Response  to  neoadjuvant  \ntherapy  and  long-  term  survival  in  patients  with  triple-  \nnegative  breast  cancer",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 1533,
    "unit": null,
    "population": null,
    "notes": "Response  to  neoadjuvant  \ntherapy  and  long-  term  survival  in  patients  with  triple-  \nnegative  breast  cancer",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 1539,
    "unit": null,
    "population": null,
    "notes": "Response  to  neoadjuvant  \ntherapy  and  long-  term  survival  in  patients  with  triple-  \nnegative  breast  cancer",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 10,
    "unit": null,
    "population": null,
    "notes": "Response  to  neoadjuvant  \ntherapy  and  long-  term  survival  in  patients  with  triple-  \nnegative  breast  cancer",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 2015,
    "unit": null,
    "population": null,
    "notes": "Breast  cancer  subtypes  \npredispose  the  site  of  distant  metastases",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": "2015",
    "value": 2015,
    "unit": null,
    "population": null,
    "notes": ").\n13.  Soni,  A.,  Z.  Ren,  O.  Hameed,  D.  Chanda,  C.  J.  \nMorgan,  G.  P.  Siegal,  et  al.  2015.  Breast  cancer  subtypes  \npredispose  the  site  of  distant  metastases.  Am.  J.  Clin.  \n",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1581,
    "unit": "count",
    "population": "patients  with  metastatic",
    "notes": "Results  and  long  \nterm  follow-  up  for  1581  patients  with  metastatic  breast  \ncarcinoma  treated  with  standard  dose  doxorubicin-  \ncontaining  chemotherapy:  a  reference",
    "pageHint": 8,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 467,
    "unit": "count",
    "population": null,
    "notes": "Results  of  lung  \nmetastasectomy  from  breast  cancer:  prognostic  criteria  \non  the  basis  of  467  cases  of  the  International  Registry  of  \nLung  Metastases",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": null,
    "unit": "year",
    "population": "patients  with  metastatic",
    "notes": "Results  and  long  \nterm  follow-  up  for  1581  patients  with  metastatic  breast  \ncarcinoma  treated  with  standard  dose  doxorubicin-  \ncontaining  chemotherapy:  a  reference",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Results  of  lung  \nmetastasectomy  from  breast  cancer:  prognostic  criteria  \non  the  basis  of  467  cases  of  the  International  Registry  of  \nLung  Metastases",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Brain  \nmetastases  in  newly  diagnosed  breast  cancer:  a  \npopulation-  based  study",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Breast  cancer  survival  by  molecular  subtype:  a  \npopulation-  based  analysis  of  cancer  registry  data",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Molecular  subtypes,  histopathological  grade  and  survival  \nin  a  historic  cohort  of  breast  cancer  patients",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Poor  outcome  of  hormone  \nreceptor-  positive  breast  cancer  at  very  young  age  is  due  \nto  tamoxifen  resistance:  nationwide  survival  data  in  \nKorea–a  report  from  the  Korean  Breas",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Koshy,  et  al",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1999,
    "unit": null,
    "population": "patients  with  metastatic",
    "notes": "Results  and  long  \nterm  follow-  up  for  1581  patients  with  metastatic  breast  \ncarcinoma  treated  with  standard  dose  doxorubicin-  \ncontaining  chemotherapy:  a  reference",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 1581,
    "unit": null,
    "population": "patients  with  metastatic",
    "notes": "Results  and  long  \nterm  follow-  up  for  1581  patients  with  metastatic  breast  \ncarcinoma  treated  with  standard  dose  doxorubicin-  \ncontaining  chemotherapy:  a  reference",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 85,
    "unit": null,
    "population": null,
    "notes": "Yoshimoto,  M.,  K",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 104,
    "unit": null,
    "population": null,
    "notes": "Yoshimoto,  M.,  K",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 111,
    "unit": null,
    "population": null,
    "notes": "Yoshimoto,  M.,  K",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 16,
    "unit": null,
    "population": null,
    "notes": "Yoshimoto,  M.,  K",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 2002,
    "unit": null,
    "population": null,
    "notes": "Results  of  lung  \nmetastasectomy  from  breast  cancer:  prognostic  criteria  \non  the  basis  of  467  cases  of  the  International  Registry  of  \nLung  Metastases",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 467,
    "unit": null,
    "population": null,
    "notes": "Results  of  lung  \nmetastasectomy  from  breast  cancer:  prognostic  criteria  \non  the  basis  of  467  cases  of  the  International  Registry  of  \nLung  Metastases",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 2017,
    "unit": null,
    "population": null,
    "notes": "Brain  \nmetastases  in  newly  diagnosed  breast  cancer:  a  \npopulation-  based  study",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 1069,
    "unit": null,
    "population": null,
    "notes": "Breast  cancer  survival  by  molecular  subtype:  a  \npopulation-  based  analysis  of  cancer  registry  data",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 1077,
    "unit": null,
    "population": null,
    "notes": "Breast  cancer  survival  by  molecular  subtype:  a  \npopulation-  based  analysis  of  cancer  registry  data",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 21,
    "unit": null,
    "population": null,
    "notes": "Breast  cancer  survival  by  molecular  subtype:  a  \npopulation-  based  analysis  of  cancer  registry  data",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 2017,
    "unit": null,
    "population": null,
    "notes": "Breast  cancer  survival  by  molecular  subtype:  a  \npopulation-  based  analysis  of  cancer  registry  data",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 2013,
    "unit": null,
    "population": null,
    "notes": "Molecular  subtypes,  histopathological  grade  and  survival  \nin  a  historic  cohort  of  breast  cancer  patients",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 52,
    "unit": null,
    "population": null,
    "notes": "Poor  outcome  of  hormone  \nreceptor-  positive  breast  cancer  at  very  young  age  is  due  \nto  tamoxifen  resistance:  nationwide  survival  data  in  \nKorea–a  report  from  the  Korean  Breas",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 108,
    "unit": null,
    "population": null,
    "notes": "Poor  outcome  of  hormone  \nreceptor-  positive  breast  cancer  at  very  young  age  is  due  \nto  tamoxifen  resistance:  nationwide  survival  data  in  \nKorea–a  report  from  the  Korean  Breas",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 118,
    "unit": null,
    "population": null,
    "notes": "Poor  outcome  of  hormone  \nreceptor-  positive  breast  cancer  at  very  young  age  is  due  \nto  tamoxifen  resistance:  nationwide  survival  data  in  \nKorea–a  report  from  the  Korean  Breas",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 25,
    "unit": null,
    "population": null,
    "notes": "Poor  outcome  of  hormone  \nreceptor-  positive  breast  cancer  at  very  young  age  is  due  \nto  tamoxifen  resistance:  nationwide  survival  data  in  \nKorea–a  report  from  the  Korean  Breas",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 2007,
    "unit": null,
    "population": null,
    "notes": "Poor  outcome  of  hormone  \nreceptor-  positive  breast  cancer  at  very  young  age  is  due  \nto  tamoxifen  resistance:  nationwide  survival  data  in  \nKorea–a  report  from  the  Korean  Breas",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 25,
    "unit": null,
    "population": null,
    "notes": "Subtype-  \ndependent  relationship  between  young  age  at  diagnosis  \nand  breast  cancer  survival",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 2360,
    "unit": null,
    "population": null,
    "notes": "Subtype-  \ndependent  relationship  between  young  age  at  diagnosis  \nand  breast  cancer  survival",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 2368,
    "unit": null,
    "population": null,
    "notes": "Subtype-  \ndependent  relationship  between  young  age  at  diagnosis  \nand  breast  cancer  survival",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 26,
    "unit": null,
    "population": null,
    "notes": "Subtype-  \ndependent  relationship  between  young  age  at  diagnosis  \nand  breast  cancer  survival",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 2013,
    "unit": null,
    "population": null,
    "notes": "Koshy,  et  al",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 31,
    "unit": null,
    "population": null,
    "notes": "Disparities  in  stage  at  diagnosis,  treatment,  and  survival  \nin  nonelderly  adult  patients  with  cancer  according  to  \ninsurance  status",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 3869,
    "unit": null,
    "population": null,
    "notes": "Disparities  in  stage  at  diagnosis,  treatment,  and  survival  \nin  nonelderly  adult  patients  with  cancer  according  to  \ninsurance  status",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 3876,
    "unit": null,
    "population": null,
    "notes": "Disparities  in  stage  at  diagnosis,  treatment,  and  survival  \nin  nonelderly  adult  patients  with  cancer  according  to  \ninsurance  status",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-007",
    "filename": "Xiao_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 29,
    "unit": null,
    "population": null,
    "notes": "Disparities  in  stage  at  diagnosis,  treatment,  and  survival  \nin  nonelderly  adult  patients  with  cancer  according  to  \ninsurance  status",
    "pageHint": 8,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 18,
    "unit": "%",
    "population": null,
    "notes": "We esti-\nmate a two-fold increase in 5-year relative survival rate from 18%\nto 36%, for women diagnosed withde novoMBC at age 15–49\nbetween 1992–1994 and 2005–2012, respectively",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 36,
    "unit": "%",
    "population": null,
    "notes": "We esti-\nmate a two-fold increase in 5-year relative survival rate from 18%\nto 36%, for women diagnosed withde novoMBC at age 15–49\nbetween 1992–1994 and 2005–2012, respectively",
    "pageHint": 1,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2017",
    "value": 794,
    "unit": "count",
    "population": null,
    "notes": "Results:We estimate that by January 1, 2017, there will be\n154,794 women living with MBC in the United States, three in\nfour initially diagnosed with stage I–III breast cancer who later\nprogressed to ",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2017",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Results:We estimate that by January 1, 2017, there will be\n154,794 women living with MBC in the United States, three in\nfour initially diagnosed with stage I–III breast cancer who later\nprogressed to ",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We esti-\nmate a two-fold increase in 5-year relative survival rate from 18%\nto 36%, for women diagnosed withde novoMBC at age 15–49\nbetween 1992–1994 and 2005–2012, respectively",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We esti-\nmate a two-fold increase in 5-year relative survival rate from 18%\nto 36%, for women diagnosed withde novoMBC at age 15–49\nbetween 1992–1994 and 2005–2012, respectively",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We esti-\nmate a two-fold increase in 5-year relative survival rate from 18%\nto 36%, for women diagnosed withde novoMBC at age 15–49\nbetween 1992–1994 and 2005–2012, respectively",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We esti-\nmate a two-fold increase in 5-year relative survival rate from 18%\nto 36%, for women diagnosed withde novoMBC at age 15–49\nbetween 1992–1994 and 2005–2012, respectively",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2017",
    "value": 2017,
    "unit": null,
    "population": null,
    "notes": "Results:We estimate that by January 1, 2017, there will be\n154,794 women living with MBC in the United States, three in\nfour initially diagnosed with stage I–III breast cancer who later\nprogressed to ",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2017",
    "value": 154,
    "unit": null,
    "population": null,
    "notes": "Results:We estimate that by January 1, 2017, there will be\n154,794 women living with MBC in the United States, three in\nfour initially diagnosed with stage I–III breast cancer who later\nprogressed to ",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2017",
    "value": 794,
    "unit": null,
    "population": null,
    "notes": "Results:We estimate that by January 1, 2017, there will be\n154,794 women living with MBC in the United States, three in\nfour initially diagnosed with stage I–III breast cancer who later\nprogressed to ",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 18,
    "unit": "year",
    "population": null,
    "notes": "We esti-\nmate a two-fold increase in 5-year relative survival rate from 18%\nto 36%, for women diagnosed withde novoMBC at age 15–49\nbetween 1992–1994 and 2005–2012, respectively",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 36,
    "unit": "year",
    "population": null,
    "notes": "We esti-\nmate a two-fold increase in 5-year relative survival rate from 18%\nto 36%, for women diagnosed withde novoMBC at age 15–49\nbetween 1992–1994 and 2005–2012, respectively",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 15,
    "unit": "year",
    "population": null,
    "notes": "We esti-\nmate a two-fold increase in 5-year relative survival rate from 18%\nto 36%, for women diagnosed withde novoMBC at age 15–49\nbetween 1992–1994 and 2005–2012, respectively",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 49,
    "unit": "year",
    "population": null,
    "notes": "We esti-\nmate a two-fold increase in 5-year relative survival rate from 18%\nto 36%, for women diagnosed withde novoMBC at age 15–49\nbetween 1992–1994 and 2005–2012, respectively",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 1992,
    "unit": "year",
    "population": null,
    "notes": "We esti-\nmate a two-fold increase in 5-year relative survival rate from 18%\nto 36%, for women diagnosed withde novoMBC at age 15–49\nbetween 1992–1994 and 2005–2012, respectively",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 1994,
    "unit": "year",
    "population": null,
    "notes": "We esti-\nmate a two-fold increase in 5-year relative survival rate from 18%\nto 36%, for women diagnosed withde novoMBC at age 15–49\nbetween 1992–1994 and 2005–2012, respectively",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 2005,
    "unit": "year",
    "population": null,
    "notes": "We esti-\nmate a two-fold increase in 5-year relative survival rate from 18%\nto 36%, for women diagnosed withde novoMBC at age 15–49\nbetween 1992–1994 and 2005–2012, respectively",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 2012,
    "unit": "year",
    "population": null,
    "notes": "We esti-\nmate a two-fold increase in 5-year relative survival rate from 18%\nto 36%, for women diagnosed withde novoMBC at age 15–49\nbetween 1992–1994 and 2005–2012, respectively",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "rate",
    "timePeriod": null,
    "value": 11,
    "unit": null,
    "population": null,
    "notes": "The SEERde novoMBC prevalence is compared\nwith an estimate based on the back-calculation method to vali-\ndate the method and calibrate survival (11)",
    "pageHint": 1,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 20,
    "unit": "%",
    "population": null,
    "notes": "S1which showsthattheresulting estimatedwis0.2,implying that\n20% of breast cancer deaths in a given year originate from women\ndiagnosed withde novoMBC, whereas 80% are deaths from\nwomen diagnosed with ",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 80,
    "unit": "%",
    "population": null,
    "notes": "S1which showsthattheresulting estimatedwis0.2,implying that\n20% of breast cancer deaths in a given year originate from women\ndiagnosed withde novoMBC, whereas 80% are deaths from\nwomen diagnosed with ",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "99 year",
    "value": 99,
    "unit": "years",
    "population": null,
    "notes": "Deaths and\npopulations were obtained by single calendar year and single\nage (0–99 years) using the SEER\n\u0001\nStat software",
    "pageHint": 2,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1992",
    "value": 643,
    "unit": "count",
    "population": null,
    "notes": "Anderson Cancer\nCenter (MDACC) study that included 2,881 and 643 women,\nretrospectively identified and diagnosed between 1992 and 2007\nwith recurrent andde novoMBC, respectively (15)",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "population and includes Atlanta,\nConnecticut, Detroit, Hawaii, Iowa, New Mexico, San Francisco-\nOakland,Seattle-PugetSound,andUtah.Forsurvivalanalyses,we\nused data from 1992–2012 from the SEER-11 regi",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "population and includes Atlanta,\nConnecticut, Detroit, Hawaii, Iowa, New Mexico, San Francisco-\nOakland,Seattle-PugetSound,andUtah.Forsurvivalanalyses,we\nused data from 1992–2012 from the SEER-11 regi",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "This stage definition uses extent of disease information for\ncases diagnosed in 1988–2003 and collaborative staging for cases\ndiagnosed in 2004–2012.De novoMBC was defined as AJCC 6\nstage IV which inc",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "This stage definition uses extent of disease information for\ncases diagnosed in 1988–2003 and collaborative staging for cases\ndiagnosed in 2004–2012.De novoMBC was defined as AJCC 6\nstage IV which inc",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "This stage definition uses extent of disease information for\ncases diagnosed in 1988–2003 and collaborative staging for cases\ndiagnosed in 2004–2012.De novoMBC was defined as AJCC 6\nstage IV which inc",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "This stage definition uses extent of disease information for\ncases diagnosed in 1988–2003 and collaborative staging for cases\ndiagnosed in 2004–2012.De novoMBC was defined as AJCC 6\nstage IV which inc",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "female deaths due to breast cancer and all\ncauses, from 1990 to 2012 from the National Center for Health\nStatistics (NCHS) and U.S",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "female deaths due to breast cancer and all\ncauses, from 1990 to 2012 from the National Center for Health\nStatistics (NCHS) and U.S",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2013",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Prevalence ofdenovoMBC using the counting method\nThe prevalence ofde novoMBC in the SEER-9 areas (counts and\nproportions) is calculated directly using the SEER\n\u0001\nStat counting\nmethod (7), which counts",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2013",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Prevalence ofdenovoMBC using the counting method\nThe prevalence ofde novoMBC in the SEER-9 areas (counts and\nproportions) is calculated directly using the SEER\n\u0001\nStat counting\nmethod (7), which counts",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2013",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Prevalence ofdenovoMBC using the counting method\nThe prevalence ofde novoMBC in the SEER-9 areas (counts and\nproportions) is calculated directly using the SEER\n\u0001\nStat counting\nmethod (7), which counts",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Modeling survival time from MBC includingdenovoand\nrecurrence\nTo model survival forde novoMBC cases, we estimated\nrelative survival by age and year at diagnosis for women\ndiagnosed with stage IV breas",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Modeling survival time from MBC includingdenovoand\nrecurrence\nTo model survival forde novoMBC cases, we estimated\nrelative survival by age and year at diagnosis for women\ndiagnosed with stage IV breas",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Anderson Cancer\nCenter (MDACC) study that included 2,881 and 643 women,\nretrospectively identified and diagnosed between 1992 and 2007\nwith recurrent andde novoMBC, respectively (15)",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Anderson Cancer\nCenter (MDACC) study that included 2,881 and 643 women,\nretrospectively identified and diagnosed between 1992 and 2007\nwith recurrent andde novoMBC, respectively (15)",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 1.35,
    "unit": null,
    "population": null,
    "notes": "The compar-\nison of the overall survival curves for recurrent andde novo\nMBC,Figure1inDawoodandcolleagues(15),showedanaverage\nrisk of death for recurrent relative tode novodisease of 1.35 [i.e.,\n1.35¼",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 1.35,
    "unit": null,
    "population": null,
    "notes": "The compar-\nison of the overall survival curves for recurrent andde novo\nMBC,Figure1inDawoodandcolleagues(15),showedanaverage\nrisk of death for recurrent relative tode novodisease of 1.35 [i.e.,\n1.35¼",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 1.35,
    "unit": null,
    "population": null,
    "notes": "Recurrent\nMBC survival was estimated by applying the 1.35 relative risk\nadjustment to each of the modeledde novoMBC survival curves\n(recurrent MBC survival¼de novoMBC survival\n1.35\n)",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 1.35,
    "unit": null,
    "population": null,
    "notes": "Recurrent\nMBC survival was estimated by applying the 1.35 relative risk\nadjustment to each of the modeledde novoMBC survival curves\n(recurrent MBC survival¼de novoMBC survival\n1.35\n)",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 1992,
    "unit": null,
    "population": null,
    "notes": "population and includes Atlanta,\nConnecticut, Detroit, Hawaii, Iowa, New Mexico, San Francisco-\nOakland,Seattle-PugetSound,andUtah.Forsurvivalanalyses,we\nused data from 1992–2012 from the SEER-11 regi",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 2012,
    "unit": null,
    "population": null,
    "notes": "population and includes Atlanta,\nConnecticut, Detroit, Hawaii, Iowa, New Mexico, San Francisco-\nOakland,Seattle-PugetSound,andUtah.Forsurvivalanalyses,we\nused data from 1992–2012 from the SEER-11 regi",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 11,
    "unit": null,
    "population": null,
    "notes": "population and includes Atlanta,\nConnecticut, Detroit, Hawaii, Iowa, New Mexico, San Francisco-\nOakland,Seattle-PugetSound,andUtah.Forsurvivalanalyses,we\nused data from 1992–2012 from the SEER-11 regi",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 12,
    "unit": null,
    "population": null,
    "notes": "Stage at diagnosis was defined using adjusted American Joint\nCommittee on Cancer (AJCC) 6th edition staging classification\n(12)",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 1988,
    "unit": null,
    "population": null,
    "notes": "This stage definition uses extent of disease information for\ncases diagnosed in 1988–2003 and collaborative staging for cases\ndiagnosed in 2004–2012.De novoMBC was defined as AJCC 6\nstage IV which inc",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2003,
    "unit": null,
    "population": null,
    "notes": "This stage definition uses extent of disease information for\ncases diagnosed in 1988–2003 and collaborative staging for cases\ndiagnosed in 2004–2012.De novoMBC was defined as AJCC 6\nstage IV which inc",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2004,
    "unit": null,
    "population": null,
    "notes": "This stage definition uses extent of disease information for\ncases diagnosed in 1988–2003 and collaborative staging for cases\ndiagnosed in 2004–2012.De novoMBC was defined as AJCC 6\nstage IV which inc",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1988",
    "value": 2012,
    "unit": null,
    "population": null,
    "notes": "This stage definition uses extent of disease information for\ncases diagnosed in 1988–2003 and collaborative staging for cases\ndiagnosed in 2004–2012.De novoMBC was defined as AJCC 6\nstage IV which inc",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 1990,
    "unit": null,
    "population": null,
    "notes": "female deaths due to breast cancer and all\ncauses, from 1990 to 2012 from the National Center for Health\nStatistics (NCHS) and U.S",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1990",
    "value": 2012,
    "unit": null,
    "population": null,
    "notes": "female deaths due to breast cancer and all\ncauses, from 1990 to 2012 from the National Center for Health\nStatistics (NCHS) and U.S",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "99 year",
    "value": 99,
    "unit": "year",
    "population": null,
    "notes": "Deaths and\npopulations were obtained by single calendar year and single\nage (0–99 years) using the SEER\n\u0001\nStat software",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2013",
    "value": 31,
    "unit": null,
    "population": null,
    "notes": "Prevalence ofdenovoMBC using the counting method\nThe prevalence ofde novoMBC in the SEER-9 areas (counts and\nproportions) is calculated directly using the SEER\n\u0001\nStat counting\nmethod (7), which counts",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2013",
    "value": 2013,
    "unit": null,
    "population": null,
    "notes": "Prevalence ofdenovoMBC using the counting method\nThe prevalence ofde novoMBC in the SEER-9 areas (counts and\nproportions) is calculated directly using the SEER\n\u0001\nStat counting\nmethod (7), which counts",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2013",
    "value": 1988,
    "unit": null,
    "population": null,
    "notes": "Prevalence ofdenovoMBC using the counting method\nThe prevalence ofde novoMBC in the SEER-9 areas (counts and\nproportions) is calculated directly using the SEER\n\u0001\nStat counting\nmethod (7), which counts",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2013",
    "value": 2012,
    "unit": null,
    "population": null,
    "notes": "Prevalence ofdenovoMBC using the counting method\nThe prevalence ofde novoMBC in the SEER-9 areas (counts and\nproportions) is calculated directly using the SEER\n\u0001\nStat counting\nmethod (7), which counts",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 1992,
    "unit": "year",
    "population": null,
    "notes": "Modeling survival time from MBC includingdenovoand\nrecurrence\nTo model survival forde novoMBC cases, we estimated\nrelative survival by age and year at diagnosis for women\ndiagnosed with stage IV breas",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 2012,
    "unit": "year",
    "population": null,
    "notes": "Modeling survival time from MBC includingdenovoand\nrecurrence\nTo model survival forde novoMBC cases, we estimated\nrelative survival by age and year at diagnosis for women\ndiagnosed with stage IV breas",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 11,
    "unit": "year",
    "population": null,
    "notes": "Modeling survival time from MBC includingdenovoand\nrecurrence\nTo model survival forde novoMBC cases, we estimated\nrelative survival by age and year at diagnosis for women\ndiagnosed with stage IV breas",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1992",
    "value": 881,
    "unit": null,
    "population": null,
    "notes": "Anderson Cancer\nCenter (MDACC) study that included 2,881 and 643 women,\nretrospectively identified and diagnosed between 1992 and 2007\nwith recurrent andde novoMBC, respectively (15)",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1992",
    "value": 643,
    "unit": null,
    "population": null,
    "notes": "Anderson Cancer\nCenter (MDACC) study that included 2,881 and 643 women,\nretrospectively identified and diagnosed between 1992 and 2007\nwith recurrent andde novoMBC, respectively (15)",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1992",
    "value": 1992,
    "unit": null,
    "population": null,
    "notes": "Anderson Cancer\nCenter (MDACC) study that included 2,881 and 643 women,\nretrospectively identified and diagnosed between 1992 and 2007\nwith recurrent andde novoMBC, respectively (15)",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1992",
    "value": 2007,
    "unit": null,
    "population": null,
    "notes": "Anderson Cancer\nCenter (MDACC) study that included 2,881 and 643 women,\nretrospectively identified and diagnosed between 1992 and 2007\nwith recurrent andde novoMBC, respectively (15)",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1992",
    "value": 15,
    "unit": null,
    "population": null,
    "notes": "Anderson Cancer\nCenter (MDACC) study that included 2,881 and 643 women,\nretrospectively identified and diagnosed between 1992 and 2007\nwith recurrent andde novoMBC, respectively (15)",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 15,
    "unit": null,
    "population": null,
    "notes": "The compar-\nison of the overall survival curves for recurrent andde novo\nMBC,Figure1inDawoodandcolleagues(15),showedanaverage\nrisk of death for recurrent relative tode novodisease of 1.35 [i.e.,\n1.35¼",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 35,
    "unit": null,
    "population": null,
    "notes": "The compar-\nison of the overall survival curves for recurrent andde novo\nMBC,Figure1inDawoodandcolleagues(15),showedanaverage\nrisk of death for recurrent relative tode novodisease of 1.35 [i.e.,\n1.35¼",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "overall survival",
    "timePeriod": null,
    "value": 35,
    "unit": null,
    "population": null,
    "notes": "The compar-\nison of the overall survival curves for recurrent andde novo\nMBC,Figure1inDawoodandcolleagues(15),showedanaverage\nrisk of death for recurrent relative tode novodisease of 1.35 [i.e.,\n1.35¼",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 35,
    "unit": null,
    "population": null,
    "notes": "Recurrent\nMBC survival was estimated by applying the 1.35 relative risk\nadjustment to each of the modeledde novoMBC survival curves\n(recurrent MBC survival¼de novoMBC survival\n1.35\n)",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 35,
    "unit": null,
    "population": null,
    "notes": "Recurrent\nMBC survival was estimated by applying the 1.35 relative risk\nadjustment to each of the modeledde novoMBC survival curves\n(recurrent MBC survival¼de novoMBC survival\n1.35\n)",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 20,
    "unit": "year",
    "population": null,
    "notes": "S1which showsthattheresulting estimatedwis0.2,implying that\n20% of breast cancer deaths in a given year originate from women\ndiagnosed withde novoMBC, whereas 80% are deaths from\nwomen diagnosed with ",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 80,
    "unit": "year",
    "population": null,
    "notes": "S1which showsthattheresulting estimatedwis0.2,implying that\n20% of breast cancer deaths in a given year originate from women\ndiagnosed withde novoMBC, whereas 80% are deaths from\nwomen diagnosed with ",
    "pageHint": 2,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 11,
    "unit": "%",
    "population": null,
    "notes": "The\ncalibration suggests adjusting MBC survival by a factor of 0.92¼\nexp(\u00040.08) to correct for 11% underestimation of the observed\nprevalence, that is,S\n\u0001\nMBC\nðtÞ¼S\nMBC\nðtÞ\n0:92",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2013",
    "value": 28,
    "unit": "%",
    "population": null,
    "notes": "Results\nIn 2013, the last year with observed data, we estimate a\nprevalence of MBC of 138,622; of which, 38,897 (28%) are\nsurvivors who were initially diagnosed withde novostage IV\ndisease and 99,725 ",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2013",
    "value": 72,
    "unit": "%",
    "population": null,
    "notes": "Results\nIn 2013, the last year with observed data, we estimate a\nprevalence of MBC of 138,622; of which, 38,897 (28%) are\nsurvivors who were initially diagnosed withde novostage IV\ndisease and 99,725 ",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2013",
    "value": 26,
    "unit": "%",
    "population": null,
    "notes": "The\nback-calculation method also estimates 50,344 new diagnoses of\nMBC in 2013, of which 12,966 (26%) arede novoand 37,378\n(74%) recurrences, thus 3 in 4 are undocumented diagnoses of\nMBC",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2013",
    "value": 74,
    "unit": "%",
    "population": null,
    "notes": "The\nback-calculation method also estimates 50,344 new diagnoses of\nMBC in 2013, of which 12,966 (26%) arede novoand 37,378\n(74%) recurrences, thus 3 in 4 are undocumented diagnoses of\nMBC",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 18,
    "unit": "%",
    "population": null,
    "notes": "The 5-year relative survival rate\nhad a 2-fold increase from 18% to 36%, for women diagnosed\nwithde novoMBC at age 15–49 between 1992–1994 and 2005–\n2012, respectively",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 36,
    "unit": "%",
    "population": null,
    "notes": "The 5-year relative survival rate\nhad a 2-fold increase from 18% to 36%, for women diagnosed\nwithde novoMBC at age 15–49 between 1992–1994 and 2005–\n2012, respectively",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 11,
    "unit": "%",
    "population": null,
    "notes": "Despite a poor prognosis, there is a small but\nmeaningful percentage of these cases who survive 10 years or\nmore; more than 11% of women diagnosed between 2000–2004\nunder the age of 64 years survived ",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 27,
    "unit": "%",
    "population": null,
    "notes": "The 4-year relative survival rate ofde novo\nMBC in SEER was 27% compared with 41% and 29% overall\nsurvival forde novoand recurrent MBC in the MDACC cohort,\nrespectively",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 41,
    "unit": "%",
    "population": null,
    "notes": "The 4-year relative survival rate ofde novo\nMBC in SEER was 27% compared with 41% and 29% overall\nsurvival forde novoand recurrent MBC in the MDACC cohort,\nrespectively",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 29,
    "unit": "%",
    "population": null,
    "notes": "The 4-year relative survival rate ofde novo\nMBC in SEER was 27% compared with 41% and 29% overall\nsurvival forde novoand recurrent MBC in the MDACC cohort,\nrespectively",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 38.7,
    "unit": "months",
    "population": null,
    "notes": "Median relative survival time increased from\n22.3 to 38.7 months and from 19.1 to 29.7 months for women\ndiagnosed between ages 15–49 and 50–64, respectively, during\n1992–1994 versus 2005–2012",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 29.7,
    "unit": "months",
    "population": null,
    "notes": "Median relative survival time increased from\n22.3 to 38.7 months and from 19.1 to 29.7 months for women\ndiagnosed between ages 15–49 and 50–64, respectively, during\n1992–1994 versus 2005–2012",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 10,
    "unit": "years",
    "population": null,
    "notes": "Despite a poor prognosis, there is a small but\nmeaningful percentage of these cases who survive 10 years or\nmore; more than 11% of women diagnosed between 2000–2004\nunder the age of 64 years survived ",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 64,
    "unit": "years",
    "population": null,
    "notes": "Despite a poor prognosis, there is a small but\nmeaningful percentage of these cases who survive 10 years or\nmore; more than 11% of women diagnosed between 2000–2004\nunder the age of 64 years survived ",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 10,
    "unit": "years",
    "population": null,
    "notes": "Despite a poor prognosis, there is a small but\nmeaningful percentage of these cases who survive 10 years or\nmore; more than 11% of women diagnosed between 2000–2004\nunder the age of 64 years survived ",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 91,
    "unit": "years",
    "population": null,
    "notes": "Figure 4 compares MBC survival in SEER and in the MDACC\nstudycohort.TheMDACCcohortincluded2,881and643women\nwith recurrent andde novoMBC, respectively, retrospectively\nidentified and diagnosed between ",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "In the MDACC cohort, the median age at\ndiagnosis was 52 and 50 years forde novoand recurrent MBC,\nrespectively, whereas in SEER, the median age at diagnosis was 61\nyears",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 61,
    "unit": "years",
    "population": null,
    "notes": "In the MDACC cohort, the median age at\ndiagnosis was 52 and 50 years forde novoand recurrent MBC,\nrespectively, whereas in SEER, the median age at diagnosis was 61\nyears",
    "pageHint": 3,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 935,
    "unit": "count",
    "population": null,
    "notes": "Relative survival estimates used in the modeling included\n25,935 women diagnosed withde novostage IV BC from 1992–\n2012 (Table 2)",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 643,
    "unit": "count",
    "population": null,
    "notes": "Figure 4 compares MBC survival in SEER and in the MDACC\nstudycohort.TheMDACCcohortincluded2,881and643women\nwith recurrent andde novoMBC, respectively, retrospectively\nidentified and diagnosed between ",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2014",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Prevalence projec-\ntions from 2014 to 2020 assume constant breast cancer mortality\nrates at 2014 levels and constant survival but use dynamic\npopulation size projections for these years",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2014",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Prevalence projec-\ntions from 2014 to 2020 assume constant breast cancer mortality\nrates at 2014 levels and constant survival but use dynamic\npopulation size projections for these years",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2014",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Prevalence projec-\ntions from 2014 to 2020 assume constant breast cancer mortality\nrates at 2014 levels and constant survival but use dynamic\npopulation size projections for these years",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2013",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Results\nIn 2013, the last year with observed data, we estimate a\nprevalence of MBC of 138,622; of which, 38,897 (28%) are\nsurvivors who were initially diagnosed withde novostage IV\ndisease and 99,725 ",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2013",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "The\nback-calculation method also estimates 50,344 new diagnoses of\nMBC in 2013, of which 12,966 (26%) arede novoand 37,378\n(74%) recurrences, thus 3 in 4 are undocumented diagnoses of\nMBC",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Relative survival estimates used in the modeling included\n25,935 women diagnosed withde novostage IV BC from 1992–\n2012 (Table 2)",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Relative survival estimates used in the modeling included\n25,935 women diagnosed withde novostage IV BC from 1992–\n2012 (Table 2)",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1995",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Median survival and 5-year relative survival\nincreased over the years especially for younger women diagnosed\nafter 1995 (Table 2)",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Median relative survival time increased from\n22.3 to 38.7 months and from 19.1 to 29.7 months for women\ndiagnosed between ages 15–49 and 50–64, respectively, during\n1992–1994 versus 2005–2012",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Median relative survival time increased from\n22.3 to 38.7 months and from 19.1 to 29.7 months for women\ndiagnosed between ages 15–49 and 50–64, respectively, during\n1992–1994 versus 2005–2012",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Median relative survival time increased from\n22.3 to 38.7 months and from 19.1 to 29.7 months for women\ndiagnosed between ages 15–49 and 50–64, respectively, during\n1992–1994 versus 2005–2012",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Median relative survival time increased from\n22.3 to 38.7 months and from 19.1 to 29.7 months for women\ndiagnosed between ages 15–49 and 50–64, respectively, during\n1992–1994 versus 2005–2012",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "The 5-year relative survival rate\nhad a 2-fold increase from 18% to 36%, for women diagnosed\nwithde novoMBC at age 15–49 between 1992–1994 and 2005–\n2012, respectively",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "The 5-year relative survival rate\nhad a 2-fold increase from 18% to 36%, for women diagnosed\nwithde novoMBC at age 15–49 between 1992–1994 and 2005–\n2012, respectively",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "The 5-year relative survival rate\nhad a 2-fold increase from 18% to 36%, for women diagnosed\nwithde novoMBC at age 15–49 between 1992–1994 and 2005–\n2012, respectively",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "The 5-year relative survival rate\nhad a 2-fold increase from 18% to 36%, for women diagnosed\nwithde novoMBC at age 15–49 between 1992–1994 and 2005–\n2012, respectively",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Despite a poor prognosis, there is a small but\nmeaningful percentage of these cases who survive 10 years or\nmore; more than 11% of women diagnosed between 2000–2004\nunder the age of 64 years survived ",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Despite a poor prognosis, there is a small but\nmeaningful percentage of these cases who survive 10 years or\nmore; more than 11% of women diagnosed between 2000–2004\nunder the age of 64 years survived ",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Figure 4 compares MBC survival in SEER and in the MDACC\nstudycohort.TheMDACCcohortincluded2,881and643women\nwith recurrent andde novoMBC, respectively, retrospectively\nidentified and diagnosed between ",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Figure 4 compares MBC survival in SEER and in the MDACC\nstudycohort.TheMDACCcohortincluded2,881and643women\nwith recurrent andde novoMBC, respectively, retrospectively\nidentified and diagnosed between ",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Figure 4 compares MBC survival in SEER and in the MDACC\nstudycohort.TheMDACCcohortincluded2,881and643women\nwith recurrent andde novoMBC, respectively, retrospectively\nidentified and diagnosed between ",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Figure 4 compares MBC survival in SEER and in the MDACC\nstudycohort.TheMDACCcohortincluded2,881and643women\nwith recurrent andde novoMBC, respectively, retrospectively\nidentified and diagnosed between ",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 0.92,
    "unit": "%",
    "population": null,
    "notes": "The\ncalibration suggests adjusting MBC survival by a factor of 0.92¼\nexp(\u00040.08) to correct for 11% underestimation of the observed\nprevalence, that is,S\n\u0001\nMBC\nðtÞ¼S\nMBC\nðtÞ\n0:92",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 0.08,
    "unit": "%",
    "population": null,
    "notes": "The\ncalibration suggests adjusting MBC survival by a factor of 0.92¼\nexp(\u00040.08) to correct for 11% underestimation of the observed\nprevalence, that is,S\n\u0001\nMBC\nðtÞ¼S\nMBC\nðtÞ\n0:92",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 22.3,
    "unit": "months",
    "population": null,
    "notes": "Median relative survival time increased from\n22.3 to 38.7 months and from 19.1 to 29.7 months for women\ndiagnosed between ages 15–49 and 50–64, respectively, during\n1992–1994 versus 2005–2012",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 38.7,
    "unit": "months",
    "population": null,
    "notes": "Median relative survival time increased from\n22.3 to 38.7 months and from 19.1 to 29.7 months for women\ndiagnosed between ages 15–49 and 50–64, respectively, during\n1992–1994 versus 2005–2012",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 19.1,
    "unit": "months",
    "population": null,
    "notes": "Median relative survival time increased from\n22.3 to 38.7 months and from 19.1 to 29.7 months for women\ndiagnosed between ages 15–49 and 50–64, respectively, during\n1992–1994 versus 2005–2012",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 29.7,
    "unit": "months",
    "population": null,
    "notes": "Median relative survival time increased from\n22.3 to 38.7 months and from 19.1 to 29.7 months for women\ndiagnosed between ages 15–49 and 50–64, respectively, during\n1992–1994 versus 2005–2012",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2014",
    "value": 2014,
    "unit": "years",
    "population": null,
    "notes": "Prevalence projec-\ntions from 2014 to 2020 assume constant breast cancer mortality\nrates at 2014 levels and constant survival but use dynamic\npopulation size projections for these years",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2014",
    "value": 2020,
    "unit": "years",
    "population": null,
    "notes": "Prevalence projec-\ntions from 2014 to 2020 assume constant breast cancer mortality\nrates at 2014 levels and constant survival but use dynamic\npopulation size projections for these years",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2014",
    "value": 2014,
    "unit": "years",
    "population": null,
    "notes": "Prevalence projec-\ntions from 2014 to 2020 assume constant breast cancer mortality\nrates at 2014 levels and constant survival but use dynamic\npopulation size projections for these years",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 11,
    "unit": null,
    "population": null,
    "notes": "To adjust for data inconsistencies, such as underreporting of\ndeaths and misclassification of deaths to site of metastasis as\nfound elsewhere (11), we calibrate the back-calculation method\nby comparin",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 92,
    "unit": "%",
    "population": null,
    "notes": "The\ncalibration suggests adjusting MBC survival by a factor of 0.92¼\nexp(\u00040.08) to correct for 11% underestimation of the observed\nprevalence, that is,S\n\u0001\nMBC\nðtÞ¼S\nMBC\nðtÞ\n0:92",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 8,
    "unit": "%",
    "population": null,
    "notes": "The\ncalibration suggests adjusting MBC survival by a factor of 0.92¼\nexp(\u00040.08) to correct for 11% underestimation of the observed\nprevalence, that is,S\n\u0001\nMBC\nðtÞ¼S\nMBC\nðtÞ\n0:92",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 11,
    "unit": "%",
    "population": null,
    "notes": "The\ncalibration suggests adjusting MBC survival by a factor of 0.92¼\nexp(\u00040.08) to correct for 11% underestimation of the observed\nprevalence, that is,S\n\u0001\nMBC\nðtÞ¼S\nMBC\nðtÞ\n0:92",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 92,
    "unit": "%",
    "population": null,
    "notes": "The\ncalibration suggests adjusting MBC survival by a factor of 0.92¼\nexp(\u00040.08) to correct for 11% underestimation of the observed\nprevalence, that is,S\n\u0001\nMBC\nðtÞ¼S\nMBC\nðtÞ\n0:92",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2013",
    "value": 2013,
    "unit": "year",
    "population": null,
    "notes": "Results\nIn 2013, the last year with observed data, we estimate a\nprevalence of MBC of 138,622; of which, 38,897 (28%) are\nsurvivors who were initially diagnosed withde novostage IV\ndisease and 99,725 ",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2013",
    "value": 138,
    "unit": "year",
    "population": null,
    "notes": "Results\nIn 2013, the last year with observed data, we estimate a\nprevalence of MBC of 138,622; of which, 38,897 (28%) are\nsurvivors who were initially diagnosed withde novostage IV\ndisease and 99,725 ",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2013",
    "value": 622,
    "unit": "year",
    "population": null,
    "notes": "Results\nIn 2013, the last year with observed data, we estimate a\nprevalence of MBC of 138,622; of which, 38,897 (28%) are\nsurvivors who were initially diagnosed withde novostage IV\ndisease and 99,725 ",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2013",
    "value": 38,
    "unit": "year",
    "population": null,
    "notes": "Results\nIn 2013, the last year with observed data, we estimate a\nprevalence of MBC of 138,622; of which, 38,897 (28%) are\nsurvivors who were initially diagnosed withde novostage IV\ndisease and 99,725 ",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2013",
    "value": 897,
    "unit": "year",
    "population": null,
    "notes": "Results\nIn 2013, the last year with observed data, we estimate a\nprevalence of MBC of 138,622; of which, 38,897 (28%) are\nsurvivors who were initially diagnosed withde novostage IV\ndisease and 99,725 ",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2013",
    "value": 28,
    "unit": "year",
    "population": null,
    "notes": "Results\nIn 2013, the last year with observed data, we estimate a\nprevalence of MBC of 138,622; of which, 38,897 (28%) are\nsurvivors who were initially diagnosed withde novostage IV\ndisease and 99,725 ",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2013",
    "value": 99,
    "unit": "year",
    "population": null,
    "notes": "Results\nIn 2013, the last year with observed data, we estimate a\nprevalence of MBC of 138,622; of which, 38,897 (28%) are\nsurvivors who were initially diagnosed withde novostage IV\ndisease and 99,725 ",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2013",
    "value": 725,
    "unit": "year",
    "population": null,
    "notes": "Results\nIn 2013, the last year with observed data, we estimate a\nprevalence of MBC of 138,622; of which, 38,897 (28%) are\nsurvivors who were initially diagnosed withde novostage IV\ndisease and 99,725 ",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2013",
    "value": 72,
    "unit": "year",
    "population": null,
    "notes": "Results\nIn 2013, the last year with observed data, we estimate a\nprevalence of MBC of 138,622; of which, 38,897 (28%) are\nsurvivors who were initially diagnosed withde novostage IV\ndisease and 99,725 ",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2013",
    "value": 50,
    "unit": "%",
    "population": null,
    "notes": "The\nback-calculation method also estimates 50,344 new diagnoses of\nMBC in 2013, of which 12,966 (26%) arede novoand 37,378\n(74%) recurrences, thus 3 in 4 are undocumented diagnoses of\nMBC",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2013",
    "value": 344,
    "unit": "%",
    "population": null,
    "notes": "The\nback-calculation method also estimates 50,344 new diagnoses of\nMBC in 2013, of which 12,966 (26%) arede novoand 37,378\n(74%) recurrences, thus 3 in 4 are undocumented diagnoses of\nMBC",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2013",
    "value": 2013,
    "unit": "%",
    "population": null,
    "notes": "The\nback-calculation method also estimates 50,344 new diagnoses of\nMBC in 2013, of which 12,966 (26%) arede novoand 37,378\n(74%) recurrences, thus 3 in 4 are undocumented diagnoses of\nMBC",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2013",
    "value": 12,
    "unit": "%",
    "population": null,
    "notes": "The\nback-calculation method also estimates 50,344 new diagnoses of\nMBC in 2013, of which 12,966 (26%) arede novoand 37,378\n(74%) recurrences, thus 3 in 4 are undocumented diagnoses of\nMBC",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2013",
    "value": 966,
    "unit": "%",
    "population": null,
    "notes": "The\nback-calculation method also estimates 50,344 new diagnoses of\nMBC in 2013, of which 12,966 (26%) arede novoand 37,378\n(74%) recurrences, thus 3 in 4 are undocumented diagnoses of\nMBC",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2013",
    "value": 26,
    "unit": "%",
    "population": null,
    "notes": "The\nback-calculation method also estimates 50,344 new diagnoses of\nMBC in 2013, of which 12,966 (26%) arede novoand 37,378\n(74%) recurrences, thus 3 in 4 are undocumented diagnoses of\nMBC",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2013",
    "value": 37,
    "unit": "%",
    "population": null,
    "notes": "The\nback-calculation method also estimates 50,344 new diagnoses of\nMBC in 2013, of which 12,966 (26%) arede novoand 37,378\n(74%) recurrences, thus 3 in 4 are undocumented diagnoses of\nMBC",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2013",
    "value": 378,
    "unit": "%",
    "population": null,
    "notes": "The\nback-calculation method also estimates 50,344 new diagnoses of\nMBC in 2013, of which 12,966 (26%) arede novoand 37,378\n(74%) recurrences, thus 3 in 4 are undocumented diagnoses of\nMBC",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2013",
    "value": 74,
    "unit": "%",
    "population": null,
    "notes": "The\nback-calculation method also estimates 50,344 new diagnoses of\nMBC in 2013, of which 12,966 (26%) arede novoand 37,378\n(74%) recurrences, thus 3 in 4 are undocumented diagnoses of\nMBC",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 25,
    "unit": null,
    "population": null,
    "notes": "Relative survival estimates used in the modeling included\n25,935 women diagnosed withde novostage IV BC from 1992–\n2012 (Table 2)",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 935,
    "unit": null,
    "population": null,
    "notes": "Relative survival estimates used in the modeling included\n25,935 women diagnosed withde novostage IV BC from 1992–\n2012 (Table 2)",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 1992,
    "unit": null,
    "population": null,
    "notes": "Relative survival estimates used in the modeling included\n25,935 women diagnosed withde novostage IV BC from 1992–\n2012 (Table 2)",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 2012,
    "unit": null,
    "population": null,
    "notes": "Relative survival estimates used in the modeling included\n25,935 women diagnosed withde novostage IV BC from 1992–\n2012 (Table 2)",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "Median survival",
    "timePeriod": "1995",
    "value": 1995,
    "unit": "year",
    "population": null,
    "notes": "Median survival and 5-year relative survival\nincreased over the years especially for younger women diagnosed\nafter 1995 (Table 2)",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 22,
    "unit": "months",
    "population": null,
    "notes": "Median relative survival time increased from\n22.3 to 38.7 months and from 19.1 to 29.7 months for women\ndiagnosed between ages 15–49 and 50–64, respectively, during\n1992–1994 versus 2005–2012",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 38,
    "unit": "months",
    "population": null,
    "notes": "Median relative survival time increased from\n22.3 to 38.7 months and from 19.1 to 29.7 months for women\ndiagnosed between ages 15–49 and 50–64, respectively, during\n1992–1994 versus 2005–2012",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 19,
    "unit": "months",
    "population": null,
    "notes": "Median relative survival time increased from\n22.3 to 38.7 months and from 19.1 to 29.7 months for women\ndiagnosed between ages 15–49 and 50–64, respectively, during\n1992–1994 versus 2005–2012",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 29,
    "unit": "months",
    "population": null,
    "notes": "Median relative survival time increased from\n22.3 to 38.7 months and from 19.1 to 29.7 months for women\ndiagnosed between ages 15–49 and 50–64, respectively, during\n1992–1994 versus 2005–2012",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 15,
    "unit": "months",
    "population": null,
    "notes": "Median relative survival time increased from\n22.3 to 38.7 months and from 19.1 to 29.7 months for women\ndiagnosed between ages 15–49 and 50–64, respectively, during\n1992–1994 versus 2005–2012",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 49,
    "unit": "months",
    "population": null,
    "notes": "Median relative survival time increased from\n22.3 to 38.7 months and from 19.1 to 29.7 months for women\ndiagnosed between ages 15–49 and 50–64, respectively, during\n1992–1994 versus 2005–2012",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 50,
    "unit": "months",
    "population": null,
    "notes": "Median relative survival time increased from\n22.3 to 38.7 months and from 19.1 to 29.7 months for women\ndiagnosed between ages 15–49 and 50–64, respectively, during\n1992–1994 versus 2005–2012",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 64,
    "unit": "months",
    "population": null,
    "notes": "Median relative survival time increased from\n22.3 to 38.7 months and from 19.1 to 29.7 months for women\ndiagnosed between ages 15–49 and 50–64, respectively, during\n1992–1994 versus 2005–2012",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 1992,
    "unit": "months",
    "population": null,
    "notes": "Median relative survival time increased from\n22.3 to 38.7 months and from 19.1 to 29.7 months for women\ndiagnosed between ages 15–49 and 50–64, respectively, during\n1992–1994 versus 2005–2012",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 1994,
    "unit": "months",
    "population": null,
    "notes": "Median relative survival time increased from\n22.3 to 38.7 months and from 19.1 to 29.7 months for women\ndiagnosed between ages 15–49 and 50–64, respectively, during\n1992–1994 versus 2005–2012",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 2005,
    "unit": "months",
    "population": null,
    "notes": "Median relative survival time increased from\n22.3 to 38.7 months and from 19.1 to 29.7 months for women\ndiagnosed between ages 15–49 and 50–64, respectively, during\n1992–1994 versus 2005–2012",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 2012,
    "unit": "months",
    "population": null,
    "notes": "Median relative survival time increased from\n22.3 to 38.7 months and from 19.1 to 29.7 months for women\ndiagnosed between ages 15–49 and 50–64, respectively, during\n1992–1994 versus 2005–2012",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 18,
    "unit": "year",
    "population": null,
    "notes": "The 5-year relative survival rate\nhad a 2-fold increase from 18% to 36%, for women diagnosed\nwithde novoMBC at age 15–49 between 1992–1994 and 2005–\n2012, respectively",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 36,
    "unit": "year",
    "population": null,
    "notes": "The 5-year relative survival rate\nhad a 2-fold increase from 18% to 36%, for women diagnosed\nwithde novoMBC at age 15–49 between 1992–1994 and 2005–\n2012, respectively",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 15,
    "unit": "year",
    "population": null,
    "notes": "The 5-year relative survival rate\nhad a 2-fold increase from 18% to 36%, for women diagnosed\nwithde novoMBC at age 15–49 between 1992–1994 and 2005–\n2012, respectively",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 49,
    "unit": "year",
    "population": null,
    "notes": "The 5-year relative survival rate\nhad a 2-fold increase from 18% to 36%, for women diagnosed\nwithde novoMBC at age 15–49 between 1992–1994 and 2005–\n2012, respectively",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 1992,
    "unit": "year",
    "population": null,
    "notes": "The 5-year relative survival rate\nhad a 2-fold increase from 18% to 36%, for women diagnosed\nwithde novoMBC at age 15–49 between 1992–1994 and 2005–\n2012, respectively",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 1994,
    "unit": "year",
    "population": null,
    "notes": "The 5-year relative survival rate\nhad a 2-fold increase from 18% to 36%, for women diagnosed\nwithde novoMBC at age 15–49 between 1992–1994 and 2005–\n2012, respectively",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 2005,
    "unit": "year",
    "population": null,
    "notes": "The 5-year relative survival rate\nhad a 2-fold increase from 18% to 36%, for women diagnosed\nwithde novoMBC at age 15–49 between 1992–1994 and 2005–\n2012, respectively",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 2012,
    "unit": "year",
    "population": null,
    "notes": "The 5-year relative survival rate\nhad a 2-fold increase from 18% to 36%, for women diagnosed\nwithde novoMBC at age 15–49 between 1992–1994 and 2005–\n2012, respectively",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 10,
    "unit": "years",
    "population": null,
    "notes": "Despite a poor prognosis, there is a small but\nmeaningful percentage of these cases who survive 10 years or\nmore; more than 11% of women diagnosed between 2000–2004\nunder the age of 64 years survived ",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 11,
    "unit": "years",
    "population": null,
    "notes": "Despite a poor prognosis, there is a small but\nmeaningful percentage of these cases who survive 10 years or\nmore; more than 11% of women diagnosed between 2000–2004\nunder the age of 64 years survived ",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 2000,
    "unit": "years",
    "population": null,
    "notes": "Despite a poor prognosis, there is a small but\nmeaningful percentage of these cases who survive 10 years or\nmore; more than 11% of women diagnosed between 2000–2004\nunder the age of 64 years survived ",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 2004,
    "unit": "years",
    "population": null,
    "notes": "Despite a poor prognosis, there is a small but\nmeaningful percentage of these cases who survive 10 years or\nmore; more than 11% of women diagnosed between 2000–2004\nunder the age of 64 years survived ",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 64,
    "unit": "years",
    "population": null,
    "notes": "Despite a poor prognosis, there is a small but\nmeaningful percentage of these cases who survive 10 years or\nmore; more than 11% of women diagnosed between 2000–2004\nunder the age of 64 years survived ",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2000",
    "value": 10,
    "unit": "years",
    "population": null,
    "notes": "Despite a poor prognosis, there is a small but\nmeaningful percentage of these cases who survive 10 years or\nmore; more than 11% of women diagnosed between 2000–2004\nunder the age of 64 years survived ",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 1992,
    "unit": "years",
    "population": null,
    "notes": "Figure 4 compares MBC survival in SEER and in the MDACC\nstudycohort.TheMDACCcohortincluded2,881and643women\nwith recurrent andde novoMBC, respectively, retrospectively\nidentified and diagnosed between ",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 2007,
    "unit": "years",
    "population": null,
    "notes": "Figure 4 compares MBC survival in SEER and in the MDACC\nstudycohort.TheMDACCcohortincluded2,881and643women\nwith recurrent andde novoMBC, respectively, retrospectively\nidentified and diagnosed between ",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 91,
    "unit": "years",
    "population": null,
    "notes": "Figure 4 compares MBC survival in SEER and in the MDACC\nstudycohort.TheMDACCcohortincluded2,881and643women\nwith recurrent andde novoMBC, respectively, retrospectively\nidentified and diagnosed between ",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 1992,
    "unit": "years",
    "population": null,
    "notes": "Figure 4 compares MBC survival in SEER and in the MDACC\nstudycohort.TheMDACCcohortincluded2,881and643women\nwith recurrent andde novoMBC, respectively, retrospectively\nidentified and diagnosed between ",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 2007,
    "unit": "years",
    "population": null,
    "notes": "Figure 4 compares MBC survival in SEER and in the MDACC\nstudycohort.TheMDACCcohortincluded2,881and643women\nwith recurrent andde novoMBC, respectively, retrospectively\nidentified and diagnosed between ",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 15,
    "unit": "years",
    "population": null,
    "notes": "Figure 4 compares MBC survival in SEER and in the MDACC\nstudycohort.TheMDACCcohortincluded2,881and643women\nwith recurrent andde novoMBC, respectively, retrospectively\nidentified and diagnosed between ",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 84,
    "unit": "years",
    "population": null,
    "notes": "Figure 4 compares MBC survival in SEER and in the MDACC\nstudycohort.TheMDACCcohortincluded2,881and643women\nwith recurrent andde novoMBC, respectively, retrospectively\nidentified and diagnosed between ",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 52,
    "unit": "years",
    "population": null,
    "notes": "In the MDACC cohort, the median age at\ndiagnosis was 52 and 50 years forde novoand recurrent MBC,\nrespectively, whereas in SEER, the median age at diagnosis was 61\nyears",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 50,
    "unit": "years",
    "population": null,
    "notes": "In the MDACC cohort, the median age at\ndiagnosis was 52 and 50 years forde novoand recurrent MBC,\nrespectively, whereas in SEER, the median age at diagnosis was 61\nyears",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "50 year",
    "value": 61,
    "unit": "years",
    "population": null,
    "notes": "In the MDACC cohort, the median age at\ndiagnosis was 52 and 50 years forde novoand recurrent MBC,\nrespectively, whereas in SEER, the median age at diagnosis was 61\nyears",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 27,
    "unit": "year",
    "population": null,
    "notes": "The 4-year relative survival rate ofde novo\nMBC in SEER was 27% compared with 41% and 29% overall\nsurvival forde novoand recurrent MBC in the MDACC cohort,\nrespectively",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 41,
    "unit": "year",
    "population": null,
    "notes": "The 4-year relative survival rate ofde novo\nMBC in SEER was 27% compared with 41% and 29% overall\nsurvival forde novoand recurrent MBC in the MDACC cohort,\nrespectively",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 29,
    "unit": "year",
    "population": null,
    "notes": "The 4-year relative survival rate ofde novo\nMBC in SEER was 27% compared with 41% and 29% overall\nsurvival forde novoand recurrent MBC in the MDACC cohort,\nrespectively",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 105,
    "unit": "year",
    "population": null,
    "notes": "Relative survival is generally higher than overall\n105,354\n109,918\n128,427\n138,622\n154,794\n168,292\n0\n20,000\n40,000\n60,000\n80,000\n100,000\n120,000\n140,000\n160,000\n180,000\n1990199119921993199419951996199",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 354,
    "unit": "year",
    "population": null,
    "notes": "Relative survival is generally higher than overall\n105,354\n109,918\n128,427\n138,622\n154,794\n168,292\n0\n20,000\n40,000\n60,000\n80,000\n100,000\n120,000\n140,000\n160,000\n180,000\n1990199119921993199419951996199",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 109,
    "unit": "year",
    "population": null,
    "notes": "Relative survival is generally higher than overall\n105,354\n109,918\n128,427\n138,622\n154,794\n168,292\n0\n20,000\n40,000\n60,000\n80,000\n100,000\n120,000\n140,000\n160,000\n180,000\n1990199119921993199419951996199",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 918,
    "unit": "year",
    "population": null,
    "notes": "Relative survival is generally higher than overall\n105,354\n109,918\n128,427\n138,622\n154,794\n168,292\n0\n20,000\n40,000\n60,000\n80,000\n100,000\n120,000\n140,000\n160,000\n180,000\n1990199119921993199419951996199",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 128,
    "unit": "year",
    "population": null,
    "notes": "Relative survival is generally higher than overall\n105,354\n109,918\n128,427\n138,622\n154,794\n168,292\n0\n20,000\n40,000\n60,000\n80,000\n100,000\n120,000\n140,000\n160,000\n180,000\n1990199119921993199419951996199",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 427,
    "unit": "year",
    "population": null,
    "notes": "Relative survival is generally higher than overall\n105,354\n109,918\n128,427\n138,622\n154,794\n168,292\n0\n20,000\n40,000\n60,000\n80,000\n100,000\n120,000\n140,000\n160,000\n180,000\n1990199119921993199419951996199",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 138,
    "unit": "year",
    "population": null,
    "notes": "Relative survival is generally higher than overall\n105,354\n109,918\n128,427\n138,622\n154,794\n168,292\n0\n20,000\n40,000\n60,000\n80,000\n100,000\n120,000\n140,000\n160,000\n180,000\n1990199119921993199419951996199",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 622,
    "unit": "year",
    "population": null,
    "notes": "Relative survival is generally higher than overall\n105,354\n109,918\n128,427\n138,622\n154,794\n168,292\n0\n20,000\n40,000\n60,000\n80,000\n100,000\n120,000\n140,000\n160,000\n180,000\n1990199119921993199419951996199",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 154,
    "unit": "year",
    "population": null,
    "notes": "Relative survival is generally higher than overall\n105,354\n109,918\n128,427\n138,622\n154,794\n168,292\n0\n20,000\n40,000\n60,000\n80,000\n100,000\n120,000\n140,000\n160,000\n180,000\n1990199119921993199419951996199",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 794,
    "unit": "year",
    "population": null,
    "notes": "Relative survival is generally higher than overall\n105,354\n109,918\n128,427\n138,622\n154,794\n168,292\n0\n20,000\n40,000\n60,000\n80,000\n100,000\n120,000\n140,000\n160,000\n180,000\n1990199119921993199419951996199",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 168,
    "unit": "year",
    "population": null,
    "notes": "Relative survival is generally higher than overall\n105,354\n109,918\n128,427\n138,622\n154,794\n168,292\n0\n20,000\n40,000\n60,000\n80,000\n100,000\n120,000\n140,000\n160,000\n180,000\n1990199119921993199419951996199",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 292,
    "unit": "year",
    "population": null,
    "notes": "Relative survival is generally higher than overall\n105,354\n109,918\n128,427\n138,622\n154,794\n168,292\n0\n20,000\n40,000\n60,000\n80,000\n100,000\n120,000\n140,000\n160,000\n180,000\n1990199119921993199419951996199",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 20,
    "unit": "year",
    "population": null,
    "notes": "Relative survival is generally higher than overall\n105,354\n109,918\n128,427\n138,622\n154,794\n168,292\n0\n20,000\n40,000\n60,000\n80,000\n100,000\n120,000\n140,000\n160,000\n180,000\n1990199119921993199419951996199",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 0,
    "unit": "year",
    "population": null,
    "notes": "Relative survival is generally higher than overall\n105,354\n109,918\n128,427\n138,622\n154,794\n168,292\n0\n20,000\n40,000\n60,000\n80,000\n100,000\n120,000\n140,000\n160,000\n180,000\n1990199119921993199419951996199",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 40,
    "unit": "year",
    "population": null,
    "notes": "Relative survival is generally higher than overall\n105,354\n109,918\n128,427\n138,622\n154,794\n168,292\n0\n20,000\n40,000\n60,000\n80,000\n100,000\n120,000\n140,000\n160,000\n180,000\n1990199119921993199419951996199",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 0,
    "unit": "year",
    "population": null,
    "notes": "Relative survival is generally higher than overall\n105,354\n109,918\n128,427\n138,622\n154,794\n168,292\n0\n20,000\n40,000\n60,000\n80,000\n100,000\n120,000\n140,000\n160,000\n180,000\n1990199119921993199419951996199",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 60,
    "unit": "year",
    "population": null,
    "notes": "Relative survival is generally higher than overall\n105,354\n109,918\n128,427\n138,622\n154,794\n168,292\n0\n20,000\n40,000\n60,000\n80,000\n100,000\n120,000\n140,000\n160,000\n180,000\n1990199119921993199419951996199",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 0,
    "unit": "year",
    "population": null,
    "notes": "Relative survival is generally higher than overall\n105,354\n109,918\n128,427\n138,622\n154,794\n168,292\n0\n20,000\n40,000\n60,000\n80,000\n100,000\n120,000\n140,000\n160,000\n180,000\n1990199119921993199419951996199",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 80,
    "unit": "year",
    "population": null,
    "notes": "Relative survival is generally higher than overall\n105,354\n109,918\n128,427\n138,622\n154,794\n168,292\n0\n20,000\n40,000\n60,000\n80,000\n100,000\n120,000\n140,000\n160,000\n180,000\n1990199119921993199419951996199",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 0,
    "unit": "year",
    "population": null,
    "notes": "Relative survival is generally higher than overall\n105,354\n109,918\n128,427\n138,622\n154,794\n168,292\n0\n20,000\n40,000\n60,000\n80,000\n100,000\n120,000\n140,000\n160,000\n180,000\n1990199119921993199419951996199",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 100,
    "unit": "year",
    "population": null,
    "notes": "Relative survival is generally higher than overall\n105,354\n109,918\n128,427\n138,622\n154,794\n168,292\n0\n20,000\n40,000\n60,000\n80,000\n100,000\n120,000\n140,000\n160,000\n180,000\n1990199119921993199419951996199",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 0,
    "unit": "year",
    "population": null,
    "notes": "Relative survival is generally higher than overall\n105,354\n109,918\n128,427\n138,622\n154,794\n168,292\n0\n20,000\n40,000\n60,000\n80,000\n100,000\n120,000\n140,000\n160,000\n180,000\n1990199119921993199419951996199",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 120,
    "unit": "year",
    "population": null,
    "notes": "Relative survival is generally higher than overall\n105,354\n109,918\n128,427\n138,622\n154,794\n168,292\n0\n20,000\n40,000\n60,000\n80,000\n100,000\n120,000\n140,000\n160,000\n180,000\n1990199119921993199419951996199",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 0,
    "unit": "year",
    "population": null,
    "notes": "Relative survival is generally higher than overall\n105,354\n109,918\n128,427\n138,622\n154,794\n168,292\n0\n20,000\n40,000\n60,000\n80,000\n100,000\n120,000\n140,000\n160,000\n180,000\n1990199119921993199419951996199",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 140,
    "unit": "year",
    "population": null,
    "notes": "Relative survival is generally higher than overall\n105,354\n109,918\n128,427\n138,622\n154,794\n168,292\n0\n20,000\n40,000\n60,000\n80,000\n100,000\n120,000\n140,000\n160,000\n180,000\n1990199119921993199419951996199",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 0,
    "unit": "year",
    "population": null,
    "notes": "Relative survival is generally higher than overall\n105,354\n109,918\n128,427\n138,622\n154,794\n168,292\n0\n20,000\n40,000\n60,000\n80,000\n100,000\n120,000\n140,000\n160,000\n180,000\n1990199119921993199419951996199",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 160,
    "unit": "year",
    "population": null,
    "notes": "Relative survival is generally higher than overall\n105,354\n109,918\n128,427\n138,622\n154,794\n168,292\n0\n20,000\n40,000\n60,000\n80,000\n100,000\n120,000\n140,000\n160,000\n180,000\n1990199119921993199419951996199",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 0,
    "unit": "year",
    "population": null,
    "notes": "Relative survival is generally higher than overall\n105,354\n109,918\n128,427\n138,622\n154,794\n168,292\n0\n20,000\n40,000\n60,000\n80,000\n100,000\n120,000\n140,000\n160,000\n180,000\n1990199119921993199419951996199",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 180,
    "unit": "year",
    "population": null,
    "notes": "Relative survival is generally higher than overall\n105,354\n109,918\n128,427\n138,622\n154,794\n168,292\n0\n20,000\n40,000\n60,000\n80,000\n100,000\n120,000\n140,000\n160,000\n180,000\n1990199119921993199419951996199",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 0,
    "unit": "year",
    "population": null,
    "notes": "Relative survival is generally higher than overall\n105,354\n109,918\n128,427\n138,622\n154,794\n168,292\n0\n20,000\n40,000\n60,000\n80,000\n100,000\n120,000\n140,000\n160,000\n180,000\n1990199119921993199419951996199",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1990",
    "value": 1.9901991199219932e+123,
    "unit": "year",
    "population": null,
    "notes": "Relative survival is generally higher than overall\n105,354\n109,918\n128,427\n138,622\n154,794\n168,292\n0\n20,000\n40,000\n60,000\n80,000\n100,000\n120,000\n140,000\n160,000\n180,000\n1990199119921993199419951996199",
    "pageHint": 3,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 10,
    "unit": "%",
    "population": null,
    "notes": "Theabsolute difference decreasedwithlonger follow-\nup and 10-year relative survival was 10% in SEER versus 14% in\nthe MDACC for women diagnosed withde novoMBC (Fig",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 14,
    "unit": "%",
    "population": null,
    "notes": "Theabsolute difference decreasedwithlonger follow-\nup and 10-year relative survival was 10% in SEER versus 14% in\nthe MDACC for women diagnosed withde novoMBC (Fig",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 18,
    "unit": "%",
    "population": null,
    "notes": "We estimate a 2-fold\nincrease in 5-year relative survival rate from 18% to 36%, for\nwomen diagnosed withde novostage IV at age 15–49 between\n1992–1994 and 2005–2012, respectively, translating into an\n",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 36,
    "unit": "%",
    "population": null,
    "notes": "We estimate a 2-fold\nincrease in 5-year relative survival rate from 18% to 36%, for\nwomen diagnosed withde novostage IV at age 15–49 between\n1992–1994 and 2005–2012, respectively, translating into an\n",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 40,
    "unit": "%",
    "population": null,
    "notes": "To represent\n62,052 \n40%\n40,787 \n26%\n25,502 \n17%\n26,455 \n17%\nPrevalence of MBC  cases\n0 − <2\n2 − <5\n5 − <10\n10+\nYears since\nMBC\ndiagnosis \nFigure 2",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 26,
    "unit": "%",
    "population": null,
    "notes": "To represent\n62,052 \n40%\n40,787 \n26%\n25,502 \n17%\n26,455 \n17%\nPrevalence of MBC  cases\n0 − <2\n2 − <5\n5 − <10\n10+\nYears since\nMBC\ndiagnosis \nFigure 2",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 17,
    "unit": "%",
    "population": null,
    "notes": "To represent\n62,052 \n40%\n40,787 \n26%\n25,502 \n17%\n26,455 \n17%\nPrevalence of MBC  cases\n0 − <2\n2 − <5\n5 − <10\n10+\nYears since\nMBC\ndiagnosis \nFigure 2",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 17,
    "unit": "%",
    "population": null,
    "notes": "To represent\n62,052 \n40%\n40,787 \n26%\n25,502 \n17%\n26,455 \n17%\nPrevalence of MBC  cases\n0 − <2\n2 − <5\n5 − <10\n10+\nYears since\nMBC\ndiagnosis \nFigure 2",
    "pageHint": 4,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We estimate a 2-fold\nincrease in 5-year relative survival rate from 18% to 36%, for\nwomen diagnosed withde novostage IV at age 15–49 between\n1992–1994 and 2005–2012, respectively, translating into an\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We estimate a 2-fold\nincrease in 5-year relative survival rate from 18% to 36%, for\nwomen diagnosed withde novostage IV at age 15–49 between\n1992–1994 and 2005–2012, respectively, translating into an\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We estimate a 2-fold\nincrease in 5-year relative survival rate from 18% to 36%, for\nwomen diagnosed withde novostage IV at age 15–49 between\n1992–1994 and 2005–2012, respectively, translating into an\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We estimate a 2-fold\nincrease in 5-year relative survival rate from 18% to 36%, for\nwomen diagnosed withde novostage IV at age 15–49 between\n1992–1994 and 2005–2012, respectively, translating into an\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We estimate a 2-fold\nincrease in 5-year relative survival rate from 18% to 36%, for\nwomen diagnosed withde novostage IV at age 15–49 between\n1992–1994 and 2005–2012, respectively, translating into an\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "We estimate a 2-fold\nincrease in 5-year relative survival rate from 18% to 36%, for\nwomen diagnosed withde novostage IV at age 15–49 between\n1992–1994 and 2005–2012, respectively, translating into an\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2017",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Number of women in the United States alive at January 1, 2017, previously\ndiagnosed withdenovoor recurrent MBC by time since diagnosis",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2013",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1.Estimates (January 1, 2013) and projections (January 1, 2017) of breast cancer mortality, and incidence and prevalence of MBC includingdenovoand\nrecurrence disease in the United States\nNumber ",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2013",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1.Estimates (January 1, 2013) and projections (January 1, 2017) of breast cancer mortality, and incidence and prevalence of MBC includingdenovoand\nrecurrence disease in the United States\nNumber ",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2013",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Table 1.Estimates (January 1, 2013) and projections (January 1, 2017) of breast cancer mortality, and incidence and prevalence of MBC includingdenovoand\nrecurrence disease in the United States\nNumber ",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 10,
    "unit": "year",
    "population": null,
    "notes": "Theabsolute difference decreasedwithlonger follow-\nup and 10-year relative survival was 10% in SEER versus 14% in\nthe MDACC for women diagnosed withde novoMBC (Fig",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 10,
    "unit": "year",
    "population": null,
    "notes": "Theabsolute difference decreasedwithlonger follow-\nup and 10-year relative survival was 10% in SEER versus 14% in\nthe MDACC for women diagnosed withde novoMBC (Fig",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 14,
    "unit": "year",
    "population": null,
    "notes": "Theabsolute difference decreasedwithlonger follow-\nup and 10-year relative survival was 10% in SEER versus 14% in\nthe MDACC for women diagnosed withde novoMBC (Fig",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 18,
    "unit": "year",
    "population": null,
    "notes": "We estimate a 2-fold\nincrease in 5-year relative survival rate from 18% to 36%, for\nwomen diagnosed withde novostage IV at age 15–49 between\n1992–1994 and 2005–2012, respectively, translating into an\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 36,
    "unit": "year",
    "population": null,
    "notes": "We estimate a 2-fold\nincrease in 5-year relative survival rate from 18% to 36%, for\nwomen diagnosed withde novostage IV at age 15–49 between\n1992–1994 and 2005–2012, respectively, translating into an\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 15,
    "unit": "year",
    "population": null,
    "notes": "We estimate a 2-fold\nincrease in 5-year relative survival rate from 18% to 36%, for\nwomen diagnosed withde novostage IV at age 15–49 between\n1992–1994 and 2005–2012, respectively, translating into an\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 49,
    "unit": "year",
    "population": null,
    "notes": "We estimate a 2-fold\nincrease in 5-year relative survival rate from 18% to 36%, for\nwomen diagnosed withde novostage IV at age 15–49 between\n1992–1994 and 2005–2012, respectively, translating into an\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 1992,
    "unit": "year",
    "population": null,
    "notes": "We estimate a 2-fold\nincrease in 5-year relative survival rate from 18% to 36%, for\nwomen diagnosed withde novostage IV at age 15–49 between\n1992–1994 and 2005–2012, respectively, translating into an\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 1994,
    "unit": "year",
    "population": null,
    "notes": "We estimate a 2-fold\nincrease in 5-year relative survival rate from 18% to 36%, for\nwomen diagnosed withde novostage IV at age 15–49 between\n1992–1994 and 2005–2012, respectively, translating into an\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 2005,
    "unit": "year",
    "population": null,
    "notes": "We estimate a 2-fold\nincrease in 5-year relative survival rate from 18% to 36%, for\nwomen diagnosed withde novostage IV at age 15–49 between\n1992–1994 and 2005–2012, respectively, translating into an\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 2012,
    "unit": "year",
    "population": null,
    "notes": "We estimate a 2-fold\nincrease in 5-year relative survival rate from 18% to 36%, for\nwomen diagnosed withde novostage IV at age 15–49 between\n1992–1994 and 2005–2012, respectively, translating into an\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 105,
    "unit": "year",
    "population": null,
    "notes": "We estimate a 2-fold\nincrease in 5-year relative survival rate from 18% to 36%, for\nwomen diagnosed withde novostage IV at age 15–49 between\n1992–1994 and 2005–2012, respectively, translating into an\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 354,
    "unit": "year",
    "population": null,
    "notes": "We estimate a 2-fold\nincrease in 5-year relative survival rate from 18% to 36%, for\nwomen diagnosed withde novostage IV at age 15–49 between\n1992–1994 and 2005–2012, respectively, translating into an\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 1990,
    "unit": "year",
    "population": null,
    "notes": "We estimate a 2-fold\nincrease in 5-year relative survival rate from 18% to 36%, for\nwomen diagnosed withde novostage IV at age 15–49 between\n1992–1994 and 2005–2012, respectively, translating into an\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 138,
    "unit": "year",
    "population": null,
    "notes": "We estimate a 2-fold\nincrease in 5-year relative survival rate from 18% to 36%, for\nwomen diagnosed withde novostage IV at age 15–49 between\n1992–1994 and 2005–2012, respectively, translating into an\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 622,
    "unit": "year",
    "population": null,
    "notes": "We estimate a 2-fold\nincrease in 5-year relative survival rate from 18% to 36%, for\nwomen diagnosed withde novostage IV at age 15–49 between\n1992–1994 and 2005–2012, respectively, translating into an\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 2013,
    "unit": "year",
    "population": null,
    "notes": "We estimate a 2-fold\nincrease in 5-year relative survival rate from 18% to 36%, for\nwomen diagnosed withde novostage IV at age 15–49 between\n1992–1994 and 2005–2012, respectively, translating into an\n",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 16,
    "unit": null,
    "population": null,
    "notes": "Other studies have also shown improvement in survival for\nwomen withde novodistant disease or metastatic recurrence (16–\n18), attributed to improved treatment",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 18,
    "unit": null,
    "population": null,
    "notes": "Other studies have also shown improvement in survival for\nwomen withde novodistant disease or metastatic recurrence (16–\n18), attributed to improved treatment",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 62,
    "unit": "years",
    "population": null,
    "notes": "To represent\n62,052 \n40%\n40,787 \n26%\n25,502 \n17%\n26,455 \n17%\nPrevalence of MBC  cases\n0 − <2\n2 − <5\n5 − <10\n10+\nYears since\nMBC\ndiagnosis \nFigure 2",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 52,
    "unit": "years",
    "population": null,
    "notes": "To represent\n62,052 \n40%\n40,787 \n26%\n25,502 \n17%\n26,455 \n17%\nPrevalence of MBC  cases\n0 − <2\n2 − <5\n5 − <10\n10+\nYears since\nMBC\ndiagnosis \nFigure 2",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 40,
    "unit": "years",
    "population": null,
    "notes": "To represent\n62,052 \n40%\n40,787 \n26%\n25,502 \n17%\n26,455 \n17%\nPrevalence of MBC  cases\n0 − <2\n2 − <5\n5 − <10\n10+\nYears since\nMBC\ndiagnosis \nFigure 2",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 40,
    "unit": "years",
    "population": null,
    "notes": "To represent\n62,052 \n40%\n40,787 \n26%\n25,502 \n17%\n26,455 \n17%\nPrevalence of MBC  cases\n0 − <2\n2 − <5\n5 − <10\n10+\nYears since\nMBC\ndiagnosis \nFigure 2",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 787,
    "unit": "years",
    "population": null,
    "notes": "To represent\n62,052 \n40%\n40,787 \n26%\n25,502 \n17%\n26,455 \n17%\nPrevalence of MBC  cases\n0 − <2\n2 − <5\n5 − <10\n10+\nYears since\nMBC\ndiagnosis \nFigure 2",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 26,
    "unit": "years",
    "population": null,
    "notes": "To represent\n62,052 \n40%\n40,787 \n26%\n25,502 \n17%\n26,455 \n17%\nPrevalence of MBC  cases\n0 − <2\n2 − <5\n5 − <10\n10+\nYears since\nMBC\ndiagnosis \nFigure 2",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 25,
    "unit": "years",
    "population": null,
    "notes": "To represent\n62,052 \n40%\n40,787 \n26%\n25,502 \n17%\n26,455 \n17%\nPrevalence of MBC  cases\n0 − <2\n2 − <5\n5 − <10\n10+\nYears since\nMBC\ndiagnosis \nFigure 2",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 502,
    "unit": "years",
    "population": null,
    "notes": "To represent\n62,052 \n40%\n40,787 \n26%\n25,502 \n17%\n26,455 \n17%\nPrevalence of MBC  cases\n0 − <2\n2 − <5\n5 − <10\n10+\nYears since\nMBC\ndiagnosis \nFigure 2",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 17,
    "unit": "years",
    "population": null,
    "notes": "To represent\n62,052 \n40%\n40,787 \n26%\n25,502 \n17%\n26,455 \n17%\nPrevalence of MBC  cases\n0 − <2\n2 − <5\n5 − <10\n10+\nYears since\nMBC\ndiagnosis \nFigure 2",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 26,
    "unit": "years",
    "population": null,
    "notes": "To represent\n62,052 \n40%\n40,787 \n26%\n25,502 \n17%\n26,455 \n17%\nPrevalence of MBC  cases\n0 − <2\n2 − <5\n5 − <10\n10+\nYears since\nMBC\ndiagnosis \nFigure 2",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 455,
    "unit": "years",
    "population": null,
    "notes": "To represent\n62,052 \n40%\n40,787 \n26%\n25,502 \n17%\n26,455 \n17%\nPrevalence of MBC  cases\n0 − <2\n2 − <5\n5 − <10\n10+\nYears since\nMBC\ndiagnosis \nFigure 2",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 17,
    "unit": "years",
    "population": null,
    "notes": "To represent\n62,052 \n40%\n40,787 \n26%\n25,502 \n17%\n26,455 \n17%\nPrevalence of MBC  cases\n0 − <2\n2 − <5\n5 − <10\n10+\nYears since\nMBC\ndiagnosis \nFigure 2",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 10,
    "unit": "years",
    "population": null,
    "notes": "To represent\n62,052 \n40%\n40,787 \n26%\n25,502 \n17%\n26,455 \n17%\nPrevalence of MBC  cases\n0 − <2\n2 − <5\n5 − <10\n10+\nYears since\nMBC\ndiagnosis \nFigure 2",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 10,
    "unit": "years",
    "population": null,
    "notes": "To represent\n62,052 \n40%\n40,787 \n26%\n25,502 \n17%\n26,455 \n17%\nPrevalence of MBC  cases\n0 − <2\n2 − <5\n5 − <10\n10+\nYears since\nMBC\ndiagnosis \nFigure 2",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2017",
    "value": 2017,
    "unit": null,
    "population": null,
    "notes": "Number of women in the United States alive at January 1, 2017, previously\ndiagnosed withdenovoor recurrent MBC by time since diagnosis",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2013",
    "value": 2013,
    "unit": null,
    "population": null,
    "notes": "Table 1.Estimates (January 1, 2013) and projections (January 1, 2017) of breast cancer mortality, and incidence and prevalence of MBC includingdenovoand\nrecurrence disease in the United States\nNumber ",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2013",
    "value": 2017,
    "unit": null,
    "population": null,
    "notes": "Table 1.Estimates (January 1, 2013) and projections (January 1, 2017) of breast cancer mortality, and incidence and prevalence of MBC includingdenovoand\nrecurrence disease in the United States\nNumber ",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2013",
    "value": 2013,
    "unit": null,
    "population": null,
    "notes": "Table 1.Estimates (January 1, 2013) and projections (January 1, 2017) of breast cancer mortality, and incidence and prevalence of MBC includingdenovoand\nrecurrence disease in the United States\nNumber ",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 15,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 3952,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 450,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 8449969767051,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 8701,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 6044,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 205,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 40,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 4921,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 199,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 1163,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 5303,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 4161,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 4225,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 1294,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 73615,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 684,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 50,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 5922,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 400,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 3087,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 9798,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 952,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 9949,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 9628,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 95030,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 642,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 60,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 6917,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 143,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 15510,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 719,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 8883,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 20011,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 48111,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 236,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 194,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 70,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 7010,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 11,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 1318,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 6508,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 6172,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 6789,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 3427,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 74027,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 232,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 80,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 997,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 338,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 87111,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 21611,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 1761,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 96712,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 5604,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 86524,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 665,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 15,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 99130,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 543,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 42542,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 44242,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 16912,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 96650,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 34438,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 897138,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 622,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "incidence",
    "timePeriod": "2001",
    "value": 2017,
    "unit": null,
    "population": null,
    "notes": "female\npopulationObservedEstimated\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\nDenovo\n(Observed)\nDenovoand\nrecurrence\n(Estimated)\n15–3952,450,8449969767051,8701,6044,205\n40–4921,199,1163,5303,4",
    "pageHint": 4,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 95,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 222.318,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 14,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 21,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 10,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 8,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 14,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 419.115,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 13,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 18,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 8,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 6,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 11,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 745981617.615,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 12,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 18,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 7,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 5,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 10,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 110.916,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 12,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 20,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 7,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 4,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 11,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 84.16,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 2,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 13,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 4,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 0,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 16,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 716.715,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 14,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 17,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 8,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 7,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 9,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 524.724,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 21,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 27,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 11,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 9,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 13,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 320.621,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 18,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 23,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 10,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 8,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 12,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 415.217,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 15,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 20,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 6,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 5,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 8,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 411.813,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 10,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 16,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 7,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 5,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 10,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 75.516,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 10,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 23,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 8,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 2,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 21,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 517.719,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 17,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 20,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 8,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 8,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 9,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 3072929.329,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 26,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 31,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 14,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 12,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 16,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 625.124,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 23,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 26,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 11,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 10,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 13,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 920.32,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 18,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 23,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 8,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 6,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 10,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 311.415,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 13,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 18,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 8,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 6,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 10,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 77.214,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 9,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 20,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 9,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 3,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 19,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 821.122,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 21,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 23,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 10,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 9,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 11,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 438.736,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 34,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 38,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 8612929.725,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 24,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 27,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 324.524,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 22,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 26,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 820121418,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 16,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 21,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 86568.213,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 9,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 17,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 226.926,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 25,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 27,
    "unit": "%",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2005",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Relative survival by time since\ndiagnosis for women diagnosed with\ndenovostage IV in the SEER-11 areas\nbetween 2005 and 2012 at different\nage groups",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2005",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Relative survival by time since\ndiagnosis for women diagnosed with\ndenovostage IV in the SEER-11 areas\nbetween 2005 and 2012 at different\nage groups",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 4943022.222,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 6477718.419,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 745981617.615,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 8444210.11,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 1683.84,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 41515.716,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 4989424.524,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 32120.32,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 7497814.415,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 8479910.411,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 2924.75,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 28416.517,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 3072929.329,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 27024.625,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 31918.92,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 14210.311,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 4365.77,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 47419.821,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 74838.438,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 8612929.725,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 46823.324,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 86568.213,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 76225.226,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.1,
    "unit": "years",
    "population": null,
    "notes": "0\n0.1\n0.2\n0.3\n0.4\n0.5\n0.6\n0.7\n0.8\n0.9\n1\n012345678\nPercent surviving cancer\nYears since diagnosis\nAge at diagnosis15−4950−64\n65−7475−8485+\nFigure 3",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.2,
    "unit": "years",
    "population": null,
    "notes": "0\n0.1\n0.2\n0.3\n0.4\n0.5\n0.6\n0.7\n0.8\n0.9\n1\n012345678\nPercent surviving cancer\nYears since diagnosis\nAge at diagnosis15−4950−64\n65−7475−8485+\nFigure 3",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.3,
    "unit": "years",
    "population": null,
    "notes": "0\n0.1\n0.2\n0.3\n0.4\n0.5\n0.6\n0.7\n0.8\n0.9\n1\n012345678\nPercent surviving cancer\nYears since diagnosis\nAge at diagnosis15−4950−64\n65−7475−8485+\nFigure 3",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.4,
    "unit": "years",
    "population": null,
    "notes": "0\n0.1\n0.2\n0.3\n0.4\n0.5\n0.6\n0.7\n0.8\n0.9\n1\n012345678\nPercent surviving cancer\nYears since diagnosis\nAge at diagnosis15−4950−64\n65−7475−8485+\nFigure 3",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.5,
    "unit": "years",
    "population": null,
    "notes": "0\n0.1\n0.2\n0.3\n0.4\n0.5\n0.6\n0.7\n0.8\n0.9\n1\n012345678\nPercent surviving cancer\nYears since diagnosis\nAge at diagnosis15−4950−64\n65−7475−8485+\nFigure 3",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.6,
    "unit": "years",
    "population": null,
    "notes": "0\n0.1\n0.2\n0.3\n0.4\n0.5\n0.6\n0.7\n0.8\n0.9\n1\n012345678\nPercent surviving cancer\nYears since diagnosis\nAge at diagnosis15−4950−64\n65−7475−8485+\nFigure 3",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.7,
    "unit": "years",
    "population": null,
    "notes": "0\n0.1\n0.2\n0.3\n0.4\n0.5\n0.6\n0.7\n0.8\n0.9\n1\n012345678\nPercent surviving cancer\nYears since diagnosis\nAge at diagnosis15−4950−64\n65−7475−8485+\nFigure 3",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.8,
    "unit": "years",
    "population": null,
    "notes": "0\n0.1\n0.2\n0.3\n0.4\n0.5\n0.6\n0.7\n0.8\n0.9\n1\n012345678\nPercent surviving cancer\nYears since diagnosis\nAge at diagnosis15−4950−64\n65−7475−8485+\nFigure 3",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 0.9,
    "unit": "years",
    "population": null,
    "notes": "0\n0.1\n0.2\n0.3\n0.4\n0.5\n0.6\n0.7\n0.8\n0.9\n1\n012345678\nPercent surviving cancer\nYears since diagnosis\nAge at diagnosis15−4950−64\n65−7475−8485+\nFigure 3",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 35,
    "unit": null,
    "population": null,
    "notes": "survival/mortalityassociatedwithMBCrecurrence,weuseda1.35\nhigher risk of cancer death (inflation factor) for recurrent MBC\nrelative tode novodisease based on a single-institution study\nconducted at MD",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": null,
    "value": 15,
    "unit": null,
    "population": null,
    "notes": "survival/mortalityassociatedwithMBCrecurrence,weuseda1.35\nhigher risk of cancer death (inflation factor) for recurrent MBC\nrelative tode novodisease based on a single-institution study\nconducted at MD",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 95,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 11,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 95,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 10,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 95,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 1992,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 199415,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 4943022,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 222,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 318,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 14,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 21,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 10,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 14,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 1992,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 199450,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 6477718,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 419,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 115,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 13,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 18,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 11,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 1992,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 199465,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 745981617,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 615,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 12,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 18,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 10,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 1992,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 199475,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 8444210,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 110,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 916,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 12,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 20,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 11,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 1992,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 199485,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 1683,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 84,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 16,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 13,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 16,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 1992,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 41515,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 716,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 715,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 14,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 17,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 1995,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 199915,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 4989424,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 524,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 724,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 21,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 27,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 11,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 13,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 1995,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 199950,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 641,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 32120,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 320,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 621,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 18,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 23,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 10,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 12,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 1995,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 199965,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 7497814,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 415,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 217,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 15,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 20,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 1995,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 199975,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 8479910,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 411,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 813,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 10,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 16,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 10,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 1995,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 199985,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 2924,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 75,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 516,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 10,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 23,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 21,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 1995,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 28416,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 517,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 719,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 17,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 20,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 2000,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 200415,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 491,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 3072929,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 329,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 26,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 31,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 14,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 12,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 16,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 2000,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 200450,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 642,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 27024,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 625,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 124,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 23,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 26,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 11,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 10,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 13,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 2000,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 200465,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 741,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 31918,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 920,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 320,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 18,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 23,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 10,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 2000,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 200475,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 841,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 14210,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 311,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 415,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 13,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 18,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 10,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 2000,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 200485,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 4365,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 77,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 214,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 20,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 19,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 2000,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 47419,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 821,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 122,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 21,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 23,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 10,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 11,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 2005,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 201215,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 492,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 74838,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 438,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 736,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 34,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 38,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 2005,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 201250,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 644,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 8612929,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 725,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 24,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 27,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 2005,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 201265,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 742,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 46823,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 324,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 524,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 22,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 26,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 2005,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 201275,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 841,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 820121418,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 16,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 21,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 2005,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 201285,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 86568,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 213,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 17,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 2005,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 76225,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 226,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 926,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 25,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 27,
    "unit": "months",
    "population": null,
    "notes": "This factor accounts for greater\nsusceptibility to the cancer as well as greater vulnerability to\ntreatment morbidities due to accumulation of cancer treatments\nTable 2.Number of women, median overall",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 12345678,
    "unit": "years",
    "population": null,
    "notes": "0\n0.1\n0.2\n0.3\n0.4\n0.5\n0.6\n0.7\n0.8\n0.9\n1\n012345678\nPercent surviving cancer\nYears since diagnosis\nAge at diagnosis15−4950−64\n65−7475−8485+\nFigure 3",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 4950,
    "unit": "years",
    "population": null,
    "notes": "0\n0.1\n0.2\n0.3\n0.4\n0.5\n0.6\n0.7\n0.8\n0.9\n1\n012345678\nPercent surviving cancer\nYears since diagnosis\nAge at diagnosis15−4950−64\n65−7475−8485+\nFigure 3",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 64,
    "unit": "years",
    "population": null,
    "notes": "0\n0.1\n0.2\n0.3\n0.4\n0.5\n0.6\n0.7\n0.8\n0.9\n1\n012345678\nPercent surviving cancer\nYears since diagnosis\nAge at diagnosis15−4950−64\n65−7475−8485+\nFigure 3",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 65,
    "unit": "years",
    "population": null,
    "notes": "0\n0.1\n0.2\n0.3\n0.4\n0.5\n0.6\n0.7\n0.8\n0.9\n1\n012345678\nPercent surviving cancer\nYears since diagnosis\nAge at diagnosis15−4950−64\n65−7475−8485+\nFigure 3",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 7475,
    "unit": "years",
    "population": null,
    "notes": "0\n0.1\n0.2\n0.3\n0.4\n0.5\n0.6\n0.7\n0.8\n0.9\n1\n012345678\nPercent surviving cancer\nYears since diagnosis\nAge at diagnosis15−4950−64\n65−7475−8485+\nFigure 3",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": null,
    "value": 8485,
    "unit": "years",
    "population": null,
    "notes": "0\n0.1\n0.2\n0.3\n0.4\n0.5\n0.6\n0.7\n0.8\n0.9\n1\n012345678\nPercent surviving cancer\nYears since diagnosis\nAge at diagnosis15−4950−64\n65−7475−8485+\nFigure 3",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2005",
    "value": 11,
    "unit": null,
    "population": null,
    "notes": "Relative survival by time since\ndiagnosis for women diagnosed with\ndenovostage IV in the SEER-11 areas\nbetween 2005 and 2012 at different\nage groups",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2005",
    "value": 2005,
    "unit": null,
    "population": null,
    "notes": "Relative survival by time since\ndiagnosis for women diagnosed with\ndenovostage IV in the SEER-11 areas\nbetween 2005 and 2012 at different\nage groups",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2005",
    "value": 2012,
    "unit": null,
    "population": null,
    "notes": "Relative survival by time since\ndiagnosis for women diagnosed with\ndenovostage IV in the SEER-11 areas\nbetween 2005 and 2012 at different\nage groups",
    "pageHint": 5,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1992",
    "value": 0,
    "unit": "%",
    "population": "Metastatic Breast Cancer",
    "notes": "The authors\nacknowledge the members of the Metastatic Breast Cancer Alliance and patients\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n012345678910\nPercent surviving\nYears from diagnosis\nMDACC de novo\n",
    "pageHint": 6,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1992",
    "value": 10,
    "unit": "%",
    "population": "Metastatic Breast Cancer",
    "notes": "The authors\nacknowledge the members of the Metastatic Breast Cancer Alliance and patients\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n012345678910\nPercent surviving\nYears from diagnosis\nMDACC de novo\n",
    "pageHint": 6,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1992",
    "value": 20,
    "unit": "%",
    "population": "Metastatic Breast Cancer",
    "notes": "The authors\nacknowledge the members of the Metastatic Breast Cancer Alliance and patients\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n012345678910\nPercent surviving\nYears from diagnosis\nMDACC de novo\n",
    "pageHint": 6,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1992",
    "value": 30,
    "unit": "%",
    "population": "Metastatic Breast Cancer",
    "notes": "The authors\nacknowledge the members of the Metastatic Breast Cancer Alliance and patients\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n012345678910\nPercent surviving\nYears from diagnosis\nMDACC de novo\n",
    "pageHint": 6,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1992",
    "value": 40,
    "unit": "%",
    "population": "Metastatic Breast Cancer",
    "notes": "The authors\nacknowledge the members of the Metastatic Breast Cancer Alliance and patients\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n012345678910\nPercent surviving\nYears from diagnosis\nMDACC de novo\n",
    "pageHint": 6,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1992",
    "value": 50,
    "unit": "%",
    "population": "Metastatic Breast Cancer",
    "notes": "The authors\nacknowledge the members of the Metastatic Breast Cancer Alliance and patients\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n012345678910\nPercent surviving\nYears from diagnosis\nMDACC de novo\n",
    "pageHint": 6,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1992",
    "value": 60,
    "unit": "%",
    "population": "Metastatic Breast Cancer",
    "notes": "The authors\nacknowledge the members of the Metastatic Breast Cancer Alliance and patients\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n012345678910\nPercent surviving\nYears from diagnosis\nMDACC de novo\n",
    "pageHint": 6,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1992",
    "value": 70,
    "unit": "%",
    "population": "Metastatic Breast Cancer",
    "notes": "The authors\nacknowledge the members of the Metastatic Breast Cancer Alliance and patients\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n012345678910\nPercent surviving\nYears from diagnosis\nMDACC de novo\n",
    "pageHint": 6,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1992",
    "value": 80,
    "unit": "%",
    "population": "Metastatic Breast Cancer",
    "notes": "The authors\nacknowledge the members of the Metastatic Breast Cancer Alliance and patients\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n012345678910\nPercent surviving\nYears from diagnosis\nMDACC de novo\n",
    "pageHint": 6,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1992",
    "value": 90,
    "unit": "%",
    "population": "Metastatic Breast Cancer",
    "notes": "The authors\nacknowledge the members of the Metastatic Breast Cancer Alliance and patients\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n012345678910\nPercent surviving\nYears from diagnosis\nMDACC de novo\n",
    "pageHint": 6,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1992",
    "value": 100,
    "unit": "%",
    "population": "Metastatic Breast Cancer",
    "notes": "The authors\nacknowledge the members of the Metastatic Breast Cancer Alliance and patients\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n012345678910\nPercent surviving\nYears from diagnosis\nMDACC de novo\n",
    "pageHint": 6,
    "needsManualReview": false
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2017",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "prevalence of MBC estimates would vary from 136,000 to\n178,000 in 2017 using a higher relative risk of death (RR¼\n1.5) or a lower relative risk of death (RR¼1.2) for recurrent\nMBC survival compared wi",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": "Metastatic Breast Cancer",
    "notes": "The authors\nacknowledge the members of the Metastatic Breast Cancer Alliance and patients\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n012345678910\nPercent surviving\nYears from diagnosis\nMDACC de novo\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": "Metastatic Breast Cancer",
    "notes": "The authors\nacknowledge the members of the Metastatic Breast Cancer Alliance and patients\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n012345678910\nPercent surviving\nYears from diagnosis\nMDACC de novo\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Relative survival by time since diagnosis\nfor women diagnosed withdenovo\nstage IV in the SEER-11 areas in 1992–\n2007 at ages 15–84 (black) and the\nadjusted survival for recurrence stage IV\nfor ages 15",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Relative survival by time since diagnosis\nfor women diagnosed withdenovo\nstage IV in the SEER-11 areas in 1992–\n2007 at ages 15–84 (black) and the\nadjusted survival for recurrence stage IV\nfor ages 15",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2017",
    "value": 1.5,
    "unit": null,
    "population": null,
    "notes": "prevalence of MBC estimates would vary from 136,000 to\n178,000 in 2017 using a higher relative risk of death (RR¼\n1.5) or a lower relative risk of death (RR¼1.2) for recurrent\nMBC survival compared wi",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2017",
    "value": 1.2,
    "unit": null,
    "population": null,
    "notes": "prevalence of MBC estimates would vary from 136,000 to\n178,000 in 2017 using a higher relative risk of death (RR¼\n1.5) or a lower relative risk of death (RR¼1.2) for recurrent\nMBC survival compared wi",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1992",
    "value": 1.35,
    "unit": "years",
    "population": "Metastatic Breast Cancer",
    "notes": "The authors\nacknowledge the members of the Metastatic Breast Cancer Alliance and patients\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n012345678910\nPercent surviving\nYears from diagnosis\nMDACC de novo\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 1.35,
    "unit": null,
    "population": null,
    "notes": "Relative survival by time since diagnosis\nfor women diagnosed withdenovo\nstage IV in the SEER-11 areas in 1992–\n2007 at ages 15–84 (black) and the\nadjusted survival for recurrence stage IV\nfor ages 15",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2017",
    "value": 136,
    "unit": null,
    "population": null,
    "notes": "prevalence of MBC estimates would vary from 136,000 to\n178,000 in 2017 using a higher relative risk of death (RR¼\n1.5) or a lower relative risk of death (RR¼1.2) for recurrent\nMBC survival compared wi",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2017",
    "value": 0,
    "unit": null,
    "population": null,
    "notes": "prevalence of MBC estimates would vary from 136,000 to\n178,000 in 2017 using a higher relative risk of death (RR¼\n1.5) or a lower relative risk of death (RR¼1.2) for recurrent\nMBC survival compared wi",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2017",
    "value": 178,
    "unit": null,
    "population": null,
    "notes": "prevalence of MBC estimates would vary from 136,000 to\n178,000 in 2017 using a higher relative risk of death (RR¼\n1.5) or a lower relative risk of death (RR¼1.2) for recurrent\nMBC survival compared wi",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2017",
    "value": 0,
    "unit": null,
    "population": null,
    "notes": "prevalence of MBC estimates would vary from 136,000 to\n178,000 in 2017 using a higher relative risk of death (RR¼\n1.5) or a lower relative risk of death (RR¼1.2) for recurrent\nMBC survival compared wi",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "2017",
    "value": 2017,
    "unit": null,
    "population": null,
    "notes": "prevalence of MBC estimates would vary from 136,000 to\n178,000 in 2017 using a higher relative risk of death (RR¼\n1.5) or a lower relative risk of death (RR¼1.2) for recurrent\nMBC survival compared wi",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1992",
    "value": 10,
    "unit": "years",
    "population": "Metastatic Breast Cancer",
    "notes": "The authors\nacknowledge the members of the Metastatic Breast Cancer Alliance and patients\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n012345678910\nPercent surviving\nYears from diagnosis\nMDACC de novo\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1992",
    "value": 20,
    "unit": "years",
    "population": "Metastatic Breast Cancer",
    "notes": "The authors\nacknowledge the members of the Metastatic Breast Cancer Alliance and patients\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n012345678910\nPercent surviving\nYears from diagnosis\nMDACC de novo\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1992",
    "value": 30,
    "unit": "years",
    "population": "Metastatic Breast Cancer",
    "notes": "The authors\nacknowledge the members of the Metastatic Breast Cancer Alliance and patients\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n012345678910\nPercent surviving\nYears from diagnosis\nMDACC de novo\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1992",
    "value": 40,
    "unit": "years",
    "population": "Metastatic Breast Cancer",
    "notes": "The authors\nacknowledge the members of the Metastatic Breast Cancer Alliance and patients\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n012345678910\nPercent surviving\nYears from diagnosis\nMDACC de novo\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1992",
    "value": 50,
    "unit": "years",
    "population": "Metastatic Breast Cancer",
    "notes": "The authors\nacknowledge the members of the Metastatic Breast Cancer Alliance and patients\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n012345678910\nPercent surviving\nYears from diagnosis\nMDACC de novo\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1992",
    "value": 60,
    "unit": "years",
    "population": "Metastatic Breast Cancer",
    "notes": "The authors\nacknowledge the members of the Metastatic Breast Cancer Alliance and patients\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n012345678910\nPercent surviving\nYears from diagnosis\nMDACC de novo\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1992",
    "value": 70,
    "unit": "years",
    "population": "Metastatic Breast Cancer",
    "notes": "The authors\nacknowledge the members of the Metastatic Breast Cancer Alliance and patients\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n012345678910\nPercent surviving\nYears from diagnosis\nMDACC de novo\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1992",
    "value": 80,
    "unit": "years",
    "population": "Metastatic Breast Cancer",
    "notes": "The authors\nacknowledge the members of the Metastatic Breast Cancer Alliance and patients\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n012345678910\nPercent surviving\nYears from diagnosis\nMDACC de novo\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1992",
    "value": 90,
    "unit": "years",
    "population": "Metastatic Breast Cancer",
    "notes": "The authors\nacknowledge the members of the Metastatic Breast Cancer Alliance and patients\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n012345678910\nPercent surviving\nYears from diagnosis\nMDACC de novo\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1992",
    "value": 100,
    "unit": "years",
    "population": "Metastatic Breast Cancer",
    "notes": "The authors\nacknowledge the members of the Metastatic Breast Cancer Alliance and patients\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n012345678910\nPercent surviving\nYears from diagnosis\nMDACC de novo\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1992",
    "value": 12345678910,
    "unit": "years",
    "population": "Metastatic Breast Cancer",
    "notes": "The authors\nacknowledge the members of the Metastatic Breast Cancer Alliance and patients\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n012345678910\nPercent surviving\nYears from diagnosis\nMDACC de novo\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1992",
    "value": 30,
    "unit": "years",
    "population": "Metastatic Breast Cancer",
    "notes": "The authors\nacknowledge the members of the Metastatic Breast Cancer Alliance and patients\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n012345678910\nPercent surviving\nYears from diagnosis\nMDACC de novo\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1992",
    "value": 84,
    "unit": "years",
    "population": "Metastatic Breast Cancer",
    "notes": "The authors\nacknowledge the members of the Metastatic Breast Cancer Alliance and patients\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n012345678910\nPercent surviving\nYears from diagnosis\nMDACC de novo\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1992",
    "value": 1992,
    "unit": "years",
    "population": "Metastatic Breast Cancer",
    "notes": "The authors\nacknowledge the members of the Metastatic Breast Cancer Alliance and patients\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n012345678910\nPercent surviving\nYears from diagnosis\nMDACC de novo\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1992",
    "value": 2007,
    "unit": "years",
    "population": "Metastatic Breast Cancer",
    "notes": "The authors\nacknowledge the members of the Metastatic Breast Cancer Alliance and patients\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n012345678910\nPercent surviving\nYears from diagnosis\nMDACC de novo\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "1992",
    "value": 35,
    "unit": "years",
    "population": "Metastatic Breast Cancer",
    "notes": "The authors\nacknowledge the members of the Metastatic Breast Cancer Alliance and patients\n0%\n10%\n20%\n30%\n40%\n50%\n60%\n70%\n80%\n90%\n100%\n012345678910\nPercent surviving\nYears from diagnosis\nMDACC de novo\n",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 11,
    "unit": null,
    "population": null,
    "notes": "Relative survival by time since diagnosis\nfor women diagnosed withdenovo\nstage IV in the SEER-11 areas in 1992–\n2007 at ages 15–84 (black) and the\nadjusted survival for recurrence stage IV\nfor ages 15",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 1992,
    "unit": null,
    "population": null,
    "notes": "Relative survival by time since diagnosis\nfor women diagnosed withdenovo\nstage IV in the SEER-11 areas in 1992–\n2007 at ages 15–84 (black) and the\nadjusted survival for recurrence stage IV\nfor ages 15",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 2007,
    "unit": null,
    "population": null,
    "notes": "Relative survival by time since diagnosis\nfor women diagnosed withdenovo\nstage IV in the SEER-11 areas in 1992–\n2007 at ages 15–84 (black) and the\nadjusted survival for recurrence stage IV\nfor ages 15",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 15,
    "unit": null,
    "population": null,
    "notes": "Relative survival by time since diagnosis\nfor women diagnosed withdenovo\nstage IV in the SEER-11 areas in 1992–\n2007 at ages 15–84 (black) and the\nadjusted survival for recurrence stage IV\nfor ages 15",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 84,
    "unit": null,
    "population": null,
    "notes": "Relative survival by time since diagnosis\nfor women diagnosed withdenovo\nstage IV in the SEER-11 areas in 1992–\n2007 at ages 15–84 (black) and the\nadjusted survival for recurrence stage IV\nfor ages 15",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 15,
    "unit": null,
    "population": null,
    "notes": "Relative survival by time since diagnosis\nfor women diagnosed withdenovo\nstage IV in the SEER-11 areas in 1992–\n2007 at ages 15–84 (black) and the\nadjusted survival for recurrence stage IV\nfor ages 15",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 84,
    "unit": null,
    "population": null,
    "notes": "Relative survival by time since diagnosis\nfor women diagnosed withdenovo\nstage IV in the SEER-11 areas in 1992–\n2007 at ages 15–84 (black) and the\nadjusted survival for recurrence stage IV\nfor ages 15",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1992",
    "value": 35,
    "unit": null,
    "population": null,
    "notes": "Relative survival by time since diagnosis\nfor women diagnosed withdenovo\nstage IV in the SEER-11 areas in 1992–\n2007 at ages 15–84 (black) and the\nadjusted survival for recurrence stage IV\nfor ages 15",
    "pageHint": 6,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2010",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Projections of the\ncost of cancer care in the United States: 2010–2020",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2010",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Projections of the\ncost of cancer care in the United States: 2010–2020",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1974",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Trends in survival for patients with\nrecurrent breast cancer diagnosed from 1974 through 2000",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1974",
    "value": null,
    "unit": "year",
    "population": null,
    "notes": "Trends in survival for patients with\nrecurrent breast cancer diagnosed from 1974 through 2000",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2010",
    "value": 2010,
    "unit": null,
    "population": null,
    "notes": "Projections of the\ncost of cancer care in the United States: 2010–2020",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": null,
    "timePeriod": "2010",
    "value": 2020,
    "unit": null,
    "population": null,
    "notes": "Projections of the\ncost of cancer care in the United States: 2010–2020",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1974",
    "value": 1974,
    "unit": null,
    "population": null,
    "notes": "Trends in survival for patients with\nrecurrent breast cancer diagnosed from 1974 through 2000",
    "pageHint": 7,
    "needsManualReview": true
  },
  {
    "sourceRefId": "ref-011",
    "filename": "Mariotto_et_al.pdf",
    "metricName": "survival",
    "timePeriod": "1974",
    "value": 2000,
    "unit": null,
    "population": null,
    "notes": "Trends in survival for patients with\nrecurrent breast cancer diagnosed from 1974 through 2000",
    "pageHint": 7,
    "needsManualReview": true
  }
]